data_2rms_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rms _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.914 0.388 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.557 HG21 ' HG ' ' B' ' 142' ' ' LEU . 22.0 t -87.78 -33.4 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.61 -37.87 74.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.4 -36.86 83.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.494 ' HB1' HD11 ' B' ' 142' ' ' LEU . . . -62.72 -44.49 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.376 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.58 -43.69 98.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.094 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -55.68 -39.57 71.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.418 ' O ' HG21 ' A' ' 133' ' ' VAL . 65.4 t80 -65.72 -36.17 82.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.828 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.6 tp -61.04 -45.11 96.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.141 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.75 -39.0 93.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.237 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -59.56 -41.49 90.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.53 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.48 HG22 HD12 ' A' ' 178' ' ' LEU . 59.8 t -67.02 -41.93 87.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.7 -26.43 67.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.412 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.2 -58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.657 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.648 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.37 -58.36 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -55.19 -40.12 70.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.518 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.35 -37.93 86.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.17 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.54 -59.86 4.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' B' ' 134' ' ' GLU . 7.5 mp -59.43 -39.76 84.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.224 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.44 -46.78 80.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 109.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.77 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.379 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.607 ' HE1' ' HG ' ' B' ' 141' ' ' LEU . 70.0 mmm -54.56 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.418 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.08 -37.5 75.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.589 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.81 -38.66 86.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.1 0.476 . . . . 0.0 109.801 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -78.6 -31.75 47.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.811 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.425 ' HG2' HG22 ' B' ' 136' ' ' ILE . 58.4 tptt -68.53 -26.3 65.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.5 t -98.57 -81.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.786 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -177.54 102.16 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -165.01 -66.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -113.86 178.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.527 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.53 -174.82 2.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 64.8 m -57.99 -51.96 77.93 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.727 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.6 Cg_endo -59.09 -28.65 88.41 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.919 1.746 . . . . 0.0 111.725 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.71 -40.01 65.98 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 56.9 t -67.75 -44.38 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.778 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.12 -45.72 97.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.456 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.4 m -66.57 -54.98 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.631 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -54.72 -49.0 71.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.1 t -61.95 -39.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.718 0.294 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.9 t -58.3 -39.45 79.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.334 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -84.12 -18.64 36.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.65 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.1 -21.35 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -111.13 26.63 10.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.913 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 0.5 OUTLIER -57.79 112.43 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.06 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 130.84 -30.31 3.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.589 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -120.97 90.08 46.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.394 0.14 . . . . 0.0 110.751 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.95 -6.48 18.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.579 2.186 . . . . 0.0 112.704 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -70.28 -59.83 2.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -56.62 -42.28 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.95 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.8 tpp -57.56 -42.34 82.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.828 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.42 -18.96 72.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.546 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -75.99 -40.4 53.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.616 0.246 . . . . 0.0 111.332 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -65.43 -20.37 66.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 m -62.28 -36.45 82.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -64.13 -49.65 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.504 HD23 ' HE3' ' B' ' 144' ' ' MET . 60.8 mt -59.57 151.64 60.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.85 122.04 10.62 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.432 2.088 . . . . 0.0 112.099 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--N 1.348 0.521 0 C-N-CA 122.177 1.918 . . . . 0.0 112.384 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.813 0.339 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.14 74.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.561 ' HA ' HD22 ' A' ' 148' ' ' LEU . 1.1 pp20? -69.54 -29.98 67.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.229 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 47.5 ttp -68.78 -36.0 77.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 155' ' ' LYS . 85.8 mt -74.99 -52.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 151' ' ' MET . . . -55.62 -46.06 77.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.975 0.416 . . . . 0.0 110.683 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.672 ' HA ' HD11 ' B' ' 141' ' ' LEU . 4.1 mm? -63.85 -46.26 85.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.89 -49.94 28.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.179 0.514 . . . . 0.0 109.76 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.76 -32.21 83.45 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.964 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' B' ' 138' ' ' LEU . 24.1 mt -61.38 -55.51 30.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.708 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.557 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.1 mm? -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.1 -26.34 29.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.211 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.504 ' HE3' HD23 ' A' ' 186' ' ' LEU . 54.7 ttp -80.95 -38.26 28.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 54.8 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.082 179.681 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.569 HG21 ' HG ' ' B' ' 142' ' ' LEU . 19.9 t -70.99 -24.85 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.611 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -59.67 -43.52 93.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.634 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.92 -31.6 72.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.103 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.97 -53.55 52.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.521 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.14 -40.46 85.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.303 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -56.26 -40.93 74.99 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -65.94 -36.45 83.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.001 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.449 HD12 HD22 ' B' ' 138' ' ' LEU . 28.6 tp -60.9 -44.82 96.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.196 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.78 -39.78 91.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.732 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.82 -47.83 81.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 178' ' ' LEU . 60.7 t -62.22 -47.52 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -70.84 -13.58 62.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.4 tp -81.08 -63.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.347 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.523 HE22 HD22 ' A' ' 178' ' ' LEU . 27.6 mt-30 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.533 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.848 0.356 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -58.84 -54.75 43.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.83 -39.34 77.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.217 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -62.2 -40.66 96.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.006 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.92 -60.0 3.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -60.05 -34.83 73.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.207 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.84 -48.06 83.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.7 mt -55.83 -50.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.335 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.53 ' HE1' HD13 ' B' ' 141' ' ' LEU . 80.7 mmm -52.47 -44.4 65.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.02 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -63.04 -36.33 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.19 -39.77 95.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.598 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -78.58 -33.03 47.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -64.81 -43.42 93.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.264 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.1 m -78.79 -84.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -176.7 96.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -152.63 -79.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -103.23 -178.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 m-20 -113.72 -179.23 3.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.9 m -53.84 -50.83 81.64 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.46 -39.37 91.73 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.015 1.81 . . . . 0.0 112.04 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.33 84.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.378 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 160' ' ' ASP . 93.3 t -68.48 -45.34 82.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.94 -44.26 97.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.587 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.4 m -67.05 -55.87 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.562 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 30.8 ttm180 -56.96 -43.26 81.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.397 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.28 -34.12 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.355 . . . . 0.0 110.881 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.4 t -64.35 -41.4 96.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 1.3 pp0? -84.19 -18.91 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.0 tp -63.45 -38.95 93.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -89.59 30.98 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.6 99.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.28 -33.44 1.34 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.147 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -132.7 88.82 37.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.474 0.178 . . . . 0.0 110.714 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.472 ' HA ' HD13 ' A' ' 179' ' ' ILE . 38.0 Cg_exo -60.75 -7.19 7.0 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.599 2.199 . . . . 0.0 112.653 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.65 -55.94 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.175 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.523 HD22 HE22 ' A' ' 136' ' ' GLN . 3.2 mm? -59.09 -38.36 79.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.402 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 176' ' ' PRO . 62.6 mt -62.28 -45.35 98.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.7 tpp -62.8 -34.79 78.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.507 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.45 64.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -66.39 -40.82 89.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.81 -18.27 64.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.5 m -74.29 -41.07 61.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.94 -41.02 90.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.593 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.53 HD21 ' HE1' ' B' ' 144' ' ' MET . 85.6 mt -59.91 145.91 83.21 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.686 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 31.5 Cg_exo -59.51 116.06 3.03 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.476 2.118 . . . . 0.0 112.078 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo . . . . . 0 C--N 1.348 0.54 0 C-N-CA 122.448 2.099 . . . . 0.0 112.495 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.601 0.239 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.84 -24.61 16.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.512 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.51 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -76.07 -57.47 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 23.3 ptp -60.94 -29.01 69.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -75.48 -51.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -56.08 -49.34 74.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 110.106 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.536 HD12 HD12 ' B' ' 141' ' ' LEU . 4.6 mm? -60.87 -42.43 97.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.823 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.553 ' HA ' HD22 ' B' ' 142' ' ' LEU . . . -50.0 -44.81 51.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.11 72.63 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.52 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.536 HD12 HD12 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -61.95 -56.58 17.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.569 ' HG ' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.0 -15.03 58.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.782 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -82.07 -27.22 33.05 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.53 ' HE1' HD21 ' A' ' 186' ' ' LEU . 54.5 ttp -86.18 -40.42 15.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.69 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 14.7 m . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.787 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.68 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.4 tptp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.739 0.304 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.562 HG21 ' HG ' ' B' ' 142' ' ' LEU . 61.9 t -56.77 -27.69 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.061 0.457 . . . . 0.0 110.573 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.68 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 42.3 tt0 -57.71 -32.74 67.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.519 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.433 ' HA ' ' HG ' ' A' ' 128' ' ' SER . 8.8 m-20 -67.88 -31.88 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.014 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' B' ' 142' ' ' LEU . . . -69.63 -44.05 71.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.12 -44.97 94.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.242 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.433 ' HG ' ' HA ' ' A' ' 125' ' ' ASP . 90.6 p -57.93 -40.39 80.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -63.78 -35.3 80.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.458 HD23 HD22 ' B' ' 138' ' ' LEU . 22.3 tp -61.06 -43.66 98.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.803 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.557 HE21 ' HA ' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -58.95 -40.98 86.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.389 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.431 HG23 HD13 ' A' ' 178' ' ' LEU . 97.8 t -64.04 -52.63 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -63.03 -21.59 66.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -52.41 8.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.272 -179.767 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.927 0.394 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -63.78 -57.38 10.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.44 -41.63 76.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.554 ' HB3' HD22 ' A' ' 171' ' ' LEU . 9.9 t70 -70.06 -28.1 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.066 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.65 -60.1 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.29 -36.51 80.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.6 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -59.47 -45.16 92.41 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.8 mt -56.94 -44.74 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.628 ' HE1' ' HG ' ' B' ' 141' ' ' LEU . 90.5 mmm -55.99 -40.16 72.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.261 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.527 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 2.4 mmmp? -61.28 -43.34 99.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -56.19 -46.45 79.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -70.56 -23.15 62.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.687 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -86.18 -12.6 49.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 80.7 p -117.05 20.98 13.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.838 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 62.08 94.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 65.6 m -150.38 -62.41 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.725 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.14 168.29 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -97.83 -179.55 4.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 27.6 m -54.99 -52.06 74.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.1 Cg_endo -56.3 -30.15 79.44 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.073 1.849 . . . . 0.0 111.786 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.7 58.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.094 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.89 -45.38 80.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.286 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.78 -38.87 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.7 t -62.24 -58.54 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -58.4 -48.39 80.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.198 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.31 -36.4 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.6 t -62.67 -44.14 97.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.408 . . . . 0.0 109.938 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.08 -12.73 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.376 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 146' ' ' ASP . 14.6 tp -84.29 -33.26 24.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -99.86 14.49 30.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -52.61 105.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.46 -39.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.405 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -124.87 95.93 41.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.459 0.171 . . . . 0.0 110.713 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.3 -21.75 72.65 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.677 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.27 -49.06 77.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.192 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.431 HD13 HG23 ' A' ' 133' ' ' VAL . 4.0 mm? -57.31 -45.88 83.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.717 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -67.32 -29.06 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.3 mtt -69.06 -36.0 77.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -88.17 -19.32 53.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.271 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -77.95 -44.03 28.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.62 -19.79 62.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.822 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 23.3 m -66.04 -44.36 84.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -57.68 -47.67 81.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.614 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.509 HD21 ' HE3' ' B' ' 144' ' ' MET . 85.5 mt -57.58 156.73 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.789 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 32.5 Cg_exo -57.73 155.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.39 2.06 . . . . 0.0 112.243 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.0 112.311 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.742 0.306 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -21.34 6.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.668 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -67.58 -69.04 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 24.4 ptm -63.76 -25.83 68.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.985 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.26 -53.58 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.437 ' O ' ' HE1' ' A' ' 151' ' ' MET . . . -56.97 -48.31 78.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.599 HD11 HD11 ' B' ' 141' ' ' LEU . 4.2 mm? -59.4 -46.71 87.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.332 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.57 -44.88 47.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.991 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.66 -36.44 93.15 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.079 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.628 ' HG ' ' HE1' ' A' ' 151' ' ' MET . 54.1 mt -62.66 -56.61 16.16 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.915 0.388 . . . . 0.0 111.118 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.562 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.2 mm? -65.75 -23.81 66.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.145 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -84.38 -27.2 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.047 0.451 . . . . 0.0 110.705 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.509 ' HE3' HD21 ' A' ' 186' ' ' LEU . 44.8 ttp -74.87 -42.03 58.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.984 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' SER . . . . . 0.523 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 77.9 p . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.913 0.387 . . . . 0.0 111.338 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 123' ' ' VAL . 48.7 tptt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.692 0.282 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.575 HG21 ' HG ' ' B' ' 142' ' ' LEU . 25.3 t -68.65 -36.75 75.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.96 -28.87 64.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.073 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -66.54 -44.19 83.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.419 ' HB1' HD23 ' B' ' 142' ' ' LEU . . . -62.04 -34.04 75.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.279 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.31 -43.02 95.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.371 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -57.68 -39.28 76.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.0 -30.58 69.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.781 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.434 HD12 HD21 ' B' ' 138' ' ' LEU . 34.0 tp -65.6 -40.94 93.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.048 0.452 . . . . 0.0 110.001 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.43 -40.34 81.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.235 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -57.63 -46.86 83.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.44 -46.71 94.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.774 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -60.53 -26.62 67.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.681 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.6 tp -76.8 -62.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.507 -179.41 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.922 0.391 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.62 -54.28 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.818 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -59.79 -42.98 94.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.378 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -61.53 -36.19 79.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.339 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -66.18 -59.44 3.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.533 HD22 ' HA ' ' B' ' 134' ' ' GLU . 8.2 mp -60.66 -30.11 69.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.974 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -63.33 -50.22 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -55.63 -51.5 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.48 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 70.8 mmm -53.01 -44.24 67.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.587 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE2' HD11 ' B' ' 136' ' ' ILE . 44.1 tttm -59.61 -38.19 80.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.78 -46.68 86.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.2 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -61.24 -42.76 99.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' B' ' 136' ' ' ILE . 60.6 tptt -70.81 -24.5 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.515 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -97.7 19.05 14.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 61.3 93.13 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.3 t -149.76 -68.57 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.4 pt -111.89 171.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.29 175.48 6.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.571 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 49.5 m -54.31 -51.17 80.19 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.559 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.36 -33.63 96.54 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.085 1.857 . . . . 0.0 111.878 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.94 -36.83 82.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.33 -45.19 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.82 -39.01 83.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.4 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.2 m -67.91 -55.71 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.041 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -55.18 -47.18 75.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.004 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -61.76 -39.75 84.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.686 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.6 t -59.31 -39.26 82.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -84.32 -18.1 37.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.884 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.5 tp -77.97 -29.88 50.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.74 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.24 24.05 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -55.8 108.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.92 -41.97 0.8 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.586 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -125.38 103.46 29.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.422 0.153 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.67 -0.14 8.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.075 . . . . 0.0 112.237 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -59.84 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.042 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.7 mm? -58.3 -38.93 78.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.587 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.32 -44.03 94.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.764 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.43 -39.47 83.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.79 66.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.11 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -74.73 -38.38 62.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 110.771 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -70.38 -19.06 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 51.9 m -69.94 -33.48 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.135 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -61.09 -49.95 75.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.3 mt -53.84 145.62 30.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.8 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.95 141.11 79.12 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.377 2.051 . . . . 0.0 112.209 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.349 0.565 0 C-N-CA 122.42 2.08 . . . . 0.0 112.17 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.797 0.332 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.4 84.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.48 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.533 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -69.28 -28.33 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.812 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -35.7 72.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.496 HD11 ' HE2' ' A' ' 152' ' ' LYS . 73.0 mt -76.28 -50.35 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -56.55 -50.38 72.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.113 0.482 . . . . 0.0 110.197 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.542 HD12 HD11 ' B' ' 141' ' ' LEU . 4.2 mm? -62.25 -41.98 98.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.93 -47.73 43.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.92 -39.82 98.51 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.942 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.542 HD11 HD12 ' B' ' 138' ' ' LEU . 0.3 OUTLIER -56.09 -56.15 24.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.575 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.2 mm? -65.28 -24.78 67.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.478 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -77.27 -26.66 52.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 110.051 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 30.0 mtm -75.64 -38.57 58.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.929 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 73.4 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.835 179.612 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.8 tptt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.662 0.268 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.572 HG23 ' HG ' ' B' ' 142' ' ' LEU . 22.4 t -76.22 -44.6 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.674 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.41 -27.29 64.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.752 0.311 . . . . 0.0 110.458 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -66.52 -41.13 89.26 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.84 79.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.263 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.54 -46.26 86.78 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.464 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -56.78 -37.17 70.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.408 ' O ' HG21 ' A' ' 133' ' ' VAL . 78.8 t80 -69.51 -31.87 70.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.858 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.413 HD22 HD21 ' B' ' 138' ' ' LEU . 44.2 tp -62.46 -52.25 64.27 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.6 -34.9 76.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.646 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -56.91 -45.42 82.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.896 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 129' ' ' TYR . 96.0 t -63.34 -47.28 92.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.517 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.54 -19.71 65.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.11 -39.15 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.425 ' HG3' HD22 ' A' ' 178' ' ' LEU . 30.8 mm-40 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.441 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.75 0.31 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -59.62 -59.05 6.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.984 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -56.51 -45.27 81.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -33.75 75.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.87 -60.02 3.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.3 -34.93 76.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.25 -51.45 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.492 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 159' ' ' ILE . 8.0 mt -55.09 -47.47 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.362 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.614 ' HE1' HD11 ' B' ' 141' ' ' LEU . 79.6 mmm -52.83 -42.62 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.927 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.402 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.55 -35.32 72.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.131 0.491 . . . . 0.0 109.779 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -78.88 -38.83 36.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.568 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.471 ' HG2' HG22 ' B' ' 136' ' ' ILE . 59.0 tptt -65.6 -24.33 67.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.7 t -103.22 8.95 38.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.141 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 62.51 106.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.85 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.2 m -158.21 -53.58 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 150' ' ' ILE . 36.5 pt -113.59 15.37 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.427 ' O ' HG21 ' A' ' 164' ' ' VAL . 6.8 m-20 50.5 -165.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.577 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 88.2 m -76.37 -51.58 2.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.923 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 161' ' ' THR . 9.9 Cg_endo -53.21 -35.0 71.94 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.166 1.911 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.04 87.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 160' ' ' ASP . 57.9 t -70.95 -45.27 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.079 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.11 -44.44 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.223 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.8 p -65.94 -58.84 4.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.437 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.493 ' HA ' HE21 ' A' ' 170' ' ' GLN . 95.3 mtt180 -54.22 -54.38 40.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.481 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.66 -37.57 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.647 0.261 . . . . 0.0 110.975 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -57.65 -47.78 81.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.841 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 167' ' ' ARG . 30.0 pt20 -83.77 -11.73 56.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.5 tp -78.87 -18.74 53.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.192 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -109.58 30.96 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.252 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.51 112.45 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.816 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 141.53 -47.07 0.86 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -117.81 94.97 47.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.421 0.153 . . . . 0.0 110.947 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.35 -4.76 14.4 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.424 2.083 . . . . 0.0 112.382 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.35 -57.02 5.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.425 HD22 ' HG3' ' A' ' 136' ' ' GLN . 3.9 mm? -57.61 -38.19 74.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -68.42 -38.42 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.4 ttm -63.15 -46.0 89.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.762 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.49 -30.97 63.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.318 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -40.06 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.29 -21.82 66.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.2 m -70.05 -33.62 72.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -66.0 -50.31 64.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.574 HD21 ' HE2' ' B' ' 144' ' ' MET . 90.2 mt -51.18 143.84 16.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.43 111.92 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.474 2.116 . . . . 0.0 112.016 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.42 2.08 . . . . 0.0 112.36 -179.806 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.794 0.33 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.81 19.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.63 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -71.12 -57.08 4.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 66.1 mtm -63.51 -23.98 67.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.471 HG22 ' HG2' ' A' ' 155' ' ' LYS . 84.2 mt -75.47 -51.3 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.651 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.418 ' O ' HD11 ' B' ' 141' ' ' LEU . . . -57.34 -50.12 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.055 0.455 . . . . 0.0 110.077 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.54 HD12 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -60.67 -40.82 93.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.58 62.13 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.15 -34.74 90.48 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.63 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.614 HD11 ' HE1' ' A' ' 151' ' ' MET . 0.3 OUTLIER -59.28 -56.09 26.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.989 0.423 . . . . 0.0 110.74 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.572 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.1 mm? -70.16 -21.13 63.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -82.16 -26.59 33.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.574 ' HE2' HD21 ' A' ' 186' ' ' LEU . 49.3 ttp -81.72 -38.63 25.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.678 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 68.0 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.74 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.72 0.295 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.571 HG22 ' HG ' ' B' ' 142' ' ' LEU . 36.0 t -63.42 -46.91 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.301 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 -31.48 64.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.468 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.3 -39.49 92.58 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.03 -38.7 92.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.609 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.25 -43.21 99.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.17 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -58.81 -40.54 84.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.525 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 59.7 t80 -62.85 -36.15 82.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.994 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.67 -46.8 86.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.142 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.59 -35.19 78.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.139 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.528 HE21 ' HA ' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -62.38 -43.06 99.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.245 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.65 -38.42 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.683 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -67.09 -33.5 75.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.721 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -71.21 -51.03 27.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.391 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.559 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.529 0.149 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.15 -59.43 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -58.63 -40.28 82.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.459 ' HB3' HD13 ' A' ' 171' ' ' LEU . 10.2 m-20 -64.85 -34.78 79.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.01 -60.37 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.231 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.45 -40.55 94.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.299 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.46 -47.49 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 109.671 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mt -56.17 -45.93 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.065 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.412 ' HE3' HD12 ' B' ' 141' ' ' LEU . 77.6 mmm -55.23 -40.33 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.25 -36.38 82.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.23 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.75 -42.69 97.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.19 -23.14 41.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.345 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -69.5 -56.27 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.8 m -73.47 -83.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.7 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -175.6 102.37 0.08 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -156.05 -77.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.8 pt -107.24 171.35 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.249 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -101.28 -176.34 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 30.6 m -57.08 -50.54 87.61 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.0 Cg_exo -53.61 -32.89 66.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.037 1.824 . . . . 0.0 112.065 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.73 -35.99 66.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.239 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.13 -45.22 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.9 mp -65.86 -44.7 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.15 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.0 m -61.7 -55.96 24.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.385 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.55 -55.6 32.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.323 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.34 -33.21 30.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -64.33 -49.84 70.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.661 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -78.5 -11.63 59.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 146' ' ' ASP . 3.4 tp -74.82 -45.45 43.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -91.21 27.81 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.987 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.57 104.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.53 -44.18 0.73 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.436 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -117.37 98.37 51.78 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.413 0.149 . . . . 0.0 110.803 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.15 -9.41 26.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.385 2.057 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.46 -56.99 9.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.64 -42.01 82.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.663 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.13 -37.79 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.5 ttm -64.6 -43.65 93.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.721 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.31 -23.37 75.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.525 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 84.6 t80 -75.09 -46.64 33.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 111.037 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.99 -23.14 63.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 79.4 m -66.36 -35.78 81.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -59.41 -43.55 92.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.531 HD22 ' HE1' ' B' ' 144' ' ' MET . 89.3 mt -61.31 150.43 79.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.781 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 24.7 Cg_exo -62.85 124.19 13.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.432 2.088 . . . . 0.0 112.012 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 C--N 1.348 0.538 0 C-N-CA 122.338 2.026 . . . . 0.0 112.414 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.732 0.301 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.78 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.28 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -74.75 -42.05 58.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.16 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtm -66.21 -32.75 74.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.081 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.3 mt -75.19 -53.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.16 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.401 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.64 -48.85 74.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.495 HD11 HD11 ' B' ' 141' ' ' LEU . 4.3 mm? -63.09 -39.89 96.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.45 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.64 -51.97 44.0 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.33 -29.25 74.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.919 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.495 HD11 HD11 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -61.16 -56.65 18.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.798 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.571 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -73.67 -19.71 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.683 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -80.11 -26.67 39.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.278 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.531 ' HE1' HD22 ' A' ' 186' ' ' LEU . 53.4 ttp -84.02 -41.38 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.798 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 46.4 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.204 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.078 0.466 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.531 HG23 ' HG ' ' B' ' 142' ' ' LEU . 61.8 t -95.86 -26.0 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -58.85 -41.56 87.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.547 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.82 -33.06 75.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB2' HD12 ' B' ' 142' ' ' LEU . . . -65.42 -41.95 93.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.324 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.42 -44.4 94.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.055 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -55.95 -41.58 74.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.457 ' O ' HG21 ' A' ' 133' ' ' VAL . 43.5 t80 -64.46 -36.94 85.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.715 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.3 tp -59.96 -45.09 93.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.76 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.29 -37.59 87.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.037 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -60.89 -40.86 94.64 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.473 HG22 HD11 ' A' ' 178' ' ' LEU . 58.2 t -65.21 -52.97 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.623 ' HZ2' ' HB3' ' A' ' 134' ' ' LYS . 6.9 ttpm? -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.2 tt -71.96 -57.75 4.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -179.618 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.48 -52.53 63.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.668 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.01 -38.81 80.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.684 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.527 ' HB3' HD21 ' A' ' 171' ' ' LEU . 8.8 t70 -65.12 -31.79 73.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.485 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.78 -59.65 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.736 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.22 -29.98 71.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.05 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.92 -51.75 66.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 159' ' ' ILE . 10.0 mt -54.54 -48.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.677 ' HE2' HD22 ' B' ' 141' ' ' LEU . 82.4 mmm -53.01 -46.17 68.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.04 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.065 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.05 -37.9 84.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.03 -46.4 84.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.334 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HD3' ' HA2' ' B' ' 140' ' ' GLY . 29.2 mmmt -74.6 -17.94 60.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.678 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.1 t -97.63 11.75 35.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.488 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 62.91 99.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.121 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -161.37 -60.52 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.811 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.447 HD11 HG21 ' A' ' 150' ' ' ILE . 35.5 pt -116.34 153.45 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.157 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.06 -179.89 6.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.586 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 89.6 m -55.18 -50.75 84.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.799 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.9 Cg_endo -55.72 -39.73 89.37 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.184 1.923 . . . . 0.0 112.148 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.14 -40.68 99.45 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.25 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.39 -42.93 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.12 -43.04 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.422 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.9 t -65.32 -55.14 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.619 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.12 -50.22 74.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.88 -43.05 87.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 87.6 p -60.91 -45.2 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.732 0.301 . . . . 0.0 111.018 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -79.82 -11.71 59.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 146' ' ' ASP . 13.9 tp -72.83 -35.0 67.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.653 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -96.52 33.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -52.42 129.8 29.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.007 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.8 -38.1 3.48 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.254 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -112.22 94.85 27.96 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.407 0.146 . . . . 0.0 110.753 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.59 -4.45 15.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.47 2.113 . . . . 0.0 112.657 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -68.08 -49.04 63.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.036 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.473 HD11 HG22 ' A' ' 133' ' ' VAL . 3.2 mm? -66.41 -35.34 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.12 -44.11 91.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.8 ttm -67.61 -37.39 82.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.23 -35.5 77.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -76.79 -34.39 57.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.725 0.298 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -64.65 -22.73 67.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.1 m -71.12 -37.38 72.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.135 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -57.51 -45.9 84.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.2 150.24 32.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.55 113.3 2.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.349 2.033 . . . . 0.0 112.173 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 C--N 1.35 0.632 0 C-N-CA 122.354 2.036 . . . . 0.0 112.258 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 CA--C 1.526 0.049 0 CA-C-O 120.647 0.26 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.88 -25.35 19.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.43 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -71.66 -56.27 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.2 mtm -64.02 -25.74 68.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.629 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 99.7 mt -76.19 -53.23 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.54 -50.57 71.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.309 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 4.6 mm? -58.69 -52.66 64.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.459 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.64 29.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 109.65 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . 0.571 ' HA2' ' HD3' ' A' ' 155' ' ' LYS . . . -67.02 -50.95 42.71 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.876 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.677 HD22 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -69.13 -46.26 68.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.229 0.515 . . . . 0.0 111.198 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.531 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.7 mm? -58.59 -33.5 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.993 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -83.99 -31.58 25.43 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.855 0.359 . . . . 0.0 111.011 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 59.1 ttp -73.19 -23.97 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.049 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.388 -179.548 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.802 0.334 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.554 HG23 ' HG ' ' B' ' 142' ' ' LEU . 40.0 t -89.99 -35.06 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.32 -34.03 70.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.59 -38.32 86.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 0.0 110.058 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.01 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.319 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.421 HD22 HG11 ' A' ' 123' ' ' VAL . 4.4 mm? -63.15 -34.93 78.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.072 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.3 t -62.56 -48.52 79.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.692 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.469 HD11 HD21 ' A' ' 148' ' ' LEU . 28.8 tp -61.01 -50.58 72.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.65 -25.81 68.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.536 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -65.11 -41.56 94.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.913 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.1 t -70.2 -45.92 73.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.852 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -57.02 -44.66 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.36 -36.28 76.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.063 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.852 0.358 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -53.14 34.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.179 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -54.45 -52.81 60.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.413 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -52.41 -42.05 63.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.399 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -60.12 -56.99 14.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' B' ' 134' ' ' GLU . 7.6 mp -63.91 -25.7 68.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -62.95 -49.38 74.98 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.81 -47.78 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.703 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.475 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 76.9 mmm -54.04 -37.06 63.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.774 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -71.8 -32.73 67.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.28 -44.0 89.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.876 0.369 . . . . 0.0 110.02 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.25 -42.86 87.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.936 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.415 ' HD2' HG23 ' B' ' 136' ' ' ILE . 12.1 tmtt? -62.7 -40.14 96.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.167 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 90.5 p -85.85 13.75 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 64.63 102.37 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.195 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -153.1 -64.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.79 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.2 pt -111.9 168.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -90.8 177.08 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.597 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 27.6 m -57.52 -50.94 85.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.893 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.1 Cg_exo -54.83 -33.12 80.13 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.022 1.814 . . . . 0.0 112.194 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.02 -37.54 83.18 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.25 -45.5 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.97 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.299 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -69.6 -58.31 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.652 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.43 -48.05 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.89 -29.26 69.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.204 0.526 . . . . 0.0 109.758 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -84.09 -18.76 35.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.167 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.29 -43.85 22.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -93.81 30.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.19 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -58.29 -28.29 64.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.25 -48.53 68.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.628 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -116.87 93.56 41.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.406 0.146 . . . . 0.0 110.772 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.79 -14.65 28.01 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.61 2.206 . . . . 0.0 112.645 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.18 -55.82 29.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.28 -33.51 65.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.63 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.53 -48.3 78.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.49 -30.73 73.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -71.22 -36.3 71.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 110.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.06 -16.96 62.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.0 m -71.63 -39.82 70.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.177 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -58.23 -49.56 76.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.991 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.459 HD21 ' HE1' ' B' ' 144' ' ' MET . 87.2 mt -53.82 151.78 11.16 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.521 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.73 135.46 52.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.333 2.022 . . . . 0.0 112.081 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 C--N 1.351 0.694 0 C-N-CA 122.445 2.097 . . . . 0.0 112.36 -179.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.65 -27.83 66.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.543 ' HA ' HD22 ' A' ' 148' ' ' LEU . 45.2 mt-10 -77.26 -46.13 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.3 ttm -64.52 -36.41 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.021 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.415 HG23 ' HD2' ' A' ' 155' ' ' LYS . 86.2 mt -74.23 -53.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.13 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.28 -46.71 69.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.112 0.482 . . . . 0.0 110.257 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -67.31 -35.28 79.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.427 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.82 -53.87 51.41 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.77 73.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.525 HD13 HD11 ' B' ' 138' ' ' LEU . 0.8 OUTLIER -64.19 -56.56 13.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.424 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.554 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.6 mm? -70.8 -21.16 62.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.466 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -82.74 -26.5 31.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.459 ' HE1' HD21 ' A' ' 186' ' ' LEU . 58.6 ttp -80.96 -38.99 26.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.013 179.628 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.498 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 17.3 tppt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.778 0.323 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 38.4 t -77.55 -35.35 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.297 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.498 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 35.8 tt0 -56.35 -35.7 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.408 ' OD1' ' HB3' ' A' ' 122' ' ' LYS . 4.4 m-20 -65.3 -39.86 93.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 109.711 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.44 77.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.012 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.59 -51.25 66.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.829 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -55.39 -36.4 66.35 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.548 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 86.4 t80 -67.98 -32.21 72.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.804 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.493 HD13 HD23 ' B' ' 138' ' ' LEU . 38.1 tp -64.74 -43.16 94.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.887 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.19 -40.52 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.292 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -58.55 -45.94 87.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.601 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.65 -41.0 91.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.614 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.02 -27.98 69.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.4 -61.2 1.86 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.739 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.791 0.329 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.21 -57.92 10.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.101 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -55.87 -42.44 75.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.298 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.07 -32.59 73.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -68.8 -59.55 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.2 mp -61.26 -31.12 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.195 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.12 -52.12 57.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.4 mt -54.08 -45.04 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.649 ' HE1' ' HG ' ' B' ' 141' ' ' LEU . 76.2 mmm -55.52 -48.93 73.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.51 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.26 -35.68 67.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.427 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.75 -43.72 92.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.973 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.65 -34.5 78.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HG2' HG21 ' B' ' 136' ' ' ILE . 27.8 tptp -77.22 -27.55 53.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.389 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 18.24 12.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.59 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 62.43 96.92 0.04 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.838 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.2 m -155.59 -46.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.08 178.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -113.37 -173.35 2.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 93.6 m -58.55 -50.01 90.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.658 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.7 Cg_exo -56.58 -32.49 90.32 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.031 1.82 . . . . 0.0 112.037 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.0 -44.19 68.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.55 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.4 t -65.18 -44.36 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.65 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.453 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -61.2 -58.04 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.578 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -53.19 -56.48 16.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.91 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.4 t -57.65 -34.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.644 0.259 . . . . 0.0 111.321 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.2 t -60.34 -50.4 73.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.835 0.35 . . . . 0.0 110.805 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.11 -11.78 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.45 -38.72 65.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.726 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -97.3 23.72 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.808 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -54.49 106.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.63 -32.44 1.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.288 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -129.54 100.84 19.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.413 0.149 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.31 -0.08 9.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.413 2.075 . . . . 0.0 112.548 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.36 -58.75 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 178' ' ' LEU . 3.5 mm? -60.54 -39.18 86.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.86 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.21 -42.87 93.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.87 76.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.548 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 68.2 t80 -81.42 -33.6 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.826 0.346 . . . . 0.0 111.115 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -63.13 -26.42 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.1 m -67.87 -37.91 82.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.138 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -56.86 -50.85 71.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.424 HD22 ' HE1' ' B' ' 144' ' ' MET . 91.0 mt -57.59 156.81 15.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.98 144.81 71.63 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.251 1.967 . . . . 0.0 112.0 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.348 0.522 0 C-N-CA 122.398 2.066 . . . . 0.0 112.496 -179.712 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.709 0.29 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.48 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.471 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.417 ' HA ' HD23 ' A' ' 148' ' ' LEU . 46.2 mt-10 -76.8 -49.99 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 58.4 ttp -63.66 -33.33 75.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.579 HG21 ' HG2' ' A' ' 155' ' ' LYS . 61.5 mt -76.35 -51.75 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.152 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -57.34 -47.78 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.028 0.442 . . . . 0.0 110.446 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.607 HD13 HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.82 -50.07 73.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.524 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.71 -46.66 40.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.055 0.455 . . . . 0.0 109.96 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.93 -32.95 85.88 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.767 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.649 ' HG ' ' HE1' ' A' ' 151' ' ' MET . 55.8 mt -62.42 -55.01 31.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.308 . . . . 0.0 111.028 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.591 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -68.92 -22.37 64.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -86.32 -26.49 24.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.37 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 161' ' ' THR . 15.7 tmm? -88.21 -24.79 23.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.545 179.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.771 0.32 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.582 HG23 ' HG ' ' B' ' 142' ' ' LEU . 26.9 t -83.6 -35.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.95 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.88 -27.44 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.78 -44.41 81.41 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.436 ' HB1' HD22 ' B' ' 142' ' ' LEU . . . -66.56 -29.48 69.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.9 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 mt -63.51 -54.96 28.1 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.936 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -55.88 -37.07 68.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 133' ' ' VAL . 84.3 t80 -64.0 -34.22 77.51 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.667 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.611 HD13 HD22 ' B' ' 138' ' ' LEU . 28.6 tp -65.56 -42.43 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.86 -38.54 88.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.081 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 -52.52 65.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.627 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 129' ' ' TYR . 46.5 t -59.18 -39.2 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -76.86 -17.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tt -75.16 -56.58 4.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.404 ' NE2' HD23 ' A' ' 178' ' ' LEU . 25.0 mt-30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.793 0.33 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.84 -57.43 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -55.8 -32.86 63.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.154 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.63 -52.28 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -56.2 -56.18 24.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' B' ' 134' ' ' GLU . 8.8 mp -58.83 -37.77 77.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.514 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.67 -42.45 88.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 159' ' ' ILE . 13.9 mt -57.18 -49.71 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.027 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.626 ' HE2' HD13 ' B' ' 141' ' ' LEU . 83.5 mmm -52.76 -42.58 65.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.487 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.599 ' HB2' ' HZ3' ' A' ' 152' ' ' LYS . 10.3 mtmp? -64.55 -35.63 81.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.209 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.0 -33.44 75.42 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -79.4 -28.42 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.861 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 152' ' ' LYS . 27.6 mmtt -71.46 -59.48 2.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.64 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.2 m -63.27 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -179.32 104.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -165.39 -69.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.197 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 150' ' ' ILE . 40.7 pt -116.23 158.08 16.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.217 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -100.86 -172.19 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.54 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 84.8 m -52.56 -51.96 68.32 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.265 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.6 Cg_endo -58.56 -38.38 89.96 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.168 1.912 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.61 -42.21 93.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.27 -45.44 96.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.761 0.315 . . . . 0.0 111.26 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.38 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.482 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.1 m -62.01 -54.46 41.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.567 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.32 -35.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 69.0 m -64.82 -39.96 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.55 -13.89 55.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.97 -49.27 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -96.63 25.22 5.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.183 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.42 -26.22 60.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.947 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.0 -32.71 85.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.409 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -125.81 102.41 28.63 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 120.369 0.128 . . . . 0.0 110.988 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.34 -3.37 9.86 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.435 2.09 . . . . 0.0 112.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.86 -53.78 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -61.15 -35.77 78.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -67.29 -47.97 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.8 ttp -57.46 -42.76 83.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.695 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.27 -32.46 62.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.389 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -67.95 -31.63 71.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 110.574 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -67.35 -23.87 65.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 35.0 m -65.57 -40.68 93.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -57.42 -50.85 71.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.34 146.22 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.05 114.26 2.23 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.398 2.065 . . . . 0.0 111.977 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo . . . . . 0 C--N 1.35 0.621 0 C-N-CA 122.461 2.107 . . . . 0.0 112.347 -179.844 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' B' ' 135' ' ' MET . 11.1 pt-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.494 ' HA ' HD22 ' A' ' 148' ' ' LEU . 13.0 pt-20 -76.45 -41.59 46.85 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' MET . . . . . 0.521 ' HG2' ' HA ' ' B' ' 132' ' ' GLU . 22.3 ptp -63.29 -33.31 75.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.0 mt -76.48 -53.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.45 ' O ' HD13 ' B' ' 141' ' ' LEU . . . -53.83 -51.01 64.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.611 HD22 HD13 ' A' ' 130' ' ' LEU . 3.9 mt -61.62 -43.67 98.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.02 -37.16 52.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.69 -37.58 76.77 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.598 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.626 HD13 ' HE2' ' A' ' 151' ' ' MET . 1.5 mp -56.84 -56.03 26.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.046 0.45 . . . . 0.0 110.018 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' A' ' 123' ' ' VAL . 2.9 mm? -68.52 -24.13 64.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.466 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -75.45 -27.5 58.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.194 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.428 ' SD ' HG21 ' A' ' 161' ' ' THR . 12.7 ttm -79.46 -40.42 29.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' SER . . . . . 0.414 ' HG ' ' HA ' ' B' ' 142' ' ' LEU . 80.4 p . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.943 0.402 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.593 HG21 ' HG ' ' B' ' 142' ' ' LEU . 41.8 t -95.11 -27.65 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.77 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -59.58 -35.35 74.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -68.33 -39.03 82.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.923 0.392 . . . . 0.0 110.539 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' B' ' 142' ' ' LEU . . . -63.99 -44.72 91.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.487 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.499 HD22 HG11 ' A' ' 123' ' ' VAL . 4.5 mm? -61.55 -40.79 95.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.174 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -58.96 -42.16 89.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.8 -40.56 93.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.852 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.2 tp -59.47 -41.56 90.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.191 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.47 -43.09 99.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.56 -41.19 85.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.26 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.93 -46.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.866 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.612 ' HZ1' ' HB2' ' A' ' 134' ' ' LYS . 4.3 ttmp? -64.61 -25.55 68.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.749 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -72.73 -59.54 2.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.177 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.419 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.756 0.312 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.503 ' HH ' ' HZ2' ' A' ' 134' ' ' LYS . 76.2 t80 -65.23 -57.66 7.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -56.43 -35.51 67.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.142 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.57 -36.48 73.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.014 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -64.58 -58.36 6.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.971 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.8 mp -60.39 -42.72 96.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.76 -44.86 74.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.117 0.484 . . . . 0.0 109.714 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.06 -47.95 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.235 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.486 ' HE3' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -54.96 -42.41 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.548 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -61.72 -39.64 92.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.262 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.11 -39.74 91.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.066 0.46 . . . . 0.0 109.874 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.81 -21.7 57.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.878 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -86.31 -22.87 26.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.63 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 62.7 m -104.01 16.35 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 61.43 93.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.984 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.8 m -147.6 -61.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.668 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 pt -114.54 155.07 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -83.17 171.75 13.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.114 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 63.5 m -53.67 -51.57 75.14 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.624 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 51.6 Cg_exo -53.03 -32.16 57.08 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.923 1.749 . . . . 0.0 111.896 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.09 62.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.207 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.4 t -66.93 -43.81 89.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.739 0.304 . . . . 0.0 110.813 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -66.1 -43.61 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.171 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.1 p -65.42 -54.06 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.375 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.496 ' HA ' HE21 ' A' ' 170' ' ' GLN . 74.1 mtp180 -55.78 -51.26 68.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.309 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.76 -36.16 69.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 t -59.39 -45.74 90.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.524 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.496 HE21 ' HA ' ' A' ' 167' ' ' ARG . 28.0 pt20 -84.09 -11.58 56.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.6 tp -75.96 -26.34 56.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -109.29 30.48 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.57 118.28 4.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.06 -54.84 0.77 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.198 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -109.03 95.72 18.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.76 0.88 4.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.506 2.137 . . . . 0.0 112.643 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.72 -56.02 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.006 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.52 -37.7 76.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.7 mt -71.07 -37.78 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.74 -38.64 91.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.13 -28.62 40.38 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.649 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -68.99 -40.98 78.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -63.8 -21.27 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 m -66.38 -39.96 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.309 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -60.7 -40.37 91.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.558 HD23 ' HE3' ' B' ' 144' ' ' MET . 79.1 mt -58.26 152.0 44.68 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.614 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.63 111.12 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.313 2.009 . . . . 0.0 112.091 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 C--N 1.35 0.631 0 C-N-CA 122.339 2.026 . . . . 0.0 112.188 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.83 0.348 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.1 -28.74 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.89 -42.87 60.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.6 tpp -65.44 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.41 -52.28 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.414 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -52.47 -47.0 66.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.091 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' B' ' 141' ' ' LEU . 4.2 mm? -64.74 -38.72 91.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.276 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.39 -46.76 62.95 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.31 -31.42 71.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.584 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.486 HD12 ' HE3' ' A' ' 151' ' ' MET . 0.1 OUTLIER -59.02 -54.95 41.29 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 110.399 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.0 mm? -73.51 -21.63 60.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.83 -26.3 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.356 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.558 ' HE3' HD23 ' A' ' 186' ' ' LEU . 53.8 ttp -87.51 -34.75 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.689 179.662 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.86 0.362 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.594 HG23 ' HG ' ' B' ' 142' ' ' LEU . 48.7 t -64.03 -31.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.519 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -56.98 -35.87 69.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.17 -37.83 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.11 86.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.119 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.91 -49.3 73.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -55.06 -36.61 65.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.598 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 64.9 t80 -67.68 -33.55 75.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.83 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.5 tp -62.3 -48.62 79.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.024 0.44 . . . . 0.0 110.041 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.54 -38.54 91.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -57.97 -44.78 87.29 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 110.296 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.416 HG22 HD11 ' A' ' 178' ' ' LEU . 89.2 t -61.88 -48.11 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -68.22 -15.93 63.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.56 -54.87 6.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.45 ' HG3' HD23 ' A' ' 178' ' ' LEU . 15.8 mm100 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.435 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.803 0.335 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.26 -55.28 36.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.048 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -54.94 -42.0 71.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.22 -32.04 73.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.201 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.18 -60.53 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.077 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.416 HD21 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -61.86 -38.75 89.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.004 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.18 -46.14 83.08 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.494 HD11 HD21 ' A' ' 171' ' ' LEU . 3.2 mt -56.99 -45.49 83.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.855 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.643 ' HE3' ' HG ' ' B' ' 141' ' ' LEU . 77.4 mmm -55.03 -40.19 69.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.658 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.35 -37.77 88.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.218 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.06 -39.88 93.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 109.856 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.4 -37.46 63.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.818 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.484 ' HG2' HG23 ' B' ' 136' ' ' ILE . 22.0 tptm -65.93 -27.44 68.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.383 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 92.7 p -102.33 -154.76 0.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.905 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -102.89 87.61 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.812 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.4 t -148.56 -70.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.57 167.21 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.677 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.3 -170.49 1.67 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.555 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 56.8 m -53.58 -52.31 68.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.745 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 161' ' ' THR . 10.1 Cg_endo -53.25 -36.39 77.73 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.033 1.822 . . . . 0.0 111.883 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.05 -38.59 88.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.13 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.42 -45.2 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.23 -49.0 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.43 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -62.66 -59.24 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.717 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -52.82 -54.33 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.605 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.25 -35.34 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.676 0.274 . . . . 0.0 111.235 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.3 t -61.3 -46.51 90.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -83.96 -11.79 56.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.494 HD21 HD11 ' A' ' 150' ' ' ILE . 19.1 tp -77.94 -24.76 48.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -113.0 25.68 11.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.65 103.51 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 144.65 -25.97 1.96 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.557 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -125.47 95.12 41.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.388 0.137 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -7.36 21.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.387 2.058 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.88 -54.26 10.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.45 HD23 ' HG3' ' A' ' 136' ' ' GLN . 3.6 mm? -60.79 -41.92 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.9 mt -63.8 -49.58 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 57.0 ttp -58.89 -35.82 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.6 -20.56 63.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.434 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.598 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 64.3 t80 -77.99 -41.31 36.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.39 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 89.4 m -63.75 -35.9 82.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -65.15 -52.03 57.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.553 HD22 ' HE3' ' B' ' 144' ' ' MET . 77.2 mt -54.78 148.59 26.27 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.57 145.44 58.66 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.428 2.085 . . . . 0.0 112.108 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.348 0.509 0 C-N-CA 122.364 2.043 . . . . 0.0 112.402 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.804 0.335 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.24 94.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.725 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.416 ' HA ' HD21 ' A' ' 148' ' ' LEU . 39.3 mt-10 -70.97 -39.17 72.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.17 -34.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.484 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.6 mt -75.7 -52.81 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.061 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -54.24 -48.52 71.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 110.574 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.606 ' HA ' HD11 ' B' ' 141' ' ' LEU . 3.7 mm? -63.9 -43.79 94.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.258 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.13 -47.28 45.65 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.44 -36.66 92.88 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.891 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.643 ' HG ' ' HE3' ' A' ' 151' ' ' MET . 56.9 mt -59.51 -55.32 36.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.919 0.39 . . . . 0.0 110.901 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.594 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.1 mm? -72.76 -18.76 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.332 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.343 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.553 ' HE3' HD22 ' A' ' 186' ' ' LEU . 44.7 ttp -81.76 -39.35 24.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.354 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' SER . . . . . 0.464 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.6 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.882 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.849 0.357 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.58 HG22 ' HG ' ' B' ' 142' ' ' LEU . 30.2 t -67.02 -28.72 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.63 -39.06 79.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.779 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.51 -36.8 84.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 109.969 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' B' ' 142' ' ' LEU . . . -61.77 -45.22 94.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.174 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.082 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -56.99 -38.59 73.26 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -64.98 -40.67 95.33 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.731 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.4 HD21 HD22 ' B' ' 138' ' ' LEU . 53.2 tp -59.32 -36.06 74.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.909 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.26 -39.84 74.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.01 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -57.87 -39.21 77.27 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.869 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.543 HG21 HD23 ' A' ' 178' ' ' LEU . 47.4 t -72.51 -38.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -68.28 -20.58 64.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.288 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.21 -55.9 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.57 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.168 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 C--O 1.231 0.094 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.49 -56.78 16.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.908 0.385 . . . . 0.0 110.568 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.8 -36.28 76.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB3' HD13 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -68.85 -31.58 70.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -69.65 -59.7 2.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -38.26 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.462 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 15.1 t70 -58.22 -50.12 74.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -53.74 -44.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.196 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.638 ' HE1' ' HG ' ' B' ' 141' ' ' LEU . 75.7 mmm -58.2 -39.66 79.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 55.2 mtmt -67.02 -31.17 71.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.115 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.57 -42.73 86.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.69 -21.82 60.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.818 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.47 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.5 tptp -82.31 -34.61 28.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.9 t -95.2 18.99 11.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 64.04 98.86 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -153.08 -61.92 0.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.567 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.37 172.42 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -100.37 -178.33 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.135 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.57 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 87.5 m -60.22 -50.04 87.88 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.603 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 53.1 Cg_exo -55.51 -32.95 84.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.964 1.776 . . . . 0.0 111.939 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.49 -40.49 59.66 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.235 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.9 -45.27 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 110.927 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.94 -49.87 77.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.308 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.4 p -58.89 -53.2 61.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -54.3 -52.31 61.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.397 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.7 -31.13 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.752 0.311 . . . . 0.0 111.007 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.1 m -64.41 -45.36 87.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.781 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -82.25 -16.5 49.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 146' ' ' ASP . 1.2 tp -76.03 -42.53 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -95.94 15.6 20.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -51.61 120.09 4.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.46 -45.68 0.78 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.36 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -120.45 100.7 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.46 0.172 . . . . 0.0 110.758 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.41 -11.27 13.14 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.489 2.126 . . . . 0.0 112.707 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.5 -64.74 0.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.543 HD23 HG21 ' A' ' 133' ' ' VAL . 4.8 mp -57.7 -27.12 62.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.64 -55.06 24.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.1 ttp -64.2 -40.96 97.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.008 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.15 -30.97 79.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.59 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.04 -35.85 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -63.72 -30.7 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.7 m -55.76 -51.91 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -53.52 -44.48 69.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.524 HD21 ' HE3' ' B' ' 144' ' ' MET . 97.6 mt -58.91 154.09 39.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 19.5 Cg_endo -60.01 146.91 94.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.369 2.046 . . . . 0.0 112.126 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 31.4 Cg_exo . . . . . 0 C--N 1.348 0.52 0 C-N-CA 122.327 2.018 . . . . 0.0 112.105 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.787 0.327 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.99 14.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -72.28 -54.95 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.772 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 51.8 ttm -64.63 -25.89 68.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.47 HG23 ' HG2' ' A' ' 155' ' ' LYS . 93.5 mt -73.55 -53.43 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.402 ' O ' ' HE1' ' A' ' 151' ' ' MET . . . -57.24 -47.77 80.54 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.509 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.634 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.08 -45.69 93.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.543 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.38 49.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.09 -34.36 89.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.867 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.638 ' HG ' ' HE1' ' A' ' 151' ' ' MET . 58.4 mt -61.25 -56.13 24.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.895 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.58 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -69.13 -21.97 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -82.71 -26.25 32.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.556 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.524 ' HE3' HD21 ' A' ' 186' ' ' LEU . 48.2 ttp -80.47 -39.23 28.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.542 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.637 179.516 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 16.4 tppt? . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.893 0.377 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.574 HG12 ' HG ' ' B' ' 142' ' ' LEU . 58.9 t -71.41 -32.04 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 36.8 tt0 -57.67 -39.21 76.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.934 0.397 . . . . 0.0 110.504 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.808 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.4 -41.51 98.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.132 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.73 -44.23 96.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.84 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.5 m -55.74 -40.03 71.95 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -65.63 -34.52 78.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.086 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.425 HD21 HD22 ' B' ' 138' ' ' LEU . 28.2 tp -61.96 -48.58 79.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.241 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.36 -31.46 72.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.17 -43.61 94.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.614 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.19 -47.83 80.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -58.2 -39.14 78.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.333 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.8 -31.98 63.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.779 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 -179.717 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.744 0.307 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.66 -57.93 10.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.448 . . . . 0.0 110.661 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -57.56 -33.47 68.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -62.43 -49.52 75.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.31 -58.14 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.273 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.14 -30.24 70.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.709 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.0 -55.1 36.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.172 0.511 . . . . 0.0 109.709 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mt -54.46 -46.33 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.247 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.683 ' HE2' HD23 ' B' ' 141' ' ' LEU . 69.1 mmm -52.95 -42.91 65.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.681 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -64.66 -39.05 93.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.611 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.75 -40.82 89.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.547 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -77.61 -38.6 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HZ2' HE22 ' B' ' 143' ' ' GLN . 61.0 tptt -62.54 -30.58 71.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.78 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.4 m -89.64 -83.29 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.783 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -178.17 94.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.521 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.1 m -157.37 -73.01 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -103.48 -178.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.319 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -120.23 -175.25 2.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.547 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.0 m -54.58 -51.53 77.74 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.807 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.4 Cg_endo -58.31 -37.03 96.95 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.081 1.854 . . . . 0.0 112.037 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.273 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.39 -45.15 82.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 110.957 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.23 -45.76 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.485 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.6 p -64.68 -55.81 17.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.835 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.561 ' HA ' HE21 ' A' ' 170' ' ' GLN . 99.5 mtt180 -57.66 -53.27 60.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.793 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.66 -41.1 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.787 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 85.2 p -60.77 -44.37 96.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.551 0.215 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' A' ' 167' ' ' ARG . 30.0 pt20 -82.59 -12.02 58.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.0 tp -70.2 -39.18 75.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.566 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -92.83 33.04 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -52.4 112.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 132.01 -46.65 1.05 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.551 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -114.37 95.59 40.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.433 0.158 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.81 3.55 5.41 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.5 2.134 . . . . 0.0 112.376 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -69.83 -60.64 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.29 -35.66 76.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.547 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.17 -49.86 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.784 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.7 ttp -59.29 -38.8 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.68 -25.82 73.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.386 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -77.32 -34.88 55.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.724 0.297 . . . . 0.0 111.06 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -65.54 -16.98 64.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.2 m -70.32 -34.15 72.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.226 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -62.75 -43.62 98.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.559 HD22 ' HE3' ' B' ' 144' ' ' MET . 94.0 mt -58.57 155.72 27.4 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.77 129.09 25.08 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.523 2.149 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.349 0.572 0 C-N-CA 122.391 2.061 . . . . 0.0 112.252 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.436 ' O ' HG13 ' B' ' 136' ' ' ILE . 39.9 mt-10 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.649 0.262 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.87 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.47 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -67.71 -46.68 71.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.0 -28.51 69.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.201 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.483 HG21 ' HG2' ' A' ' 155' ' ' LYS . 96.5 mt -74.91 -53.91 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.449 ' O ' HD23 ' B' ' 141' ' ' LEU . . . -56.71 -49.86 73.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.106 0.479 . . . . 0.0 110.138 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.526 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 4.4 mm? -56.71 -52.54 64.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.243 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.69 -31.66 26.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.67 -51.46 47.07 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.001 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.683 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -68.4 -47.08 68.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.207 0.504 . . . . 0.0 111.338 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.574 ' HG ' HG12 ' A' ' 123' ' ' VAL . 3.6 mm? -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.548 0.213 . . . . 0.0 111.32 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . 0.549 HE22 ' HZ2' ' A' ' 155' ' ' LYS . 9.1 tt0 -86.15 -28.56 23.89 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.66 0.267 . . . . 0.0 111.382 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.559 ' HE3' HD22 ' A' ' 186' ' ' LEU . 55.2 ttp -73.51 -25.78 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.482 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.793 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.694 0.283 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.582 HG21 ' HG ' ' B' ' 142' ' ' LEU . 25.1 t -67.94 -26.28 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.68 -42.31 88.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.035 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -64.96 -33.17 75.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' B' ' 142' ' ' LEU . . . -63.44 -50.12 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.48 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.27 -41.59 89.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.257 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.0 t -55.78 -42.46 75.58 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.37 -35.46 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.01 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.65 -46.0 88.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.746 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.78 -40.3 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.886 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.407 ' HG3' ' NE2' ' A' ' 136' ' ' GLN . 7.6 tp60 -55.34 -42.94 74.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.153 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.63 -47.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.48 -25.08 65.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.654 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.4 tp -75.47 -65.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.295 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' A' ' 132' ' ' GLN . 2.8 mp0 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.388 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.834 0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.66 -55.88 29.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.982 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -56.05 -49.97 72.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.53 -36.57 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.79 -60.63 2.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.827 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.524 HD21 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.365 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -48.78 80.02 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.36 -48.0 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.082 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.442 ' HB2' ' HB3' ' B' ' 137' ' ' ALA . 81.2 mmm -53.24 -44.67 68.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.615 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.682 ' HZ1' ' HB2' ' A' ' 152' ' ' LYS . 3.0 ttmp? -61.59 -37.28 83.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.543 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.11 -41.12 96.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 0.0 109.895 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -70.35 -41.61 72.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.468 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' B' ' 136' ' ' ILE . 28.6 tptp -65.37 -29.21 69.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.3 t -89.09 -85.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.793 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -178.5 101.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.611 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -165.34 -69.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.974 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.94 175.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.337 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.78 -171.95 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.972 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 61.3 m -53.53 -51.99 70.99 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.671 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 161' ' ' THR . 22.3 Cg_endo -61.68 -34.01 84.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.835 1.69 . . . . 0.0 111.686 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.67 93.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.089 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.72 -45.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.84 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.105 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -67.08 -56.6 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -55.59 -49.21 73.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.227 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.7 t -62.9 -34.56 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.564 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.3 t -59.34 -47.65 84.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.487 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.77 -15.68 56.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.5 tp -77.81 -31.01 51.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -118.99 24.55 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.33 -23.3 62.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.144 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -59.55 -32.51 73.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.804 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.32 108.31 10.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.525 0.163 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.33 -15.13 48.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.393 2.062 . . . . 0.0 112.425 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.93 -52.95 63.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.849 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.65 -33.93 70.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.572 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.31 -46.72 94.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.8 tpp -61.59 -48.06 82.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -26.05 72.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.547 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -78.81 -37.41 40.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.643 0.259 . . . . 0.0 111.111 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.62 -30.49 71.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.024 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.9 m -60.85 -39.7 90.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.415 ' O ' ' HB3' ' B' ' 145' ' ' SER . 59.6 m-85 -58.46 -52.0 67.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.492 HD22 ' HE2' ' B' ' 144' ' ' MET . 96.0 mt -54.33 149.05 21.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.658 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 21.8 Cg_endo -60.8 140.56 91.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.357 2.038 . . . . 0.0 111.944 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo . . . . . 0 C--N 1.347 0.498 0 C-N-CA 122.355 2.036 . . . . 0.0 112.281 -179.746 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.705 0.288 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.53 68.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.512 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.524 ' HA ' HD21 ' A' ' 148' ' ' LEU . 0.9 OUTLIER -69.58 -47.9 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.189 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.1 ttm -60.69 -31.53 70.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.532 HG22 ' HG2' ' A' ' 155' ' ' LYS . 77.0 mt -76.57 -53.18 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.347 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 151' ' ' MET . . . -53.88 -47.63 70.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.579 HD12 HD11 ' B' ' 141' ' ' LEU . 4.5 mm? -66.69 -38.33 86.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.06 -53.17 45.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.011 0.434 . . . . 0.0 109.837 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.54 -31.0 79.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.589 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.579 HD11 HD12 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -58.34 -56.07 26.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 179.211 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 126' ' ' ALA . 3.1 mm? -75.7 -17.3 59.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -83.12 -26.17 31.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.736 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.492 ' HE2' HD22 ' A' ' 186' ' ' LEU . 62.5 ttp -91.09 -32.25 15.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 185' ' ' PHE . 57.3 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.397 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.4 tptt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.821 0.343 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.592 HG21 ' HG ' ' B' ' 142' ' ' LEU . 61.2 t -57.57 -40.29 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.677 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.22 -40.72 74.51 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.691 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.76 -37.24 86.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.197 0.522 . . . . 0.0 109.727 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' B' ' 142' ' ' LEU . . . -61.53 -41.81 97.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.987 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.04 -42.24 98.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.976 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m -55.47 -43.39 75.48 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -61.66 -38.13 86.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.1 tp -58.86 -44.59 91.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.992 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.25 -37.05 85.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.932 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.27 -35.61 80.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.399 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 178' ' ' LEU . 85.3 t -67.32 -55.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.857 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.09 -40.05 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.729 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.64 -37.98 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.145 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.496 ' HG2' HD21 ' A' ' 178' ' ' LEU . 5.8 tp-100 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.989 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.784 0.326 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -52.76 -58.51 6.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.142 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -54.96 -42.45 72.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.391 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -62.35 -38.16 88.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.464 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.61 -59.16 4.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.327 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.552 HD22 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -63.29 -34.29 77.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.299 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.12 -52.16 66.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.448 . . . . 0.0 109.836 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.2 mt -55.99 -48.32 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.49 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 71.1 mmm -55.38 -35.0 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.951 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -72.18 -34.18 68.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.28 -45.34 91.92 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -69.14 -33.05 72.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.892 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.3 tptt -74.8 -21.79 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.0 t -107.22 18.46 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.742 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 62.29 99.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.1 m -153.67 -65.29 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.09 165.38 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.96 -179.46 6.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.592 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 81.9 m -61.35 -50.06 85.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.63 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.31 -29.35 83.72 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.021 1.814 . . . . 0.0 111.912 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.8 -39.28 65.7 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.01 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.7 -44.16 79.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 110.996 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.43 -43.75 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.7 -56.01 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -54.5 39.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.23 -36.81 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -59.49 -49.39 77.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.818 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -80.31 -12.15 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.4 tp -76.9 -19.83 56.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -125.62 29.18 6.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.986 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -55.6 -21.54 18.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.52 -53.08 46.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -120.37 98.03 48.73 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.399 0.142 . . . . 0.0 110.996 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.7 -14.98 23.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.467 2.111 . . . . 0.0 112.388 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.49 -54.33 48.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.496 HD21 ' HG2' ' A' ' 136' ' ' GLN . 3.8 mm? -57.21 -41.98 80.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.388 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.42 -35.85 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.812 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -63.8 -53.09 56.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.49 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.12 -22.88 72.82 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.235 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -72.77 -47.27 48.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.342 . . . . 0.0 111.03 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.97 -20.86 65.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.4 m -60.79 -36.09 78.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.811 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -70.9 -49.1 49.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.6 HD21 ' HE1' ' B' ' 144' ' ' MET . 75.8 mt -51.61 147.84 10.58 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.048 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.53 123.93 13.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.313 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.732 0.301 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.94 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.498 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.552 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -71.95 -46.43 57.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtp -65.68 -31.34 72.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.435 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 88.7 mt -74.94 -53.73 15.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.164 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -55.5 -49.52 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.611 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.477 HD13 HD12 ' B' ' 141' ' ' LEU . 4.4 mm? -62.49 -42.94 99.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.666 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.35 59.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.92 80.1 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.582 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.477 HD12 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -60.77 -56.54 19.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.739 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.592 ' HG ' HG21 ' A' ' 123' ' ' VAL . 2.9 mm? -69.4 -22.12 63.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.02 -26.8 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.6 ' HE1' HD21 ' A' ' 186' ' ' LEU . 55.2 ttp -80.84 -40.19 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.888 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.149 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.687 0.279 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.504 HG21 ' HG ' ' B' ' 142' ' ' LEU . 49.1 t -82.05 -44.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.749 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.27 -24.85 45.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.05 -43.56 82.42 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.466 ' HB2' HD23 ' B' ' 142' ' ' LEU . . . -65.33 -35.59 81.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.475 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.86 -42.87 99.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.841 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -60.6 -42.51 96.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -58.79 -39.19 80.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.785 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.413 HD21 HD22 ' B' ' 138' ' ' LEU . 22.8 tp -58.75 -46.91 86.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.0 -37.03 78.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.438 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.517 ' HG3' HE22 ' A' ' 136' ' ' GLN . 5.7 tp-100 -59.6 -51.63 68.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.375 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 178' ' ' LEU . 95.8 t -58.88 -39.88 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.67 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -69.0 -25.81 64.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.787 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.86 -53.57 12.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.517 HE22 ' HG3' ' A' ' 132' ' ' GLN . 2.4 mp0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.847 0.355 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.06 -52.16 66.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.686 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -58.4 -38.48 77.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.802 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.13 -31.56 71.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -66.44 -60.07 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.558 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.17 -30.52 71.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.04 -48.8 80.21 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.2 mt -56.05 -43.54 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.547 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.506 ' HB3' ' HA ' ' B' ' 137' ' ' ALA . 0.0 OUTLIER -53.38 -48.85 68.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.984 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -58.54 -41.6 85.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.084 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.84 -39.74 78.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.847 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.65 -22.97 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.851 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -84.58 -14.13 49.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.3 m -111.53 15.66 21.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 62.95 93.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.8 m -147.15 -49.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.28 171.57 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.939 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.556 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 5.3 t70 -111.2 -177.23 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.765 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 34.1 m -51.02 -50.58 74.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 33.1 Cg_exo -57.75 -37.09 97.84 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.898 1.732 . . . . 0.0 111.953 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.72 -37.91 89.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.506 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 160' ' ' ASP . 61.5 t -67.18 -45.17 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.756 0.313 . . . . 0.0 110.938 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.63 -43.85 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -66.26 -55.41 16.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.499 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -53.62 -53.9 45.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.345 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.9 -35.72 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 111.097 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 t -57.66 -50.34 73.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.449 HE21 ' HB2' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -79.34 -18.39 52.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 tp -68.49 -35.84 78.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.909 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -100.83 30.15 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.31 113.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 134.96 -32.07 2.63 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.463 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -126.07 93.3 43.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.514 0.197 . . . . 0.0 110.863 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.89 -3.46 12.81 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.474 2.116 . . . . 0.0 112.17 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.64 -53.9 19.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 133' ' ' VAL . 3.6 mm? -64.59 -39.1 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.51 -49.47 84.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.743 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 51.9 ttm -61.01 -43.4 98.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.559 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.44 -25.59 72.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.352 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -78.13 -37.43 46.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.86 -20.2 65.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.3 m -70.63 -37.99 73.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.361 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -62.16 -43.0 99.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.415 HD23 ' HE3' ' B' ' 144' ' ' MET . 84.5 mt -58.33 153.73 36.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.27 114.15 2.22 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.519 2.146 . . . . 0.0 112.245 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.348 0.523 0 C-N-CA 122.36 2.04 . . . . 0.0 112.231 179.857 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 CA--C 1.524 -0.036 0 CA-C-O 120.682 0.277 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.66 65.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.423 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -75.82 -47.83 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 92.3 mmm -63.54 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -52.68 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.024 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.26 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.5 mm? -62.99 -39.8 95.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.266 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.32 -47.11 55.91 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.84 -29.2 72.6 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.745 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' B' ' 138' ' ' LEU . 0.2 OUTLIER -62.47 -56.41 18.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.504 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.0 mm? -70.73 -21.55 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.776 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -83.36 -26.78 30.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.902 0.382 . . . . 0.0 110.853 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.462 ' SD ' HG22 ' A' ' 161' ' ' THR . 10.1 tmm? -86.8 -25.37 24.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.151 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.821 179.288 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.461 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 60.9 tptt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.837 0.351 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.592 HG21 ' HG ' ' B' ' 142' ' ' LEU . 42.0 t -70.43 -33.06 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.461 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 37.4 tt0 -55.33 -36.51 66.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.32 -36.97 85.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.72 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' B' ' 142' ' ' LEU . . . -62.64 -43.02 99.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.089 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.06 -45.3 95.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.066 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.1 t -56.13 -38.16 70.44 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -67.52 -34.5 77.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.072 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.5 HD11 HD23 ' B' ' 138' ' ' LEU . 40.7 tp -61.95 -39.86 93.54 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.824 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.54 -38.55 74.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.177 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -57.2 -42.69 81.72 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.28 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.67 -38.92 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.654 ' HZ1' ' HB2' ' A' ' 134' ' ' LYS . 5.0 ttmp? -61.14 -28.5 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.812 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.2 -51.33 7.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.074 -179.707 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.603 0.24 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.23 -55.62 26.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.54 -43.64 84.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.003 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.572 ' HB3' HD22 ' A' ' 171' ' ' LEU . 9.8 t70 -67.45 -25.55 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.844 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -70.21 -59.65 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.2 -35.74 79.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.27 -46.83 88.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 109.843 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.59 -46.89 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.387 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.579 ' HE2' HD11 ' B' ' 141' ' ' LEU . 85.3 mmm -54.19 -48.9 70.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.847 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.3 -34.81 74.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.373 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.55 -38.08 88.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.96 -32.31 65.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.824 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -76.54 -23.14 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.845 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.6 t -98.36 10.36 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.574 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 63.77 95.6 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.043 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -149.65 -51.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.745 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.7 pt -123.46 172.02 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.068 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.92 -175.79 2.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.193 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.9 m -59.38 -51.38 81.82 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.667 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.5 Cg_endo -58.07 -31.42 93.05 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.037 1.825 . . . . 0.0 111.851 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.14 -45.39 62.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.114 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.17 -41.5 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.885 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.4 mt -62.34 -53.63 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.4 m -58.62 -55.67 32.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.766 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -51.74 -54.36 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.95 -35.83 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.428 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 71.0 m -59.4 -47.12 86.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.828 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -84.3 -11.92 55.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.182 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 146' ' ' ASP . 16.1 tp -76.5 -25.1 53.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.25 31.11 5.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.083 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.59 107.49 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.2 -47.0 0.57 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.632 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -124.58 103.57 31.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.01 -0.112 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.91 -9.56 25.28 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.381 2.054 . . . . 0.0 112.252 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -54.38 20.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.05 -44.88 83.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.731 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.68 -41.73 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.2 tpp -62.83 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.61 -30.53 74.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.339 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -72.21 -39.62 68.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.37 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.36 -25.92 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.3 m -63.33 -39.65 95.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -57.54 -51.35 69.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.028 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.494 HD23 ' HE1' ' B' ' 144' ' ' MET . 76.7 mt -53.31 155.1 5.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.093 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.94 117.36 4.72 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.428 2.085 . . . . 0.0 112.337 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 C--N 1.35 0.607 0 C-N-CA 122.407 2.071 . . . . 0.0 112.191 179.922 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.765 0.317 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.3 -23.79 16.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -70.53 -58.1 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 79.7 mtp -63.99 -29.25 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.782 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.83 -53.47 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.293 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.434 ' O ' HD11 ' B' ' 141' ' ' LEU . . . -55.68 -49.34 73.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.542 ' HA ' HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -61.7 -42.21 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.368 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.4 -46.75 56.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.36 -32.56 82.3 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.742 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.579 HD11 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -59.01 -54.02 51.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.592 ' HG ' HG21 ' A' ' 123' ' ' VAL . 2.8 mm? -76.22 -17.95 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.945 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' B' ' 143' ' ' GLN . 1.0 OUTLIER -81.46 -30.63 33.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.41 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.494 ' HE1' HD23 ' A' ' 186' ' ' LEU . 56.7 ttp -83.98 -38.77 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 145' ' ' SER . . . . . 0.407 ' HG ' ' HA ' ' B' ' 142' ' ' LEU . 74.7 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.073 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.821 0.344 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.537 HG21 ' HG ' ' B' ' 142' ' ' LEU . 32.4 t -74.78 -38.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.794 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -57.08 -27.62 61.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.825 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.29 -44.22 79.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.48 -31.75 73.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.575 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.62 -49.68 70.13 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.964 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.2 t -54.54 -39.26 67.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.442 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 77.3 t80 -67.34 -33.41 75.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.094 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.469 HD13 HD22 ' B' ' 138' ' ' LEU . 44.7 tp -61.28 -48.87 79.43 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.943 0.402 . . . . 0.0 110.001 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.8 -32.99 74.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.03 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -57.67 -46.75 83.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.23 -45.93 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -61.22 -22.61 64.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.54 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.1 tp -78.57 -58.62 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.982 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.476 HE21 ' HA ' ' A' ' 136' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.136 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -63.3 -55.55 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -57.17 -37.51 72.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.434 ' HB3' HD12 ' A' ' 171' ' ' LEU . 3.6 m-20 -65.48 -38.5 89.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -64.48 -59.44 4.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.913 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -58.71 -38.9 79.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.827 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.485 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 22.1 t70 -56.18 -47.43 78.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.3 mt -56.0 -48.31 78.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.212 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.505 ' HE1' HD11 ' B' ' 141' ' ' LEU . 82.3 mmm -54.6 -38.43 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.693 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 56.2 mtmt -68.44 -35.78 78.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.47 -42.13 95.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.155 0.502 . . . . 0.0 109.667 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -77.25 -27.5 53.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.208 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.427 ' HG2' HG23 ' B' ' 136' ' ' ILE . 29.4 tptp -73.48 -28.5 61.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.2 m -98.69 -84.44 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -173.04 105.45 0.14 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.704 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.8 t -169.38 -69.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.239 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.2 pt -116.45 168.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.363 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.412 ' O ' HG22 ' A' ' 164' ' ' VAL . 9.2 m-20 -108.95 -172.57 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.552 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.547 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 55.3 m -51.53 -51.0 73.55 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.9 Cg_endo -60.11 -32.7 95.03 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.904 1.736 . . . . 0.0 111.694 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.75 -32.28 70.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 160' ' ' ASP . 57.5 t -73.85 -45.17 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.725 0.298 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.65 -41.78 93.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.9 m -68.31 -54.0 20.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.699 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -58.97 -44.41 91.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.563 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.79 -44.94 99.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 90.6 p -59.73 -36.46 76.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.911 0.386 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -84.15 -17.58 39.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.746 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 146' ' ' ASP . 15.8 tp -75.41 -36.81 60.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.25 28.86 5.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -55.46 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.38 -37.47 1.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.422 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -121.52 99.52 45.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 -1.67 11.45 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.458 2.105 . . . . 0.0 112.301 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.95 -60.27 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.411 ' N ' HD21 ' A' ' 178' ' ' LEU . 3.4 mm? -60.71 -41.86 96.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.95 -39.42 82.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.718 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.4 ttm -62.23 -52.8 62.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.7 69.14 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.305 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.442 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 88.8 t80 -74.62 -37.42 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -67.42 -15.61 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.739 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 27.9 m -74.42 -38.37 63.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -57.43 -41.16 79.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.767 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.496 HD23 ' HE1' ' B' ' 144' ' ' MET . 92.0 mt -59.76 154.92 44.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.77 117.55 5.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.407 2.071 . . . . 0.0 112.356 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--N 1.349 0.604 0 C-N-CA 122.282 1.988 . . . . 0.0 112.248 179.798 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' B' ' 133' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.703 0.287 . . . . 0.0 111.191 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . 0.4 ' N ' ' HG2' ' B' ' 132' ' ' GLU . . . -54.06 -39.21 66.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.159 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.427 ' HA ' HD22 ' A' ' 148' ' ' LEU . 5.4 mm-40 -64.0 -47.85 78.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.67 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 94.3 mmm -62.48 -27.59 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.11 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.427 HG23 ' HG2' ' A' ' 155' ' ' LYS . 81.1 mt -73.2 -53.49 18.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.119 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.02 -48.07 76.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 110.33 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.502 HD11 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -63.51 -37.72 88.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.385 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.26 -49.53 63.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.96 -33.9 88.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.545 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.505 HD11 ' HE1' ' A' ' 151' ' ' MET . 0.2 OUTLIER -59.08 -56.17 25.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.921 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.537 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.1 mm? -73.43 -17.33 61.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.44 -26.78 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.831 0.348 . . . . 0.0 110.891 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.496 ' HE1' HD23 ' A' ' 186' ' ' LEU . 55.0 ttp -86.13 -36.95 19.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.605 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 59.7 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.691 179.628 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.0 tptp . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.717 0.294 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.558 HG23 ' HG ' ' B' ' 142' ' ' LEU . 72.6 t -58.84 -34.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.504 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 38.0 mt-10 -57.68 -23.61 52.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.01 -44.52 72.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.079 0.466 . . . . 0.0 109.819 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' B' ' 142' ' ' LEU . . . -66.5 -37.74 85.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.132 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 123' ' ' VAL . 4.4 mm? -62.12 -43.06 99.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.982 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.9 t -62.72 -38.87 92.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.709 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.96 -50.27 74.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.391 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.583 HD21 HD22 ' B' ' 138' ' ' LEU . 30.4 tp -57.59 -39.87 77.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.22 -39.49 94.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.51 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.98 -45.41 93.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.417 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.09 -41.13 89.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -68.0 -26.77 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.533 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.71 -51.83 15.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.308 -179.663 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 171' ' ' LEU . 2.3 t . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.75 0.31 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.03 -59.28 5.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.15 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -51.31 -51.95 49.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.96 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.13 -42.76 81.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -59.19 -60.68 3.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.838 0.351 . . . . 0.0 111.518 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' B' ' 134' ' ' GLU . 6.7 mp -61.58 -34.26 75.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.89 -44.55 96.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.0 -48.22 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.909 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.521 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -55.72 -47.76 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.377 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -56.8 -35.88 69.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.444 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.32 -39.63 92.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -66.97 -37.03 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.014 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.589 ' HZ2' ' HB3' ' A' ' 155' ' ' LYS . 4.0 mmmp? -75.74 -27.55 58.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -91.76 14.34 15.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.455 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 62.99 93.59 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.315 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.4 m -150.77 -70.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.691 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.0 pt -104.95 166.9 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.103 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -103.67 -170.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.799 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.561 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 32.3 m -57.14 -51.03 84.71 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.8 Cg_endo -58.88 -27.86 85.61 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.018 1.812 . . . . 0.0 111.91 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.3 -42.32 50.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.53 -45.07 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.2 mt -64.19 -46.23 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.421 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.4 t -62.5 -57.71 10.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.583 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.6 -56.35 17.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.489 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 75.3 t -57.3 -35.46 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 t -61.74 -40.64 95.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.968 0.413 . . . . 0.0 110.139 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.8 -22.79 56.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.422 HD13 HG13 ' A' ' 143' ' ' VAL . 2.7 tm? -72.44 -38.26 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -94.0 25.42 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.765 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.594 ' HZ2' ' HB2' ' A' ' 173' ' ' LYS . 4.6 ttmp? -53.08 137.8 32.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.99 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.75 88.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.61 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -139.11 85.33 15.9 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.615 0.245 . . . . 0.0 111.181 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.55 2.09 7.75 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.481 2.121 . . . . 0.0 112.36 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -72.59 -63.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.76 -31.75 71.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.97 -52.06 48.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.3 ttp -61.78 -31.86 72.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.25 -26.65 59.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.174 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -80.9 -31.54 35.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 0.0 111.004 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -62.86 -18.98 63.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.3 m -72.52 -37.04 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.946 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -61.58 -45.54 93.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.579 HD23 ' HB3' ' B' ' 145' ' ' SER . 94.9 mt -58.57 145.75 75.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.77 119.14 6.17 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.351 2.034 . . . . 0.0 112.186 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo . . . . . 0 C--N 1.35 0.641 0 C-N-CA 122.362 2.041 . . . . 0.0 112.215 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.79 0.328 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.88 -21.82 32.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.493 ' HA ' HD22 ' A' ' 148' ' ' LEU . 7.9 mm-40 -70.87 -61.72 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 80.0 mtp -60.53 -26.33 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.26 -50.28 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.443 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.25 -50.02 72.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.583 HD22 HD21 ' A' ' 130' ' ' LEU . 4.6 mm? -61.94 -41.24 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.167 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -46.27 59.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.8 -35.45 90.92 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.644 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.521 HD12 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -58.45 -56.14 25.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.87 0.366 . . . . 0.0 110.756 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.558 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.2 mm? -69.6 -22.82 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -77.53 -27.13 51.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 144' ' ' MET . . . . . 0.515 ' HE3' HD22 ' A' ' 186' ' ' LEU . 57.6 ttp -83.44 -36.26 24.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.578 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 145' ' ' SER . . . . . 0.579 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.5 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.895 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -118.94 -55.08 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.92 -49.25 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.14 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? 65.97 133.08 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.557 HG21 ' HG ' ' B' ' 142' ' ' LEU . 22.0 t -87.78 -33.4 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.61 -37.87 74.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.4 -36.86 83.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.494 ' HB1' HD11 ' B' ' 142' ' ' LEU . . . -62.72 -44.49 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.376 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.58 -43.69 98.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.094 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -55.68 -39.57 71.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.418 ' O ' HG21 ' A' ' 133' ' ' VAL . 65.4 t80 -65.72 -36.17 82.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.828 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.6 tp -61.04 -45.11 96.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.141 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.75 -39.0 93.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.237 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -59.56 -41.49 90.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.53 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.48 HG22 HD12 ' A' ' 178' ' ' LEU . 59.8 t -67.02 -41.93 87.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.7 -26.43 67.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.412 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.2 -58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.657 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -57.1 -54.39 47.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.95 33.36 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.174 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.12 -28.41 68.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.604 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.0 m -89.97 -8.13 52.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -134.25 79.34 55.8 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.74 3.89 2.95 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.792 2.328 . . . . 0.0 112.438 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.12 -56.15 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.8 -34.57 25.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.269 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.37 -58.36 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -55.19 -40.12 70.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.518 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.35 -37.93 86.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.17 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.54 -59.86 4.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' B' ' 134' ' ' GLU . 7.5 mp -59.43 -39.76 84.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.224 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.44 -46.78 80.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 109.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.77 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.379 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.607 ' HE1' ' HG ' ' B' ' 141' ' ' LEU . 70.0 mmm -54.56 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.418 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.08 -37.5 75.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.589 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.81 -38.66 86.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.1 0.476 . . . . 0.0 109.801 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -78.6 -31.75 47.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.811 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.425 ' HG2' HG22 ' B' ' 136' ' ' ILE . 58.4 tptt -68.53 -26.3 65.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.5 t -98.57 -81.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.786 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -177.54 102.16 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -165.01 -66.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -113.86 178.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.527 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.53 -174.82 2.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 64.8 m -57.99 -51.96 77.93 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.727 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.6 Cg_endo -59.09 -28.65 88.41 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.919 1.746 . . . . 0.0 111.725 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.71 -40.01 65.98 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 56.9 t -67.75 -44.38 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.778 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.12 -45.72 97.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.456 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.4 m -66.57 -54.98 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.631 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -54.72 -49.0 71.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.1 t -61.95 -39.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.718 0.294 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.9 t -58.3 -39.45 79.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.334 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.561 ' HA ' HE21 ' A' ' 170' ' ' GLN . 0.1 OUTLIER -84.12 -18.64 36.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.65 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.1 -21.35 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -111.13 26.63 10.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.913 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 0.5 OUTLIER -57.79 112.43 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.06 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 130.84 -30.31 3.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.589 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -120.97 90.08 46.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.394 0.14 . . . . 0.0 110.751 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.95 -6.48 18.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.579 2.186 . . . . 0.0 112.704 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -70.28 -59.83 2.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -56.62 -42.28 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.95 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.8 tpp -57.56 -42.34 82.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.828 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.42 -18.96 72.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.546 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -75.99 -40.4 53.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.616 0.246 . . . . 0.0 111.332 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -65.43 -20.37 66.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 m -62.28 -36.45 82.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -64.13 -49.65 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.504 HD23 ' HE3' ' B' ' 144' ' ' MET . 60.8 mt -59.57 151.64 60.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG3' ' HG2' ' B' ' 148' ' ' GLU . 18.7 Cg_endo -60.85 122.04 10.62 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.432 2.088 . . . . 0.0 112.099 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.52 -169.84 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.177 1.918 . . . . 0.0 112.384 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.459 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.891 0.377 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.3 t -99.36 112.14 24.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.972 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 70.1 p -96.88 125.97 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -108.53 -164.01 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.67 -173.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.981 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 47.0 t -48.46 153.62 0.74 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.195 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.74 -27.11 61.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.841 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.14 74.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.561 ' HA ' HD22 ' A' ' 148' ' ' LEU . 1.1 pp20? -69.54 -29.98 67.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.229 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 47.5 ttp -68.78 -36.0 77.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 155' ' ' LYS . 85.8 mt -74.99 -52.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 151' ' ' MET . . . -55.62 -46.06 77.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.975 0.416 . . . . 0.0 110.683 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.672 ' HA ' HD11 ' B' ' 141' ' ' LEU . 4.1 mm? -63.85 -46.26 85.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.89 -49.94 28.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.179 0.514 . . . . 0.0 109.76 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.76 -32.21 83.45 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.964 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' B' ' 138' ' ' LEU . 24.1 mt -61.38 -55.51 30.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.708 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.557 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.1 mm? -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.1 -26.34 29.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.211 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.504 ' HE3' HD23 ' A' ' 186' ' ' LEU . 54.7 ttp -80.95 -38.26 28.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 54.8 m -64.69 -11.29 34.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.082 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -127.43 -12.32 5.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.84 61.14 4.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.639 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -147.93 12.96 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.659 0.266 . . . . 0.0 111.257 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -142.75 -88.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.288 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.601 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.1 OUTLIER -114.43 -34.73 0.1 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.601 ' HD3' HG23 ' B' ' 150' ' ' THR . 83.1 Cg_exo -49.21 -55.11 4.46 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.825 1.683 . . . . 0.0 112.727 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -121.37 -55.41 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.011 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 31.5 t -65.81 169.34 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.798 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.53 108.58 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -165.99 142.84 5.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 10.8 t 60.09 99.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 53.7 m -86.33 7.92 23.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.537 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 3.1 mm? -76.91 -51.3 2.19 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.649 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 27.9 Cg_endo -61.75 -75.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.134 1.889 . . . . 0.0 112.504 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 45.4 t -163.89 100.82 0.88 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 32.5 m -134.8 -42.3 0.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 45.8 t -90.92 -6.11 54.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 84.5 m -130.6 77.78 75.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.255 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.96 -50.41 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.567 2.178 . . . . 0.0 112.007 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -166.17 65.76 0.96 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.688 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.14 173.11 1.43 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.491 2.128 . . . . 0.0 112.221 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.66 -14.22 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.2 m 58.2 88.2 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.573 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 9.8 p -162.63 142.45 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 48.3 t -151.79 158.37 43.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.771 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -61.43 143.32 56.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.566 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -49.74 105.93 0.57 Allowed Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' B' ' 181' ' ' CYS . 56.3 Cg_endo -93.3 -66.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.839 2.359 . . . . 0.0 112.894 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.44 -157.54 15.38 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.574 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.49 104.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.629 2.219 . . . . 0.0 112.817 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 83.6 p -166.36 21.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.746 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.62 148.24 8.65 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.502 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.69 20.05 4.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.781 0.324 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.42 -75.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.069 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.2 p -165.52 19.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.956 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . 0.514 ' HB2' ' HD3' ' B' ' 173' ' ' PRO . 14.7 p -145.99 108.29 4.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.958 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 47.6 t -179.37 68.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 51.9 -106.39 0.33 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.908 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 74.4 m -154.12 -42.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.953 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -157.13 -22.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.31 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -99.3 163.74 12.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.782 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.26 168.92 16.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -133.89 130.08 37.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.569 HG21 ' HG ' ' B' ' 142' ' ' LEU . 19.9 t -70.99 -24.85 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.611 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -59.67 -43.52 93.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.634 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.92 -31.6 72.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.103 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.97 -53.55 52.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.521 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.14 -40.46 85.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.303 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -56.26 -40.93 74.99 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -65.94 -36.45 83.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.001 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.449 HD12 HD22 ' B' ' 138' ' ' LEU . 28.6 tp -60.9 -44.82 96.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.196 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.78 -39.78 91.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.732 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.82 -47.83 81.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 178' ' ' LEU . 60.7 t -62.22 -47.52 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -70.84 -13.58 62.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.4 tp -81.08 -63.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.347 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.523 HE22 HD22 ' A' ' 178' ' ' LEU . 27.6 mt-30 -50.77 -58.39 6.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.533 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -58.0 -68.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.684 0.278 . . . . 0.0 110.796 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.94 -85.55 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.761 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -63.91 -10.61 21.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.666 0.269 . . . . 0.0 111.153 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -119.1 77.44 16.36 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.66 2.06 8.81 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.67 2.247 . . . . 0.0 112.391 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -62.25 -60.37 3.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.9 t -53.66 -35.47 26.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -58.84 -54.75 43.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.83 -39.34 77.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.217 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -62.2 -40.66 96.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.006 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.92 -60.0 3.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -60.05 -34.83 73.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.207 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.84 -48.06 83.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.7 mt -55.83 -50.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.335 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.53 ' HE1' HD13 ' B' ' 141' ' ' LEU . 80.7 mmm -52.47 -44.4 65.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.02 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -63.04 -36.33 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.19 -39.77 95.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.598 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -78.58 -33.03 47.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -64.81 -43.42 93.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.264 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.1 m -78.79 -84.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -176.7 96.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -152.63 -79.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -103.23 -178.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 m-20 -113.72 -179.23 3.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.9 m -53.84 -50.83 81.64 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.46 -39.37 91.73 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.015 1.81 . . . . 0.0 112.04 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.33 84.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.378 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 160' ' ' ASP . 93.3 t -68.48 -45.34 82.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.94 -44.26 97.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.587 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.4 m -67.05 -55.87 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.562 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 30.8 ttm180 -56.96 -43.26 81.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.397 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.28 -34.12 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.355 . . . . 0.0 110.881 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.4 t -64.35 -41.4 96.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 1.3 pp0? -84.19 -18.91 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.0 tp -63.45 -38.95 93.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -89.59 30.98 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.6 99.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.28 -33.44 1.34 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.147 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -132.7 88.82 37.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.474 0.178 . . . . 0.0 110.714 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.472 ' HA ' HD13 ' A' ' 179' ' ' ILE . 38.0 Cg_exo -60.75 -7.19 7.0 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.599 2.199 . . . . 0.0 112.653 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.65 -55.94 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.175 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.523 HD22 HE22 ' A' ' 136' ' ' GLN . 3.2 mm? -59.09 -38.36 79.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.402 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 176' ' ' PRO . 62.6 mt -62.28 -45.35 98.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.7 tpp -62.8 -34.79 78.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.507 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.45 64.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -66.39 -40.82 89.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.81 -18.27 64.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.5 m -74.29 -41.07 61.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.94 -41.02 90.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.593 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.53 HD21 ' HE1' ' B' ' 144' ' ' MET . 85.6 mt -59.91 145.91 83.21 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.686 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 31.5 Cg_exo -59.51 116.06 3.03 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.476 2.118 . . . . 0.0 112.078 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.93 139.64 75.0 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.448 2.099 . . . . 0.0 112.495 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.333 179.791 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.683 0.278 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 55.2 m 59.24 -173.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 8.6 t -168.79 -26.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.255 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -63.01 -31.89 73.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.004 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.41 ' HB2' ' HG2' ' B' ' 134' ' ' GLU . 2.4 pt? -63.65 134.39 55.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 66.2 m -71.16 -175.59 1.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.56 -39.43 81.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.178 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.84 -24.61 16.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.512 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.51 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -76.07 -57.47 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 23.3 ptp -60.94 -29.01 69.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -75.48 -51.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -56.08 -49.34 74.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 110.106 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.536 HD12 HD12 ' B' ' 141' ' ' LEU . 4.6 mm? -60.87 -42.43 97.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.823 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.553 ' HA ' HD22 ' B' ' 142' ' ' LEU . . . -50.0 -44.81 51.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.11 72.63 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.52 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.536 HD12 HD12 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -61.95 -56.58 17.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.569 ' HG ' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.0 -15.03 58.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.782 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -82.07 -27.22 33.05 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.53 ' HE1' HD21 ' A' ' 186' ' ' LEU . 54.5 ttp -86.18 -40.42 15.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.69 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 14.7 m -89.86 85.34 6.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.787 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -133.65 -70.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.432 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.77 79.45 0.21 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 187' ' ' PRO . 11.7 tp10 -83.67 104.98 14.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.948 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 58.18 20.31 6.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.241 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.2 t -132.78 139.57 35.01 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.018 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.76 95.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.401 2.067 . . . . 0.0 112.352 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -160.76 -61.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -92.25 -83.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.71 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 p -175.55 -23.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.686 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.28 109.17 1.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 48.8 m -152.58 168.65 24.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.719 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.8 p -153.27 -25.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.438 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 7.2 mp -73.96 -50.49 5.37 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.326 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 75.7 Cg_endo -76.21 6.04 4.18 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.172 1.914 . . . . 0.0 112.368 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 52.5 m 64.31 113.95 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.216 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 22.5 m -58.53 147.19 32.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 49.8 m -123.79 170.58 10.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.227 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 73.8 m -138.39 80.55 27.27 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.11 -10.92 6.65 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.835 2.357 . . . . 0.0 112.541 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.553 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 20.9 t70 -92.31 -48.36 0.31 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.865 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 6.7 Cg_exo -74.6 22.66 0.39 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.483 2.122 . . . . 0.0 112.854 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' B' ' 165' ' ' ASP . 48.6 t -72.2 -67.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 111.007 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.9 m -153.11 12.1 0.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.76 -71.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.207 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 47.7 t -131.05 -33.91 1.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.65 99.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.39 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 27.5 t70 57.05 94.97 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.207 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.6 ' HB3' ' H ' ' B' ' 182' ' ' SER . 33.9 Cg_endo -64.59 -27.9 61.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.457 2.105 . . . . 0.0 112.141 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.72 -75.69 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.321 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.0 -169.85 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.66 2.24 . . . . 0.0 112.203 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 60.3 m -94.27 141.15 28.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.15 87.86 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.56 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.53 108.5 3.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.95 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -159.29 -65.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -149.04 173.24 13.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -94.63 139.55 31.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.692 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.6 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 62.2 m -134.91 6.61 3.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.014 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -96.44 84.25 0.82 Allowed Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.562 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 80.9 p -105.03 -2.71 24.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 111.001 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.72 -48.15 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.206 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.842 0.354 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -72.06 -17.18 62.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.753 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.82 103.09 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.965 0.412 . . . . 0.0 110.531 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.68 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.4 tptp -100.11 138.91 36.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.617 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.562 HG21 ' HG ' ' B' ' 142' ' ' LEU . 61.9 t -56.77 -27.69 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.061 0.457 . . . . 0.0 110.573 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.68 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 42.3 tt0 -57.71 -32.74 67.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.519 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.433 ' HA ' ' HG ' ' A' ' 128' ' ' SER . 8.8 m-20 -67.88 -31.88 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.014 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' B' ' 142' ' ' LEU . . . -69.63 -44.05 71.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.12 -44.97 94.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.242 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.433 ' HG ' ' HA ' ' A' ' 125' ' ' ASP . 90.6 p -57.93 -40.39 80.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -63.78 -35.3 80.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.458 HD23 HD22 ' B' ' 138' ' ' LEU . 22.3 tp -61.06 -43.66 98.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.803 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.557 ' HA ' HE21 ' A' ' 132' ' ' GLN . 0.0 OUTLIER -58.95 -40.98 86.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.389 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.431 HG23 HD13 ' A' ' 178' ' ' LEU . 97.8 t -64.04 -52.63 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -63.03 -21.59 66.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -52.41 8.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -54.01 -71.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.272 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -59.5 -72.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.786 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.0 0.15 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.9 p -59.56 -15.23 16.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -115.1 80.78 7.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.98 6.99 4.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.525 2.15 . . . . 0.0 112.4 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -74.42 -32.6 62.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.969 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.88 -41.2 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -63.78 -57.38 10.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.44 -41.63 76.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.554 ' HB3' HD22 ' A' ' 171' ' ' LEU . 9.9 t70 -70.06 -28.1 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.066 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.65 -60.1 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.29 -36.51 80.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.6 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -59.47 -45.16 92.41 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.8 mt -56.94 -44.74 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.628 ' HE1' ' HG ' ' B' ' 141' ' ' LEU . 90.5 mmm -55.99 -40.16 72.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.261 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.527 ' HZ3' ' HB3' ' A' ' 152' ' ' LYS . 2.4 mmmp? -61.28 -43.34 99.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -56.19 -46.45 79.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -70.56 -23.15 62.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.687 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -86.18 -12.6 49.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 80.7 p -117.05 20.98 13.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.838 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 62.08 94.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 65.6 m -150.38 -62.41 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.725 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.14 168.29 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -97.83 -179.55 4.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 27.6 m -54.99 -52.06 74.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.1 Cg_endo -56.3 -30.15 79.44 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.073 1.849 . . . . 0.0 111.786 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.7 58.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.094 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.89 -45.38 80.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.286 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.78 -38.87 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.7 t -62.24 -58.54 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -58.4 -48.39 80.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.198 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.31 -36.4 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.6 t -62.67 -44.14 97.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.408 . . . . 0.0 109.938 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.08 -12.73 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.376 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 146' ' ' ASP . 14.6 tp -84.29 -33.26 24.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -99.86 14.49 30.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -52.61 105.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.46 -39.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.405 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -124.87 95.93 41.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.459 0.171 . . . . 0.0 110.713 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.3 -21.75 72.65 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.677 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.27 -49.06 77.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.192 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.431 HD13 HG23 ' A' ' 133' ' ' VAL . 4.0 mm? -57.31 -45.88 83.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.717 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -67.32 -29.06 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.3 mtt -69.06 -36.0 77.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -88.17 -19.32 53.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.271 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -77.95 -44.03 28.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.62 -19.79 62.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.822 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 23.3 m -66.04 -44.36 84.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -57.68 -47.67 81.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.614 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.509 HD21 ' HE3' ' B' ' 144' ' ' MET . 85.5 mt -57.58 156.73 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.789 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 32.5 Cg_exo -57.73 155.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.39 2.06 . . . . 0.0 112.243 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.69 157.16 48.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.0 112.311 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.431 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 76.4 p . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.3 t -121.73 -36.21 3.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.075 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 72.5 p -77.91 100.04 6.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.188 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -149.89 -60.17 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' B' ' 134' ' ' GLU . 72.1 mt -73.45 167.76 20.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.758 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 39.6 t -63.53 167.0 6.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -65.32 -51.25 61.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -21.34 6.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.668 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.482 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 17.3 mm-40 -67.58 -69.04 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 24.4 ptm -63.76 -25.83 68.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.985 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.26 -53.58 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.437 ' O ' ' HE1' ' A' ' 151' ' ' MET . . . -56.97 -48.31 78.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.599 HD11 HD11 ' B' ' 141' ' ' LEU . 4.2 mm? -59.4 -46.71 87.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.332 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.57 -44.88 47.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.991 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.66 -36.44 93.15 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.079 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.628 ' HG ' ' HE1' ' A' ' 151' ' ' MET . 54.1 mt -62.66 -56.61 16.16 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.915 0.388 . . . . 0.0 111.118 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.562 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.2 mm? -65.75 -23.81 66.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.145 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -84.38 -27.2 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.047 0.451 . . . . 0.0 110.705 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.509 ' HE3' HD21 ' A' ' 186' ' ' LEU . 44.8 ttp -74.87 -42.03 58.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.984 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' SER . . . . . 0.523 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 77.9 p -71.02 -39.9 72.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.913 0.387 . . . . 0.0 111.338 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.495 ' HB2' ' HA ' ' B' ' 153' ' ' CYS . 0.2 OUTLIER -134.15 -80.47 0.46 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.364 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' B' ' 146' ' ' GLN . . . 176.51 -63.81 0.1 OUTLIER Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.613 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 59.11 21.93 9.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -67.43 -41.27 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.664 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.1 OUTLIER -167.4 -40.35 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.664 ' HD3' HG23 ' B' ' 150' ' ' THR . 79.6 Cg_endo -84.31 -104.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.701 1.6 . . . . 0.0 112.29 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -177.11 93.39 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . 0.495 ' HA ' ' HB2' ' B' ' 146' ' ' GLN . 24.3 t 63.77 11.26 5.74 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -98.21 4.34 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 64.39 -81.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.219 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 75.9 p -143.44 139.05 29.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 44.4 t -147.38 -43.13 0.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.773 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 95.3 mt -74.44 -51.09 4.46 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.664 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 43.5 Cg_endo -67.73 -57.28 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.978 1.785 . . . . 0.0 112.416 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 47.7 t -162.92 107.29 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 18.3 m -76.78 -22.11 54.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.852 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 45.1 t -60.26 163.3 5.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 82.7 m 56.68 79.52 0.33 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.99 -60.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.472 2.115 . . . . 0.0 112.225 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -150.25 70.76 9.2 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.662 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.02 155.44 60.78 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.61 2.207 . . . . 0.0 112.271 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.39 6.91 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.056 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 52.6 m 57.65 98.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.064 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.11 79.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.663 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 60.7 m -133.41 -15.23 2.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.724 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -138.67 8.04 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -125.48 90.52 50.51 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.151 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' B' ' 184' ' ' THR . 58.9 Cg_endo -72.42 161.27 44.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.398 2.066 . . . . 0.0 112.163 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.45 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.79 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.96 152.08 24.52 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.531 2.154 . . . . 0.0 112.55 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.7 m 58.19 -178.9 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.365 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -150.7 94.92 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.47 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -93.46 -73.82 0.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 111.01 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -167.94 -37.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -138.53 153.07 48.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.757 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 17.2 p 44.57 27.68 0.26 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.656 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 47.6 t -165.68 108.28 0.79 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 59.99 63.14 5.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.313 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' B' ' 173' ' ' PRO . 60.8 m -109.48 -34.91 6.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 111.282 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -138.47 6.97 2.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.081 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.306 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.662 0.268 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 55.69 30.39 15.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.729 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.05 97.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.645 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 123' ' ' VAL . 48.7 tptt -132.27 166.96 20.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.607 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.575 HG21 ' HG ' ' B' ' 142' ' ' LEU . 25.3 t -68.65 -36.75 75.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.96 -28.87 64.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.073 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -66.54 -44.19 83.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.419 ' HB1' HD23 ' B' ' 142' ' ' LEU . . . -62.04 -34.04 75.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.279 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.31 -43.02 95.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.371 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -57.68 -39.28 76.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.0 -30.58 69.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.781 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.434 HD12 HD21 ' B' ' 138' ' ' LEU . 34.0 tp -65.6 -40.94 93.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.048 0.452 . . . . 0.0 110.001 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.43 -40.34 81.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.235 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -57.63 -46.86 83.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.44 -46.71 94.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.774 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -60.53 -26.62 67.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.681 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.6 tp -76.8 -62.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -51.21 -50.32 59.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.507 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -89.39 41.62 1.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.324 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.07 -20.06 70.57 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.512 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 t -97.34 -10.74 25.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.887 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -130.35 78.94 73.47 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.803 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.66 -13.75 39.83 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.428 2.085 . . . . 0.0 112.227 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -61.84 -52.06 65.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.016 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.65 -38.0 33.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.62 -54.28 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.818 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -59.79 -42.98 94.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.378 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -61.53 -36.19 79.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.339 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -66.18 -59.44 3.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.533 HD22 ' HA ' ' B' ' 134' ' ' GLU . 8.2 mp -60.66 -30.11 69.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.974 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -63.33 -50.22 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -55.63 -51.5 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.48 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 70.8 mmm -53.01 -44.24 67.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.587 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE2' HD11 ' B' ' 136' ' ' ILE . 44.1 tttm -59.61 -38.19 80.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.78 -46.68 86.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.2 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -61.24 -42.76 99.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' B' ' 136' ' ' ILE . 60.6 tptt -70.81 -24.5 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.515 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -97.7 19.05 14.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 61.3 93.13 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.3 t -149.76 -68.57 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.4 pt -111.89 171.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.29 175.48 6.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.571 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 49.5 m -54.31 -51.17 80.19 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.559 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.36 -33.63 96.54 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.085 1.857 . . . . 0.0 111.878 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.94 -36.83 82.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.33 -45.19 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.82 -39.01 83.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.4 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.2 m -67.91 -55.71 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.041 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -55.18 -47.18 75.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.004 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -61.76 -39.75 84.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.686 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.6 t -59.31 -39.26 82.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -84.32 -18.1 37.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.884 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.5 tp -77.97 -29.88 50.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.74 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.24 24.05 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -55.8 108.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.92 -41.97 0.8 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.586 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -125.38 103.46 29.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.422 0.153 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.67 -0.14 8.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.075 . . . . 0.0 112.237 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -59.84 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.042 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.7 mm? -58.3 -38.93 78.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.587 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.32 -44.03 94.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.764 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.43 -39.47 83.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.79 66.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.11 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -74.73 -38.38 62.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 110.771 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -70.38 -19.06 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 51.9 m -69.94 -33.48 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.135 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -61.09 -49.95 75.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.3 mt -53.84 145.62 30.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.8 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.95 141.11 79.12 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.377 2.051 . . . . 0.0 112.209 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.7 145.65 58.9 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.42 2.08 . . . . 0.0 112.17 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.512 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.768 0.318 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 78.6 p -84.43 177.89 7.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 5.7 t -90.4 -38.43 13.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 20.4 t90 58.04 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.8 mt -92.27 176.31 6.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.971 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' B' ' 134' ' ' GLU . 45.7 t -59.71 154.02 18.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.725 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.41 -30.52 60.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.162 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.4 84.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.48 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.533 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -69.28 -28.33 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.812 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -35.7 72.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.496 HD11 ' HE2' ' A' ' 152' ' ' LYS . 73.0 mt -76.28 -50.35 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -56.55 -50.38 72.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.113 0.482 . . . . 0.0 110.197 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.542 HD12 HD11 ' B' ' 141' ' ' LEU . 4.2 mm? -62.25 -41.98 98.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.93 -47.73 43.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.92 -39.82 98.51 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.942 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.542 HD11 HD12 ' B' ' 138' ' ' LEU . 0.3 OUTLIER -56.09 -56.15 24.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.575 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.2 mm? -65.28 -24.78 67.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.478 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -77.27 -26.66 52.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 110.051 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 30.0 mtm -75.64 -38.57 58.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.929 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 73.4 p -118.69 106.33 12.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.835 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.495 ' HG3' ' H ' ' B' ' 147' ' ' GLY . 3.0 pt20 -132.49 -83.83 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.409 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.495 ' H ' ' HG3' ' B' ' 146' ' ' GLN . . . -145.98 -111.9 0.73 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.647 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -108.98 -74.19 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.616 0.246 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' B' ' 149' ' ' GLN . 1.7 mp0 -127.58 -71.35 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 110.772 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.2 t -65.14 145.07 99.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.05 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.2 149.93 11.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.601 2.201 . . . . 0.0 112.564 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.93 47.51 14.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.899 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 77.6 m 58.53 -174.48 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.091 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.73 109.94 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.045 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -152.29 -43.45 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.175 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.0 m 64.38 115.1 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.313 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 49.5 m -142.1 -39.26 0.37 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.656 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 3.6 mm? -71.46 -49.9 11.22 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.309 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 46.2 Cg_endo -68.83 -53.73 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.131 1.888 . . . . 0.0 112.372 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 45.8 t -161.41 112.63 1.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.145 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 5.9 m -87.56 141.64 28.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.612 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 83.9 p -113.24 158.37 20.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.132 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 65.2 m 56.31 87.31 0.14 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.113 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.31 -62.0 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.562 2.174 . . . . 0.0 112.334 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.543 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 20.8 t70 -97.64 -48.79 0.23 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.808 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 52.7 Cg_exo -55.47 131.64 47.41 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.085 1.857 . . . . 0.0 112.426 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.401 HG21 ' O ' ' B' ' 165' ' ' ASP . 40.7 t -134.66 -56.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 65.0 m -153.97 30.91 0.45 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.405 ' HA ' ' H ' ' B' ' 181' ' ' CYS . 47.6 t -68.67 143.91 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.001 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.563 ' H ' ' HA ' ' B' ' 181' ' ' CYS . 32.9 t 58.96 25.69 14.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.18 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -81.85 -55.34 4.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -166.85 64.71 0.79 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.339 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.548 ' HB3' ' H ' ' B' ' 183' ' ' GLY . 8.8 Cg_endo -50.57 -72.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.829 2.353 . . . . 0.0 112.594 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 55.66 -139.77 41.93 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.481 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.35 113.66 3.38 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.445 2.097 . . . . 0.0 112.219 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 95.5 p 51.21 -166.4 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.208 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -170.82 -169.27 33.67 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.458 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -112.43 -68.78 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -154.27 -2.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.756 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.9 p -117.62 -159.17 0.73 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.8 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . 0.563 ' HA ' ' H ' ' B' ' 170' ' ' SER . 76.3 m 61.61 -173.51 0.14 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.7 m -100.06 -12.99 19.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . 0.548 ' H ' ' HB3' ' B' ' 173' ' ' PRO . . . -111.22 117.53 4.57 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.541 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 73.4 p -139.95 1.48 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 111.271 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.86 -69.98 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.015 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.342 179.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.832 0.349 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -105.59 123.06 47.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -80.66 107.43 13.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.489 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -133.98 155.92 49.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.608 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.572 HG23 ' HG ' ' B' ' 142' ' ' LEU . 22.4 t -76.22 -44.6 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.674 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.41 -27.29 64.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.752 0.311 . . . . 0.0 110.458 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -66.52 -41.13 89.26 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.84 79.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.263 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.54 -46.26 86.78 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.464 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -56.78 -37.17 70.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.408 ' O ' HG21 ' A' ' 133' ' ' VAL . 78.8 t80 -69.51 -31.87 70.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.858 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.413 HD22 HD21 ' B' ' 138' ' ' LEU . 44.2 tp -62.46 -52.25 64.27 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.6 -34.9 76.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.646 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -56.91 -45.42 82.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.896 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 129' ' ' TYR . 96.0 t -63.34 -47.28 92.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.517 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 139' ' ' SER . 87.2 tttt -64.54 -19.71 65.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.11 -39.15 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.425 ' HG3' HD22 ' A' ' 178' ' ' LEU . 30.8 mm-40 -70.36 -67.26 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.441 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.436 ' HB3' HE21 ' A' ' 140' ' ' GLN . 96.4 m-85 -56.81 -34.75 68.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.38 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.58 47.49 2.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.611 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.45 ' HA ' ' HG3' ' A' ' 134' ' ' LYS . 46.8 m 60.84 18.18 8.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.472 0.177 . . . . 0.0 111.323 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' A' ' 137' ' ' PHE . 40.5 mt-30 -54.56 109.11 1.37 Allowed Pre-proline 0 CA--C 1.529 0.162 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.755 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.4 2.89 2.94 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.742 2.295 . . . . 0.0 112.555 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -84.2 -52.88 5.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.177 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.8 t -86.76 -35.83 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.232 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -59.62 -59.05 6.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.984 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -56.51 -45.27 81.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -33.75 75.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.87 -60.02 3.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.3 -34.93 76.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.25 -51.45 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.492 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 159' ' ' ILE . 8.0 mt -55.09 -47.47 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.362 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.614 ' HE1' HD11 ' B' ' 141' ' ' LEU . 79.6 mmm -52.83 -42.62 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.927 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.402 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.55 -35.32 72.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.131 0.491 . . . . 0.0 109.779 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -78.88 -38.83 36.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.568 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.471 ' HG2' HG22 ' B' ' 136' ' ' ILE . 59.0 tptt -65.6 -24.33 67.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.7 t -103.22 8.95 38.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.141 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 62.51 106.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.85 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.2 m -158.21 -53.58 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 150' ' ' ILE . 36.5 pt -113.59 15.37 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.427 ' O ' HG21 ' A' ' 164' ' ' VAL . 6.8 m-20 50.5 -165.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.577 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 88.2 m -76.37 -51.58 2.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.923 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 161' ' ' THR . 9.9 Cg_endo -53.21 -35.0 71.94 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.166 1.911 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.04 87.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 160' ' ' ASP . 57.9 t -70.95 -45.27 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.079 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.11 -44.44 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.223 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.8 p -65.94 -58.84 4.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.437 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.493 ' HA ' HE21 ' A' ' 170' ' ' GLN . 95.3 mtt180 -54.22 -54.38 40.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.481 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.66 -37.57 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.647 0.261 . . . . 0.0 110.975 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -57.65 -47.78 81.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.841 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 167' ' ' ARG . 30.0 pt20 -83.77 -11.73 56.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.5 tp -78.87 -18.74 53.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.192 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -109.58 30.96 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.252 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.51 112.45 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.816 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 141.53 -47.07 0.86 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -117.81 94.97 47.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.421 0.153 . . . . 0.0 110.947 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.35 -4.76 14.4 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.424 2.083 . . . . 0.0 112.382 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.35 -57.02 5.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.425 HD22 ' HG3' ' A' ' 136' ' ' GLN . 3.9 mm? -57.61 -38.19 74.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -68.42 -38.42 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.4 ttm -63.15 -46.0 89.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.762 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.49 -30.97 63.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.318 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -40.06 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.29 -21.82 66.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.2 m -70.05 -33.62 72.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -66.0 -50.31 64.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.574 HD21 ' HE2' ' B' ' 144' ' ' MET . 90.2 mt -51.18 143.84 16.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.43 111.92 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.474 2.116 . . . . 0.0 112.016 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.49 150.26 88.1 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.42 2.08 . . . . 0.0 112.36 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.32 -1.267 . . . . 0.0 112.511 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 78.8 p -95.24 -44.72 7.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 68.1 p -116.5 132.0 56.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.043 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -160.87 -53.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 tp -73.14 147.78 44.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.553 ' HB2' ' HG2' ' B' ' 134' ' ' GLU . 66.8 m -64.62 167.01 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.241 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -75.44 -47.88 25.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.278 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.81 19.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.63 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.553 ' HG2' ' HB2' ' B' ' 131' ' ' SER . 19.6 mm-40 -71.12 -57.08 4.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 66.1 mtm -63.51 -23.98 67.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.471 HG22 ' HG2' ' A' ' 155' ' ' LYS . 84.2 mt -75.47 -51.3 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.651 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.418 ' O ' HD11 ' B' ' 141' ' ' LEU . . . -57.34 -50.12 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.055 0.455 . . . . 0.0 110.077 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.54 HD12 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -60.67 -40.82 93.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.58 62.13 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.15 -34.74 90.48 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.63 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.614 HD11 ' HE1' ' A' ' 151' ' ' MET . 0.3 OUTLIER -59.28 -56.09 26.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.989 0.423 . . . . 0.0 110.74 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.572 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.1 mm? -70.16 -21.13 63.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -82.16 -26.59 33.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.574 ' HE2' HD21 ' A' ' 186' ' ' LEU . 49.3 ttp -81.72 -38.63 25.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.678 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 68.0 p -119.72 95.86 4.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.74 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -138.39 -52.25 0.59 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.342 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' B' ' 153' ' ' CYS . . . 59.18 21.69 53.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.758 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.1 3.39 8.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.907 0.384 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.5 ' O ' HG23 ' B' ' 150' ' ' THR . 8.6 tt0 -152.52 131.8 12.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.534 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.5 HG23 ' O ' ' B' ' 149' ' ' GLN . 0.7 OUTLIER 57.3 147.7 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 123.727 0.642 . . . . 0.0 111.63 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' B' ' 155' ' ' ALA . 3.5 Cg_endo -46.91 112.67 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.848 2.365 . . . . 0.0 112.984 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -155.21 -81.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.76 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . 0.522 ' HB3' ' HA3' ' B' ' 147' ' ' GLY . 52.6 t -87.86 -74.21 0.46 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 31.3 m -79.22 -20.37 12.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.206 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' B' ' 151' ' ' PRO . . . 60.22 -171.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.146 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.9 m -68.53 172.35 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' B' ' 161' ' ' THR . 48.0 t -156.35 -5.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.77 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.604 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 89.4 mt -111.37 -53.31 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.51 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.604 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 60.2 Cg_endo -72.81 -62.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.966 1.777 . . . . 0.0 112.527 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.463 ' H ' ' HG2' ' B' ' 159' ' ' PRO . 79.5 p -92.99 -54.62 3.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.992 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.619 HG22 ' H ' ' B' ' 163' ' ' CYS . 7.2 m 66.23 146.33 0.04 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.184 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 47.7 t -93.78 -18.42 22.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.872 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . 0.619 ' H ' HG22 ' B' ' 161' ' ' THR . 12.6 p -158.65 86.92 2.32 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.48 -44.21 3.47 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.295 1.997 . . . . 0.0 111.854 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -160.48 68.64 2.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.561 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.43 ' HG3' ' HB2' ' B' ' 163' ' ' CYS . 53.9 Cg_endo -69.18 171.6 13.55 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.547 2.165 . . . . 0.0 112.345 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 61.8 t -143.36 97.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.316 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 38.4 t 59.33 18.09 6.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.218 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 66.1 t 61.61 94.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.103 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 45.5 t -166.02 -77.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.54 -88.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.255 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -166.34 94.68 0.76 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.028 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.75 -171.95 0.62 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.449 2.099 . . . . 0.0 112.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -83.64 172.64 50.52 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.827 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.57 114.07 3.63 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.74 2.293 . . . . 0.0 112.385 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 33.1 t 60.25 176.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.051 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 99.2 -10.34 61.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 56.85 97.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.894 0.378 . . . . 0.0 111.411 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -161.18 141.65 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.83 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -94.34 113.04 24.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 51.8 t 59.57 -88.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.071 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 43.5 t 59.62 -83.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.272 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 102.45 157.76 25.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 51.3 p -138.1 -49.77 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.352 . . . . 0.0 111.12 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -95.39 5.28 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.042 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.189 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.736 0.303 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -93.85 -18.12 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.15 119.99 23.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -138.96 148.51 43.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.571 HG22 ' HG ' ' B' ' 142' ' ' LEU . 36.0 t -63.42 -46.91 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.301 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 -31.48 64.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.468 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.3 -39.49 92.58 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.03 -38.7 92.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.609 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.25 -43.21 99.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.17 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -58.81 -40.54 84.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.525 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 59.7 t80 -62.85 -36.15 82.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.994 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.67 -46.8 86.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.142 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.59 -35.19 78.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.139 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.528 ' HA ' HE21 ' A' ' 132' ' ' GLN . 0.0 OUTLIER -62.38 -43.06 99.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.245 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.65 -38.42 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.683 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -67.09 -33.5 75.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.721 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -71.21 -51.03 27.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.391 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.61 -67.42 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.559 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -78.51 76.26 5.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.634 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.26 -54.93 2.45 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.37 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.4 m -78.33 7.95 5.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.935 0.398 . . . . 0.0 110.506 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 142' ' ' GLN . 53.1 tp60 -120.55 72.77 21.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.562 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.2 -7.94 21.27 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.561 2.174 . . . . 0.0 112.233 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.438 ' HB2' HE21 ' A' ' 140' ' ' GLN . 80.7 mt-30 -68.9 -59.37 3.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.885 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.22 -37.64 23.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.555 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.15 -59.43 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -58.63 -40.28 82.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.459 ' HB3' HD13 ' A' ' 171' ' ' LEU . 10.2 m-20 -64.85 -34.78 79.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.01 -60.37 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.231 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.45 -40.55 94.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.299 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.46 -47.49 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 109.671 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mt -56.17 -45.93 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.065 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.412 ' HE3' HD12 ' B' ' 141' ' ' LEU . 77.6 mmm -55.23 -40.33 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.25 -36.38 82.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.23 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.75 -42.69 97.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.19 -23.14 41.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.345 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -69.5 -56.27 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.8 m -73.47 -83.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.7 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -175.6 102.37 0.08 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -156.05 -77.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.8 pt -107.24 171.35 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.249 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -101.28 -176.34 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 30.6 m -57.08 -50.54 87.61 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.0 Cg_exo -53.61 -32.89 66.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.037 1.824 . . . . 0.0 112.065 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.73 -35.99 66.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.239 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.13 -45.22 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.9 mp -65.86 -44.7 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.15 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.0 m -61.7 -55.96 24.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.385 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.55 -55.6 32.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.323 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.34 -33.21 30.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -64.33 -49.84 70.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.661 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -78.5 -11.63 59.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 146' ' ' ASP . 3.4 tp -74.82 -45.45 43.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -91.21 27.81 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.987 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.57 104.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.53 -44.18 0.73 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.436 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -117.37 98.37 51.78 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.413 0.149 . . . . 0.0 110.803 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.15 -9.41 26.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.385 2.057 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.46 -56.99 9.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.64 -42.01 82.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.663 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.13 -37.79 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.5 ttm -64.6 -43.65 93.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.721 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.31 -23.37 75.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.525 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 84.6 t80 -75.09 -46.64 33.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 111.037 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.99 -23.14 63.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 79.4 m -66.36 -35.78 81.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -59.41 -43.55 92.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.531 HD22 ' HE1' ' B' ' 144' ' ' MET . 89.3 mt -61.31 150.43 79.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.781 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 24.7 Cg_exo -62.85 124.19 13.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.432 2.088 . . . . 0.0 112.012 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.42 151.65 66.92 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.338 2.026 . . . . 0.0 112.414 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.38 -1.234 . . . . 0.0 112.462 -179.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.731 0.3 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.1 t -102.31 127.66 49.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 61.7 p -106.98 146.12 31.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.309 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -122.52 -24.62 4.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.731 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.99 177.4 4.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -87.73 150.28 23.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.705 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.02 -34.78 75.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.78 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.28 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -74.75 -42.05 58.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.16 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtm -66.21 -32.75 74.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.081 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.3 mt -75.19 -53.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.16 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.401 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.64 -48.85 74.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.495 HD11 HD11 ' B' ' 141' ' ' LEU . 4.3 mm? -63.09 -39.89 96.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.45 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.64 -51.97 44.0 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.33 -29.25 74.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.919 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.495 HD11 HD11 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -61.16 -56.65 18.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.798 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.571 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -73.67 -19.71 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.683 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -80.11 -26.67 39.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.278 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.531 ' HE1' HD22 ' A' ' 186' ' ' LEU . 53.4 ttp -84.02 -41.38 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.798 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 46.4 m -79.46 81.7 5.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.204 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -137.88 -69.08 0.45 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.145 0.498 . . . . 0.0 110.174 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.65 98.96 2.31 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.418 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -108.24 -63.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 0.0 111.06 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.563 ' HG2' ' H ' ' B' ' 150' ' ' THR . 10.0 tt0 -94.54 -179.7 4.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.591 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.616 HG22 ' HD3' ' B' ' 151' ' ' PRO . 0.1 OUTLIER -62.31 -43.31 84.85 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.616 ' HD3' HG22 ' B' ' 150' ' ' THR . 41.7 Cg_endo -66.15 -68.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.729 1.619 . . . . 0.0 112.223 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . 0.453 ' H ' ' HG2' ' B' ' 151' ' ' PRO . 3.7 p-10 -155.39 -173.73 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.505 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -66.24 86.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.82 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 p -172.08 145.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.18 135.89 40.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.123 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 51.0 m -137.85 162.94 32.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.8 p -130.59 13.21 5.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.644 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 4.3 pp -97.71 -28.32 0.25 Allowed Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 37.1 Cg_endo -66.54 -67.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.378 1.385 . . . . 0.0 112.628 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 55.2 m -147.24 -14.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.167 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 13.0 m -76.4 142.64 41.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 78.1 p -131.52 4.45 4.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.01 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 77.2 m 58.76 78.19 0.36 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.02 -42.12 6.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.435 2.09 . . . . 0.0 111.79 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -168.37 72.13 0.84 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.747 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.74 30.59 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.725 2.283 . . . . 0.0 112.719 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 41.8 t -93.15 -65.52 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.988 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t -122.07 -34.28 3.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 39.2 t 65.35 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.334 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 76.0 p -79.86 176.4 9.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.806 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.48 -44.04 12.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -151.66 136.59 10.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.773 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.98 -54.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.267 1.978 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.75 178.28 35.01 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.491 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.52 -52.51 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.549 2.166 . . . . 0.0 112.439 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 79.5 p -113.45 121.86 45.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.994 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 173.89 -153.06 16.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.541 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -82.99 156.65 23.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 111.04 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -80.8 81.26 7.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.808 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 48.2 t -169.49 160.88 9.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 85.9 m -100.82 117.41 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 46.4 t -137.43 -77.84 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 61.18 49.64 75.82 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.46 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 5.3 t -99.24 -29.06 13.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.695 0.283 . . . . 0.0 111.379 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -118.77 -47.79 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.086 -0.959 . . . . 0.0 111.25 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.66 0.267 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 63.37 14.15 7.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.87 -73.07 0.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.471 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 63.41 150.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.57 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.531 HG23 ' HG ' ' B' ' 142' ' ' LEU . 61.8 t -95.86 -26.0 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -58.85 -41.56 87.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.547 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.82 -33.06 75.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB2' HD12 ' B' ' 142' ' ' LEU . . . -65.42 -41.95 93.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.324 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.42 -44.4 94.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.055 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -55.95 -41.58 74.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.457 ' O ' HG21 ' A' ' 133' ' ' VAL . 43.5 t80 -64.46 -36.94 85.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.715 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.3 tp -59.96 -45.09 93.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.76 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.29 -37.59 87.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.037 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -60.89 -40.86 94.64 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.473 HG22 HD11 ' A' ' 178' ' ' LEU . 58.2 t -65.21 -52.97 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.623 ' HZ2' ' HB3' ' A' ' 134' ' ' LYS . 6.9 ttpm? -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.2 tt -71.96 -57.75 4.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -51.94 -60.82 2.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 140' ' ' GLN . 76.0 m-85 -61.23 -67.22 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.63 -85.77 0.06 OUTLIER Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.64 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.6 t -65.38 -7.19 12.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.848 0.356 . . . . 0.0 110.977 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 137' ' ' PHE . 44.7 mt-30 -117.42 75.63 9.03 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.71 -2.5 11.45 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.65 2.234 . . . . 0.0 112.554 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -68.06 -29.14 68.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.978 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.48 -49.8 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.48 -52.53 63.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.668 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.01 -38.81 80.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.684 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.527 ' HB3' HD21 ' A' ' 171' ' ' LEU . 8.8 t70 -65.12 -31.79 73.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.485 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.78 -59.65 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.736 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.22 -29.98 71.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.05 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.92 -51.75 66.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 159' ' ' ILE . 10.0 mt -54.54 -48.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.677 ' HE2' HD22 ' B' ' 141' ' ' LEU . 82.4 mmm -53.01 -46.17 68.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.04 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.065 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.05 -37.9 84.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.03 -46.4 84.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.334 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HD3' ' HA2' ' B' ' 140' ' ' GLY . 29.2 mmmt -74.6 -17.94 60.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.678 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.1 t -97.63 11.75 35.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.488 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 62.91 99.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.121 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -161.37 -60.52 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.811 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.447 HD11 HG21 ' A' ' 150' ' ' ILE . 35.5 pt -116.34 153.45 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.157 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.06 -179.89 6.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.586 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 89.6 m -55.18 -50.75 84.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.799 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.9 Cg_endo -55.72 -39.73 89.37 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.184 1.923 . . . . 0.0 112.148 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.14 -40.68 99.45 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.25 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.39 -42.93 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.12 -43.04 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.422 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.9 t -65.32 -55.14 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.619 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.12 -50.22 74.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.88 -43.05 87.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 87.6 p -60.91 -45.2 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.732 0.301 . . . . 0.0 111.018 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -79.82 -11.71 59.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 146' ' ' ASP . 13.9 tp -72.83 -35.0 67.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.653 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -96.52 33.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -52.42 129.8 29.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.007 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.8 -38.1 3.48 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.254 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -112.22 94.85 27.96 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.407 0.146 . . . . 0.0 110.753 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.59 -4.45 15.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.47 2.113 . . . . 0.0 112.657 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -68.08 -49.04 63.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.036 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.473 HD11 HG22 ' A' ' 133' ' ' VAL . 3.2 mm? -66.41 -35.34 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.12 -44.11 91.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.8 ttm -67.61 -37.39 82.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.23 -35.5 77.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -76.79 -34.39 57.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.725 0.298 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -64.65 -22.73 67.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.1 m -71.12 -37.38 72.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.135 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -57.51 -45.9 84.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.2 150.24 32.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.55 113.3 2.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.349 2.033 . . . . 0.0 112.173 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.37 155.05 59.71 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.354 2.036 . . . . 0.0 112.258 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.514 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.765 0.317 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 59.6 m -141.15 141.43 34.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 28.2 m -135.18 133.47 39.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.777 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -131.89 -31.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 mp -99.88 147.6 25.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.122 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 43.8 t -79.48 175.63 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.862 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.8 -53.78 35.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.88 -25.35 19.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.43 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.457 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 15.7 mm-40 -71.66 -56.27 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.2 mtm -64.02 -25.74 68.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.629 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 99.7 mt -76.19 -53.23 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.54 -50.57 71.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.309 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 4.6 mm? -58.69 -52.66 64.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.459 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.64 29.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 109.65 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . 0.571 ' HA2' ' HD3' ' A' ' 155' ' ' LYS . . . -67.02 -50.95 42.71 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.876 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.677 HD22 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -69.13 -46.26 68.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.229 0.515 . . . . 0.0 111.198 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.531 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.7 mm? -58.59 -33.5 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.993 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -83.99 -31.58 25.43 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.855 0.359 . . . . 0.0 111.011 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 59.1 ttp -73.19 -23.97 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.049 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 64.0 m -86.52 -0.5 56.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.388 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' B' ' 146' ' ' GLN . 0.0 OUTLIER -128.0 -8.45 5.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.753 0.311 . . . . 0.0 110.981 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.57 115.24 1.09 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.523 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.78 -37.1 86.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.336 . . . . 0.0 110.95 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -141.84 -48.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.554 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 2.7 t -89.65 149.63 42.61 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.711 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.9 -28.54 2.13 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.582 2.188 . . . . 0.0 112.581 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -132.62 107.96 8.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.484 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 53.0 t -49.85 99.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.353 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.65 15.19 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 63.84 100.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.833 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 52.7 m -63.99 153.42 37.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.317 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' SER . . . . . 0.555 ' HA ' ' HB ' ' B' ' 161' ' ' THR . 62.2 p -166.95 0.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.817 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.763 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 3.2 mm? -114.21 -52.36 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.308 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.763 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 3.4 Cg_exo -39.14 -74.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.913 2.409 . . . . 0.0 113.433 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 56.9 m -141.41 -1.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.675 0.274 . . . . 0.0 111.489 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' B' ' 157' ' ' SER . 28.3 m -59.48 -27.67 66.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.932 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 48.7 m -117.18 -168.7 1.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.578 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' B' ' 166' ' ' PRO . 77.3 m -56.32 110.24 2.21 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.816 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.71 -53.64 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.313 2.008 . . . . 0.0 112.474 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.544 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 19.6 t70 -92.73 -48.56 0.3 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.599 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 51.7 Cg_exo -53.86 123.3 13.1 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.028 1.818 . . . . 0.0 112.336 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.18 141.97 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.121 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.1 m -68.97 99.41 1.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 64.4 t -131.14 109.33 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.033 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.429 ' HG ' ' H ' ' B' ' 171' ' ' GLU . 71.4 p -105.73 -60.8 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.429 ' H ' ' HG ' ' B' ' 170' ' ' SER . 12.0 pt-20 -161.33 1.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.789 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 56.85 85.54 0.19 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.899 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -91.27 -65.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.747 2.298 . . . . 0.0 112.941 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.94 -179.14 33.57 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.547 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.23 123.07 10.99 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.572 2.181 . . . . 0.0 112.198 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 80.6 p -163.76 125.19 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.731 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.8 -127.09 22.09 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.41 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -140.7 14.9 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.647 0.261 . . . . 0.0 111.302 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . 0.442 ' NE2' ' H ' ' B' ' 179' ' ' GLN . 1.7 mp0 -82.84 179.71 7.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.331 . . . . 0.0 110.994 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 76.4 p -85.98 -2.43 58.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.181 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 24.2 p -65.36 111.84 3.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 46.2 t 177.94 113.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.977 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.21 131.01 10.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.282 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 7.6 t -98.5 -7.75 27.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 111.031 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -140.5 -57.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.937 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.259 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.773 0.321 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -81.15 125.54 30.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.794 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.66 116.27 15.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.674 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -132.45 173.11 11.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.554 HG23 ' HG ' ' B' ' 142' ' ' LEU . 40.0 t -89.99 -35.06 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.32 -34.03 70.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.59 -38.32 86.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 0.0 110.058 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.01 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.319 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.421 HD22 HG11 ' A' ' 123' ' ' VAL . 4.4 mm? -63.15 -34.93 78.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.072 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.3 t -62.56 -48.52 79.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.692 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.469 HD11 HD21 ' A' ' 148' ' ' LEU . 28.8 tp -61.01 -50.58 72.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.65 -25.81 68.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.536 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -65.11 -41.56 94.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.913 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.1 t -70.2 -45.92 73.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.852 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -57.02 -44.66 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.36 -36.28 76.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -55.83 -70.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.063 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -65.6 -72.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.71 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.49 -76.62 1.49 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.923 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 54.1 m -58.85 -16.62 18.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.602 0.239 . . . . 0.0 111.437 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -116.7 81.29 11.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.79 -12.33 24.17 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.509 2.139 . . . . 0.0 112.027 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -69.67 -40.29 76.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.636 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.4 t -60.12 -56.62 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.27 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -53.14 34.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.179 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -54.45 -52.81 60.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.413 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -52.41 -42.05 63.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.399 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -60.12 -56.99 14.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' B' ' 134' ' ' GLU . 7.6 mp -63.91 -25.7 68.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -62.95 -49.38 74.98 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.81 -47.78 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.703 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.475 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 76.9 mmm -54.04 -37.06 63.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.774 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -71.8 -32.73 67.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.28 -44.0 89.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.876 0.369 . . . . 0.0 110.02 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.25 -42.86 87.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.936 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.415 ' HD2' HG23 ' B' ' 136' ' ' ILE . 12.1 tmtt? -62.7 -40.14 96.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.167 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 90.5 p -85.85 13.75 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 64.63 102.37 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.195 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -153.1 -64.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.79 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.2 pt -111.9 168.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -90.8 177.08 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.597 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 27.6 m -57.52 -50.94 85.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.893 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.1 Cg_exo -54.83 -33.12 80.13 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.022 1.814 . . . . 0.0 112.194 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.02 -37.54 83.18 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.25 -45.5 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.97 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.299 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -69.6 -58.31 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.652 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.43 -48.05 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.89 -29.26 69.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.204 0.526 . . . . 0.0 109.758 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -84.09 -18.76 35.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.167 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.29 -43.85 22.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -93.81 30.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.19 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -58.29 -28.29 64.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.25 -48.53 68.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.628 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -116.87 93.56 41.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.406 0.146 . . . . 0.0 110.772 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.79 -14.65 28.01 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.61 2.206 . . . . 0.0 112.645 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.18 -55.82 29.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.28 -33.51 65.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.63 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.53 -48.3 78.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.49 -30.73 73.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -71.22 -36.3 71.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 110.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.06 -16.96 62.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.0 m -71.63 -39.82 70.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.177 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -58.23 -49.56 76.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.991 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.459 HD21 ' HE1' ' B' ' 144' ' ' MET . 87.2 mt -53.82 151.78 11.16 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.521 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.73 135.46 52.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.333 2.022 . . . . 0.0 112.081 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.93 150.6 77.19 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.445 2.097 . . . . 0.0 112.36 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.615 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.78 0.324 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 79.9 p -156.02 -30.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 73.0 p -85.87 -19.73 30.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.063 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -112.29 101.56 9.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.533 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 87.8 mt -109.81 -175.59 2.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.017 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 47.6 t -59.22 155.29 14.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.974 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.73 -42.52 86.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.65 -27.83 66.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.543 ' HA ' HD22 ' A' ' 148' ' ' LEU . 45.2 mt-10 -77.26 -46.13 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.3 ttm -64.52 -36.41 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.021 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.415 HG23 ' HD2' ' A' ' 155' ' ' LYS . 86.2 mt -74.23 -53.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.13 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.28 -46.71 69.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.112 0.482 . . . . 0.0 110.257 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -67.31 -35.28 79.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.427 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.82 -53.87 51.41 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.77 73.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.525 HD13 HD11 ' B' ' 138' ' ' LEU . 0.8 OUTLIER -64.19 -56.56 13.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.424 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.554 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.6 mm? -70.8 -21.16 62.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.466 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -82.74 -26.5 31.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.459 ' HE1' HD21 ' A' ' 186' ' ' LEU . 58.6 ttp -80.96 -38.99 26.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 60.3 p -60.51 -19.17 56.14 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.013 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -108.21 -69.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.41 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 164.84 -83.75 0.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.524 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.69 -69.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.514 ' HG2' HG23 ' B' ' 150' ' ' THR . 26.1 tt0 -72.16 -58.97 2.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.647 ' H ' ' HD2' ' B' ' 151' ' ' PRO . 0.5 OUTLIER -177.69 -36.13 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' B' ' 150' ' ' THR . 72.4 Cg_endo -83.88 -165.3 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.631 1.554 . . . . 0.0 112.066 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -64.66 106.88 1.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.675 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 28.9 t 64.19 169.88 0.17 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.779 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 13.3 p -56.13 -23.83 16.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.127 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.49 154.66 28.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.223 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.5 m -130.78 154.64 47.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 79.4 p -146.66 -24.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.483 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 83.4 mt -63.29 -49.92 77.17 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 64.0 Cg_endo -72.83 -152.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.09 1.86 . . . . 0.0 112.222 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.402 ' H ' ' HB2' ' B' ' 159' ' ' PRO . 32.8 t -81.53 29.49 0.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 59.5 m 63.01 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.444 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 47.2 t -108.35 134.64 50.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.069 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' B' ' 166' ' ' PRO . 79.2 m 58.56 91.81 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.34 -43.42 1.48 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.304 2.003 . . . . 0.0 112.551 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.571 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 14.9 t70 -91.38 -49.37 0.33 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.564 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 33.6 Cg_exo -59.38 114.41 2.02 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.103 1.869 . . . . 0.0 112.289 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.441 HG21 ' H ' ' B' ' 169' ' ' VAL . 34.4 m -93.39 176.21 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 33.6 t -100.94 18.83 18.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.755 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.441 ' H ' HG21 ' B' ' 167' ' ' VAL . 59.2 t -118.49 120.4 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 35.6 t -105.31 174.07 6.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.778 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.13 174.46 1.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.014 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.52 147.65 98.73 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.723 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.91 -176.46 3.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.474 2.116 . . . . 0.0 112.223 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.87 -83.11 1.69 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.158 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.03 137.52 24.22 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.602 2.201 . . . . 0.0 112.3 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.0 t -62.54 114.37 3.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.716 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -149.16 -175.96 22.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.55 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.18 13.03 24.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.878 0.371 . . . . 0.0 110.721 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . 0.403 ' NE2' ' HA2' ' B' ' 183' ' ' GLY . 26.2 mt-30 -80.22 7.16 9.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.026 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 71.1 m 61.03 -85.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.525 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -115.77 153.24 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.237 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 40.5 t 59.52 103.3 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.17 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . 0.403 ' HA2' ' NE2' ' B' ' 179' ' ' GLN . . . -109.32 -8.99 26.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.295 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 45.0 m -68.41 111.16 4.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -166.25 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.304 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.765 0.317 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.482 ' N ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -140.7 162.91 34.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 55.97 89.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.498 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 17.3 tppt? -105.86 152.55 23.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.668 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 38.4 t -77.55 -35.35 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.297 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.498 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 35.8 tt0 -56.35 -35.7 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.408 ' OD1' ' HB3' ' A' ' 122' ' ' LYS . 4.4 m-20 -65.3 -39.86 93.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 109.711 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.44 77.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.012 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.59 -51.25 66.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.829 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -55.39 -36.4 66.35 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.548 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 86.4 t80 -67.98 -32.21 72.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.804 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.493 HD13 HD23 ' B' ' 138' ' ' LEU . 38.1 tp -64.74 -43.16 94.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.887 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.19 -40.52 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.292 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -58.55 -45.94 87.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.601 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.65 -41.0 91.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.614 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.02 -27.98 69.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.4 -61.2 1.86 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.739 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -53.84 -50.28 66.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -97.3 72.46 2.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.561 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.62 -60.45 1.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.382 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.5 p -72.9 -5.62 39.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.939 0.4 . . . . 0.0 110.517 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -123.93 86.44 53.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.32 13.51 2.71 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.66 2.24 . . . . 0.0 112.432 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -75.72 -56.3 4.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.04 -44.84 92.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.319 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.21 -57.92 10.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.101 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -55.87 -42.44 75.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.298 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.07 -32.59 73.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -68.8 -59.55 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.2 mp -61.26 -31.12 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.195 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.12 -52.12 57.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.4 mt -54.08 -45.04 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.649 ' HE1' ' HG ' ' B' ' 141' ' ' LEU . 76.2 mmm -55.52 -48.93 73.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.51 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.26 -35.68 67.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.427 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.75 -43.72 92.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.973 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.65 -34.5 78.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HG2' HG21 ' B' ' 136' ' ' ILE . 27.8 tptp -77.22 -27.55 53.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.389 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 18.24 12.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.59 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 62.43 96.92 0.04 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.838 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.2 m -155.59 -46.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.08 178.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -113.37 -173.35 2.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 93.6 m -58.55 -50.01 90.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.658 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.7 Cg_exo -56.58 -32.49 90.32 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.031 1.82 . . . . 0.0 112.037 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.0 -44.19 68.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.55 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.4 t -65.18 -44.36 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.65 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.453 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -61.2 -58.04 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.578 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -53.19 -56.48 16.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.91 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.4 t -57.65 -34.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.644 0.259 . . . . 0.0 111.321 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.2 t -60.34 -50.4 73.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.835 0.35 . . . . 0.0 110.805 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.11 -11.78 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.45 -38.72 65.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.726 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -97.3 23.72 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.808 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -54.49 106.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.63 -32.44 1.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.288 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -129.54 100.84 19.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.413 0.149 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.31 -0.08 9.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.413 2.075 . . . . 0.0 112.548 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.36 -58.75 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 178' ' ' LEU . 3.5 mm? -60.54 -39.18 86.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.86 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.21 -42.87 93.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.87 76.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.548 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 68.2 t80 -81.42 -33.6 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.826 0.346 . . . . 0.0 111.115 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -63.13 -26.42 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.1 m -67.87 -37.91 82.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.138 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -56.86 -50.85 71.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.424 HD22 ' HE1' ' B' ' 144' ' ' MET . 91.0 mt -57.59 156.81 15.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.98 144.81 71.63 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.251 1.967 . . . . 0.0 112.0 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.48 164.22 3.12 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.398 2.066 . . . . 0.0 112.496 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.374 -1.236 . . . . 0.0 112.468 179.842 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 51.6 m 59.12 18.76 6.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.927 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 34.4 p -117.13 -11.01 10.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.17 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -84.28 -0.34 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.413 HD12 ' N ' ' B' ' 130' ' ' LEU . 6.5 mp -83.49 148.63 27.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.4 ' HG ' ' HG3' ' B' ' 134' ' ' GLU . 81.5 p -62.47 160.87 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.986 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.1 -36.86 85.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.48 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.471 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.417 ' HA ' HD23 ' A' ' 148' ' ' LEU . 46.2 mt-10 -76.8 -49.99 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 58.4 ttp -63.66 -33.33 75.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.579 HG21 ' HG2' ' A' ' 155' ' ' LYS . 61.5 mt -76.35 -51.75 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.152 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -57.34 -47.78 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.028 0.442 . . . . 0.0 110.446 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.607 HD13 HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.82 -50.07 73.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.524 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.71 -46.66 40.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.055 0.455 . . . . 0.0 109.96 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.93 -32.95 85.88 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.767 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.649 ' HG ' ' HE1' ' A' ' 151' ' ' MET . 55.8 mt -62.42 -55.01 31.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.308 . . . . 0.0 111.028 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.591 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -68.92 -22.37 64.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -86.32 -26.49 24.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.37 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 161' ' ' THR . 15.7 tmm? -88.21 -24.79 23.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 55.0 m -76.26 -1.23 25.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.545 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -131.31 -30.53 1.71 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.812 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' B' ' 153' ' ' CYS . . . 127.68 -80.78 0.36 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.584 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.529 ' HB2' HG11 ' B' ' 154' ' ' VAL . 38.0 tt0 -131.59 -59.18 0.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -151.78 -89.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.223 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.542 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 4.9 t -102.83 -30.31 0.21 Allowed Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' B' ' 150' ' ' THR . 97.1 Cg_endo -82.58 149.32 14.51 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.594 1.529 . . . . 0.0 112.506 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.49 108.27 0.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.56 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . 0.509 ' HA ' ' HA3' ' B' ' 147' ' ' GLY . 52.0 t 65.44 149.64 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.064 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' B' ' 148' ' ' GLU . 27.4 m -45.32 141.27 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.328 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -153.92 -27.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.285 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.413 ' HB2' ' HG3' ' B' ' 159' ' ' PRO . 46.5 m -86.25 171.15 11.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.984 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 44.2 t -142.79 2.78 1.39 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.674 ' N ' ' CD ' ' B' ' 159' ' ' PRO . 0.0 OUTLIER -122.36 6.69 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' B' ' 158' ' ' LEU . 96.8 Cg_endo -84.19 -42.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 121.611 1.541 . . . . 0.0 112.227 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 75.8 p -162.5 4.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 3.1 m -82.39 11.54 5.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 49.0 m -84.5 17.85 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 13.0 p -106.55 93.25 8.18 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.12 -57.19 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.253 1.968 . . . . 0.0 111.97 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.15 66.35 0.39 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.818 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.93 118.53 5.74 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.38 2.053 . . . . 0.0 112.102 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 30.7 m -123.68 177.97 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.359 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.6 m -82.64 135.09 35.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.19 -26.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 63.6 m -153.13 16.42 0.55 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.285 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.88 147.57 52.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.723 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.62 119.83 66.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.93 -179.24 2.85 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.201 1.934 . . . . 0.0 112.217 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -70.31 -160.5 3.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.0 97.95 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.465 2.11 . . . . 0.0 112.226 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 80.4 p -172.39 -173.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.808 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -113.66 -98.38 2.3 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.475 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -97.25 117.37 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.745 0.307 . . . . 0.0 110.77 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -138.36 -79.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.993 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 40.1 t -170.43 -76.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 26.6 p -171.31 130.14 0.73 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 33.2 t 60.35 175.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.302 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -149.42 -26.67 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.224 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 80.6 p -76.3 -4.43 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 111.147 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -142.18 117.43 10.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.178 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -148.17 106.99 3.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.8 tt -128.18 119.0 24.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.722 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -123.0 176.45 6.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.809 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.582 HG23 ' HG ' ' B' ' 142' ' ' LEU . 26.9 t -83.6 -35.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.95 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.88 -27.44 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.78 -44.41 81.41 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.436 ' HB1' HD22 ' B' ' 142' ' ' LEU . . . -66.56 -29.48 69.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.9 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 mt -63.51 -54.96 28.1 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.936 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -55.88 -37.07 68.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 133' ' ' VAL . 84.3 t80 -64.0 -34.22 77.51 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.667 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.611 HD13 HD22 ' B' ' 138' ' ' LEU . 28.6 tp -65.56 -42.43 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.86 -38.54 88.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.081 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 -52.52 65.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.627 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 129' ' ' TYR . 46.5 t -59.18 -39.2 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -76.86 -17.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tt -75.16 -56.58 4.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.404 ' NE2' HD23 ' A' ' 178' ' ' LEU . 25.0 mt-30 -66.5 -52.5 45.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.11 33.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.189 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.93 4.27 31.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.769 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.6 p -116.41 -6.92 11.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 0.0 110.784 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -132.75 91.32 30.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.3 -11.29 31.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.568 2.179 . . . . 0.0 112.196 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.32 -46.33 73.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.55 -52.49 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.84 -57.43 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -55.8 -32.86 63.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.154 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.63 -52.28 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -56.2 -56.18 24.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' B' ' 134' ' ' GLU . 8.8 mp -58.83 -37.77 77.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.514 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.67 -42.45 88.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 159' ' ' ILE . 13.9 mt -57.18 -49.71 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.027 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.626 ' HE2' HD13 ' B' ' 141' ' ' LEU . 83.5 mmm -52.76 -42.58 65.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.487 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.599 ' HB2' ' HZ3' ' A' ' 152' ' ' LYS . 10.3 mtmp? -64.55 -35.63 81.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.209 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.0 -33.44 75.42 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -79.4 -28.42 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.861 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 152' ' ' LYS . 27.6 mmtt -71.46 -59.48 2.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.64 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.2 m -63.27 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -179.32 104.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -165.39 -69.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.197 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 150' ' ' ILE . 40.7 pt -116.23 158.08 16.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.217 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -100.86 -172.19 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.54 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 84.8 m -52.56 -51.96 68.32 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.265 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.6 Cg_endo -58.56 -38.38 89.96 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.168 1.912 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.61 -42.21 93.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.27 -45.44 96.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.761 0.315 . . . . 0.0 111.26 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.38 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.482 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.1 m -62.01 -54.46 41.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.567 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.32 -35.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 69.0 m -64.82 -39.96 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.55 -13.89 55.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.97 -49.27 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -96.63 25.22 5.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.183 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.42 -26.22 60.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.947 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.0 -32.71 85.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.409 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -125.81 102.41 28.63 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 120.369 0.128 . . . . 0.0 110.988 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.34 -3.37 9.86 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.435 2.09 . . . . 0.0 112.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.86 -53.78 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -61.15 -35.77 78.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -67.29 -47.97 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.8 ttp -57.46 -42.76 83.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.695 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.27 -32.46 62.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.389 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -67.95 -31.63 71.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 110.574 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -67.35 -23.87 65.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 35.0 m -65.57 -40.68 93.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -57.42 -50.85 71.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.34 146.22 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.05 114.26 2.23 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.398 2.065 . . . . 0.0 111.977 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.28 161.16 11.85 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.461 2.107 . . . . 0.0 112.347 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.548 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.826 0.346 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.2 t -105.64 -17.09 14.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.749 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 8.3 t -139.98 145.52 37.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -117.72 -159.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.788 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 54.0 mt -53.44 162.93 0.69 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.284 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 87.1 p -61.96 161.09 11.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.866 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' B' ' 135' ' ' MET . 11.1 pt-20 -75.1 -33.47 61.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.509 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.494 ' HA ' HD22 ' A' ' 148' ' ' LEU . 13.0 pt-20 -76.45 -41.59 46.85 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' MET . . . . . 0.521 ' HG2' ' HA ' ' B' ' 132' ' ' GLU . 22.3 ptp -63.29 -33.31 75.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.0 mt -76.48 -53.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.45 ' O ' HD13 ' B' ' 141' ' ' LEU . . . -53.83 -51.01 64.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.611 HD22 HD13 ' A' ' 130' ' ' LEU . 3.9 mt -61.62 -43.67 98.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.02 -37.16 52.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.69 -37.58 76.77 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.598 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.626 HD13 ' HE2' ' A' ' 151' ' ' MET . 1.5 mp -56.84 -56.03 26.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.046 0.45 . . . . 0.0 110.018 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' A' ' 123' ' ' VAL . 2.9 mm? -68.52 -24.13 64.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.466 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -75.45 -27.5 58.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.194 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.428 ' SD ' HG21 ' A' ' 161' ' ' THR . 12.7 ttm -79.46 -40.42 29.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' SER . . . . . 0.414 ' HG ' ' HA ' ' B' ' 142' ' ' LEU . 80.4 p -60.66 -29.95 69.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -137.47 -126.72 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.95 27.16 69.31 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.33 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -139.52 117.36 11.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.677 0.275 . . . . 0.0 110.601 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 61.69 -167.68 0.19 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.772 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 2.8 t 37.35 90.82 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.326 0 O-C-N 123.463 0.477 . . . . 0.0 111.854 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -38.21 105.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.879 2.386 . . . . 0.0 113.069 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.7 -67.38 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.664 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 51.5 t -110.04 -17.4 13.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.028 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.07 -88.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.264 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -167.79 110.46 0.63 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.194 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 67.3 m -156.69 158.85 37.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.1 t -159.95 -21.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.626 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 62.7 tp -81.02 -50.33 0.99 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.666 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 41.6 Cg_endo -66.94 -78.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.912 1.741 . . . . 0.0 112.449 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.404 ' H ' ' HG2' ' B' ' 159' ' ' PRO . 66.4 m -160.97 106.83 1.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.811 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -142.72 -61.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 49.1 m -69.82 162.11 28.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 15.6 p -156.8 72.3 4.74 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.39 -44.19 7.01 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.518 2.145 . . . . 0.0 111.794 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -165.96 76.07 1.24 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.674 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.15 123.91 11.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.64 2.227 . . . . 0.0 112.564 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.35 -50.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 40.0 t -163.89 6.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.669 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.612 ' HA ' ' HG3' ' B' ' 173' ' ' PRO . 9.3 p -73.23 145.26 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.033 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 33.8 t 65.63 6.08 3.65 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.146 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.48 -66.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.364 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . 0.594 ' N ' ' HD3' ' B' ' 173' ' ' PRO . 4.9 p-10 -166.55 43.67 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.627 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.612 ' HG3' ' HA ' ' B' ' 169' ' ' VAL . 43.0 Cg_endo -92.36 -176.43 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.497 2.132 . . . . 0.0 112.75 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.58 -69.08 0.45 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.464 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.06 -45.23 24.75 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.712 2.275 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 53.1 m -70.71 131.07 43.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 92.74 -163.94 27.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.605 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -148.94 -51.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.918 0.39 . . . . 0.0 110.696 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -107.54 -61.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.731 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 58.0 m -72.73 83.11 1.16 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 20.1 p -175.7 154.24 1.54 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.726 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.9 m -105.32 -76.37 0.61 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.627 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 118.81 -152.55 17.3 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.473 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 82.4 p -97.2 -49.73 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.738 0.304 . . . . 0.0 111.434 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -123.69 -61.41 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.03 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.296 -179.889 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.717 0.294 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -93.55 6.9 46.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.51 98.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.598 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -95.52 168.37 10.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.256 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.593 HG21 ' HG ' ' B' ' 142' ' ' LEU . 41.8 t -95.11 -27.65 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.77 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -59.58 -35.35 74.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -68.33 -39.03 82.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.923 0.392 . . . . 0.0 110.539 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' B' ' 142' ' ' LEU . . . -63.99 -44.72 91.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.487 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.499 HD22 HG11 ' A' ' 123' ' ' VAL . 4.5 mm? -61.55 -40.79 95.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.174 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -58.96 -42.16 89.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.8 -40.56 93.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.852 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.2 tp -59.47 -41.56 90.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.191 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.47 -43.09 99.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.56 -41.19 85.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.26 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.93 -46.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.866 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.612 ' HB2' ' HZ1' ' A' ' 134' ' ' LYS . 4.3 ttmp? -64.61 -25.55 68.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.749 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -72.73 -59.54 2.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.177 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -61.87 -56.37 20.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -83.71 30.56 0.49 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.336 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.0 -25.08 69.12 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.866 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -87.81 -22.22 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.05 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.91 98.12 45.44 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.26 13.58 2.18 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.451 2.101 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -75.01 -61.57 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.65 -37.27 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.278 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.503 ' HH ' ' HZ2' ' A' ' 134' ' ' LYS . 76.2 t80 -65.23 -57.66 7.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -56.43 -35.51 67.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.142 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.57 -36.48 73.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.014 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -64.58 -58.36 6.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.971 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.8 mp -60.39 -42.72 96.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.76 -44.86 74.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.117 0.484 . . . . 0.0 109.714 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.06 -47.95 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.235 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.486 ' HE3' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -54.96 -42.41 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.548 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -61.72 -39.64 92.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.262 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.11 -39.74 91.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.066 0.46 . . . . 0.0 109.874 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.81 -21.7 57.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.878 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -86.31 -22.87 26.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.63 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 62.7 m -104.01 16.35 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 61.43 93.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.984 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.8 m -147.6 -61.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.668 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 pt -114.54 155.07 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -83.17 171.75 13.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.114 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 63.5 m -53.67 -51.57 75.14 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.624 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 51.6 Cg_exo -53.03 -32.16 57.08 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.923 1.749 . . . . 0.0 111.896 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.09 62.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.207 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.4 t -66.93 -43.81 89.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.739 0.304 . . . . 0.0 110.813 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -66.1 -43.61 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.171 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.1 p -65.42 -54.06 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.375 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.496 ' HA ' HE21 ' A' ' 170' ' ' GLN . 74.1 mtp180 -55.78 -51.26 68.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.309 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.76 -36.16 69.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 t -59.39 -45.74 90.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.524 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.496 HE21 ' HA ' ' A' ' 167' ' ' ARG . 28.0 pt20 -84.09 -11.58 56.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.6 tp -75.96 -26.34 56.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -109.29 30.48 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.57 118.28 4.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.06 -54.84 0.77 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.198 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -109.03 95.72 18.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.76 0.88 4.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.506 2.137 . . . . 0.0 112.643 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.72 -56.02 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.006 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.52 -37.7 76.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.7 mt -71.07 -37.78 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.74 -38.64 91.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.13 -28.62 40.38 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.649 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -68.99 -40.98 78.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -63.8 -21.27 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 m -66.38 -39.96 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.309 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -60.7 -40.37 91.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.558 HD23 ' HE3' ' B' ' 144' ' ' MET . 79.1 mt -58.26 152.0 44.68 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.614 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.63 111.12 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.313 2.009 . . . . 0.0 112.091 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.87 145.26 94.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.339 2.026 . . . . 0.0 112.188 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.396 -1.224 . . . . 0.0 112.546 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.782 0.325 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 74.9 p -94.81 116.35 28.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.785 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 67.5 p -65.2 116.03 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -74.73 -3.97 34.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.786 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.403 ' N ' HD13 ' B' ' 130' ' ' LEU . 7.2 mp -91.38 173.95 7.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.64 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 59.4 m -93.35 164.35 13.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.724 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.47 -36.56 63.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.783 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.1 -28.74 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.89 -42.87 60.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.6 tpp -65.44 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.41 -52.28 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.414 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -52.47 -47.0 66.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.091 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.473 ' HA ' HD11 ' B' ' 141' ' ' LEU . 4.2 mm? -64.74 -38.72 91.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.276 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.39 -46.76 62.95 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.31 -31.42 71.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.584 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.486 HD12 ' HE3' ' A' ' 151' ' ' MET . 0.1 OUTLIER -59.02 -54.95 41.29 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 110.399 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.0 mm? -73.51 -21.63 60.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.83 -26.3 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.356 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.558 ' HE3' HD23 ' A' ' 186' ' ' LEU . 53.8 ttp -87.51 -34.75 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m -60.3 -17.29 41.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.689 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -127.03 -17.56 4.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.015 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -102.08 50.95 0.92 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.523 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -118.57 125.11 49.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.738 0.304 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.53 ' O ' HG21 ' B' ' 150' ' ' THR . 54.5 tt0 63.03 169.74 0.14 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.838 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.53 HG21 ' O ' ' B' ' 149' ' ' GLN . 0.7 OUTLIER 58.56 146.68 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 123.289 0.635 . . . . 0.0 111.857 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.1 114.22 1.63 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.379 2.053 . . . . 0.0 112.133 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -157.66 -81.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.804 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 29.8 t -152.44 20.96 0.63 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.221 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.52 -27.36 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.903 0.382 . . . . 0.0 111.102 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -163.7 106.63 0.97 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.252 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 49.7 m -133.13 112.13 11.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.719 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 81.1 p -135.85 -7.21 2.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.786 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.485 ' HB3' ' HD3' ' B' ' 159' ' ' PRO . 47.6 tp -86.27 -49.54 0.51 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.307 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' B' ' 158' ' ' LEU . 91.4 Cg_endo -78.86 -1.38 11.55 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.143 1.895 . . . . 0.0 112.064 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 47.4 t 56.98 93.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.959 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 56.7 m -88.37 -51.22 5.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.14 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 59.1 m -119.68 -71.26 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 69.1 m 55.03 73.88 0.81 Allowed Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.47 31.75 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.598 2.199 . . . . 0.0 112.112 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 23.9 t70 58.69 72.36 0.85 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.603 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.81 142.95 84.76 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.583 2.188 . . . . 0.0 112.339 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 47.9 t -74.13 144.85 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 59.2 m -58.76 114.06 2.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.91 -27.65 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 45.0 t -106.31 153.54 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.941 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -100.16 -29.12 12.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.767 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -144.74 92.33 5.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.515 ' HB3' ' H ' ' B' ' 182' ' ' SER . 57.5 Cg_endo -70.49 -42.42 2.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.126 . . . . 0.0 112.142 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.39 -159.99 10.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.447 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.12 173.34 11.44 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.527 2.151 . . . . 0.0 112.311 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.0 t -71.42 103.76 3.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -175.32 -7.09 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.345 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.28 173.54 11.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -118.1 166.23 12.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 70.3 m 58.08 -176.1 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.135 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 27.2 p -90.05 145.04 25.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.515 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 47.0 t -158.3 3.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -88.56 -47.4 4.3 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.394 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 35.5 p 49.11 -89.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 122.518 0.327 . . . . 0.0 111.786 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -122.9 -50.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.746 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.399 -0.81 . . . . 0.0 111.202 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -154.75 -10.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.975 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 tt 63.44 109.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.62 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -113.48 145.48 41.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.265 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.594 HG23 ' HG ' ' B' ' 142' ' ' LEU . 48.7 t -64.03 -31.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.519 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -56.98 -35.87 69.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.17 -37.83 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.11 86.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.119 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.91 -49.3 73.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -55.06 -36.61 65.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.598 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 64.9 t80 -67.68 -33.55 75.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.83 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.5 tp -62.3 -48.62 79.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.024 0.44 . . . . 0.0 110.041 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.54 -38.54 91.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -57.97 -44.78 87.29 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 110.296 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.416 HG22 HD11 ' A' ' 178' ' ' LEU . 89.2 t -61.88 -48.11 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -68.22 -15.93 63.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.56 -54.87 6.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.45 ' HG3' HD23 ' A' ' 178' ' ' LEU . 15.8 mm100 -52.0 -65.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.435 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -61.91 -64.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.816 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.57 -87.19 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.735 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.7 m -64.72 -9.33 19.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 111.037 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 142' ' ' GLN . 55.7 tp60 -119.01 77.52 15.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.541 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.0 4.56 6.88 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.643 2.228 . . . . 0.0 112.54 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.412 ' HB3' HE21 ' A' ' 140' ' ' GLN . 22.5 tm0? -62.21 -38.9 90.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.705 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t -72.34 -39.03 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.121 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.26 -55.28 36.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.048 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -54.94 -42.0 71.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.22 -32.04 73.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.201 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.18 -60.53 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.077 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.416 HD21 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -61.86 -38.75 89.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.004 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.18 -46.14 83.08 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.494 HD11 HD21 ' A' ' 171' ' ' LEU . 3.2 mt -56.99 -45.49 83.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.855 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.643 ' HE3' ' HG ' ' B' ' 141' ' ' LEU . 77.4 mmm -55.03 -40.19 69.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.658 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.35 -37.77 88.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.218 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.06 -39.88 93.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 109.856 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.4 -37.46 63.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.818 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.484 ' HG2' HG23 ' B' ' 136' ' ' ILE . 22.0 tptm -65.93 -27.44 68.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.383 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 92.7 p -102.33 -154.76 0.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.905 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -102.89 87.61 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.812 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.4 t -148.56 -70.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.57 167.21 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.677 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.3 -170.49 1.67 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.555 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 56.8 m -53.58 -52.31 68.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.745 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 161' ' ' THR . 10.1 Cg_endo -53.25 -36.39 77.73 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.033 1.822 . . . . 0.0 111.883 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.05 -38.59 88.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.13 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.42 -45.2 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.23 -49.0 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.43 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -62.66 -59.24 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.717 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -52.82 -54.33 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.605 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.25 -35.34 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.676 0.274 . . . . 0.0 111.235 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.3 t -61.3 -46.51 90.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -83.96 -11.79 56.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.494 HD21 HD11 ' A' ' 150' ' ' ILE . 19.1 tp -77.94 -24.76 48.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -113.0 25.68 11.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.65 103.51 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 144.65 -25.97 1.96 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.557 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -125.47 95.12 41.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.388 0.137 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -7.36 21.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.387 2.058 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.88 -54.26 10.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.45 HD23 ' HG3' ' A' ' 136' ' ' GLN . 3.6 mm? -60.79 -41.92 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.9 mt -63.8 -49.58 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 57.0 ttp -58.89 -35.82 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.6 -20.56 63.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.434 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.598 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 64.3 t80 -77.99 -41.31 36.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.39 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 89.4 m -63.75 -35.9 82.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -65.15 -52.03 57.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.553 HD22 ' HE3' ' B' ' 144' ' ' MET . 77.2 mt -54.78 148.59 26.27 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.57 145.44 58.66 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.428 2.085 . . . . 0.0 112.108 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.22 166.52 2.29 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.364 2.043 . . . . 0.0 112.402 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.443 -1.198 . . . . 0.0 112.441 -179.923 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 56.6 m . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.793 0.33 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 45.1 t -101.77 2.87 38.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -75.71 -22.52 56.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.999 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 60.33 18.06 7.68 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.061 0.457 . . . . 0.0 110.72 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' B' ' 131' ' ' SER . 17.2 tp -105.25 170.39 7.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.771 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.479 ' H ' ' HG ' ' B' ' 130' ' ' LEU . 78.3 p -85.5 161.92 19.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.8 -37.37 81.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.203 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.24 94.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.725 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.416 ' HA ' HD21 ' A' ' 148' ' ' LEU . 39.3 mt-10 -70.97 -39.17 72.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.17 -34.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.484 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.6 mt -75.7 -52.81 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.061 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -54.24 -48.52 71.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 110.574 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.606 ' HA ' HD11 ' B' ' 141' ' ' LEU . 3.7 mm? -63.9 -43.79 94.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.258 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.13 -47.28 45.65 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.44 -36.66 92.88 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.891 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.643 ' HG ' ' HE3' ' A' ' 151' ' ' MET . 56.9 mt -59.51 -55.32 36.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.919 0.39 . . . . 0.0 110.901 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.594 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.1 mm? -72.76 -18.76 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.332 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.343 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.553 ' HE3' HD22 ' A' ' 186' ' ' LEU . 44.7 ttp -81.76 -39.35 24.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.354 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' SER . . . . . 0.464 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.6 p -110.12 76.55 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.882 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' B' ' 153' ' ' CYS . 13.0 pt20 -130.79 -10.1 3.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.122 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -99.43 64.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.519 ' HG2' ' HG2' ' B' ' 149' ' ' GLN . 0.3 OUTLIER -59.38 -31.13 68.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.0 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.519 ' HG2' ' HG2' ' B' ' 148' ' ' GLU . 15.2 mm100 -112.24 -157.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.782 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.521 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 1.1 t -70.97 -32.01 2.24 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' B' ' 150' ' ' THR . 2.9 Cg_exo -76.38 -161.56 0.14 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.953 1.769 . . . . 0.0 112.067 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -133.13 136.25 45.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.988 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . 0.4 ' HA ' ' HB2' ' B' ' 146' ' ' GLN . 35.5 t 60.28 9.08 1.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.337 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.672 HG22 ' H ' ' B' ' 156' ' ' SER . 7.6 p -172.28 159.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.815 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.83 -7.36 23.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.351 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.672 ' H ' HG22 ' B' ' 154' ' ' VAL . 92.5 p 51.6 -169.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.281 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.8 p -171.0 -31.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.463 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 62.4 tp -65.77 -51.15 50.55 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.643 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 58.3 Cg_endo -71.6 -56.72 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.021 1.814 . . . . 0.0 112.344 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 55.1 m -148.6 101.05 3.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 33.3 m -62.31 148.78 44.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.157 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 45.9 t -65.2 138.08 58.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.973 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 22.6 p 38.54 73.07 0.82 Allowed Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.61 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.81 -43.16 46.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.553 2.168 . . . . 0.0 111.863 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -154.63 69.52 5.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.481 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.48 137.86 48.15 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.527 2.152 . . . . 0.0 112.526 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 11.2 t -115.31 158.83 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.631 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t -55.43 101.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.937 0.399 . . . . 0.0 111.142 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 94.1 t -144.43 135.68 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.826 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 46.9 t -112.47 142.43 45.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.06 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.87 110.95 22.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.691 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 21.4 t70 57.07 88.72 0.12 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.015 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.462 ' HG3' ' HA ' ' B' ' 181' ' ' CYS . 58.3 Cg_endo -71.67 -169.51 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.46 2.107 . . . . 0.0 112.241 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.63 165.73 40.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.448 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.24 -25.81 42.56 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.614 2.209 . . . . 0.0 112.185 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 47.8 t -158.38 112.98 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.843 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.93 -48.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.603 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -142.24 152.27 42.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.748 0.309 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.71 -19.79 66.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.325 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 79.4 p -131.53 -176.84 4.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . 0.462 ' HA ' ' HG3' ' B' ' 173' ' ' PRO . 28.2 p -59.63 154.25 18.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.766 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 66.7 p -159.11 -61.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.38 21.8 76.92 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.561 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 82.1 p -76.26 -46.5 27.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -154.24 140.28 18.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.955 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.264 179.783 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.761 0.315 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -70.05 157.02 38.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.844 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.33 118.5 23.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -137.18 128.17 27.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.918 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.58 HG22 ' HG ' ' B' ' 142' ' ' LEU . 30.2 t -67.02 -28.72 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.63 -39.06 79.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.779 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.51 -36.8 84.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 109.969 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' B' ' 142' ' ' LEU . . . -61.77 -45.22 94.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.174 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.082 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -56.99 -38.59 73.26 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -64.98 -40.67 95.33 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.731 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.4 HD21 HD22 ' B' ' 138' ' ' LEU . 53.2 tp -59.32 -36.06 74.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.909 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.26 -39.84 74.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.01 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -57.87 -39.21 77.27 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.869 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.543 HG21 HD23 ' A' ' 178' ' ' LEU . 47.4 t -72.51 -38.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -68.28 -20.58 64.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.288 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.21 -55.9 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.57 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -74.76 -59.9 2.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.168 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -83.46 24.91 0.79 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.13 -26.08 68.85 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.498 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.4 m -90.36 5.49 47.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -114.11 87.2 12.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.68 -7.26 18.41 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.357 2.038 . . . . 0.0 112.034 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -84.27 -62.34 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.0 t -57.68 -44.9 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.596 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.49 -56.78 16.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.908 0.385 . . . . 0.0 110.568 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.8 -36.28 76.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB3' HD13 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -68.85 -31.58 70.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -69.65 -59.7 2.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -38.26 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.462 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 15.1 t70 -58.22 -50.12 74.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -53.74 -44.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.196 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.638 ' HE1' ' HG ' ' B' ' 141' ' ' LEU . 75.7 mmm -58.2 -39.66 79.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 55.2 mtmt -67.02 -31.17 71.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.115 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.57 -42.73 86.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.69 -21.82 60.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.818 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.47 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.5 tptp -82.31 -34.61 28.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.9 t -95.2 18.99 11.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 64.04 98.86 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -153.08 -61.92 0.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.567 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.37 172.42 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -100.37 -178.33 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.135 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.57 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 87.5 m -60.22 -50.04 87.88 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.603 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 53.1 Cg_exo -55.51 -32.95 84.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.964 1.776 . . . . 0.0 111.939 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.49 -40.49 59.66 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.235 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.9 -45.27 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 110.927 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.94 -49.87 77.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.308 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.4 p -58.89 -53.2 61.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -54.3 -52.31 61.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.397 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.7 -31.13 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.752 0.311 . . . . 0.0 111.007 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.1 m -64.41 -45.36 87.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.781 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -82.25 -16.5 49.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 146' ' ' ASP . 1.2 tp -76.03 -42.53 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -95.94 15.6 20.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -51.61 120.09 4.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.46 -45.68 0.78 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.36 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -120.45 100.7 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.46 0.172 . . . . 0.0 110.758 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.41 -11.27 13.14 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.489 2.126 . . . . 0.0 112.707 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.5 -64.74 0.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.543 HD23 HG21 ' A' ' 133' ' ' VAL . 4.8 mp -57.7 -27.12 62.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.64 -55.06 24.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.1 ttp -64.2 -40.96 97.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.008 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.15 -30.97 79.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.59 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.04 -35.85 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -63.72 -30.7 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.7 m -55.76 -51.91 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -53.52 -44.48 69.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.524 HD21 ' HE3' ' B' ' 144' ' ' MET . 97.6 mt -58.91 154.09 39.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 19.5 Cg_endo -60.01 146.91 94.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.369 2.046 . . . . 0.0 112.126 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 31.4 Cg_exo -61.42 142.41 95.39 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.327 2.018 . . . . 0.0 112.105 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.423 -1.209 . . . . 0.0 112.57 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 54.2 m -104.92 175.21 5.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.946 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 26.2 m 65.32 130.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.205 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -156.51 -29.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.73 162.67 15.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 43.9 t -66.1 170.8 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.999 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -67.13 -48.76 67.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.99 14.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 11.1 mm-40 -72.28 -54.95 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.772 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 51.8 ttm -64.63 -25.89 68.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.47 HG23 ' HG2' ' A' ' 155' ' ' LYS . 93.5 mt -73.55 -53.43 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.402 ' O ' ' HE1' ' A' ' 151' ' ' MET . . . -57.24 -47.77 80.54 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.509 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.634 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.08 -45.69 93.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.543 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.38 49.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.09 -34.36 89.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.867 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.638 ' HG ' ' HE1' ' A' ' 151' ' ' MET . 58.4 mt -61.25 -56.13 24.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.895 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.58 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -69.13 -21.97 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -82.71 -26.25 32.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.556 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.524 ' HE3' HD21 ' A' ' 186' ' ' LEU . 48.2 ttp -80.47 -39.23 28.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.542 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 77.8 p -59.2 -19.49 45.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.637 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -119.23 -15.36 9.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.846 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -71.26 -19.28 77.34 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.795 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 62.97 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.611 0.243 . . . . 0.0 111.29 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -136.58 -45.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.969 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.547 ' HG1' ' H ' ' B' ' 152' ' ' ASN . 5.8 t -82.94 143.54 46.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.055 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.95 -16.79 29.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.411 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . 0.547 ' H ' ' HG1' ' B' ' 150' ' ' THR . 24.7 t-20 -96.46 6.69 48.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 70.1 m 65.68 144.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.102 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 47.1 t 61.59 104.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.339 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.28 120.64 12.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 53.9 m -144.01 155.36 43.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 55.4 m -91.9 -1.35 57.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.538 ' HB3' ' HD3' ' B' ' 159' ' ' PRO . 44.9 tp -74.44 -48.3 5.46 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' B' ' 158' ' ' LEU . 52.6 Cg_exo -54.93 -72.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.191 1.928 . . . . 0.0 112.542 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 80.0 p -163.84 -9.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.197 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.541 HG23 ' H ' ' B' ' 163' ' ' CYS . 25.3 m 65.39 148.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.242 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 57.6 m -132.32 6.83 4.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . 0.541 ' H ' HG23 ' B' ' 161' ' ' THR . 63.6 m -128.94 80.12 73.37 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.19 30.52 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.675 2.25 . . . . 0.0 112.062 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.2 t70 58.69 66.95 2.25 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.861 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.52 129.47 5.0 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.664 2.243 . . . . 0.0 112.239 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 20.6 t -125.69 96.58 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.123 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 94.1 p 50.01 22.09 0.84 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.394 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 35.9 m -80.82 154.46 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.326 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 47.6 t -156.37 -16.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.828 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -159.48 -9.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.692 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 65.34 124.9 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.038 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.85 179.06 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.307 2.005 . . . . 0.0 112.246 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.03 -143.04 10.87 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.445 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.82 -29.55 63.51 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.645 2.23 . . . . 0.0 112.643 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.7 m -128.75 167.64 16.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.027 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -125.93 153.73 18.52 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.423 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -152.59 119.99 5.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.693 0.282 . . . . 0.0 111.137 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 59.99 -86.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.493 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 78.3 p -115.93 -47.49 2.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 71.6 m -60.89 99.99 0.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.007 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.1 t -162.11 115.2 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.653 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.04 -134.83 8.67 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.6 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 4.8 t -151.48 -32.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -158.08 -47.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.28 -179.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.607 0.241 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 65.34 130.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.187 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.12 103.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.413 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 16.4 tppt? -132.06 145.29 51.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.574 HG12 ' HG ' ' B' ' 142' ' ' LEU . 58.9 t -71.41 -32.04 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 36.8 tt0 -57.67 -39.21 76.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.934 0.397 . . . . 0.0 110.504 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.808 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.4 -41.51 98.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.132 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.73 -44.23 96.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.84 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.5 m -55.74 -40.03 71.95 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -65.63 -34.52 78.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.086 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.425 HD21 HD22 ' B' ' 138' ' ' LEU . 28.2 tp -61.96 -48.58 79.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.241 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.36 -31.46 72.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.17 -43.61 94.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.614 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.19 -47.83 80.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -58.2 -39.14 78.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.333 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.8 -31.98 63.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.779 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -54.26 -55.78 24.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.35 -62.79 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.536 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.1 -80.46 0.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.861 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.2 m -58.41 -19.51 36.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.323 . . . . 0.0 111.159 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -122.1 81.39 43.82 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.962 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.31 6.36 3.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.767 2.311 . . . . 0.0 112.197 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -65.92 -56.21 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.216 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -50.46 -36.81 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.474 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.66 -57.93 10.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.448 . . . . 0.0 110.661 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -57.56 -33.47 68.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -62.43 -49.52 75.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.31 -58.14 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.273 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.14 -30.24 70.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.709 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.0 -55.1 36.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.172 0.511 . . . . 0.0 109.709 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mt -54.46 -46.33 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.247 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.683 ' HE2' HD23 ' B' ' 141' ' ' LEU . 69.1 mmm -52.95 -42.91 65.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.681 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -64.66 -39.05 93.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.611 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.75 -40.82 89.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.547 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -77.61 -38.6 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HZ2' HE22 ' B' ' 143' ' ' GLN . 61.0 tptt -62.54 -30.58 71.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.78 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.4 m -89.64 -83.29 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.783 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -178.17 94.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.521 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.1 m -157.37 -73.01 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -103.48 -178.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.319 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -120.23 -175.25 2.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.547 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.0 m -54.58 -51.53 77.74 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.807 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.4 Cg_endo -58.31 -37.03 96.95 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.081 1.854 . . . . 0.0 112.037 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.273 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.39 -45.15 82.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 110.957 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.23 -45.76 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.485 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.6 p -64.68 -55.81 17.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.835 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.561 ' HA ' HE21 ' A' ' 170' ' ' GLN . 99.5 mtt180 -57.66 -53.27 60.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.793 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.66 -41.1 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.787 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 85.2 p -60.77 -44.37 96.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.551 0.215 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' A' ' 167' ' ' ARG . 30.0 pt20 -82.59 -12.02 58.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.0 tp -70.2 -39.18 75.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.566 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -92.83 33.04 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -52.4 112.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 132.01 -46.65 1.05 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.551 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -114.37 95.59 40.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.433 0.158 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.81 3.55 5.41 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.5 2.134 . . . . 0.0 112.376 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -69.83 -60.64 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.29 -35.66 76.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.547 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.17 -49.86 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.784 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.7 ttp -59.29 -38.8 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.68 -25.82 73.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.386 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -77.32 -34.88 55.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.724 0.297 . . . . 0.0 111.06 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -65.54 -16.98 64.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.2 m -70.32 -34.15 72.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.226 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -62.75 -43.62 98.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.559 HD22 ' HE3' ' B' ' 144' ' ' MET . 94.0 mt -58.57 155.72 27.4 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.77 129.09 25.08 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.523 2.149 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.21 171.89 11.94 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.391 2.061 . . . . 0.0 112.252 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.491 -179.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.716 0.293 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.433 ' HG ' ' H ' ' B' ' 128' ' ' THR . 29.9 t 59.93 176.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.164 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.433 ' H ' ' HG ' ' B' ' 127' ' ' SER . 5.7 t -80.2 144.94 32.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.962 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -137.26 -20.64 1.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.966 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.82 164.76 2.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 50.0 m -65.95 -178.31 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.436 ' O ' HG13 ' B' ' 136' ' ' ILE . 39.9 mt-10 -74.41 -41.62 60.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.103 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.87 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.47 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -67.71 -46.68 71.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.0 -28.51 69.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.201 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.483 HG21 ' HG2' ' A' ' 155' ' ' LYS . 96.5 mt -74.91 -53.91 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.449 ' O ' HD23 ' B' ' 141' ' ' LEU . . . -56.71 -49.86 73.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.106 0.479 . . . . 0.0 110.138 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.526 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 4.4 mm? -56.71 -52.54 64.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.243 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.69 -31.66 26.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.67 -51.46 47.07 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.001 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.683 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -68.4 -47.08 68.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.207 0.504 . . . . 0.0 111.338 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.574 ' HG ' HG12 ' A' ' 123' ' ' VAL . 3.6 mm? -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.548 0.213 . . . . 0.0 111.32 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.549 HE22 ' HZ2' ' A' ' 155' ' ' LYS . 9.1 tt0 -86.15 -28.56 23.89 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.66 0.267 . . . . 0.0 111.382 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.559 ' HE3' HD22 ' A' ' 186' ' ' LEU . 55.2 ttp -73.51 -25.78 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.482 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 78.6 p -70.9 -18.07 62.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -111.89 -20.17 12.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.57 -68.97 0.21 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.703 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -158.83 -69.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.715 0.293 . . . . 0.0 110.983 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -68.0 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.592 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 3.5 t -64.24 147.09 97.32 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.88 -20.44 6.95 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.745 2.296 . . . . 0.0 113.269 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -131.19 112.16 12.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.783 0.325 . . . . 0.0 111.203 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 74.0 m 59.7 -155.12 0.36 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.752 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.03 133.66 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 111.061 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.53 -22.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.174 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 64.2 m -73.36 156.59 38.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.2 p -166.18 6.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.794 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.547 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 6.9 mp -91.99 -50.37 0.3 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.671 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 25.9 Cg_endo -61.76 -76.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.088 1.858 . . . . 0.0 112.615 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 47.0 t -72.23 -44.93 62.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.893 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 49.9 m 63.36 -82.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.382 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 47.7 t -133.97 141.8 47.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.013 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 16.3 p -120.2 80.62 28.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -85.69 -8.54 8.21 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.853 2.369 . . . . 0.0 112.973 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.554 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 20.2 t70 -83.07 -53.23 0.6 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.577 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 90.9 Cg_endo -81.62 86.1 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.98 1.786 . . . . 0.0 112.356 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.6 -68.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.816 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 33.5 t -165.67 12.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.788 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.03 147.87 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.117 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' B' ' 181' ' ' CYS . 77.7 p -156.51 113.31 3.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -167.6 -177.17 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.15 119.22 75.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.707 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.13 -54.88 2.25 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.325 2.017 . . . . 0.0 112.327 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -148.97 -84.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.424 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.92 -176.49 2.11 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.574 2.183 . . . . 0.0 112.175 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 67.5 m -74.02 123.78 24.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -154.02 -164.47 12.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.41 -3.3 1.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -73.71 176.25 6.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.1 p -79.5 -176.06 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . 0.405 ' HB2' ' HA ' ' B' ' 170' ' ' SER . 46.4 t -60.14 125.27 23.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.2 m -140.04 3.0 1.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.067 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -84.65 173.16 49.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 92.3 m 58.42 96.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.7 0.286 . . . . 0.0 111.327 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.2 t70 66.87 90.72 0.09 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.126 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.442 -179.391 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.697 0.284 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 59.56 96.2 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.984 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 99.1 mt 58.73 -173.74 0.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -160.17 140.64 11.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.733 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.582 HG21 ' HG ' ' B' ' 142' ' ' LEU . 25.1 t -67.94 -26.28 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.68 -42.31 88.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.035 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -64.96 -33.17 75.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' B' ' 142' ' ' LEU . . . -63.44 -50.12 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.48 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.27 -41.59 89.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.257 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.0 t -55.78 -42.46 75.58 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.37 -35.46 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.01 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.65 -46.0 88.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.746 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.78 -40.3 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.886 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.407 ' HG3' ' NE2' ' A' ' 136' ' ' GLN . 7.6 tp60 -55.34 -42.94 74.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.153 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.63 -47.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.48 -25.08 65.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.654 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.4 tp -75.47 -65.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.295 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' A' ' 132' ' ' GLN . 2.8 mp0 -52.01 -45.7 64.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.388 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -93.16 38.17 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.48 150.75 33.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.523 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.5 t 60.34 11.69 3.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.791 0.329 . . . . 0.0 111.052 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.43 80.09 28.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.693 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.04 9.78 3.2 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.712 2.275 . . . . 0.0 112.56 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -66.09 -61.1 2.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.19 -34.6 57.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.66 -55.88 29.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.982 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -56.05 -49.97 72.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.53 -36.57 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.79 -60.63 2.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.827 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.524 HD21 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.365 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -48.78 80.02 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.36 -48.0 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.082 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.442 ' HB2' ' HB3' ' B' ' 137' ' ' ALA . 81.2 mmm -53.24 -44.67 68.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.615 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.682 ' HB2' ' HZ1' ' A' ' 152' ' ' LYS . 3.0 ttmp? -61.59 -37.28 83.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.543 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.11 -41.12 96.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 0.0 109.895 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -70.35 -41.61 72.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.468 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' B' ' 136' ' ' ILE . 28.6 tptp -65.37 -29.21 69.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.3 t -89.09 -85.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.793 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -178.5 101.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.611 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -165.34 -69.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.974 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.94 175.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.337 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.78 -171.95 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.972 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 61.3 m -53.53 -51.99 70.99 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.671 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 161' ' ' THR . 22.3 Cg_endo -61.68 -34.01 84.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.835 1.69 . . . . 0.0 111.686 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.67 93.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.089 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.72 -45.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.84 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.105 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -67.08 -56.6 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -55.59 -49.21 73.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.227 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.7 t -62.9 -34.56 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.564 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.3 t -59.34 -47.65 84.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.487 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.77 -15.68 56.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.5 tp -77.81 -31.01 51.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -118.99 24.55 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.33 -23.3 62.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.144 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -59.55 -32.51 73.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.804 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.32 108.31 10.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.525 0.163 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.33 -15.13 48.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.393 2.062 . . . . 0.0 112.425 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.93 -52.95 63.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.849 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.65 -33.93 70.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.572 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.31 -46.72 94.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.8 tpp -61.59 -48.06 82.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -26.05 72.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.547 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -78.81 -37.41 40.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.643 0.259 . . . . 0.0 111.111 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.62 -30.49 71.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.024 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.9 m -60.85 -39.7 90.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.415 ' O ' ' HB3' ' B' ' 145' ' ' SER . 59.6 m-85 -58.46 -52.0 67.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.492 HD22 ' HE2' ' B' ' 144' ' ' MET . 96.0 mt -54.33 149.05 21.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.658 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 21.8 Cg_endo -60.8 140.56 91.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.357 2.038 . . . . 0.0 111.944 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.37 154.51 58.18 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.355 2.036 . . . . 0.0 112.281 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.561 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.813 0.34 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 55.6 m -138.88 163.57 31.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 5.9 t -142.73 -29.12 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.378 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -74.72 -32.89 62.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.04 179.18 7.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.857 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 89.5 p -104.49 -169.88 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.945 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.04 -38.52 79.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.185 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.53 68.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.512 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.524 ' HA ' HD21 ' A' ' 148' ' ' LEU . 0.9 OUTLIER -69.58 -47.9 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.189 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.1 ttm -60.69 -31.53 70.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.532 HG22 ' HG2' ' A' ' 155' ' ' LYS . 77.0 mt -76.57 -53.18 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.347 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 151' ' ' MET . . . -53.88 -47.63 70.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.579 HD12 HD11 ' B' ' 141' ' ' LEU . 4.5 mm? -66.69 -38.33 86.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.06 -53.17 45.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.011 0.434 . . . . 0.0 109.837 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.54 -31.0 79.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.589 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.579 HD11 HD12 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -58.34 -56.07 26.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 179.211 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 126' ' ' ALA . 3.1 mm? -75.7 -17.3 59.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -83.12 -26.17 31.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.736 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.492 ' HE2' HD22 ' A' ' 186' ' ' LEU . 62.5 ttp -91.09 -32.25 15.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 185' ' ' PHE . 57.3 m -80.09 14.67 1.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.397 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.413 ' HG3' ' N ' ' B' ' 147' ' ' GLY . 4.1 pt20 -126.25 -131.86 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.474 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.413 ' N ' ' HG3' ' B' ' 146' ' ' GLN . . . 62.64 91.32 0.02 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.651 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -68.86 -60.67 2.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.772 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -140.34 16.33 2.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.5 t -171.22 145.63 1.89 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.66 127.03 17.62 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.358 2.039 . . . . 0.0 112.128 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 15.2 m120 64.29 119.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.932 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 77.9 m -51.37 115.84 1.78 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.956 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 13.6 p -151.51 -17.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 62.59 108.3 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.273 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 49.9 m -125.13 165.87 17.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' B' ' 161' ' ' THR . 48.7 m -151.03 5.72 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.567 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 62.3 tp -99.89 -50.09 0.2 Allowed Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.791 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 41.7 Cg_endo -67.36 -64.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.066 1.844 . . . . 0.0 112.643 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' B' ' 159' ' ' PRO . 85.8 p -98.71 -25.02 14.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.453 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.496 HG22 ' H ' ' B' ' 163' ' ' CYS . 20.6 m 66.21 146.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.094 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 74.0 p -136.72 14.73 3.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.372 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . 0.496 ' H ' HG22 ' B' ' 161' ' ' THR . 78.7 m 61.57 101.78 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.096 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.1 -52.3 6.07 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.588 2.192 . . . . 0.0 113.077 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.564 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 17.0 t70 -93.08 -49.9 0.28 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 35.5 Cg_exo -60.9 98.67 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.08 1.854 . . . . 0.0 112.329 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 47.6 t -137.59 -66.53 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.27 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 44.0 t -167.38 2.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.169 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 13.6 p -66.37 142.84 16.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.061 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 51.8 m -107.03 -171.69 1.93 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.088 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.56 151.56 51.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 24.5 t70 55.24 86.43 0.17 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.118 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.5 ' HB3' ' H ' ' B' ' 182' ' ' SER . 54.3 Cg_endo -69.58 -47.75 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.589 2.193 . . . . 0.0 112.409 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.25 -155.38 21.34 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.584 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.26 -23.49 20.85 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.403 2.069 . . . . 0.0 112.354 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 50.6 m -149.29 126.45 11.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -175.14 29.16 0.08 OUTLIER Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.764 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 55.51 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.663 0.268 . . . . 0.0 111.282 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -151.06 -12.44 0.22 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.936 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.3 p -87.19 150.88 23.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . 0.436 ' HA ' ' HB3' ' B' ' 173' ' ' PRO . 27.0 p -78.24 147.0 34.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 50.2 m -147.86 18.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.776 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.28 -33.57 71.02 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.617 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 56.9 m -75.87 112.8 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.688 0.28 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.46 -36.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.216 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.717 0.294 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 62.36 175.1 0.14 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.966 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.58 91.97 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.955 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -137.0 127.32 26.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.592 HG21 ' HG ' ' B' ' 142' ' ' LEU . 61.2 t -57.57 -40.29 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.677 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.22 -40.72 74.51 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.691 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.76 -37.24 86.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.197 0.522 . . . . 0.0 109.727 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' B' ' 142' ' ' LEU . . . -61.53 -41.81 97.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.987 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.04 -42.24 98.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.976 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m -55.47 -43.39 75.48 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -61.66 -38.13 86.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.1 tp -58.86 -44.59 91.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.992 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.25 -37.05 85.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.932 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.27 -35.61 80.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.399 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 178' ' ' LEU . 85.3 t -67.32 -55.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.857 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.09 -40.05 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.729 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.64 -37.98 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.145 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.496 ' HG2' HD21 ' A' ' 178' ' ' LEU . 5.8 tp-100 -57.86 -61.04 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.989 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 140' ' ' GLN . 92.6 m-85 -76.82 -1.62 29.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.17 -83.06 1.35 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.678 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.9 t -146.58 24.16 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.002 0.43 . . . . 0.0 110.44 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 137' ' ' PHE . 3.6 pm0 -46.42 118.78 4.95 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.52 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -92.87 -11.91 1.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.029 2.486 . . . . 0.0 111.797 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -84.67 -63.5 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.296 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.417 ' HB ' ' HG3' ' A' ' 140' ' ' GLN . 3.3 t -58.36 -50.2 79.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.267 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -52.76 -58.51 6.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.142 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -54.96 -42.45 72.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.391 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -62.35 -38.16 88.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.464 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.61 -59.16 4.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.327 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.552 HD22 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -63.29 -34.29 77.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.299 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.12 -52.16 66.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.448 . . . . 0.0 109.836 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.2 mt -55.99 -48.32 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.49 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 71.1 mmm -55.38 -35.0 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.951 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -72.18 -34.18 68.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.28 -45.34 91.92 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -69.14 -33.05 72.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.892 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.3 tptt -74.8 -21.79 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.0 t -107.22 18.46 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.742 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 62.29 99.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.1 m -153.67 -65.29 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.09 165.38 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.96 -179.46 6.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.592 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 81.9 m -61.35 -50.06 85.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.63 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.31 -29.35 83.72 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.021 1.814 . . . . 0.0 111.912 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.8 -39.28 65.7 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.01 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.7 -44.16 79.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 110.996 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.43 -43.75 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.7 -56.01 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -54.5 39.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.23 -36.81 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -59.49 -49.39 77.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.818 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -80.31 -12.15 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.4 tp -76.9 -19.83 56.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -125.62 29.18 6.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.986 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -55.6 -21.54 18.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.52 -53.08 46.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -120.37 98.03 48.73 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.399 0.142 . . . . 0.0 110.996 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.7 -14.98 23.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.467 2.111 . . . . 0.0 112.388 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.49 -54.33 48.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.496 HD21 ' HG2' ' A' ' 136' ' ' GLN . 3.8 mm? -57.21 -41.98 80.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.388 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.42 -35.85 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.812 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -63.8 -53.09 56.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.49 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.12 -22.88 72.82 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.235 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -72.77 -47.27 48.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.342 . . . . 0.0 111.03 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.97 -20.86 65.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.4 m -60.79 -36.09 78.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.811 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -70.9 -49.1 49.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.6 HD21 ' HE1' ' B' ' 144' ' ' MET . 75.8 mt -51.61 147.84 10.58 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.048 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.53 123.93 13.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 -170.32 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.313 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.305 -1.275 . . . . 0.0 112.511 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.695 0.283 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 81.8 p -102.54 142.67 33.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.806 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 75.7 m -141.4 133.25 27.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -109.9 -1.46 17.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.421 ' N ' HD13 ' B' ' 130' ' ' LEU . 6.2 mp -101.18 147.76 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.984 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 49.6 m -74.76 -174.92 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.703 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.31 -35.33 71.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.052 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.94 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.498 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.552 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -71.95 -46.43 57.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtp -65.68 -31.34 72.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.435 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 88.7 mt -74.94 -53.73 15.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.164 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -55.5 -49.52 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.611 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.477 HD13 HD12 ' B' ' 141' ' ' LEU . 4.4 mm? -62.49 -42.94 99.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.666 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.35 59.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.92 80.1 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.582 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.477 HD12 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -60.77 -56.54 19.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.739 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.592 ' HG ' HG21 ' A' ' 123' ' ' VAL . 2.9 mm? -69.4 -22.12 63.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.02 -26.8 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.6 ' HE1' HD21 ' A' ' 186' ' ' LEU . 55.2 ttp -80.84 -40.19 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.888 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 79.4 p -104.22 98.4 8.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.149 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -108.76 -71.4 0.76 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.8 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.656 ' HA3' ' HB2' ' B' ' 152' ' ' ASN . . . -159.92 -69.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.553 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 51.89 73.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 111.174 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.562 ' HG2' HG22 ' B' ' 150' ' ' THR . 62.2 tt0 -175.84 -71.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.706 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.744 ' H ' ' HD2' ' B' ' 151' ' ' PRO . 4.0 t 177.04 -34.56 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.744 ' HD2' ' H ' ' B' ' 150' ' ' THR . 58.5 Cg_endo -70.83 -51.8 0.28 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.336 1.357 . . . . 0.0 112.152 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . 0.656 ' HB2' ' HA3' ' B' ' 147' ' ' GLY . 84.6 m-20 -86.56 -82.79 0.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.666 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 98.2 m -66.04 174.25 2.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.696 0.284 . . . . 0.0 110.753 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 32.2 m -131.78 11.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.455 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.91 -74.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.12 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 75.0 p 54.06 -177.17 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.48 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' SER . . . . . 0.518 ' HA ' ' HB ' ' B' ' 161' ' ' THR . 48.0 t -165.08 -29.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.815 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.612 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 3.8 mm? -60.7 -50.0 87.17 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.675 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 9.3 Cg_endo -51.21 -74.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.218 1.945 . . . . 0.0 112.44 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 79.0 p -170.71 14.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.665 0.269 . . . . 0.0 111.355 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.518 ' HB ' ' HA ' ' B' ' 157' ' ' SER . 45.7 m -61.47 -47.75 84.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.811 0.338 . . . . 0.0 110.846 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 39.2 t -140.9 120.76 13.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 82.1 m 56.18 80.84 0.27 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.298 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.64 -48.46 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.543 2.162 . . . . 0.0 112.215 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 26.0 t70 -103.51 -47.93 0.16 Allowed Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.653 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 35.0 Cg_exo -60.88 111.54 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.14 1.893 . . . . 0.0 112.506 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.69 -47.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 85.8 p -149.75 -21.24 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.789 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 60.7 t 60.68 -86.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.312 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 77.6 p -171.54 -61.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 110.764 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -135.74 179.99 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.799 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 18.8 t70 59.51 98.32 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.26 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.01 140.32 24.4 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.552 2.168 . . . . 0.0 112.581 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -149.92 -72.08 0.01 OUTLIER Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.479 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.55 -171.02 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.464 2.109 . . . . 0.0 112.114 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 80.3 p -85.78 156.11 20.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 166.67 -139.82 5.97 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.348 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -126.12 -63.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.782 0.325 . . . . 0.0 110.844 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -150.96 -178.57 6.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.624 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 44.1 t 59.03 103.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.29 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 20.4 p 43.32 32.91 0.53 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.658 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 53.8 m -152.71 111.94 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.961 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 160.88 91.82 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 4.7 t -73.81 -20.39 60.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.822 0.344 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -165.95 122.66 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.144 -0.932 . . . . 0.0 111.251 179.847 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.793 0.33 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.502 ' HA ' ' HE ' ' A' ' 120' ' ' ARG . 3.1 mmp_? -114.02 112.68 23.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.9 tp -109.15 122.3 46.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.782 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.83 175.04 5.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.504 HG21 ' HG ' ' B' ' 142' ' ' LEU . 49.1 t -82.05 -44.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.749 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.27 -24.85 45.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.05 -43.56 82.42 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.466 ' HB2' HD23 ' B' ' 142' ' ' LEU . . . -65.33 -35.59 81.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.475 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.86 -42.87 99.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.841 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -60.6 -42.51 96.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -58.79 -39.19 80.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.785 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.413 HD21 HD22 ' B' ' 138' ' ' LEU . 22.8 tp -58.75 -46.91 86.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.0 -37.03 78.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.438 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.517 ' HG3' HE22 ' A' ' 136' ' ' GLN . 5.7 tp-100 -59.6 -51.63 68.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.375 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 178' ' ' LEU . 95.8 t -58.88 -39.88 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.67 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -69.0 -25.81 64.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.787 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.86 -53.57 12.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.517 HE22 ' HG3' ' A' ' 132' ' ' GLN . 2.4 mp0 -60.9 -56.46 20.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -85.52 31.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.126 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.08 -28.8 67.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.481 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.8 p -85.88 -18.48 32.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.826 0.346 . . . . 0.0 110.779 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -130.55 87.21 50.72 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.875 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.36 10.12 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.477 2.118 . . . . 0.0 112.37 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.16 -58.5 4.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.04 -43.96 77.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.06 -52.16 66.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.686 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -58.4 -38.48 77.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.802 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.13 -31.56 71.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -66.44 -60.07 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.558 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.17 -30.52 71.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.04 -48.8 80.21 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.2 mt -56.05 -43.54 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.547 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.506 ' HB3' ' HA ' ' B' ' 137' ' ' ALA . 0.0 OUTLIER -53.38 -48.85 68.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.984 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -58.54 -41.6 85.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.084 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.84 -39.74 78.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.847 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.65 -22.97 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.851 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -84.58 -14.13 49.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.3 m -111.53 15.66 21.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 62.95 93.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.8 m -147.15 -49.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.28 171.57 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.939 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.556 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 5.3 t70 -111.2 -177.23 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.765 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 34.1 m -51.02 -50.58 74.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 33.1 Cg_exo -57.75 -37.09 97.84 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.898 1.732 . . . . 0.0 111.953 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.72 -37.91 89.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.506 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 160' ' ' ASP . 61.5 t -67.18 -45.17 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.756 0.313 . . . . 0.0 110.938 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.63 -43.85 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -66.26 -55.41 16.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.499 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -53.62 -53.9 45.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.345 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.9 -35.72 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 111.097 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 t -57.66 -50.34 73.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.449 HE21 ' HB2' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -79.34 -18.39 52.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 tp -68.49 -35.84 78.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.909 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -100.83 30.15 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.31 113.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 134.96 -32.07 2.63 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.463 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -126.07 93.3 43.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.514 0.197 . . . . 0.0 110.863 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.89 -3.46 12.81 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.474 2.116 . . . . 0.0 112.17 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.64 -53.9 19.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 133' ' ' VAL . 3.6 mm? -64.59 -39.1 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.51 -49.47 84.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.743 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 51.9 ttm -61.01 -43.4 98.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.559 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.44 -25.59 72.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.352 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -78.13 -37.43 46.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.86 -20.2 65.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.3 m -70.63 -37.99 73.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.361 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -62.16 -43.0 99.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.415 HD23 ' HE3' ' B' ' 144' ' ' MET . 84.5 mt -58.33 153.73 36.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.27 114.15 2.22 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.519 2.146 . . . . 0.0 112.245 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.75 152.93 80.22 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.36 2.04 . . . . 0.0 112.231 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.553 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.613 0.244 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 56.8 m 65.61 132.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.061 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 69.8 p -119.99 -20.54 7.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.312 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -129.76 123.07 30.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 92.3 mt -128.57 -168.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.654 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 79.9 p -64.78 162.8 15.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.803 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.84 -40.48 83.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.308 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.66 65.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.423 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -75.82 -47.83 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 92.3 mmm -63.54 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -52.68 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.024 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.26 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.5 mm? -62.99 -39.8 95.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.266 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.32 -47.11 55.91 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.84 -29.2 72.6 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.745 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' B' ' 138' ' ' LEU . 0.2 OUTLIER -62.47 -56.41 18.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.504 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.0 mm? -70.73 -21.55 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.776 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -83.36 -26.78 30.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.902 0.382 . . . . 0.0 110.853 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.462 ' SD ' HG22 ' A' ' 161' ' ' THR . 10.1 tmm? -86.8 -25.37 24.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.151 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 66.9 m -68.01 -17.14 64.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.821 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . 0.487 ' HG3' ' H ' ' B' ' 147' ' ' GLY . 1.6 pt20 -137.45 -100.35 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.154 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.487 ' H ' ' HG3' ' B' ' 146' ' ' GLN . . . 55.42 41.75 81.38 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.627 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -149.91 103.96 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 52.24 70.66 0.54 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.2 t -178.11 145.46 0.53 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.57 93.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.251 1.967 . . . . 0.0 112.178 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -174.46 -77.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.062 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 14.0 p -55.38 -58.08 9.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.301 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 14.8 p -168.74 -23.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 111.235 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.35 163.87 6.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.053 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 49.6 m 59.25 101.0 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.104 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 78.8 p -104.13 4.25 33.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.995 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.549 ' HB2' ' HD3' ' B' ' 159' ' ' PRO . 97.9 mt -87.21 -48.88 0.47 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.728 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' B' ' 158' ' ' LEU . 50.2 Cg_exo -54.13 -66.43 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.141 1.894 . . . . 0.0 112.469 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.408 ' H ' ' H ' ' B' ' 161' ' ' THR . 41.5 t -167.96 -3.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.823 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.408 ' H ' ' H ' ' B' ' 160' ' ' SER . 25.0 m 64.63 -81.98 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.214 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 79.3 p -170.06 156.57 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 64.1 m -130.61 96.44 23.73 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.38 -56.71 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.428 2.085 . . . . 0.0 112.536 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 14.5 t70 -93.15 -48.13 0.29 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.709 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 49.7 Cg_exo -56.18 -179.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.106 1.871 . . . . 0.0 112.608 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.02 27.54 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.252 0.548 . . . . 0.0 109.874 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' SER . . . . . 0.517 ' O ' ' HB ' ' B' ' 169' ' ' VAL . 74.7 m 62.52 -85.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.401 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' B' ' 168' ' ' SER . 7.1 p 165.17 141.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 O-C-N 123.601 0.563 . . . . 0.0 110.936 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 50.7 m -82.16 167.93 18.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.798 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -121.12 14.38 11.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -124.94 77.69 66.18 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.023 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.73 -164.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.506 2.137 . . . . 0.0 112.351 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.23 -151.51 21.78 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.587 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.57 -36.15 15.54 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.585 2.19 . . . . 0.0 112.539 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 59.8 m -135.57 174.95 10.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.987 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 160.26 -173.22 36.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.269 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.07 -32.78 2.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.311 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -103.24 -173.0 2.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.76 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 47.3 t -58.52 -50.33 74.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 27.9 p -100.36 -171.57 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.0 t -172.84 -41.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.936 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -98.31 70.47 0.64 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.491 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 82.2 p -102.06 -17.5 16.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 111.078 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -145.66 -29.78 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.295 -179.819 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -121.91 114.49 21.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.8 tp -115.71 125.27 52.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.461 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 60.9 tptt -107.24 136.64 46.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.977 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.592 HG21 ' HG ' ' B' ' 142' ' ' LEU . 42.0 t -70.43 -33.06 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.461 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 37.4 tt0 -55.33 -36.51 66.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.32 -36.97 85.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.72 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' B' ' 142' ' ' LEU . . . -62.64 -43.02 99.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.089 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.06 -45.3 95.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.066 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.1 t -56.13 -38.16 70.44 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -67.52 -34.5 77.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.072 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.5 HD11 HD23 ' B' ' 138' ' ' LEU . 40.7 tp -61.95 -39.86 93.54 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.824 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.54 -38.55 74.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.177 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -57.2 -42.69 81.72 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.28 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.67 -38.92 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.654 ' HB2' ' HZ1' ' A' ' 134' ' ' LYS . 5.0 ttmp? -61.14 -28.5 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.812 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.2 -51.33 7.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -54.75 -62.54 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.074 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.55 28.34 1.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.66 -29.65 74.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.6 p -81.73 -4.5 56.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.822 0.344 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 142' ' ' GLN . 86.8 mm-40 -139.12 96.55 8.99 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.979 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.0 23.66 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.526 2.151 . . . . 0.0 112.342 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 140' ' ' GLN . 9.1 tt0 -83.69 -63.04 1.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.013 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.1 t -61.12 -51.13 76.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.629 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.23 -55.62 26.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.54 -43.64 84.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.003 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.572 ' HB3' HD22 ' A' ' 171' ' ' LEU . 9.8 t70 -67.45 -25.55 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.844 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -70.21 -59.65 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.2 -35.74 79.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.27 -46.83 88.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 109.843 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.59 -46.89 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.387 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.579 ' HE2' HD11 ' B' ' 141' ' ' LEU . 85.3 mmm -54.19 -48.9 70.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.847 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.3 -34.81 74.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.373 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.55 -38.08 88.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.96 -32.31 65.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.824 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -76.54 -23.14 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.845 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.6 t -98.36 10.36 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.574 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 63.77 95.6 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.043 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -149.65 -51.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.745 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.7 pt -123.46 172.02 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.068 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.92 -175.79 2.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.193 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.9 m -59.38 -51.38 81.82 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.667 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.5 Cg_endo -58.07 -31.42 93.05 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.037 1.825 . . . . 0.0 111.851 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.14 -45.39 62.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.114 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.17 -41.5 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.885 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.4 mt -62.34 -53.63 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.4 m -58.62 -55.67 32.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.766 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -51.74 -54.36 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.95 -35.83 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.428 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 71.0 m -59.4 -47.12 86.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.828 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -84.3 -11.92 55.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.182 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 146' ' ' ASP . 16.1 tp -76.5 -25.1 53.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.25 31.11 5.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.083 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.59 107.49 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.2 -47.0 0.57 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.632 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -124.58 103.57 31.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.01 -0.112 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.91 -9.56 25.28 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.381 2.054 . . . . 0.0 112.252 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -54.38 20.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.05 -44.88 83.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.731 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.68 -41.73 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.2 tpp -62.83 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.61 -30.53 74.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.339 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -72.21 -39.62 68.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.37 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.36 -25.92 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.3 m -63.33 -39.65 95.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -57.54 -51.35 69.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.028 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.494 HD23 ' HE1' ' B' ' 144' ' ' MET . 76.7 mt -53.31 155.1 5.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.093 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.94 117.36 4.72 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.428 2.085 . . . . 0.0 112.337 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.21 135.04 55.82 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.407 2.071 . . . . 0.0 112.191 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.488 179.919 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.873 0.368 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 77.2 p -129.55 -176.4 3.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 57.1 m -73.46 135.5 44.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.114 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -96.01 -61.93 1.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.39 158.14 21.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.117 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.401 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 41.7 t -67.6 171.36 6.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.08 -46.96 69.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.3 -23.79 16.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.401 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 13.3 mm-40 -70.53 -58.1 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 110.953 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 79.7 mtp -63.99 -29.25 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.782 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.83 -53.47 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.293 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.434 ' O ' HD11 ' B' ' 141' ' ' LEU . . . -55.68 -49.34 73.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.542 ' HA ' HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -61.7 -42.21 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.368 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.4 -46.75 56.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.36 -32.56 82.3 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.742 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.579 HD11 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -59.01 -54.02 51.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.592 ' HG ' HG21 ' A' ' 123' ' ' VAL . 2.8 mm? -76.22 -17.95 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.945 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' B' ' 143' ' ' GLN . 1.0 OUTLIER -81.46 -30.63 33.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.41 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.494 ' HE1' HD23 ' A' ' 186' ' ' LEU . 56.7 ttp -83.98 -38.77 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' SER . . . . . 0.407 ' HG ' ' HA ' ' B' ' 142' ' ' LEU . 74.7 p -64.26 -13.36 49.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.073 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -111.39 -10.65 14.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.784 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -128.41 80.1 0.36 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.626 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.88 -54.88 17.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 0.0 110.675 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.528 ' HB2' ' HD2' ' B' ' 151' ' ' PRO . 44.8 mt-30 -72.83 -163.5 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.755 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.518 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 2.0 t -87.13 -31.46 0.41 Allowed Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' B' ' 149' ' ' GLN . 71.8 Cg_endo -83.19 -74.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.529 1.486 . . . . 0.0 112.548 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . 0.483 ' H ' ' HG2' ' B' ' 151' ' ' PRO . 3.5 p-10 -174.01 132.28 0.41 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 36.4 t 61.59 169.53 0.11 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 35.7 m -85.59 5.19 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.87 124.28 30.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.066 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 85.0 p -154.91 130.55 9.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 36.1 t -156.27 8.11 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.541 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 4.0 mm? -100.32 -51.69 0.18 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.91 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.541 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 50.1 Cg_endo -69.23 -60.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.92 1.747 . . . . 0.0 112.78 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.486 ' C ' ' H ' ' B' ' 162' ' ' SER . 45.9 t -97.77 -25.18 15.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.28 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 25.3 m 71.83 -17.48 0.35 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.471 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' SER . . . . . 0.486 ' H ' ' C ' ' B' ' 160' ' ' SER . 41.2 t 57.43 98.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.87 0.367 . . . . 0.0 111.29 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 24.6 p -164.3 63.19 1.07 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.026 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.19 1.03 8.98 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.762 2.308 . . . . 0.0 112.646 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.481 ' N ' ' HD2' ' B' ' 166' ' ' PRO . 22.7 t70 -91.59 -51.19 0.3 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.713 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' B' ' 165' ' ' ASP . 57.0 Cg_endo -70.31 115.92 4.39 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.969 1.779 . . . . 0.0 112.255 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.54 130.53 65.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.1 m -65.2 95.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 48.3 t -134.8 -28.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 32.7 t -151.02 11.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.811 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.8 -82.31 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -150.75 136.0 10.23 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.002 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.18 -161.47 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.542 2.162 . . . . 0.0 112.361 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.22 -77.6 1.28 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.44 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.67 112.15 2.64 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.571 2.18 . . . . 0.0 112.458 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 28.1 t 59.16 179.15 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -129.54 -171.08 12.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.446 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 56.57 23.26 7.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.72 0.295 . . . . 0.0 111.184 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -130.5 -57.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 53.7 m -131.14 -172.37 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 75.0 m -141.85 13.72 2.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 78.7 p -114.27 112.67 23.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.25 121.8 0.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.604 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 3.3 t -101.13 -36.58 8.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.059 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -164.25 -9.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.288 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.83 0.347 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -102.93 117.43 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 tp -150.69 140.72 22.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.031 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -120.38 145.18 47.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.537 HG21 ' HG ' ' B' ' 142' ' ' LEU . 32.4 t -74.78 -38.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.794 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -57.08 -27.62 61.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.825 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.29 -44.22 79.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.48 -31.75 73.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.575 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.62 -49.68 70.13 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.964 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.2 t -54.54 -39.26 67.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.442 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 77.3 t80 -67.34 -33.41 75.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.094 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.469 HD13 HD22 ' B' ' 138' ' ' LEU . 44.7 tp -61.28 -48.87 79.43 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.943 0.402 . . . . 0.0 110.001 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.8 -32.99 74.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.03 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -57.67 -46.75 83.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.23 -45.93 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -61.22 -22.61 64.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.54 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.1 tp -78.57 -58.62 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.982 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.476 ' HA ' HE21 ' A' ' 136' ' ' GLN . 0.1 OUTLIER -55.37 -56.03 24.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.136 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -85.81 37.46 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.33 -27.38 67.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.674 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.3 p -85.66 -22.07 28.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.814 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -123.44 90.01 50.77 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.57 -13.57 13.29 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.536 2.157 . . . . 0.0 112.341 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -56.58 -35.53 68.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.4 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t -72.48 -33.12 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -63.3 -55.55 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -57.17 -37.51 72.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.434 ' HB3' HD12 ' A' ' 171' ' ' LEU . 3.6 m-20 -65.48 -38.5 89.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -64.48 -59.44 4.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.913 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -58.71 -38.9 79.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.827 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.485 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 22.1 t70 -56.18 -47.43 78.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.3 mt -56.0 -48.31 78.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.212 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.505 ' HE1' HD11 ' B' ' 141' ' ' LEU . 82.3 mmm -54.6 -38.43 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.693 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 56.2 mtmt -68.44 -35.78 78.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.47 -42.13 95.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.155 0.502 . . . . 0.0 109.667 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -77.25 -27.5 53.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.208 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.427 ' HG2' HG23 ' B' ' 136' ' ' ILE . 29.4 tptp -73.48 -28.5 61.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.2 m -98.69 -84.44 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -173.04 105.45 0.14 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.704 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.8 t -169.38 -69.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.239 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.2 pt -116.45 168.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.363 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.412 ' O ' HG22 ' A' ' 164' ' ' VAL . 9.2 m-20 -108.95 -172.57 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.552 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.547 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 55.3 m -51.53 -51.0 73.55 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.9 Cg_endo -60.11 -32.7 95.03 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.904 1.736 . . . . 0.0 111.694 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.75 -32.28 70.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 160' ' ' ASP . 57.5 t -73.85 -45.17 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.725 0.298 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.65 -41.78 93.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.9 m -68.31 -54.0 20.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.699 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -58.97 -44.41 91.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.563 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.79 -44.94 99.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 90.6 p -59.73 -36.46 76.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.911 0.386 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -84.15 -17.58 39.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.746 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 146' ' ' ASP . 15.8 tp -75.41 -36.81 60.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.25 28.86 5.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -55.46 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.38 -37.47 1.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.422 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -121.52 99.52 45.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 -1.67 11.45 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.458 2.105 . . . . 0.0 112.301 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.95 -60.27 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.411 ' N ' HD21 ' A' ' 178' ' ' LEU . 3.4 mm? -60.71 -41.86 96.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.95 -39.42 82.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.718 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.4 ttm -62.23 -52.8 62.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.7 69.14 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.305 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.442 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 88.8 t80 -74.62 -37.42 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -67.42 -15.61 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.739 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 27.9 m -74.42 -38.37 63.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -57.43 -41.16 79.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.767 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.496 HD23 ' HE1' ' B' ' 144' ' ' MET . 92.0 mt -59.76 154.92 44.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.77 117.55 5.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.407 2.071 . . . . 0.0 112.356 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.0 150.42 31.05 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.282 1.988 . . . . 0.0 112.248 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.495 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.723 0.297 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -111.2 135.65 51.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 4.1 t -160.92 149.06 15.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -106.65 -32.7 7.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.746 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.432 ' N ' HD13 ' B' ' 130' ' ' LEU . 6.5 mp -75.97 168.26 20.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.744 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 92.4 p -84.26 -176.26 6.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' B' ' 133' ' ' ALA . 0.1 OUTLIER -72.58 -42.2 64.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.191 -179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . 0.4 ' N ' ' HG2' ' B' ' 132' ' ' GLU . . . -54.06 -39.21 66.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.159 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.427 ' HA ' HD22 ' A' ' 148' ' ' LEU . 5.4 mm-40 -64.0 -47.85 78.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.67 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 94.3 mmm -62.48 -27.59 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.11 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.427 HG23 ' HG2' ' A' ' 155' ' ' LYS . 81.1 mt -73.2 -53.49 18.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.119 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.02 -48.07 76.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 110.33 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.502 HD11 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -63.51 -37.72 88.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.385 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.26 -49.53 63.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.96 -33.9 88.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.545 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.505 HD11 ' HE1' ' A' ' 151' ' ' MET . 0.2 OUTLIER -59.08 -56.17 25.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.921 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.537 ' HG ' HG21 ' A' ' 123' ' ' VAL . 3.1 mm? -73.43 -17.33 61.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.44 -26.78 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.831 0.348 . . . . 0.0 110.891 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.496 ' HE1' HD23 ' A' ' 186' ' ' LEU . 55.0 ttp -86.13 -36.95 19.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.605 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 59.7 m -58.51 -18.76 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.691 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -119.5 -21.82 7.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.57 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -82.21 -102.07 0.43 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.512 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 53.98 78.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 54.79 93.61 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.254 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.435 ' H ' ' HB ' ' B' ' 154' ' ' VAL . 6.5 t -168.02 142.98 2.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.047 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.43 21.26 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.391 2.06 . . . . 0.0 112.496 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -102.61 -59.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.991 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 84.2 m -115.99 -41.59 3.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.007 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.435 ' HB ' ' H ' ' B' ' 150' ' ' THR . 67.2 t -71.61 144.93 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.084 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -109.56 108.2 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.3 m -100.99 -172.14 2.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.029 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 59.4 m -136.74 -17.14 1.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.256 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.419 ' HB2' ' HD3' ' B' ' 159' ' ' PRO . 3.9 mm? -82.42 -52.69 0.69 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.465 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' B' ' 158' ' ' LEU . 67.9 Cg_endo -74.5 -58.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.11 1.874 . . . . 0.0 112.534 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.418 ' H ' ' HG2' ' B' ' 159' ' ' PRO . 43.8 t -158.91 118.55 3.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.751 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 67.9 m -60.38 -81.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 42.5 t -174.33 -60.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.726 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 52.8 t 56.2 76.6 0.48 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.11 37.21 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.709 2.273 . . . . 0.0 112.011 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 15.9 t70 62.82 76.59 0.37 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.765 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.42 124.75 12.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.495 2.13 . . . . 0.0 112.265 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.7 114.96 48.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.7 m 55.96 23.84 7.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.39 140.15 12.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.134 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 88.0 p -104.94 -177.33 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.702 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.15 -34.14 6.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . 0.46 ' HA ' ' HD2' ' B' ' 173' ' ' PRO . 13.7 m-20 -141.87 103.76 5.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' B' ' 182' ' ' SER . 9.4 Cg_endo -52.13 -49.3 17.82 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.71 2.273 . . . . 0.0 112.59 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.41 -161.58 31.54 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.367 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.86 -66.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.591 2.194 . . . . 0.0 112.475 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 47.7 t -162.61 166.49 24.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.89 88.08 1.71 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 16.1 t70 60.67 103.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.789 0.328 . . . . 0.0 111.071 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.04 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 46.6 t 62.55 -84.39 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.776 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 27.9 p -170.11 179.98 3.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.578 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 173' ' ' PRO . 41.0 t -56.84 103.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.398 . . . . 0.0 111.083 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 122.34 145.31 6.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.381 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 70.2 p -94.31 -44.66 7.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.798 0.332 . . . . 0.0 111.282 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -110.74 2.19 18.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.95 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.281 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.817 0.341 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -148.79 119.86 7.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.9 tp -78.39 97.99 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.0 tptp -100.03 155.62 17.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.752 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.558 HG23 ' HG ' ' B' ' 142' ' ' LEU . 72.6 t -58.84 -34.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.504 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 38.0 mt-10 -57.68 -23.61 52.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.01 -44.52 72.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.079 0.466 . . . . 0.0 109.819 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' B' ' 142' ' ' LEU . . . -66.5 -37.74 85.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.132 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 123' ' ' VAL . 4.4 mm? -62.12 -43.06 99.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.982 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.9 t -62.72 -38.87 92.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.709 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.96 -50.27 74.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.391 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.583 HD21 HD22 ' B' ' 138' ' ' LEU . 30.4 tp -57.59 -39.87 77.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.22 -39.49 94.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.51 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.98 -45.41 93.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.417 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.644 HG13 HE22 ' A' ' 140' ' ' GLN . 47.3 t -62.09 -41.13 89.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -68.0 -26.77 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.533 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.71 -51.83 15.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -63.53 -69.69 0.26 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.308 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 140' ' ' GLN . 83.2 m-85 -54.93 -35.74 64.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.66 -84.74 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.574 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.2 t -61.8 -70.07 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.536 0.207 . . . . 0.0 111.041 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.644 HE22 HG13 ' A' ' 133' ' ' VAL . 3.6 pt20 35.49 64.04 2.15 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.933 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.86 -56.63 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.44 2.094 . . . . 0.0 112.2 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.05 -34.28 32.9 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.273 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.422 HG13 HD13 ' A' ' 171' ' ' LEU . 2.3 t -57.13 -52.99 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.462 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.03 -59.28 5.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.15 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -51.31 -51.95 49.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.96 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.13 -42.76 81.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -59.19 -60.68 3.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.838 0.351 . . . . 0.0 111.518 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' B' ' 134' ' ' GLU . 6.7 mp -61.58 -34.26 75.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.89 -44.55 96.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.0 -48.22 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.909 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.521 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -55.72 -47.76 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.377 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -56.8 -35.88 69.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.444 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.32 -39.63 92.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -66.97 -37.03 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.014 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.589 ' HB3' ' HZ2' ' A' ' 155' ' ' LYS . 4.0 mmmp? -75.74 -27.55 58.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -91.76 14.34 15.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.455 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 62.99 93.59 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.315 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.4 m -150.77 -70.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.691 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.0 pt -104.95 166.9 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.103 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -103.67 -170.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.799 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.561 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 32.3 m -57.14 -51.03 84.71 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.8 Cg_endo -58.88 -27.86 85.61 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.018 1.812 . . . . 0.0 111.91 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.3 -42.32 50.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.53 -45.07 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.2 mt -64.19 -46.23 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.421 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.4 t -62.5 -57.71 10.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.583 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.6 -56.35 17.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.489 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 75.3 t -57.3 -35.46 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 t -61.74 -40.64 95.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.968 0.413 . . . . 0.0 110.139 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.8 -22.79 56.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.422 HD13 HG13 ' A' ' 143' ' ' VAL . 2.7 tm? -72.44 -38.26 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -94.0 25.42 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.765 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.594 ' HB2' ' HZ2' ' A' ' 173' ' ' LYS . 4.6 ttmp? -53.08 137.8 32.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.99 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.75 88.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.61 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -139.11 85.33 15.9 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.615 0.245 . . . . 0.0 111.181 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.55 2.09 7.75 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.481 2.121 . . . . 0.0 112.36 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -72.59 -63.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.76 -31.75 71.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.97 -52.06 48.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.3 ttp -61.78 -31.86 72.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.25 -26.65 59.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.174 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -80.9 -31.54 35.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 0.0 111.004 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -62.86 -18.98 63.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.3 m -72.52 -37.04 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.946 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -61.58 -45.54 93.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.579 HD23 ' HB3' ' B' ' 145' ' ' SER . 94.9 mt -58.57 145.75 75.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.77 119.14 6.17 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.351 2.034 . . . . 0.0 112.186 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.27 139.0 80.83 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.362 2.041 . . . . 0.0 112.215 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.604 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 79.4 p -100.3 170.5 8.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 69.9 p -101.42 -19.8 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 63.8 -81.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.11 149.68 44.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.91 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 27.7 t -69.21 177.97 2.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.94 -43.38 68.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.88 -21.82 32.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.493 ' HA ' HD22 ' A' ' 148' ' ' LEU . 7.9 mm-40 -70.87 -61.72 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 80.0 mtp -60.53 -26.33 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.26 -50.28 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.443 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.25 -50.02 72.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.583 HD22 HD21 ' A' ' 130' ' ' LEU . 4.6 mm? -61.94 -41.24 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.167 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -46.27 59.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.8 -35.45 90.92 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.644 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.521 HD11 HD11 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -58.45 -56.14 25.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.87 0.366 . . . . 0.0 110.756 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.558 ' HG ' HG23 ' A' ' 123' ' ' VAL . 3.2 mm? -69.6 -22.82 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -77.53 -27.13 51.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' MET . . . . . 0.515 ' HE3' HD22 ' A' ' 186' ' ' LEU . 57.6 ttp -83.44 -36.26 24.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.578 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' SER . . . . . 0.579 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.5 p -118.85 94.7 4.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.895 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -138.45 -53.27 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.009 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.88 -41.82 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.419 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 63.49 7.57 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.816 0.341 . . . . 0.0 111.034 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -159.48 -93.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.483 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.559 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 5.1 t -116.13 -26.84 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' B' ' 150' ' ' THR . 79.8 Cg_exo -45.31 -60.44 0.84 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.829 1.686 . . . . 0.0 113.131 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -146.32 -4.74 0.6 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.609 0.242 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' CYS . . . . . 0.539 ' HG ' HG11 ' B' ' 154' ' ' VAL . 43.1 t -51.86 -70.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.015 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.539 HG11 ' HG ' ' B' ' 153' ' ' CYS . 31.4 m -139.09 -8.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.179 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 60.36 99.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.263 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.1 m -136.27 172.26 13.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 51.3 m -123.09 -13.65 7.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.73 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.478 ' HB2' ' HD3' ' B' ' 159' ' ' PRO . 76.4 mt -64.05 -48.76 77.01 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.418 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' B' ' 158' ' ' LEU . 80.8 Cg_endo -78.35 21.06 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.152 1.901 . . . . 0.0 112.502 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 48.4 t 64.21 117.3 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.315 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 73.6 m -76.19 -61.44 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.024 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 79.4 p -148.38 8.75 0.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 17.4 p -130.66 77.09 76.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.13 -27.94 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.774 2.316 . . . . 0.0 112.862 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.441 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 16.1 t70 -58.26 -51.44 81.78 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.524 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 73.4 Cg_endo -75.02 161.36 38.83 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.961 1.774 . . . . 0.0 112.068 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.556 HG23 ' H ' ' B' ' 168' ' ' SER . 1.4 m -139.67 -59.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.307 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' SER . . . . . 0.556 ' H ' HG23 ' B' ' 167' ' ' VAL . 47.4 t -173.8 -15.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.821 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.0 t 60.74 104.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.131 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 43.6 t -85.11 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -121.74 18.67 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 14.5 t70 65.79 139.42 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' PRO . . . . . 0.552 ' HB3' ' H ' ' B' ' 182' ' ' SER . 17.2 Cg_endo -57.35 127.81 27.01 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.574 2.183 . . . . 0.0 112.277 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.34 -82.76 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.742 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.38 -62.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.523 2.149 . . . . 0.0 112.494 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 41.4 t -157.87 164.79 36.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -155.85 121.48 1.1 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.37 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -92.03 -58.26 2.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -126.87 -18.03 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.157 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.3 p -102.73 178.43 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 20.6 p 43.26 -157.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.553 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.552 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 50.3 m -110.63 -50.11 2.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.995 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' GLY . . . . . 0.5 ' H ' ' HB3' ' B' ' 173' ' ' PRO . . . 77.85 137.09 1.01 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.466 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 40.0 p -103.89 14.86 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 111.399 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -90.47 -13.03 35.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.384 -179.853 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.914 0.388 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 22.0 t -87.78 -33.4 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.61 -37.87 74.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.4 -36.86 83.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -62.72 -44.49 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.376 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.58 -43.69 98.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.094 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -55.68 -39.57 71.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.4 t80 -65.72 -36.17 82.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.828 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.6 tp -61.04 -45.11 96.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.141 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.75 -39.0 93.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.237 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -59.56 -41.49 90.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.53 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 129' ' ' TYR . 59.8 t -67.02 -41.93 87.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.7 -26.43 67.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.412 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.2 -58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.657 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.648 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.37 -58.36 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -55.19 -40.12 70.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.518 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.35 -37.93 86.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.17 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.54 -59.86 4.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.5 mp -59.43 -39.76 84.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.224 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.44 -46.78 80.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 109.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.77 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.379 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.54 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 70.0 mmm -54.56 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.418 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.08 -37.5 75.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.589 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.81 -38.66 86.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.1 0.476 . . . . 0.0 109.801 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -78.6 -31.75 47.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.811 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' B' ' 136' ' ' ILE . 58.4 tptt -68.53 -26.3 65.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.5 t -98.57 -81.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.786 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -177.54 102.16 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -165.01 -66.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -113.86 178.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.527 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 164' ' ' VAL . 9.8 m-20 -112.53 -174.82 2.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 64.8 m -57.99 -51.96 77.93 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.727 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.6 Cg_endo -59.09 -28.65 88.41 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.919 1.746 . . . . 0.0 111.725 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.71 -40.01 65.98 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 160' ' ' ASP . 56.9 t -67.75 -44.38 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.778 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.12 -45.72 97.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.456 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.4 m -66.57 -54.98 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.631 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -54.72 -49.0 71.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.1 t -61.95 -39.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.718 0.294 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.9 t -58.3 -39.45 79.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.334 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -84.12 -18.64 36.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.65 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.1 -21.35 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -111.13 26.63 10.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.913 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 0.5 OUTLIER -57.79 112.43 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.06 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 130.84 -30.31 3.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.589 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -120.97 90.08 46.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.394 0.14 . . . . 0.0 110.751 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.95 -6.48 18.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.579 2.186 . . . . 0.0 112.704 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -70.28 -59.83 2.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.6 mm? -56.62 -42.28 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.95 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.8 tpp -57.56 -42.34 82.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.828 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.42 -18.96 72.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.546 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -75.99 -40.4 53.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.616 0.246 . . . . 0.0 111.332 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -65.43 -20.37 66.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 m -62.28 -36.45 82.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -64.13 -49.65 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.8 mt -59.57 151.64 60.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.85 122.04 10.62 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.432 2.088 . . . . 0.0 112.099 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--N 1.348 0.521 0 C-N-CA 122.177 1.918 . . . . 0.0 112.384 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.813 0.339 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.14 74.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.594 ' HA ' HD23 ' A' ' 148' ' ' LEU . 1.1 pp20? -69.54 -29.98 67.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.229 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 47.5 ttp -68.78 -36.0 77.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.42 HG23 ' HG2' ' A' ' 155' ' ' LYS . 85.8 mt -74.99 -52.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.54 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -55.62 -46.06 77.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.975 0.416 . . . . 0.0 110.683 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.1 mm? -63.85 -46.26 85.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.89 -49.94 28.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.179 0.514 . . . . 0.0 109.76 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.76 -32.21 83.45 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.964 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' B' ' 138' ' ' LEU . 24.1 mt -61.38 -55.51 30.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.708 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 126' ' ' ALA . 3.1 mm? -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.1 -26.34 29.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.211 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.95 -38.26 28.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 54.8 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.082 179.681 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.724 HG22 ' HG ' ' B' ' 142' ' ' LEU . 19.9 t -70.99 -24.85 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.611 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -59.67 -43.52 93.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.634 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.92 -31.6 72.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.103 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.462 ' HB1' HD12 ' B' ' 138' ' ' LEU . . . -62.97 -53.55 52.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.521 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.14 -40.46 85.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.303 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -56.26 -40.93 74.99 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 133' ' ' VAL . 82.1 t80 -65.94 -36.45 83.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.001 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.472 HD22 HD21 ' B' ' 138' ' ' LEU . 28.6 tp -60.9 -44.82 96.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.196 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.78 -39.78 91.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.732 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.82 -47.83 81.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 178' ' ' LEU . 60.7 t -62.22 -47.52 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -70.84 -13.58 62.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.4 tp -81.08 -63.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.347 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.411 ' OE1' HD21 ' A' ' 178' ' ' LEU . 99.1 mt-30 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.533 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.848 0.356 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -58.84 -54.75 43.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.83 -39.34 77.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.217 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB3' HD11 ' A' ' 171' ' ' LEU . 28.4 m-20 -62.2 -40.66 96.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.006 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.92 -60.0 3.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -60.05 -34.83 73.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.207 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.84 -48.06 83.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.7 mt -55.83 -50.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.335 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.543 ' HE2' HD12 ' B' ' 141' ' ' LEU . 80.7 mmm -52.47 -44.4 65.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.02 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -63.04 -36.33 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.19 -39.77 95.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.598 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -78.58 -33.03 47.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 155' ' ' LYS . 9.2 tmtt? -64.81 -43.42 93.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.264 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.1 m -78.79 -84.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -176.7 96.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -152.63 -79.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -103.23 -178.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 m-20 -113.72 -179.23 3.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.9 m -53.84 -50.83 81.64 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.46 -39.37 91.73 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.015 1.81 . . . . 0.0 112.04 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.33 84.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.378 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 160' ' ' ASP . 93.3 t -68.48 -45.34 82.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.94 -44.26 97.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.587 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.4 m -67.05 -55.87 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.562 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 30.8 ttm180 -56.96 -43.26 81.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.397 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.28 -34.12 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.355 . . . . 0.0 110.881 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.4 t -64.35 -41.4 96.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 1.3 pp0? -84.19 -18.91 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 146' ' ' ASP . 20.0 tp -63.45 -38.95 93.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -89.59 30.98 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.6 99.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.28 -33.44 1.34 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.147 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -132.7 88.82 37.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.474 0.178 . . . . 0.0 110.714 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.467 ' HA ' HD12 ' A' ' 179' ' ' ILE . 38.0 Cg_exo -60.75 -7.19 7.0 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.599 2.199 . . . . 0.0 112.653 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.65 -55.94 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.175 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 178' ' ' LEU . 3.2 mm? -59.09 -38.36 79.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.402 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 176' ' ' PRO . 62.6 mt -62.28 -45.35 98.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.7 tpp -62.8 -34.79 78.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.507 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.45 64.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -66.39 -40.82 89.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.81 -18.27 64.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.5 m -74.29 -41.07 61.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.94 -41.02 90.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.593 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.455 HD23 ' OG ' ' B' ' 145' ' ' SER . 85.6 mt -59.91 145.91 83.21 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.686 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 31.5 Cg_exo -59.51 116.06 3.03 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.476 2.118 . . . . 0.0 112.078 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.3 Cg_endo . . . . . 0 C--N 1.348 0.54 0 C-N-CA 122.448 2.099 . . . . 0.0 112.495 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.601 0.239 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.84 -24.61 16.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.512 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.551 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -76.07 -57.47 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 23.3 ptp -60.94 -29.01 69.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -75.48 -51.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.414 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.08 -49.34 74.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 110.106 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -60.87 -42.43 97.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.823 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.575 ' HA ' HD21 ' B' ' 142' ' ' LEU . . . -50.0 -44.81 51.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.11 72.63 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.52 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -61.95 -56.58 17.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.724 ' HG ' HG22 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.0 -15.03 58.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.782 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -82.07 -27.22 33.05 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 54.5 ttp -86.18 -40.42 15.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 14.7 m . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.787 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.746 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.4 tptp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.739 0.304 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.626 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.9 t -56.77 -27.69 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.061 0.457 . . . . 0.0 110.573 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.746 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 42.3 tt0 -57.71 -32.74 67.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.519 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -67.88 -31.88 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.014 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -69.63 -44.05 71.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.12 -44.97 94.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.242 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.6 p -57.93 -40.39 80.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 133' ' ' VAL . 48.3 t80 -63.78 -35.3 80.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.497 HD22 HD21 ' B' ' 138' ' ' LEU . 22.3 tp -61.06 -43.66 98.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.803 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -58.95 -40.98 86.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.389 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 HD12 ' A' ' 178' ' ' LEU . 97.8 t -64.04 -52.63 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -63.03 -21.59 66.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -52.41 8.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.272 -179.767 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.927 0.394 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -63.78 -57.38 10.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.44 -41.63 76.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.635 ' HB3' HD21 ' A' ' 171' ' ' LEU . 9.9 t70 -70.06 -28.1 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.066 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.65 -60.1 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.29 -36.51 80.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.6 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -59.47 -45.16 92.41 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.8 mt -56.94 -44.74 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.588 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 90.5 mmm -55.99 -40.16 72.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.261 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 2.4 mmmp? -61.28 -43.34 99.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -56.19 -46.45 79.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -70.56 -23.15 62.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.687 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -86.18 -12.6 49.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 80.7 p -117.05 20.98 13.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.838 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 62.08 94.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 65.6 m -150.38 -62.41 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.725 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.14 168.29 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -97.83 -179.55 4.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.574 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 27.6 m -54.99 -52.06 74.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.1 Cg_endo -56.3 -30.15 79.44 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.073 1.849 . . . . 0.0 111.786 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.7 58.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.094 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.89 -45.38 80.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.286 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.78 -38.87 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.7 t -62.24 -58.54 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -58.4 -48.39 80.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.198 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.31 -36.4 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.6 t -62.67 -44.14 97.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.408 . . . . 0.0 109.938 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.08 -12.73 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.376 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 146' ' ' ASP . 14.6 tp -84.29 -33.26 24.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -99.86 14.49 30.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -52.61 105.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.46 -39.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.405 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -124.87 95.93 41.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.459 0.171 . . . . 0.0 110.713 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.3 -21.75 72.65 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.677 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.27 -49.06 77.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.192 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -57.31 -45.88 83.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.717 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -67.32 -29.06 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.3 mtt -69.06 -36.0 77.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -88.17 -19.32 53.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.271 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -77.95 -44.03 28.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.62 -19.79 62.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.822 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 23.3 m -66.04 -44.36 84.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -57.68 -47.67 81.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.614 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.58 156.73 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.789 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 32.5 Cg_exo -57.73 155.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.39 2.06 . . . . 0.0 112.243 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.0 112.311 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.742 0.306 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -21.34 6.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.668 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -67.58 -69.04 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 24.4 ptm -63.76 -25.83 68.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.985 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.26 -53.58 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.588 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -56.97 -48.31 78.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.688 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -59.4 -46.71 87.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.332 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.57 -44.88 47.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.991 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.66 -36.44 93.15 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.079 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' B' ' 138' ' ' LEU . 54.1 mt -62.66 -56.61 16.16 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.915 0.388 . . . . 0.0 111.118 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.626 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -65.75 -23.81 66.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.145 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -84.38 -27.2 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.047 0.451 . . . . 0.0 110.705 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 44.8 ttp -74.87 -42.03 58.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.984 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' SER . . . . . 0.544 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 77.9 p . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.913 0.387 . . . . 0.0 111.338 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 123' ' ' VAL . 48.7 tptt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.692 0.282 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.593 HG22 ' HG ' ' B' ' 142' ' ' LEU . 25.3 t -68.65 -36.75 75.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.96 -28.87 64.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.073 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -66.54 -44.19 83.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -62.04 -34.04 75.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.279 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.31 -43.02 95.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.371 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -57.68 -39.28 76.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.0 -30.58 69.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.781 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.471 HD13 HD21 ' B' ' 138' ' ' LEU . 34.0 tp -65.6 -40.94 93.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.048 0.452 . . . . 0.0 110.001 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.43 -40.34 81.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.235 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -57.63 -46.86 83.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.44 -46.71 94.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.774 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -60.53 -26.62 67.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.681 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.6 tp -76.8 -62.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.507 -179.41 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.922 0.391 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.62 -54.28 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.818 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -59.79 -42.98 94.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.378 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -61.53 -36.19 79.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.339 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -66.18 -59.44 3.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' B' ' 134' ' ' GLU . 8.2 mp -60.66 -30.11 69.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.974 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -63.33 -50.22 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -55.63 -51.5 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.493 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 70.8 mmm -53.01 -44.24 67.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.587 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.502 ' HE2' HD12 ' B' ' 136' ' ' ILE . 44.1 tttm -59.61 -38.19 80.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.78 -46.68 86.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.2 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -61.24 -42.76 99.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' B' ' 136' ' ' ILE . 60.6 tptt -70.81 -24.5 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.515 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -97.7 19.05 14.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 61.3 93.13 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.3 t -149.76 -68.57 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.4 pt -111.89 171.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 164' ' ' VAL . 5.3 m-20 -96.29 175.48 6.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.582 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 49.5 m -54.31 -51.17 80.19 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.559 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.36 -33.63 96.54 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.085 1.857 . . . . 0.0 111.878 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.94 -36.83 82.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 160' ' ' ASP . 60.6 t -70.33 -45.19 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.82 -39.01 83.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.4 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.2 m -67.91 -55.71 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.041 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -55.18 -47.18 75.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.004 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -61.76 -39.75 84.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.686 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.6 t -59.31 -39.26 82.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -84.32 -18.1 37.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.884 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.5 tp -77.97 -29.88 50.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.74 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.24 24.05 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -55.8 108.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.92 -41.97 0.8 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.586 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -125.38 103.46 29.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.422 0.153 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.67 -0.14 8.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.075 . . . . 0.0 112.237 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -59.84 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.042 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.7 mm? -58.3 -38.93 78.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.587 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.32 -44.03 94.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.764 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.43 -39.47 83.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.79 66.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.11 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -74.73 -38.38 62.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 110.771 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -70.38 -19.06 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 51.9 m -69.94 -33.48 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.135 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -61.09 -49.95 75.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' B' ' 145' ' ' SER . 62.3 mt -53.84 145.62 30.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.8 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.95 141.11 79.12 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.377 2.051 . . . . 0.0 112.209 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.349 0.565 0 C-N-CA 122.42 2.08 . . . . 0.0 112.17 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.797 0.332 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.4 84.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.48 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -69.28 -28.33 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.812 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -35.7 72.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.502 HD12 ' HE2' ' A' ' 152' ' ' LYS . 73.0 mt -76.28 -50.35 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -56.55 -50.38 72.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.113 0.482 . . . . 0.0 110.197 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.585 HD13 HD13 ' B' ' 141' ' ' LEU . 4.2 mm? -62.25 -41.98 98.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.93 -47.73 43.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.92 -39.82 98.51 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.942 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.585 HD13 HD13 ' B' ' 138' ' ' LEU . 0.3 OUTLIER -56.09 -56.15 24.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.593 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -65.28 -24.78 67.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.478 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -77.27 -26.66 52.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 110.051 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 30.0 mtm -75.64 -38.57 58.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.929 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 73.4 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.835 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.8 tptt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.662 0.268 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.598 HG22 ' HG ' ' B' ' 142' ' ' LEU . 22.4 t -76.22 -44.6 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.674 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.41 -27.29 64.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.752 0.311 . . . . 0.0 110.458 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -66.52 -41.13 89.26 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -64.57 -34.84 79.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.263 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.54 -46.26 86.78 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.464 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -56.78 -37.17 70.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.425 ' O ' HG23 ' A' ' 133' ' ' VAL . 78.8 t80 -69.51 -31.87 70.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.858 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.468 HD22 HD21 ' B' ' 138' ' ' LEU . 44.2 tp -62.46 -52.25 64.27 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.6 -34.9 76.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.646 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -56.91 -45.42 82.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.896 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 HD12 ' A' ' 178' ' ' LEU . 96.0 t -63.34 -47.28 92.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.517 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.54 -19.71 65.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.11 -39.15 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.461 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.4 mm100 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.441 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.75 0.31 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -59.62 -59.05 6.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.984 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -56.51 -45.27 81.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -33.75 75.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.87 -60.02 3.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.3 -34.93 76.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.25 -51.45 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.492 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.439 HD12 HD22 ' A' ' 171' ' ' LEU . 8.0 mt -55.09 -47.47 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.362 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.615 ' HE2' HD12 ' B' ' 141' ' ' LEU . 79.6 mmm -52.83 -42.62 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.927 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.402 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.55 -35.32 72.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.131 0.491 . . . . 0.0 109.779 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -78.88 -38.83 36.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.568 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HG2' HG23 ' B' ' 136' ' ' ILE . 59.0 tptt -65.6 -24.33 67.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.7 t -103.22 8.95 38.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.141 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 62.51 106.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.85 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.2 m -158.21 -53.58 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.423 HD11 HG23 ' A' ' 150' ' ' ILE . 36.5 pt -113.59 15.37 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 164' ' ' VAL . 6.8 m-20 50.5 -165.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.587 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 88.2 m -76.37 -51.58 2.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.923 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 161' ' ' THR . 9.9 Cg_endo -53.21 -35.0 71.94 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.166 1.911 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.04 87.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 160' ' ' ASP . 57.9 t -70.95 -45.27 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.079 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.11 -44.44 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.223 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.8 p -65.94 -58.84 4.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.437 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -54.22 -54.38 40.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.481 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.66 -37.57 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.647 0.261 . . . . 0.0 110.975 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -57.65 -47.78 81.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.841 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -83.77 -11.73 56.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 150' ' ' ILE . 21.5 tp -78.87 -18.74 53.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.192 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -109.58 30.96 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.252 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.51 112.45 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.816 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 141.53 -47.07 0.86 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -117.81 94.97 47.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.421 0.153 . . . . 0.0 110.947 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.35 -4.76 14.4 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.424 2.083 . . . . 0.0 112.382 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.35 -57.02 5.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -57.61 -38.19 74.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -68.42 -38.42 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.4 ttm -63.15 -46.0 89.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.762 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.49 -30.97 63.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.318 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -40.06 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.29 -21.82 66.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.2 m -70.05 -33.62 72.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -66.0 -50.31 64.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.435 ' HA ' ' HB3' ' B' ' 145' ' ' SER . 90.2 mt -51.18 143.84 16.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 53.1 Cg_exo -56.43 111.92 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.474 2.116 . . . . 0.0 112.016 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.3 Cg_endo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.42 2.08 . . . . 0.0 112.36 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.794 0.33 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.81 19.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.63 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -71.12 -57.08 4.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 66.1 mtm -63.51 -23.98 67.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.479 HG23 ' HG2' ' A' ' 155' ' ' LYS . 84.2 mt -75.47 -51.3 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.651 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.44 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -57.34 -50.12 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.055 0.455 . . . . 0.0 110.077 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.566 HD13 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -60.67 -40.82 93.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.58 62.13 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.15 -34.74 90.48 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.63 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.615 HD12 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -59.28 -56.09 26.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.989 0.423 . . . . 0.0 110.74 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.598 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -70.16 -21.13 63.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -82.16 -26.59 33.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 49.3 ttp -81.72 -38.63 25.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.678 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 68.0 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.74 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.72 0.295 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.585 HG22 ' HG ' ' B' ' 142' ' ' LEU . 36.0 t -63.42 -46.91 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.301 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 -31.48 64.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.468 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.3 -39.49 92.58 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.03 -38.7 92.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.609 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.25 -43.21 99.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.17 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -58.81 -40.54 84.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -62.85 -36.15 82.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.994 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.474 HD22 HD21 ' B' ' 138' ' ' LEU . 40.8 tp -62.67 -46.8 86.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.142 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.59 -35.19 78.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.139 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -62.38 -43.06 99.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.245 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.65 -38.42 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.683 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -67.09 -33.5 75.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.721 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -71.21 -51.03 27.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.391 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.559 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.529 0.149 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.15 -59.43 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -58.63 -40.28 82.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.488 ' HB3' HD11 ' A' ' 171' ' ' LEU . 10.2 m-20 -64.85 -34.78 79.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.01 -60.37 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.231 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.45 -40.55 94.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.299 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.46 -47.49 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 109.671 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mt -56.17 -45.93 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.065 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.6 mmm -55.23 -40.33 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.25 -36.38 82.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.23 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.75 -42.69 97.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.19 -23.14 41.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.345 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -69.5 -56.27 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.8 m -73.47 -83.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.7 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -175.6 102.37 0.08 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -156.05 -77.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.8 pt -107.24 171.35 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.249 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -101.28 -176.34 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.596 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 30.6 m -57.08 -50.54 87.61 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.0 Cg_exo -53.61 -32.89 66.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.037 1.824 . . . . 0.0 112.065 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.73 -35.99 66.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.239 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.13 -45.22 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 165' ' ' ILE . 1.9 mp -65.86 -44.7 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.15 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.0 m -61.7 -55.96 24.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.385 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.55 -55.6 32.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.323 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.34 -33.21 30.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -64.33 -49.84 70.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.661 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -78.5 -11.63 59.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 146' ' ' ASP . 3.4 tp -74.82 -45.45 43.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -91.21 27.81 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.987 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.57 104.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.53 -44.18 0.73 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.436 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -117.37 98.37 51.78 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.413 0.149 . . . . 0.0 110.803 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.15 -9.41 26.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.385 2.057 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.46 -56.99 9.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -57.64 -42.01 82.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.663 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.13 -37.79 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.5 ttm -64.6 -43.65 93.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.721 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.31 -23.37 75.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.09 -46.64 33.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 111.037 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.99 -23.14 63.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 79.4 m -66.36 -35.78 81.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -59.41 -43.55 92.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.31 150.43 79.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 24.7 Cg_exo -62.85 124.19 13.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.432 2.088 . . . . 0.0 112.012 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 C--N 1.348 0.538 0 C-N-CA 122.338 2.026 . . . . 0.0 112.414 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.732 0.301 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.78 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.28 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.443 ' O ' HD23 ' B' ' 138' ' ' LEU . 43.5 mt-10 -74.75 -42.05 58.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.16 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtm -66.21 -32.75 74.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.081 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.3 mt -75.19 -53.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.16 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.465 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.64 -48.85 74.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.474 HD21 HD22 ' A' ' 130' ' ' LEU . 4.3 mm? -63.09 -39.89 96.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.45 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.64 -51.97 44.0 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.33 -29.25 74.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.919 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.471 HD13 HD13 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -61.16 -56.65 18.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.798 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.585 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -73.67 -19.71 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.683 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -80.11 -26.67 39.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.278 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 53.4 ttp -84.02 -41.38 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.798 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 46.4 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.204 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.078 0.466 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.8 t -95.86 -26.0 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -58.85 -41.56 87.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.547 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.82 -33.06 75.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -65.42 -41.95 93.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.324 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.42 -44.4 94.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.055 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -55.95 -41.58 74.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 133' ' ' VAL . 43.5 t80 -64.46 -36.94 85.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.715 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 148' ' ' LEU . 19.3 tp -59.96 -45.09 93.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.76 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.29 -37.59 87.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.037 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -60.89 -40.86 94.64 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 178' ' ' LEU . 58.2 t -65.21 -52.97 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.039 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 135' ' ' LEU . 7.2 tt -71.96 -57.75 4.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.853 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -179.618 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.48 -52.53 63.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.668 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.01 -38.81 80.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.684 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.527 ' HB3' HD21 ' A' ' 171' ' ' LEU . 8.8 t70 -65.12 -31.79 73.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.485 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.78 -59.65 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.736 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 130' ' ' LEU . 6.9 mp -63.22 -29.98 71.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.05 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.92 -51.75 66.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 159' ' ' ILE . 10.0 mt -54.54 -48.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.656 ' HE2' HD23 ' B' ' 141' ' ' LEU . 82.4 mmm -53.01 -46.17 68.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.04 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.065 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.05 -37.9 84.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.03 -46.4 84.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.334 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HD3' ' HA2' ' B' ' 140' ' ' GLY . 29.2 mmmt -74.6 -17.94 60.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.678 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.1 t -97.63 11.75 35.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.488 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 62.91 99.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.121 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -161.37 -60.52 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.811 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 150' ' ' ILE . 35.5 pt -116.34 153.45 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.157 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.06 -179.89 6.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.596 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 89.6 m -55.18 -50.75 84.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.799 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.9 Cg_endo -55.72 -39.73 89.37 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.184 1.923 . . . . 0.0 112.148 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.14 -40.68 99.45 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.25 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.39 -42.93 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.12 -43.04 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.422 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.9 t -65.32 -55.14 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.619 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.12 -50.22 74.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.88 -43.05 87.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 87.6 p -60.91 -45.2 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.732 0.301 . . . . 0.0 111.018 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -79.82 -11.71 59.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 146' ' ' ASP . 13.9 tp -72.83 -35.0 67.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.653 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -96.52 33.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -52.42 129.8 29.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.007 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.8 -38.1 3.48 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.254 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -112.22 94.85 27.96 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.407 0.146 . . . . 0.0 110.753 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.59 -4.45 15.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.47 2.113 . . . . 0.0 112.657 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -68.08 -49.04 63.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.036 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.611 HD12 HG22 ' A' ' 133' ' ' VAL . 3.2 mm? -66.41 -35.34 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.12 -44.11 91.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.8 ttm -67.61 -37.39 82.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.23 -35.5 77.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -76.79 -34.39 57.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.725 0.298 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -64.65 -22.73 67.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.1 m -71.12 -37.38 72.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.135 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -57.51 -45.9 84.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.2 150.24 32.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 31.6 Cg_endo -64.55 113.3 2.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.349 2.033 . . . . 0.0 112.173 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 28.2 Cg_endo . . . . . 0 C--N 1.35 0.632 0 C-N-CA 122.354 2.036 . . . . 0.0 112.258 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 CA--C 1.526 0.049 0 CA-C-O 120.647 0.26 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.88 -25.35 19.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.43 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.441 ' O ' HD23 ' B' ' 138' ' ' LEU . 15.7 mm-40 -71.66 -56.27 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.2 mtm -64.02 -25.74 68.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.629 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 99.7 mt -76.19 -53.23 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.429 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -56.54 -50.57 71.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.309 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.526 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 4.6 mm? -58.69 -52.66 64.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.459 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.64 29.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 109.65 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' GLY . . . . . 0.595 ' HA2' ' HD3' ' A' ' 155' ' ' LYS . . . -67.02 -50.95 42.71 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.876 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.656 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -69.13 -46.26 68.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.229 0.515 . . . . 0.0 111.198 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.591 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.7 mm? -58.59 -33.5 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.993 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -83.99 -31.58 25.43 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.855 0.359 . . . . 0.0 111.011 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 59.1 ttp -73.19 -23.97 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.049 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.388 -179.548 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.802 0.334 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.578 HG22 ' HG ' ' B' ' 142' ' ' LEU . 40.0 t -89.99 -35.06 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.32 -34.03 70.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.59 -38.32 86.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 0.0 110.058 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.403 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -65.55 -43.01 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.319 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 123' ' ' VAL . 4.4 mm? -63.15 -34.93 78.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.072 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.3 t -62.56 -48.52 79.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.692 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.47 HD11 HD21 ' A' ' 148' ' ' LEU . 28.8 tp -61.01 -50.58 72.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.65 -25.81 68.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.536 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -65.11 -41.56 94.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.913 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.1 t -70.2 -45.92 73.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.852 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -57.02 -44.66 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.423 ' O ' HD13 ' A' ' 135' ' ' LEU . 3.3 tm? -69.36 -36.28 76.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.063 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.852 0.358 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -53.14 34.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.179 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -54.45 -52.81 60.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.413 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -52.41 -42.05 63.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.399 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -60.12 -56.99 14.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.6 mp -63.91 -25.7 68.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -62.95 -49.38 74.98 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.81 -47.78 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.703 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 76.9 mmm -54.04 -37.06 63.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.774 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -71.8 -32.73 67.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.28 -44.0 89.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.876 0.369 . . . . 0.0 110.02 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.25 -42.86 87.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.936 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' B' ' 136' ' ' ILE . 12.1 tmtt? -62.7 -40.14 96.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.167 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 90.5 p -85.85 13.75 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 64.63 102.37 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.195 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -153.1 -64.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.79 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.2 pt -111.9 168.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -90.8 177.08 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.597 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 27.6 m -57.52 -50.94 85.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.893 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.1 Cg_exo -54.83 -33.12 80.13 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.022 1.814 . . . . 0.0 112.194 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.02 -37.54 83.18 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.25 -45.5 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.97 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.299 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -69.6 -58.31 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.652 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.43 -48.05 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.89 -29.26 69.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.204 0.526 . . . . 0.0 109.758 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -84.09 -18.76 35.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.167 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.29 -43.85 22.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -93.81 30.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.19 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -58.29 -28.29 64.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.25 -48.53 68.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.628 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -116.87 93.56 41.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.406 0.146 . . . . 0.0 110.772 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.79 -14.65 28.01 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.61 2.206 . . . . 0.0 112.645 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.18 -55.82 29.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -56.28 -33.51 65.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.63 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.53 -48.3 78.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.49 -30.73 73.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -71.22 -36.3 71.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 110.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.06 -16.96 62.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.0 m -71.63 -39.82 70.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.177 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -58.23 -49.56 76.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.991 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.82 151.78 11.16 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.521 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 27.8 Cg_endo -62.73 135.46 52.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.333 2.022 . . . . 0.0 112.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 37.4 Cg_exo . . . . . 0 C--N 1.351 0.694 0 C-N-CA 122.445 2.097 . . . . 0.0 112.36 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.65 -27.83 66.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.562 ' HA ' HD23 ' A' ' 148' ' ' LEU . 45.2 mt-10 -77.26 -46.13 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.3 ttm -64.52 -36.41 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.021 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 155' ' ' LYS . 86.2 mt -74.23 -53.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.13 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.28 -46.71 69.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.112 0.482 . . . . 0.0 110.257 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -67.31 -35.28 79.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.427 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.82 -53.87 51.41 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.77 73.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 138' ' ' LEU . 0.8 OUTLIER -64.19 -56.56 13.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.424 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.578 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.6 mm? -70.8 -21.16 62.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.466 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -82.74 -26.5 31.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 58.6 ttp -80.96 -38.99 26.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.013 179.628 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.537 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 17.3 tppt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.778 0.323 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.665 HG22 ' HG ' ' B' ' 142' ' ' LEU . 38.4 t -77.55 -35.35 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.297 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.537 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 35.8 tt0 -56.35 -35.7 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 122' ' ' LYS . 4.4 m-20 -65.3 -39.86 93.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 109.711 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.44 77.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.012 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.59 -51.25 66.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.829 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -55.39 -36.4 66.35 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 133' ' ' VAL . 86.4 t80 -67.98 -32.21 72.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.804 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.516 HD13 HD21 ' B' ' 138' ' ' LEU . 38.1 tp -64.74 -43.16 94.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.887 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.19 -40.52 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.292 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -58.55 -45.94 87.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.601 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 129' ' ' TYR . 92.6 t -63.65 -41.0 91.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.614 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.02 -27.98 69.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.4 -61.2 1.86 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.739 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.791 0.329 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.21 -57.92 10.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.101 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -55.87 -42.44 75.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.298 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.07 -32.59 73.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -68.8 -59.55 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.2 mp -61.26 -31.12 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.195 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.12 -52.12 57.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.4 mt -54.08 -45.04 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.559 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 76.2 mmm -55.52 -48.93 73.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.51 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.26 -35.68 67.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.427 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.75 -43.72 92.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.973 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.65 -34.5 78.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.8 tptp -77.22 -27.55 53.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.389 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 18.24 12.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.59 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 62.43 96.92 0.04 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.838 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.2 m -155.59 -46.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.08 178.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -113.37 -173.35 2.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 93.6 m -58.55 -50.01 90.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.658 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.7 Cg_exo -56.58 -32.49 90.32 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.031 1.82 . . . . 0.0 112.037 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.0 -44.19 68.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.55 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.4 t -65.18 -44.36 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.65 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.453 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -61.2 -58.04 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.578 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -53.19 -56.48 16.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.91 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.4 t -57.65 -34.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.644 0.259 . . . . 0.0 111.321 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.2 t -60.34 -50.4 73.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.835 0.35 . . . . 0.0 110.805 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -80.11 -11.78 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.45 -38.72 65.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.726 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -97.3 23.72 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.808 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -54.49 106.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.63 -32.44 1.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.288 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -129.54 100.84 19.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.413 0.149 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.31 -0.08 9.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.413 2.075 . . . . 0.0 112.548 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.36 -58.75 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.5 mm? -60.54 -39.18 86.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.86 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.21 -42.87 93.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.87 76.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -81.42 -33.6 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.826 0.346 . . . . 0.0 111.115 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -63.13 -26.42 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.1 m -67.87 -37.91 82.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.138 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -56.86 -50.85 71.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.59 156.81 15.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 43.2 Cg_endo -66.98 144.81 71.63 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.251 1.967 . . . . 0.0 112.0 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 51.6 Cg_exo . . . . . 0 C--N 1.348 0.522 0 C-N-CA 122.398 2.066 . . . . 0.0 112.496 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.709 0.29 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.48 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.471 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.425 ' HA ' HD23 ' A' ' 148' ' ' LEU . 46.2 mt-10 -76.8 -49.99 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 58.4 ttp -63.66 -33.33 75.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.5 mt -76.35 -51.75 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.152 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.559 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -57.34 -47.78 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.028 0.442 . . . . 0.0 110.446 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.82 -50.07 73.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.524 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.71 -46.66 40.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.055 0.455 . . . . 0.0 109.96 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.93 -32.95 85.88 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.767 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' B' ' 138' ' ' LEU . 55.8 mt -62.42 -55.01 31.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.308 . . . . 0.0 111.028 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.665 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -68.92 -22.37 64.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -86.32 -26.49 24.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.37 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 161' ' ' THR . 15.7 tmm? -88.21 -24.79 23.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.545 179.508 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.771 0.32 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.607 HG22 ' HG ' ' B' ' 142' ' ' LEU . 26.9 t -83.6 -35.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.95 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.88 -27.44 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.78 -44.41 81.41 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -66.56 -29.48 69.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.9 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 mt -63.51 -54.96 28.1 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.936 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -55.88 -37.07 68.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 133' ' ' VAL . 84.3 t80 -64.0 -34.22 77.51 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.667 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.725 HD13 HD21 ' B' ' 138' ' ' LEU . 28.6 tp -65.56 -42.43 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.86 -38.54 88.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.081 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -59.93 -52.52 65.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.627 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 129' ' ' TYR . 46.5 t -59.18 -39.2 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -76.86 -17.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tt -75.16 -56.58 4.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.793 0.33 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.84 -57.43 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -55.8 -32.86 63.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.154 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.63 -52.28 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -56.2 -56.18 24.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' B' ' 134' ' ' GLU . 8.8 mp -58.83 -37.77 77.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.514 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.67 -42.45 88.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 159' ' ' ILE . 13.9 mt -57.18 -49.71 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.027 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.482 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 83.5 mmm -52.76 -42.58 65.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.487 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 10.3 mtmp? -64.55 -35.63 81.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.209 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.0 -33.44 75.42 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -79.4 -28.42 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.861 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 152' ' ' LYS . 27.6 mmtt -71.46 -59.48 2.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.64 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.2 m -63.27 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -179.32 104.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -165.39 -69.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.197 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 150' ' ' ILE . 40.7 pt -116.23 158.08 16.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.217 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 164' ' ' VAL . 6.2 m-20 -100.86 -172.19 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 84.8 m -52.56 -51.96 68.32 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.265 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.6 Cg_endo -58.56 -38.38 89.96 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.168 1.912 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.61 -42.21 93.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 168' ' ' VAL . 94.5 t -64.27 -45.44 96.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.761 0.315 . . . . 0.0 111.26 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.38 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.482 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.1 m -62.01 -54.46 41.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.567 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 164' ' ' VAL . 87.2 t -58.32 -35.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 69.0 m -64.82 -39.96 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -82.55 -13.89 55.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.97 -49.27 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -96.63 25.22 5.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.183 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.42 -26.22 60.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.947 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.0 -32.71 85.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.409 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -125.81 102.41 28.63 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 120.369 0.128 . . . . 0.0 110.988 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.34 -3.37 9.86 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.435 2.09 . . . . 0.0 112.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.86 -53.78 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -61.15 -35.77 78.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -67.29 -47.97 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.8 ttp -57.46 -42.76 83.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.695 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.27 -32.46 62.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.389 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -67.95 -31.63 71.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 110.574 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -67.35 -23.87 65.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 35.0 m -65.57 -40.68 93.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -57.42 -50.85 71.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.34 146.22 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 23.4 Cg_endo -62.05 114.26 2.23 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.398 2.065 . . . . 0.0 111.977 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 15.6 Cg_endo . . . . . 0 C--N 1.35 0.621 0 C-N-CA 122.461 2.107 . . . . 0.0 112.347 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' B' ' 135' ' ' MET . 11.1 pt-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.551 ' HA ' HD23 ' A' ' 148' ' ' LEU . 13.0 pt-20 -76.45 -41.59 46.85 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' B' ' 132' ' ' GLU . 22.3 ptp -63.29 -33.31 75.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.0 mt -76.48 -53.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.482 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -53.83 -51.01 64.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.725 HD21 HD13 ' A' ' 130' ' ' LEU . 3.9 mt -61.62 -43.67 98.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.02 -37.16 52.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.69 -37.58 76.77 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.598 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.584 HD13 ' HA ' ' B' ' 138' ' ' LEU . 1.5 mp -56.84 -56.03 26.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.046 0.45 . . . . 0.0 110.018 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.607 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -68.52 -24.13 64.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.466 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -75.45 -27.5 58.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.194 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' MET . . . . . 0.442 ' SD ' HG23 ' A' ' 161' ' ' THR . 12.7 ttm -79.46 -40.42 29.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.884 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.943 0.402 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.672 HG22 ' HG ' ' B' ' 142' ' ' LEU . 41.8 t -95.11 -27.65 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.77 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -59.58 -35.35 74.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -68.33 -39.03 82.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.923 0.392 . . . . 0.0 110.539 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -63.99 -44.72 91.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.487 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.479 HD23 HG12 ' A' ' 123' ' ' VAL . 4.5 mm? -61.55 -40.79 95.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.174 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -58.96 -42.16 89.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.8 -40.56 93.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.852 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.451 HD22 HD21 ' B' ' 138' ' ' LEU . 26.2 tp -59.47 -41.56 90.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.191 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.47 -43.09 99.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.56 -41.19 85.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.26 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.93 -46.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.866 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -64.61 -25.55 68.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -72.73 -59.54 2.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.177 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.419 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.756 0.312 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -65.23 -57.66 7.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -56.43 -35.51 67.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.142 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.57 -36.48 73.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.014 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -64.58 -58.36 6.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.971 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.8 mp -60.39 -42.72 96.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.76 -44.86 74.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.117 0.484 . . . . 0.0 109.714 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.06 -47.95 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.235 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.454 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -54.96 -42.41 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.548 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -61.72 -39.64 92.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.262 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.11 -39.74 91.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.066 0.46 . . . . 0.0 109.874 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.81 -21.7 57.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.878 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -86.31 -22.87 26.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.63 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 62.7 m -104.01 16.35 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 61.43 93.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.984 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.8 m -147.6 -61.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.668 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 pt -114.54 155.07 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.407 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 1.1 p30 -83.17 171.75 13.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.621 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 63.5 m -53.67 -51.57 75.14 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.624 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 51.6 Cg_exo -53.03 -32.16 57.08 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.923 1.749 . . . . 0.0 111.896 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.09 62.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.207 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.4 t -66.93 -43.81 89.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.739 0.304 . . . . 0.0 110.813 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -66.1 -43.61 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.171 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.1 p -65.42 -54.06 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.375 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -55.78 -51.26 68.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.309 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.76 -36.16 69.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 t -59.39 -45.74 90.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.524 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -84.09 -11.58 56.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.6 tp -75.96 -26.34 56.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -109.29 30.48 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.57 118.28 4.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.06 -54.84 0.77 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.198 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -109.03 95.72 18.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.76 0.88 4.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.506 2.137 . . . . 0.0 112.643 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.72 -56.02 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.006 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.9 mm? -58.52 -37.7 76.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.7 mt -71.07 -37.78 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.74 -38.64 91.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.13 -28.62 40.38 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.649 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -68.99 -40.98 78.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.8 -21.27 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 m -66.38 -39.96 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.309 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -60.7 -40.37 91.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.26 152.0 44.68 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.614 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.419 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 29.1 Cg_endo -63.63 111.12 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.313 2.009 . . . . 0.0 112.091 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.2 Cg_endo . . . . . 0 C--N 1.35 0.631 0 C-N-CA 122.339 2.026 . . . . 0.0 112.188 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.83 0.348 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.1 -28.74 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.89 -42.87 60.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.6 tpp -65.44 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.41 -52.28 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.48 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -52.47 -47.0 66.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.091 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 130' ' ' LEU . 4.2 mm? -64.74 -38.72 91.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.276 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.39 -46.76 62.95 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.31 -31.42 71.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.584 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.48 HD12 ' O ' ' B' ' 137' ' ' ALA . 0.1 OUTLIER -59.02 -54.95 41.29 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 110.399 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.672 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -73.51 -21.63 60.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.83 -26.3 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.356 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 53.8 ttp -87.51 -34.75 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.689 179.662 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.86 0.362 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.671 HG22 ' HG ' ' B' ' 142' ' ' LEU . 48.7 t -64.03 -31.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.519 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -56.98 -35.87 69.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.17 -37.83 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.11 86.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.119 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.91 -49.3 73.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -55.06 -36.61 65.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 133' ' ' VAL . 64.9 t80 -67.68 -33.55 75.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.83 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.5 tp -62.3 -48.62 79.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.024 0.44 . . . . 0.0 110.041 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.54 -38.54 91.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -57.97 -44.78 87.29 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 110.296 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.537 HG22 HD12 ' A' ' 178' ' ' LEU . 89.2 t -61.88 -48.11 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -68.22 -15.93 63.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.56 -54.87 6.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.48 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.8 mm100 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.435 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.803 0.335 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.26 -55.28 36.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.048 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -54.94 -42.0 71.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.22 -32.04 73.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.201 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.18 -60.53 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.077 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -61.86 -38.75 89.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.004 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.18 -46.14 83.08 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.535 HD12 HD22 ' A' ' 171' ' ' LEU . 3.2 mt -56.99 -45.49 83.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.855 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.566 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 77.4 mmm -55.03 -40.19 69.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.658 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.35 -37.77 88.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.218 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.06 -39.88 93.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 109.856 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.4 -37.46 63.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.818 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HG2' HG23 ' B' ' 136' ' ' ILE . 22.0 tptm -65.93 -27.44 68.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.383 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 92.7 p -102.33 -154.76 0.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.905 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -102.89 87.61 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.812 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.4 t -148.56 -70.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.57 167.21 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.677 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.3 -170.49 1.67 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 56.8 m -53.58 -52.31 68.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.745 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 161' ' ' THR . 10.1 Cg_endo -53.25 -36.39 77.73 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.033 1.822 . . . . 0.0 111.883 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.05 -38.59 88.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.13 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.42 -45.2 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.23 -49.0 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.43 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -62.66 -59.24 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.717 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -52.82 -54.33 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.605 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.25 -35.34 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.676 0.274 . . . . 0.0 111.235 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.3 t -61.3 -46.51 90.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -83.96 -11.79 56.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.535 HD22 HD12 ' A' ' 150' ' ' ILE . 19.1 tp -77.94 -24.76 48.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -113.0 25.68 11.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.65 103.51 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 144.65 -25.97 1.96 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.557 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -125.47 95.12 41.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.388 0.137 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -7.36 21.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.387 2.058 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.88 -54.26 10.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -60.79 -41.92 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.9 mt -63.8 -49.58 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 57.0 ttp -58.89 -35.82 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.6 -20.56 63.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.434 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.99 -41.31 36.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -62.39 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 89.4 m -63.75 -35.9 82.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' B' ' 145' ' ' SER . 97.0 m-85 -65.15 -52.03 57.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' B' ' 145' ' ' SER . 77.2 mt -54.78 148.59 26.27 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 51.3 Cg_exo -54.57 145.44 58.66 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.428 2.085 . . . . 0.0 112.108 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 53.0 Cg_exo . . . . . 0 C--N 1.348 0.509 0 C-N-CA 122.364 2.043 . . . . 0.0 112.402 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.804 0.335 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.24 94.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.725 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 148' ' ' LEU . 39.3 mt-10 -70.97 -39.17 72.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.17 -34.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.501 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.6 mt -75.7 -52.81 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.061 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.566 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -54.24 -48.52 71.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 110.574 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.625 ' HA ' HD12 ' B' ' 141' ' ' LEU . 3.7 mm? -63.9 -43.79 94.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.258 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.13 -47.28 45.65 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.44 -36.66 92.88 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.891 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' B' ' 138' ' ' LEU . 56.9 mt -59.51 -55.32 36.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.919 0.39 . . . . 0.0 110.901 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.671 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -72.76 -18.76 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.332 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.343 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 44.7 ttp -81.76 -39.35 24.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.354 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 145' ' ' SER . . . . . 0.489 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.6 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.882 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.849 0.357 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.608 HG22 ' HG ' ' B' ' 142' ' ' LEU . 30.2 t -67.02 -28.72 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.63 -39.06 79.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.779 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.51 -36.8 84.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 109.969 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -61.77 -45.22 94.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.174 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.082 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -56.99 -38.59 73.26 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 133' ' ' VAL . 67.3 t80 -64.98 -40.67 95.33 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.731 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.32 -36.06 74.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.26 -39.84 74.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.01 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -57.87 -39.21 77.27 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.869 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 178' ' ' LEU . 47.4 t -72.51 -38.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -68.28 -20.58 64.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.288 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.21 -55.9 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.57 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.168 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.451 HG13 HD23 ' A' ' 171' ' ' LEU . 17.0 t . . . . . 0 C--O 1.231 0.094 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.49 -56.78 16.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.908 0.385 . . . . 0.0 110.568 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.8 -36.28 76.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.544 ' HB3' HD11 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -68.85 -31.58 70.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -69.65 -59.7 2.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -38.26 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.496 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 15.1 t70 -58.22 -50.12 74.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -53.74 -44.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.196 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.543 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 75.7 mmm -58.2 -39.66 79.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 55.2 mtmt -67.02 -31.17 71.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.115 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.57 -42.73 86.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.69 -21.82 60.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.818 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.48 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.5 tptp -82.31 -34.61 28.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.9 t -95.2 18.99 11.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 64.04 98.86 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -153.08 -61.92 0.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.567 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.37 172.42 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 164' ' ' VAL . 12.1 m-20 -100.37 -178.33 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.135 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 87.5 m -60.22 -50.04 87.88 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.603 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 53.1 Cg_exo -55.51 -32.95 84.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.964 1.776 . . . . 0.0 111.939 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.49 -40.49 59.66 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.235 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 168' ' ' VAL . 94.4 t -64.9 -45.27 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.94 -49.87 77.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.308 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.4 p -58.89 -53.2 61.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -54.3 -52.31 61.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.397 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 164' ' ' VAL . 81.8 t -61.7 -31.13 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.752 0.311 . . . . 0.0 111.007 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.1 m -64.41 -45.36 87.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.781 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -82.25 -16.5 49.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 146' ' ' ASP . 1.2 tp -76.03 -42.53 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -95.94 15.6 20.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -51.61 120.09 4.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.46 -45.68 0.78 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.36 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -120.45 100.7 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.46 0.172 . . . . 0.0 110.758 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.41 -11.27 13.14 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.489 2.126 . . . . 0.0 112.707 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.5 -64.74 0.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 133' ' ' VAL . 4.8 mp -57.7 -27.12 62.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.64 -55.06 24.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.1 ttp -64.2 -40.96 97.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.008 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.15 -30.97 79.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.59 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.04 -35.85 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -63.72 -30.7 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.7 m -55.76 -51.91 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -53.52 -44.48 69.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.91 154.09 39.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 19.5 Cg_endo -60.01 146.91 94.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.369 2.046 . . . . 0.0 112.126 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 31.4 Cg_exo . . . . . 0 C--N 1.348 0.52 0 C-N-CA 122.327 2.018 . . . . 0.0 112.105 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.787 0.327 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.99 14.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -72.28 -54.95 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.772 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 51.8 ttm -64.63 -25.89 68.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.48 HG23 ' HG2' ' A' ' 155' ' ' LYS . 93.5 mt -73.55 -53.43 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.543 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -57.24 -47.77 80.54 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.509 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.682 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.08 -45.69 93.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.543 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.38 49.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.09 -34.36 89.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.867 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' B' ' 138' ' ' LEU . 58.4 mt -61.25 -56.13 24.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.895 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.608 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -69.13 -21.97 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -82.71 -26.25 32.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.556 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -80.47 -39.23 28.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.542 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.637 179.516 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.621 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 16.4 tppt? . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.893 0.377 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.63 HG13 ' HG ' ' B' ' 142' ' ' LEU . 58.9 t -71.41 -32.04 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.621 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 36.8 tt0 -57.67 -39.21 76.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.934 0.397 . . . . 0.0 110.504 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.808 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.4 -41.51 98.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.132 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.73 -44.23 96.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.84 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.5 m -55.74 -40.03 71.95 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 133' ' ' VAL . 40.8 t80 -65.63 -34.52 78.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.086 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.583 HD22 HD21 ' B' ' 138' ' ' LEU . 28.2 tp -61.96 -48.58 79.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.241 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.36 -31.46 72.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.17 -43.61 94.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.614 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 129' ' ' TYR . 91.0 t -67.19 -47.83 80.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 134' ' ' LYS . 10.9 tmtt? -58.2 -39.14 78.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.8 -31.98 63.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.779 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 -179.717 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.744 0.307 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.66 -57.93 10.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.448 . . . . 0.0 110.661 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -57.56 -33.47 68.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' HD11 ' A' ' 171' ' ' LEU . 58.0 m-20 -62.43 -49.52 75.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.31 -58.14 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.273 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.14 -30.24 70.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.709 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.0 -55.1 36.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.172 0.511 . . . . 0.0 109.709 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mt -54.46 -46.33 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.247 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.761 ' HE2' HD23 ' B' ' 141' ' ' LEU . 69.1 mmm -52.95 -42.91 65.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.681 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -64.66 -39.05 93.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.611 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.75 -40.82 89.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.547 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -77.61 -38.6 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.507 ' HG2' HG23 ' B' ' 136' ' ' ILE . 61.0 tptt -62.54 -30.58 71.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.78 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.4 m -89.64 -83.29 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.783 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -178.17 94.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.521 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.1 m -157.37 -73.01 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -103.48 -178.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.319 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 164' ' ' VAL . 20.9 m-20 -120.23 -175.25 2.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.559 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.0 m -54.58 -51.53 77.74 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.807 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.4 Cg_endo -58.31 -37.03 96.95 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.081 1.854 . . . . 0.0 112.037 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.273 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 160' ' ' ASP . 87.0 t -68.39 -45.15 82.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 110.957 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.23 -45.76 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.485 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.6 p -64.68 -55.81 17.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.835 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -57.66 -53.27 60.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.793 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.66 -41.1 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.787 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 85.2 p -60.77 -44.37 96.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.551 0.215 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -82.59 -12.02 58.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 146' ' ' ASP . 19.0 tp -70.2 -39.18 75.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.566 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -92.83 33.04 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -52.4 112.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 132.01 -46.65 1.05 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.551 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -114.37 95.59 40.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.433 0.158 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.81 3.55 5.41 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.5 2.134 . . . . 0.0 112.376 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -69.83 -60.64 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 178' ' ' LEU . 3.3 mm? -60.29 -35.66 76.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.547 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.17 -49.86 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.784 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.7 ttp -59.29 -38.8 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.68 -25.82 73.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.386 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -77.32 -34.88 55.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.724 0.297 . . . . 0.0 111.06 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -65.54 -16.98 64.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.2 m -70.32 -34.15 72.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.226 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -62.75 -43.62 98.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.57 155.72 27.4 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.847 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.77 129.09 25.08 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.523 2.149 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.349 0.572 0 C-N-CA 122.391 2.061 . . . . 0.0 112.252 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.434 ' O ' HG13 ' B' ' 136' ' ' ILE . 39.9 mt-10 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.649 0.262 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.87 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.498 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -67.71 -46.68 71.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.0 -28.51 69.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.201 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.507 HG23 ' HG2' ' A' ' 155' ' ' LYS . 96.5 mt -74.91 -53.91 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.86 73.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.106 0.479 . . . . 0.0 110.138 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 130' ' ' LEU . 4.4 mm? -56.71 -52.54 64.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.243 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.69 -31.66 26.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.67 -51.46 47.07 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.001 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.761 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -68.4 -47.08 68.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.207 0.504 . . . . 0.0 111.338 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.63 ' HG ' HG13 ' A' ' 123' ' ' VAL . 3.6 mm? -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.548 0.213 . . . . 0.0 111.32 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -86.15 -28.56 23.89 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.66 0.267 . . . . 0.0 111.382 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -73.51 -25.78 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.482 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.793 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.694 0.283 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.627 HG22 ' HG ' ' B' ' 142' ' ' LEU . 25.1 t -67.94 -26.28 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.68 -42.31 88.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.035 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -64.96 -33.17 75.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -63.44 -50.12 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.48 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.27 -41.59 89.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.257 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.0 t -55.78 -42.46 75.58 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.37 -35.46 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.01 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.65 -46.0 88.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.746 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.78 -40.3 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.886 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.405 ' HG3' ' NE2' ' A' ' 136' ' ' GLN . 7.6 tp60 -55.34 -42.94 74.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.153 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.63 -47.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.48 -25.08 65.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.654 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.4 tp -75.47 -65.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.295 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 132' ' ' GLN . 2.8 mp0 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.388 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.834 0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.66 -55.88 29.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.982 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -56.05 -49.97 72.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.53 -36.57 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.79 -60.63 2.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.827 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.365 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -48.78 80.02 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.36 -48.0 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.082 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.403 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 81.2 mmm -53.24 -44.67 68.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.615 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.425 ' HG3' HG21 ' B' ' 136' ' ' ILE . 3.0 ttmp? -61.59 -37.28 83.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.543 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.11 -41.12 96.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 0.0 109.895 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -70.35 -41.61 72.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.468 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.547 ' HG2' HG23 ' B' ' 136' ' ' ILE . 28.6 tptp -65.37 -29.21 69.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.3 t -89.09 -85.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.793 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -178.5 101.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.611 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -165.34 -69.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.974 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.94 175.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.337 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.78 -171.95 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.972 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.533 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 61.3 m -53.53 -51.99 70.99 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.671 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 161' ' ' THR . 22.3 Cg_endo -61.68 -34.01 84.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.835 1.69 . . . . 0.0 111.686 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.67 93.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.089 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.72 -45.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.84 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.105 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -67.08 -56.6 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -55.59 -49.21 73.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.227 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.7 t -62.9 -34.56 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.564 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.3 t -59.34 -47.65 84.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.487 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.77 -15.68 56.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.5 tp -77.81 -31.01 51.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -118.99 24.55 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.33 -23.3 62.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.144 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -59.55 -32.51 73.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.804 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.32 108.31 10.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.525 0.163 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.33 -15.13 48.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.393 2.062 . . . . 0.0 112.425 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.93 -52.95 63.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.849 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.9 mm? -58.65 -33.93 70.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.572 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.31 -46.72 94.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.8 tpp -61.59 -48.06 82.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -26.05 72.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.547 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -78.81 -37.41 40.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.643 0.259 . . . . 0.0 111.111 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.62 -30.49 71.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.024 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.9 m -60.85 -39.7 90.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' B' ' 145' ' ' SER . 59.6 m-85 -58.46 -52.0 67.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.33 149.05 21.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.658 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 21.8 Cg_endo -60.8 140.56 91.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.357 2.038 . . . . 0.0 111.944 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo . . . . . 0 C--N 1.347 0.498 0 C-N-CA 122.355 2.036 . . . . 0.0 112.281 -179.746 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.705 0.288 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.53 68.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.512 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.545 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.9 OUTLIER -69.58 -47.9 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.189 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.1 ttm -60.69 -31.53 70.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.547 HG23 ' HG2' ' A' ' 155' ' ' LYS . 77.0 mt -76.57 -53.18 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.347 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.88 -47.63 70.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.634 HD13 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -66.69 -38.33 86.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.06 -53.17 45.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.011 0.434 . . . . 0.0 109.837 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.54 -31.0 79.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.589 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.634 HD13 HD13 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -58.34 -56.07 26.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 179.211 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.705 HD11 ' HB2' ' A' ' 126' ' ' ALA . 3.1 mm? -75.7 -17.3 59.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -83.12 -26.17 31.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.736 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 62.5 ttp -91.09 -32.25 15.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 145' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 57.3 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.397 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.4 tptt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.821 0.343 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.64 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.2 t -57.57 -40.29 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.677 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.22 -40.72 74.51 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.691 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.76 -37.24 86.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.197 0.522 . . . . 0.0 109.727 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -61.53 -41.81 97.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.987 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.04 -42.24 98.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.976 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m -55.47 -43.39 75.48 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.4 t80 -61.66 -38.13 86.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.1 tp -58.86 -44.59 91.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.992 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.25 -37.05 85.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.932 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.27 -35.61 80.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.399 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 178' ' ' LEU . 85.3 t -67.32 -55.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.857 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.09 -40.05 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.729 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.64 -37.98 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.145 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.475 ' HG2' HD21 ' A' ' 178' ' ' LEU . 5.8 tp-100 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.989 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.784 0.326 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -52.76 -58.51 6.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.142 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -54.96 -42.45 72.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.391 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB3' HD11 ' A' ' 171' ' ' LEU . 63.0 m-20 -62.35 -38.16 88.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.464 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.61 -59.16 4.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.327 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -63.29 -34.29 77.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.299 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.12 -52.16 66.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.448 . . . . 0.0 109.836 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.2 mt -55.99 -48.32 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.482 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 71.1 mmm -55.38 -35.0 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.951 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -72.18 -34.18 68.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.28 -45.34 91.92 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -69.14 -33.05 72.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.892 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG2' HG23 ' B' ' 136' ' ' ILE . 61.3 tptt -74.8 -21.79 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.349 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.0 t -107.22 18.46 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.742 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 62.29 99.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.1 m -153.67 -65.29 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.09 165.38 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.96 -179.46 6.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.6 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 81.9 m -61.35 -50.06 85.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.63 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.31 -29.35 83.72 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.021 1.814 . . . . 0.0 111.912 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.8 -39.28 65.7 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.01 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.7 -44.16 79.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 110.996 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.43 -43.75 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.7 -56.01 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -54.5 39.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.23 -36.81 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -59.49 -49.39 77.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.818 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.31 -12.15 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 146' ' ' ASP . 12.4 tp -76.9 -19.83 56.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -125.62 29.18 6.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.986 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -55.6 -21.54 18.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.52 -53.08 46.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -120.37 98.03 48.73 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.399 0.142 . . . . 0.0 110.996 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.7 -14.98 23.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.467 2.111 . . . . 0.0 112.388 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.49 -54.33 48.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -57.21 -41.98 80.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.388 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.42 -35.85 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.812 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -63.8 -53.09 56.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.49 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.12 -22.88 72.82 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.235 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.451 ' HE1' HD21 ' B' ' 141' ' ' LEU . 83.9 t80 -72.77 -47.27 48.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.342 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.97 -20.86 65.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.4 m -60.79 -36.09 78.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.811 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -70.9 -49.1 49.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 75.8 mt -51.61 147.84 10.58 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.048 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.53 123.93 13.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.313 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.732 0.301 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.94 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.498 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.564 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -71.95 -46.43 57.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtp -65.68 -31.34 72.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.435 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.409 HG23 ' HG2' ' A' ' 155' ' ' LYS . 88.7 mt -74.94 -53.73 15.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -55.5 -49.52 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.611 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -62.49 -42.94 99.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.666 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.35 59.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.92 80.1 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.582 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -60.77 -56.54 19.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.739 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.64 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -69.4 -22.12 63.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -82.02 -26.8 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -80.84 -40.19 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.888 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.149 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.687 0.279 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.531 HG22 ' HG ' ' B' ' 142' ' ' LEU . 49.1 t -82.05 -44.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.749 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.27 -24.85 45.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.05 -43.56 82.42 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.544 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -65.33 -35.59 81.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.475 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.86 -42.87 99.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.841 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -60.6 -42.51 96.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -58.79 -39.19 80.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.785 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.489 HD22 HD21 ' B' ' 138' ' ' LEU . 22.8 tp -58.75 -46.91 86.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.0 -37.03 78.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.438 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -59.6 -51.63 68.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.375 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.552 HG22 HD12 ' A' ' 178' ' ' LEU . 95.8 t -58.88 -39.88 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.67 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -69.0 -25.81 64.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.787 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.86 -53.57 12.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.295 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.847 0.355 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.06 -52.16 66.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.686 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -58.4 -38.48 77.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.802 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.13 -31.56 71.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -66.44 -60.07 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.558 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.17 -30.52 71.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.04 -48.8 80.21 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.2 mt -56.05 -43.54 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.547 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.518 ' HB3' ' HA ' ' B' ' 137' ' ' ALA . 0.0 OUTLIER -53.38 -48.85 68.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.984 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -58.54 -41.6 85.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.084 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.84 -39.74 78.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.847 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.65 -22.97 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.851 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -84.58 -14.13 49.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.3 m -111.53 15.66 21.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 62.95 93.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.8 m -147.15 -49.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.28 171.57 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.939 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.569 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 5.3 t70 -111.2 -177.23 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.765 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 34.1 m -51.02 -50.58 74.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 33.1 Cg_exo -57.75 -37.09 97.84 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.898 1.732 . . . . 0.0 111.953 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.72 -37.91 89.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.506 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 160' ' ' ASP . 61.5 t -67.18 -45.17 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.756 0.313 . . . . 0.0 110.938 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.63 -43.85 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -66.26 -55.41 16.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.499 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -53.62 -53.9 45.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.345 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.9 -35.72 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 111.097 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 t -57.66 -50.34 73.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -79.34 -18.39 52.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 tp -68.49 -35.84 78.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.909 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -100.83 30.15 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.31 113.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 134.96 -32.07 2.63 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.463 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -126.07 93.3 43.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.514 0.197 . . . . 0.0 110.863 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.89 -3.46 12.81 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.474 2.116 . . . . 0.0 112.17 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.64 -53.9 19.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.552 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -64.59 -39.1 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.51 -49.47 84.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.743 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 51.9 ttm -61.01 -43.4 98.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.559 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.44 -25.59 72.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.352 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -78.13 -37.43 46.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.86 -20.2 65.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.3 m -70.63 -37.99 73.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.361 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -62.16 -43.0 99.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.33 153.73 36.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 28.5 Cg_endo -62.27 114.15 2.22 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.519 2.146 . . . . 0.0 112.245 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 37.1 Cg_endo . . . . . 0 C--N 1.348 0.523 0 C-N-CA 122.36 2.04 . . . . 0.0 112.231 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 CA--C 1.524 -0.036 0 CA-C-O 120.682 0.277 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.66 65.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.423 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -75.82 -47.83 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 92.3 mmm -63.54 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -52.68 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.024 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.26 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 130' ' ' LEU . 4.5 mm? -62.99 -39.8 95.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.266 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.32 -47.11 55.91 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.84 -29.2 72.6 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.745 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.476 HD12 ' O ' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -62.47 -56.41 18.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 126' ' ' ALA . 3.0 mm? -70.73 -21.55 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.776 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -83.36 -26.78 30.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.902 0.382 . . . . 0.0 110.853 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 144' ' ' MET . . . . . 0.469 ' SD ' HG23 ' A' ' 161' ' ' THR . 10.1 tmm? -86.8 -25.37 24.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.151 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.821 179.288 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.499 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 60.9 tptt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.837 0.351 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.621 HG22 ' HG ' ' B' ' 142' ' ' LEU . 42.0 t -70.43 -33.06 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.499 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 37.4 tt0 -55.33 -36.51 66.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.32 -36.97 85.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.72 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -62.64 -43.02 99.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.089 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.06 -45.3 95.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.066 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.1 t -56.13 -38.16 70.44 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -67.52 -34.5 77.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.072 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.516 HD13 HD21 ' B' ' 138' ' ' LEU . 40.7 tp -61.95 -39.86 93.54 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.824 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.54 -38.55 74.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.177 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -57.2 -42.69 81.72 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.28 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.67 -38.92 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -61.14 -28.5 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.812 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.2 -51.33 7.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.074 -179.707 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.603 0.24 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.23 -55.62 26.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.54 -43.64 84.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.003 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' HB3' HD21 ' A' ' 171' ' ' LEU . 9.8 t70 -67.45 -25.55 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.844 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -70.21 -59.65 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.2 -35.74 79.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.27 -46.83 88.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 109.843 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.59 -46.89 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.387 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.575 ' HE2' HD12 ' B' ' 141' ' ' LEU . 85.3 mmm -54.19 -48.9 70.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.847 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.3 -34.81 74.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.373 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.55 -38.08 88.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.96 -32.31 65.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.824 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -76.54 -23.14 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.845 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.6 t -98.36 10.36 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.574 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 63.77 95.6 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.043 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -149.65 -51.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.745 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.7 pt -123.46 172.02 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.068 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.92 -175.79 2.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.193 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.9 m -59.38 -51.38 81.82 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.667 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.5 Cg_endo -58.07 -31.42 93.05 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.037 1.825 . . . . 0.0 111.851 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.14 -45.39 62.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.114 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.17 -41.5 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.885 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.4 mt -62.34 -53.63 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.4 m -58.62 -55.67 32.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.766 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -51.74 -54.36 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.95 -35.83 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.428 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 71.0 m -59.4 -47.12 86.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.828 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -84.3 -11.92 55.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.182 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 146' ' ' ASP . 16.1 tp -76.5 -25.1 53.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.25 31.11 5.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.083 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.59 107.49 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.2 -47.0 0.57 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.632 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -124.58 103.57 31.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.01 -0.112 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.91 -9.56 25.28 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.381 2.054 . . . . 0.0 112.252 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -54.38 20.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -57.05 -44.88 83.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.731 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.68 -41.73 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.2 tpp -62.83 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.61 -30.53 74.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.339 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -72.21 -39.62 68.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.37 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -61.36 -25.92 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.3 m -63.33 -39.65 95.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 145' ' ' SER . 93.6 m-85 -57.54 -51.35 69.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.31 155.1 5.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.093 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 41.0 Cg_endo -66.94 117.36 4.72 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.428 2.085 . . . . 0.0 112.337 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 34.2 Cg_exo . . . . . 0 C--N 1.35 0.607 0 C-N-CA 122.407 2.071 . . . . 0.0 112.191 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.765 0.317 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.3 -23.79 16.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -70.53 -58.1 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 79.7 mtp -63.99 -29.25 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.782 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.83 -53.47 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.293 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.481 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.68 -49.34 73.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 130' ' ' LEU . 4.4 mm? -61.7 -42.21 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.368 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.4 -46.75 56.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.36 -32.56 82.3 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.742 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.575 HD12 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -59.01 -54.02 51.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.621 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.8 mm? -76.22 -17.95 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.945 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -81.46 -30.63 33.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.41 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 56.7 ttp -83.98 -38.77 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 145' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 185' ' ' PHE . 74.7 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.073 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.821 0.344 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.56 HG22 ' HG ' ' B' ' 142' ' ' LEU . 32.4 t -74.78 -38.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.794 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -57.08 -27.62 61.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.825 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.29 -44.22 79.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -63.48 -31.75 73.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.575 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.62 -49.68 70.13 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.964 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.2 t -54.54 -39.26 67.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.34 -33.41 75.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.094 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.503 HD13 HD21 ' B' ' 138' ' ' LEU . 44.7 tp -61.28 -48.87 79.43 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.943 0.402 . . . . 0.0 110.001 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.8 -32.99 74.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.03 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -57.67 -46.75 83.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.23 -45.93 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -61.22 -22.61 64.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.54 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.1 tp -78.57 -58.62 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.982 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.136 -179.616 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -63.3 -55.55 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -57.17 -37.51 72.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.451 ' HB3' HD11 ' A' ' 171' ' ' LEU . 3.6 m-20 -65.48 -38.5 89.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -64.48 -59.44 4.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.913 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -58.71 -38.9 79.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.827 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.518 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 22.1 t70 -56.18 -47.43 78.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.3 mt -56.0 -48.31 78.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.212 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.497 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.3 mmm -54.6 -38.43 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.693 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 56.2 mtmt -68.44 -35.78 78.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.47 -42.13 95.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.155 0.502 . . . . 0.0 109.667 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -77.25 -27.5 53.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.208 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' B' ' 136' ' ' ILE . 29.4 tptp -73.48 -28.5 61.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.2 m -98.69 -84.44 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -173.04 105.45 0.14 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.704 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.8 t -169.38 -69.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.239 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.402 HD13 ' HD2' ' A' ' 167' ' ' ARG . 47.2 pt -116.45 168.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.363 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 164' ' ' VAL . 9.2 m-20 -108.95 -172.57 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.552 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 55.3 m -51.53 -51.0 73.55 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.9 Cg_endo -60.11 -32.7 95.03 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.904 1.736 . . . . 0.0 111.694 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.75 -32.28 70.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 160' ' ' ASP . 57.5 t -73.85 -45.17 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.725 0.298 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.65 -41.78 93.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.9 m -68.31 -54.0 20.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.699 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.402 ' HD2' HD13 ' A' ' 159' ' ' ILE . 95.6 mtt180 -58.97 -44.41 91.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.563 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.79 -44.94 99.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 90.6 p -59.73 -36.46 76.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.911 0.386 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -84.15 -17.58 39.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.746 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 146' ' ' ASP . 15.8 tp -75.41 -36.81 60.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.25 28.86 5.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -55.46 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.38 -37.47 1.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.422 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -121.52 99.52 45.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 -1.67 11.45 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.458 2.105 . . . . 0.0 112.301 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.95 -60.27 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.4 mm? -60.71 -41.86 96.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.95 -39.42 82.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.718 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.4 ttm -62.23 -52.8 62.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.7 69.14 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.305 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.4 ' HE1' HD21 ' B' ' 141' ' ' LEU . 88.8 t80 -74.62 -37.42 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -67.42 -15.61 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.739 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 27.9 m -74.42 -38.37 63.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -57.43 -41.16 79.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.767 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 92.0 mt -59.76 154.92 44.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.77 117.55 5.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.407 2.071 . . . . 0.0 112.356 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--N 1.349 0.604 0 C-N-CA 122.282 1.988 . . . . 0.0 112.248 179.798 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.703 0.287 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.21 66.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.159 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.454 ' HA ' HD23 ' A' ' 148' ' ' LEU . 5.4 mm-40 -64.0 -47.85 78.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.67 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 94.3 mmm -62.48 -27.59 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.11 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.442 HG23 ' HG2' ' A' ' 155' ' ' LYS . 81.1 mt -73.2 -53.49 18.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.119 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.408 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.02 -48.07 76.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 110.33 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.514 HD13 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -63.51 -37.72 88.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.385 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.26 -49.53 63.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.96 -33.9 88.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.545 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.514 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -59.08 -56.17 25.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.921 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.56 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -73.43 -17.33 61.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.44 -26.78 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.831 0.348 . . . . 0.0 110.891 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.0 ttp -86.13 -36.95 19.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.605 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 59.7 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.691 179.628 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.0 tptp . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.717 0.294 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.585 HG22 ' HG ' ' B' ' 142' ' ' LEU . 72.6 t -58.84 -34.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 38.0 mt-10 -57.68 -23.61 52.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.01 -44.52 72.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.079 0.466 . . . . 0.0 109.819 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -66.5 -37.74 85.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.132 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 123' ' ' VAL . 4.4 mm? -62.12 -43.06 99.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.982 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.9 t -62.72 -38.87 92.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.709 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.96 -50.27 74.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.391 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.604 HD22 HD21 ' B' ' 138' ' ' LEU . 30.4 tp -57.59 -39.87 77.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.22 -39.49 94.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.51 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.98 -45.41 93.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.417 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.09 -41.13 89.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -68.0 -26.77 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.533 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.71 -51.83 15.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.308 -179.663 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 171' ' ' LEU . 2.3 t . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.75 0.31 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.03 -59.28 5.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.15 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -51.31 -51.95 49.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.96 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.13 -42.76 81.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -59.19 -60.68 3.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.838 0.351 . . . . 0.0 111.518 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.7 mp -61.58 -34.26 75.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.89 -44.55 96.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.0 -48.22 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.909 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.492 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -55.72 -47.76 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.377 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -56.8 -35.88 69.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.444 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.32 -39.63 92.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -66.97 -37.03 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.014 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' A' ' 155' ' ' LYS . 4.0 mmmp? -75.74 -27.55 58.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -91.76 14.34 15.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.455 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 62.99 93.59 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.315 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.4 m -150.77 -70.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.691 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.0 pt -104.95 166.9 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.103 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -103.67 -170.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.799 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 32.3 m -57.14 -51.03 84.71 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.8 Cg_endo -58.88 -27.86 85.61 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.018 1.812 . . . . 0.0 111.91 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.3 -42.32 50.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.53 -45.07 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.2 mt -64.19 -46.23 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.421 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.4 t -62.5 -57.71 10.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.583 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.6 -56.35 17.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.489 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 75.3 t -57.3 -35.46 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 t -61.74 -40.64 95.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.968 0.413 . . . . 0.0 110.139 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.8 -22.79 56.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 171' ' ' LEU . 2.7 tm? -72.44 -38.26 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -94.0 25.42 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.765 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 173' ' ' LYS . 4.6 ttmp? -53.08 137.8 32.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.99 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.75 88.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.61 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -139.11 85.33 15.9 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.615 0.245 . . . . 0.0 111.181 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.55 2.09 7.75 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.481 2.121 . . . . 0.0 112.36 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -72.59 -63.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.3 mm? -61.76 -31.75 71.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.97 -52.06 48.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.3 ttp -61.78 -31.86 72.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.25 -26.65 59.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.174 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -80.9 -31.54 35.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 0.0 111.004 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -62.86 -18.98 63.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.3 m -72.52 -37.04 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.946 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -61.58 -45.54 93.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' B' ' 145' ' ' SER . 94.9 mt -58.57 145.75 75.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.77 119.14 6.17 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.351 2.034 . . . . 0.0 112.186 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo . . . . . 0 C--N 1.35 0.641 0 C-N-CA 122.362 2.041 . . . . 0.0 112.215 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.79 0.328 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.88 -21.82 32.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.514 ' HA ' HD23 ' A' ' 148' ' ' LEU . 7.9 mm-40 -70.87 -61.72 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 80.0 mtp -60.53 -26.33 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.26 -50.28 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.489 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.25 -50.02 72.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 130' ' ' LEU . 4.6 mm? -61.94 -41.24 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.167 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -46.27 59.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.8 -35.45 90.92 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.644 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.572 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -58.45 -56.14 25.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.87 0.366 . . . . 0.0 110.756 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.585 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -69.6 -22.82 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -77.53 -27.13 51.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 57.6 ttp -83.44 -36.26 24.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.578 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 145' ' ' SER . . . . . 0.622 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.5 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.895 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -118.94 -55.08 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.92 -49.25 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.14 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? 65.97 133.08 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 22.0 t -87.78 -33.4 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.61 -37.87 74.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.4 -36.86 83.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -62.72 -44.49 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.376 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.58 -43.69 98.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.094 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -55.68 -39.57 71.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.4 t80 -65.72 -36.17 82.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.828 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.6 tp -61.04 -45.11 96.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.141 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.75 -39.0 93.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.237 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -59.56 -41.49 90.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.53 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 129' ' ' TYR . 59.8 t -67.02 -41.93 87.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.7 -26.43 67.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.412 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.2 -58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.657 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -57.1 -54.39 47.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.95 33.36 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.174 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.12 -28.41 68.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.604 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.0 m -89.97 -8.13 52.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -134.25 79.34 55.8 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.74 3.89 2.95 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.792 2.328 . . . . 0.0 112.438 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.12 -56.15 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.8 -34.57 25.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.269 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.37 -58.36 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -55.19 -40.12 70.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.518 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.35 -37.93 86.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.17 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.54 -59.86 4.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.5 mp -59.43 -39.76 84.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.224 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.44 -46.78 80.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 109.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.77 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.379 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.54 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 70.0 mmm -54.56 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.418 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.08 -37.5 75.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.589 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.81 -38.66 86.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.1 0.476 . . . . 0.0 109.801 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -78.6 -31.75 47.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.811 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' B' ' 136' ' ' ILE . 58.4 tptt -68.53 -26.3 65.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.5 t -98.57 -81.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.786 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -177.54 102.16 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -165.01 -66.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -113.86 178.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.527 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 164' ' ' VAL . 9.8 m-20 -112.53 -174.82 2.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 64.8 m -57.99 -51.96 77.93 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.727 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.6 Cg_endo -59.09 -28.65 88.41 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.919 1.746 . . . . 0.0 111.725 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.71 -40.01 65.98 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 160' ' ' ASP . 56.9 t -67.75 -44.38 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.778 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.12 -45.72 97.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.456 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.4 m -66.57 -54.98 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.631 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -54.72 -49.0 71.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.1 t -61.95 -39.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.718 0.294 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.9 t -58.3 -39.45 79.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.334 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -84.12 -18.64 36.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.65 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.1 -21.35 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -111.13 26.63 10.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.913 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 0.5 OUTLIER -57.79 112.43 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.06 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 130.84 -30.31 3.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.589 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -120.97 90.08 46.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.394 0.14 . . . . 0.0 110.751 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.95 -6.48 18.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.579 2.186 . . . . 0.0 112.704 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -70.28 -59.83 2.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.6 mm? -56.62 -42.28 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.95 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.8 tpp -57.56 -42.34 82.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.828 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.42 -18.96 72.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.546 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -75.99 -40.4 53.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.616 0.246 . . . . 0.0 111.332 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -65.43 -20.37 66.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 m -62.28 -36.45 82.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -64.13 -49.65 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.8 mt -59.57 151.64 60.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.529 ' HG3' ' HG2' ' B' ' 148' ' ' GLU . 18.7 Cg_endo -60.85 122.04 10.62 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.432 2.088 . . . . 0.0 112.099 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.52 -169.84 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.177 1.918 . . . . 0.0 112.384 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.459 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.891 0.377 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.3 t -99.36 112.14 24.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.972 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 70.1 p -96.88 125.97 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -108.53 -164.01 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.67 -173.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.981 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 47.0 t -48.46 153.62 0.74 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.195 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.74 -27.11 61.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.841 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.14 74.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.594 ' HA ' HD23 ' A' ' 148' ' ' LEU . 1.1 pp20? -69.54 -29.98 67.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.229 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 47.5 ttp -68.78 -36.0 77.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.42 HG23 ' HG2' ' A' ' 155' ' ' LYS . 85.8 mt -74.99 -52.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.54 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -55.62 -46.06 77.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.975 0.416 . . . . 0.0 110.683 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.1 mm? -63.85 -46.26 85.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.89 -49.94 28.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.179 0.514 . . . . 0.0 109.76 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.76 -32.21 83.45 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.964 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' B' ' 138' ' ' LEU . 24.1 mt -61.38 -55.51 30.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.708 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 126' ' ' ALA . 3.1 mm? -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.1 -26.34 29.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.211 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.95 -38.26 28.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 54.8 m -64.69 -11.29 34.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.082 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -127.43 -12.32 5.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.84 61.14 4.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.639 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.529 ' HG2' ' HG3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -147.93 12.96 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.659 0.266 . . . . 0.0 111.257 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -142.75 -88.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.288 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.766 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.1 OUTLIER -114.43 -34.73 0.1 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.766 ' HD3' HG23 ' B' ' 150' ' ' THR . 83.1 Cg_exo -49.21 -55.11 4.46 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.825 1.683 . . . . 0.0 112.727 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -121.37 -55.41 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.011 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 31.5 t -65.81 169.34 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.798 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.53 108.58 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -165.99 142.84 5.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 10.8 t 60.09 99.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 53.7 m -86.33 7.92 23.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.548 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 3.1 mm? -76.91 -51.3 2.19 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.649 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 27.9 Cg_endo -61.75 -75.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.134 1.889 . . . . 0.0 112.504 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 45.4 t -163.89 100.82 0.88 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 32.5 m -134.8 -42.3 0.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 45.8 t -90.92 -6.11 54.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 84.5 m -130.6 77.78 75.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.255 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.96 -50.41 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.567 2.178 . . . . 0.0 112.007 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -166.17 65.76 0.96 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.688 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.14 173.11 1.43 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.491 2.128 . . . . 0.0 112.221 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.66 -14.22 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.2 m 58.2 88.2 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.573 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 9.8 p -162.63 142.45 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 48.3 t -151.79 158.37 43.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.771 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -61.43 143.32 56.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.566 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' B' ' 182' ' ' SER . 5.6 m-20 -49.74 105.93 0.57 Allowed Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' B' ' 181' ' ' CYS . 56.3 Cg_endo -93.3 -66.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.839 2.359 . . . . 0.0 112.894 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.44 -157.54 15.38 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.574 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.49 104.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.629 2.219 . . . . 0.0 112.817 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 83.6 p -166.36 21.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.746 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.62 148.24 8.65 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.502 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.69 20.05 4.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.781 0.324 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.42 -75.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.069 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.2 p -165.52 19.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.956 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' CYS . . . . . 0.561 ' HB2' ' HD3' ' B' ' 173' ' ' PRO . 14.7 p -145.99 108.29 4.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.958 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' B' ' 172' ' ' ASP . 47.6 t -179.37 68.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 51.9 -106.39 0.33 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.908 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 74.4 m -154.12 -42.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.953 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -157.13 -22.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.31 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -99.3 163.74 12.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.782 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.26 168.92 16.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -133.89 130.08 37.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.724 HG22 ' HG ' ' B' ' 142' ' ' LEU . 19.9 t -70.99 -24.85 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.611 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -59.67 -43.52 93.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.634 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.92 -31.6 72.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.103 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.462 ' HB1' HD12 ' B' ' 138' ' ' LEU . . . -62.97 -53.55 52.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.521 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.14 -40.46 85.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.303 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -56.26 -40.93 74.99 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 133' ' ' VAL . 82.1 t80 -65.94 -36.45 83.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.001 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.472 HD22 HD21 ' B' ' 138' ' ' LEU . 28.6 tp -60.9 -44.82 96.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.196 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.78 -39.78 91.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.732 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.82 -47.83 81.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 178' ' ' LEU . 60.7 t -62.22 -47.52 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -70.84 -13.58 62.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.4 tp -81.08 -63.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.347 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.411 ' OE1' HD21 ' A' ' 178' ' ' LEU . 99.1 mt-30 -50.77 -58.39 6.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.533 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -58.0 -68.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.684 0.278 . . . . 0.0 110.796 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.94 -85.55 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.761 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -63.91 -10.61 21.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.666 0.269 . . . . 0.0 111.153 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -119.1 77.44 16.36 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.66 2.06 8.81 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.67 2.247 . . . . 0.0 112.391 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -62.25 -60.37 3.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.9 t -53.66 -35.47 26.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -58.84 -54.75 43.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.83 -39.34 77.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.217 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB3' HD11 ' A' ' 171' ' ' LEU . 28.4 m-20 -62.2 -40.66 96.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.006 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.92 -60.0 3.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -60.05 -34.83 73.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.207 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.84 -48.06 83.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.7 mt -55.83 -50.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.335 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.543 ' HE2' HD12 ' B' ' 141' ' ' LEU . 80.7 mmm -52.47 -44.4 65.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.02 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -63.04 -36.33 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.19 -39.77 95.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.598 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -78.58 -33.03 47.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 155' ' ' LYS . 9.2 tmtt? -64.81 -43.42 93.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.264 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.1 m -78.79 -84.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -176.7 96.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -152.63 -79.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -103.23 -178.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 m-20 -113.72 -179.23 3.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.9 m -53.84 -50.83 81.64 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.46 -39.37 91.73 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.015 1.81 . . . . 0.0 112.04 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.33 84.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.378 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 160' ' ' ASP . 93.3 t -68.48 -45.34 82.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.94 -44.26 97.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.587 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.4 m -67.05 -55.87 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.562 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 30.8 ttm180 -56.96 -43.26 81.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.397 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.28 -34.12 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.355 . . . . 0.0 110.881 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.4 t -64.35 -41.4 96.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 1.3 pp0? -84.19 -18.91 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 146' ' ' ASP . 20.0 tp -63.45 -38.95 93.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -89.59 30.98 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.6 99.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.28 -33.44 1.34 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.147 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -132.7 88.82 37.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.474 0.178 . . . . 0.0 110.714 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.467 ' HA ' HD12 ' A' ' 179' ' ' ILE . 38.0 Cg_exo -60.75 -7.19 7.0 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.599 2.199 . . . . 0.0 112.653 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.65 -55.94 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.175 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 178' ' ' LEU . 3.2 mm? -59.09 -38.36 79.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.402 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 176' ' ' PRO . 62.6 mt -62.28 -45.35 98.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.7 tpp -62.8 -34.79 78.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.507 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.45 64.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -66.39 -40.82 89.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.81 -18.27 64.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.5 m -74.29 -41.07 61.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.94 -41.02 90.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.593 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.455 HD23 ' OG ' ' B' ' 145' ' ' SER . 85.6 mt -59.91 145.91 83.21 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.686 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 31.5 Cg_exo -59.51 116.06 3.03 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.476 2.118 . . . . 0.0 112.078 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.3 Cg_endo -62.93 139.64 75.0 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.448 2.099 . . . . 0.0 112.495 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.333 179.791 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.683 0.278 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 55.2 m 59.24 -173.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 8.6 t -168.79 -26.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.255 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -63.01 -31.89 73.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.004 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.412 ' HB2' ' HG2' ' B' ' 134' ' ' GLU . 2.4 pt? -63.65 134.39 55.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 66.2 m -71.16 -175.59 1.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.56 -39.43 81.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.178 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.84 -24.61 16.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.512 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.551 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -76.07 -57.47 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 23.3 ptp -60.94 -29.01 69.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -75.48 -51.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.414 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.08 -49.34 74.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 110.106 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -60.87 -42.43 97.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.823 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.575 ' HA ' HD21 ' B' ' 142' ' ' LEU . . . -50.0 -44.81 51.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.11 72.63 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.52 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -61.95 -56.58 17.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.724 ' HG ' HG22 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.0 -15.03 58.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.782 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -82.07 -27.22 33.05 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 54.5 ttp -86.18 -40.42 15.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 14.7 m -89.86 85.34 6.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.787 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -133.65 -70.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.432 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.77 79.45 0.21 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 187' ' ' PRO . 11.7 tp10 -83.67 104.98 14.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.948 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 58.18 20.31 6.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.241 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.2 t -132.78 139.57 35.01 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.018 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.76 95.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.401 2.067 . . . . 0.0 112.352 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -160.76 -61.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -92.25 -83.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.71 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 p -175.55 -23.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.686 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.28 109.17 1.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 48.8 m -152.58 168.65 24.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.719 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.8 p -153.27 -25.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.451 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 7.2 mp -73.96 -50.49 5.37 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.326 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 75.7 Cg_endo -76.21 6.04 4.18 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.172 1.914 . . . . 0.0 112.368 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 52.5 m 64.31 113.95 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.216 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 22.5 m -58.53 147.19 32.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 49.8 m -123.79 170.58 10.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.227 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 73.8 m -138.39 80.55 27.27 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.11 -10.92 6.65 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.835 2.357 . . . . 0.0 112.541 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.554 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 20.9 t70 -92.31 -48.36 0.31 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.865 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 6.7 Cg_exo -74.6 22.66 0.39 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.483 2.122 . . . . 0.0 112.854 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.2 -67.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 111.007 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.9 m -153.11 12.1 0.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.76 -71.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.207 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 47.7 t -131.05 -33.91 1.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.65 99.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.39 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' B' ' 173' ' ' PRO . 27.5 t70 57.05 94.97 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.207 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.695 ' HB3' ' H ' ' B' ' 182' ' ' SER . 33.9 Cg_endo -64.59 -27.9 61.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.457 2.105 . . . . 0.0 112.141 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.72 -75.69 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.321 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.0 -169.85 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.66 2.24 . . . . 0.0 112.203 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 60.3 m -94.27 141.15 28.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.15 87.86 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.56 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.53 108.5 3.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.95 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -159.29 -65.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -149.04 173.24 13.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -94.63 139.55 31.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.692 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.695 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 62.2 m -134.91 6.61 3.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.014 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -96.44 84.25 0.82 Allowed Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.562 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 80.9 p -105.03 -2.71 24.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 111.001 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.72 -48.15 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.206 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.842 0.354 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -72.06 -17.18 62.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.753 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.82 103.09 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.965 0.412 . . . . 0.0 110.531 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.746 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.4 tptp -100.11 138.91 36.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.617 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.626 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.9 t -56.77 -27.69 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.061 0.457 . . . . 0.0 110.573 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.746 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 42.3 tt0 -57.71 -32.74 67.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.519 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -67.88 -31.88 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.014 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -69.63 -44.05 71.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.12 -44.97 94.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.242 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.6 p -57.93 -40.39 80.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 133' ' ' VAL . 48.3 t80 -63.78 -35.3 80.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.497 HD22 HD21 ' B' ' 138' ' ' LEU . 22.3 tp -61.06 -43.66 98.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.803 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -58.95 -40.98 86.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.389 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 HD12 ' A' ' 178' ' ' LEU . 97.8 t -64.04 -52.63 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -63.03 -21.59 66.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -52.41 8.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -54.01 -71.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.272 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -59.5 -72.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.786 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.0 0.15 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.9 p -59.56 -15.23 16.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -115.1 80.78 7.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.98 6.99 4.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.525 2.15 . . . . 0.0 112.4 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -74.42 -32.6 62.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.969 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.88 -41.2 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -63.78 -57.38 10.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.44 -41.63 76.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.635 ' HB3' HD21 ' A' ' 171' ' ' LEU . 9.9 t70 -70.06 -28.1 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.066 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.65 -60.1 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.29 -36.51 80.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.6 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -59.47 -45.16 92.41 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.8 mt -56.94 -44.74 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.588 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 90.5 mmm -55.99 -40.16 72.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.261 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 2.4 mmmp? -61.28 -43.34 99.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -56.19 -46.45 79.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -70.56 -23.15 62.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.687 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -86.18 -12.6 49.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 80.7 p -117.05 20.98 13.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.838 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 62.08 94.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 65.6 m -150.38 -62.41 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.725 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.14 168.29 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -97.83 -179.55 4.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.574 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 27.6 m -54.99 -52.06 74.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.1 Cg_endo -56.3 -30.15 79.44 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.073 1.849 . . . . 0.0 111.786 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.7 58.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.094 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.89 -45.38 80.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.286 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.78 -38.87 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.7 t -62.24 -58.54 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -58.4 -48.39 80.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.198 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.31 -36.4 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.6 t -62.67 -44.14 97.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.408 . . . . 0.0 109.938 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.08 -12.73 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.376 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 146' ' ' ASP . 14.6 tp -84.29 -33.26 24.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -99.86 14.49 30.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -52.61 105.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.46 -39.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.405 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -124.87 95.93 41.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.459 0.171 . . . . 0.0 110.713 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.3 -21.75 72.65 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.677 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.27 -49.06 77.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.192 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -57.31 -45.88 83.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.717 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -67.32 -29.06 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.3 mtt -69.06 -36.0 77.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -88.17 -19.32 53.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.271 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -77.95 -44.03 28.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.62 -19.79 62.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.822 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 23.3 m -66.04 -44.36 84.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -57.68 -47.67 81.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.614 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.58 156.73 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.789 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 32.5 Cg_exo -57.73 155.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.39 2.06 . . . . 0.0 112.243 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.69 157.16 48.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.0 112.311 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.431 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 76.4 p . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.3 t -121.73 -36.21 3.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.075 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 72.5 p -77.91 100.04 6.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.188 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -149.89 -60.17 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.464 ' HB3' ' HG3' ' B' ' 134' ' ' GLU . 72.1 mt -73.45 167.76 20.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.758 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.506 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 39.6 t -63.53 167.0 6.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -65.32 -51.25 61.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -21.34 6.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.668 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 17.3 mm-40 -67.58 -69.04 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 24.4 ptm -63.76 -25.83 68.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.985 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.26 -53.58 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.588 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -56.97 -48.31 78.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.688 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -59.4 -46.71 87.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.332 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.57 -44.88 47.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.991 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.66 -36.44 93.15 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.079 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' B' ' 138' ' ' LEU . 54.1 mt -62.66 -56.61 16.16 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.915 0.388 . . . . 0.0 111.118 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.626 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -65.75 -23.81 66.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.145 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -84.38 -27.2 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.047 0.451 . . . . 0.0 110.705 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 44.8 ttp -74.87 -42.03 58.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.984 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.544 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 77.9 p -71.02 -39.9 72.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.913 0.387 . . . . 0.0 111.338 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.524 ' HB2' ' HA ' ' B' ' 153' ' ' CYS . 0.2 OUTLIER -134.15 -80.47 0.46 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.364 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' B' ' 146' ' ' GLN . . . 176.51 -63.81 0.1 OUTLIER Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.613 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 59.11 21.93 9.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.43 -41.27 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.913 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.1 OUTLIER -167.4 -40.35 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.913 ' HD3' HG23 ' B' ' 150' ' ' THR . 79.6 Cg_endo -84.31 -104.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.701 1.6 . . . . 0.0 112.29 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -177.11 93.39 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' B' ' 146' ' ' GLN . 24.3 t 63.77 11.26 5.74 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -98.21 4.34 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 64.39 -81.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.219 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 75.9 p -143.44 139.05 29.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 44.4 t -147.38 -43.13 0.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.773 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.513 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 95.3 mt -74.44 -51.09 4.46 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.664 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 43.5 Cg_endo -67.73 -57.28 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.978 1.785 . . . . 0.0 112.416 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 47.7 t -162.92 107.29 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 18.3 m -76.78 -22.11 54.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.852 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 45.1 t -60.26 163.3 5.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 82.7 m 56.68 79.52 0.33 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.99 -60.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.472 2.115 . . . . 0.0 112.225 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -150.25 70.76 9.2 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.662 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.02 155.44 60.78 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.61 2.207 . . . . 0.0 112.271 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.39 6.91 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.056 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 52.6 m 57.65 98.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.064 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.11 79.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.663 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 60.7 m -133.41 -15.23 2.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.724 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -138.67 8.04 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -125.48 90.52 50.51 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.151 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.519 ' HG3' ' HB ' ' B' ' 184' ' ' THR . 58.9 Cg_endo -72.42 161.27 44.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.398 2.066 . . . . 0.0 112.163 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.45 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.79 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.96 152.08 24.52 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.531 2.154 . . . . 0.0 112.55 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.7 m 58.19 -178.9 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.365 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -150.7 94.92 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.47 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -93.46 -73.82 0.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 111.01 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -167.94 -37.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -138.53 153.07 48.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.757 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 17.2 p 44.57 27.68 0.26 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.656 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 47.6 t -165.68 108.28 0.79 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 59.99 63.14 5.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.313 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' THR . . . . . 0.519 ' HB ' ' HG3' ' B' ' 173' ' ' PRO . 60.8 m -109.48 -34.91 6.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 111.282 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -138.47 6.97 2.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.081 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.306 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.662 0.268 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 55.69 30.39 15.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.729 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 121' ' ' LEU . 0.4 OUTLIER 61.05 97.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.645 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 123' ' ' VAL . 48.7 tptt -132.27 166.96 20.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.607 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.593 HG22 ' HG ' ' B' ' 142' ' ' LEU . 25.3 t -68.65 -36.75 75.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.96 -28.87 64.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.073 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -66.54 -44.19 83.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -62.04 -34.04 75.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.279 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.31 -43.02 95.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.371 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -57.68 -39.28 76.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.0 -30.58 69.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.781 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.471 HD13 HD21 ' B' ' 138' ' ' LEU . 34.0 tp -65.6 -40.94 93.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.048 0.452 . . . . 0.0 110.001 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.43 -40.34 81.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.235 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -57.63 -46.86 83.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.44 -46.71 94.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.774 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -60.53 -26.62 67.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.681 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.6 tp -76.8 -62.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -51.21 -50.32 59.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.507 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -89.39 41.62 1.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.324 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.07 -20.06 70.57 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.512 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 t -97.34 -10.74 25.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.887 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -130.35 78.94 73.47 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.803 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.66 -13.75 39.83 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.428 2.085 . . . . 0.0 112.227 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -61.84 -52.06 65.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.016 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.65 -38.0 33.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.62 -54.28 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.818 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -59.79 -42.98 94.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.378 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -61.53 -36.19 79.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.339 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -66.18 -59.44 3.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' B' ' 134' ' ' GLU . 8.2 mp -60.66 -30.11 69.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.974 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -63.33 -50.22 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -55.63 -51.5 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.493 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 70.8 mmm -53.01 -44.24 67.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.587 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.502 ' HE2' HD12 ' B' ' 136' ' ' ILE . 44.1 tttm -59.61 -38.19 80.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.78 -46.68 86.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.2 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -61.24 -42.76 99.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' B' ' 136' ' ' ILE . 60.6 tptt -70.81 -24.5 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.515 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -97.7 19.05 14.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 61.3 93.13 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.3 t -149.76 -68.57 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.4 pt -111.89 171.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 164' ' ' VAL . 5.3 m-20 -96.29 175.48 6.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.582 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 49.5 m -54.31 -51.17 80.19 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.559 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.36 -33.63 96.54 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.085 1.857 . . . . 0.0 111.878 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.94 -36.83 82.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 160' ' ' ASP . 60.6 t -70.33 -45.19 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.82 -39.01 83.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.4 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.2 m -67.91 -55.71 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.041 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -55.18 -47.18 75.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.004 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -61.76 -39.75 84.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.686 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.6 t -59.31 -39.26 82.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -84.32 -18.1 37.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.884 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.5 tp -77.97 -29.88 50.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.74 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.24 24.05 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -55.8 108.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.92 -41.97 0.8 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.586 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -125.38 103.46 29.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.422 0.153 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.67 -0.14 8.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.075 . . . . 0.0 112.237 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -59.84 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.042 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.7 mm? -58.3 -38.93 78.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.587 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.32 -44.03 94.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.764 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.43 -39.47 83.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.79 66.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.11 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -74.73 -38.38 62.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 110.771 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -70.38 -19.06 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 51.9 m -69.94 -33.48 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.135 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -61.09 -49.95 75.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' B' ' 145' ' ' SER . 62.3 mt -53.84 145.62 30.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.8 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.95 141.11 79.12 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.377 2.051 . . . . 0.0 112.209 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.7 145.65 58.9 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.42 2.08 . . . . 0.0 112.17 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.512 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.768 0.318 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 78.6 p -84.43 177.89 7.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 5.7 t -90.4 -38.43 13.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 20.4 t90 58.04 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.8 mt -92.27 176.31 6.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.971 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 134' ' ' GLU . 45.7 t -59.71 154.02 18.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.725 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.41 -30.52 60.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.162 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.4 84.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.48 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -69.28 -28.33 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.812 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -35.7 72.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.502 HD12 ' HE2' ' A' ' 152' ' ' LYS . 73.0 mt -76.28 -50.35 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -56.55 -50.38 72.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.113 0.482 . . . . 0.0 110.197 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.585 HD13 HD13 ' B' ' 141' ' ' LEU . 4.2 mm? -62.25 -41.98 98.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.93 -47.73 43.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.92 -39.82 98.51 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.942 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.585 HD13 HD13 ' B' ' 138' ' ' LEU . 0.3 OUTLIER -56.09 -56.15 24.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.593 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -65.28 -24.78 67.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.478 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -77.27 -26.66 52.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 110.051 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 30.0 mtm -75.64 -38.57 58.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.929 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 73.4 p -118.69 106.33 12.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.835 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' B' ' 147' ' ' GLY . 3.0 pt20 -132.49 -83.83 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.409 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.475 ' H ' ' HG3' ' B' ' 146' ' ' GLN . . . -145.98 -111.9 0.73 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.647 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -108.98 -74.19 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.616 0.246 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -127.58 -71.35 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.2 t -65.14 145.07 99.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.05 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.2 149.93 11.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.601 2.201 . . . . 0.0 112.564 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 63.8 t30 57.93 47.51 14.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.899 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' B' ' 147' ' ' GLY . 77.6 m 58.53 -174.48 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.091 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.73 109.94 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.045 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -152.29 -43.45 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.175 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.0 m 64.38 115.1 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.313 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 49.5 m -142.1 -39.26 0.37 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.656 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.544 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 3.6 mm? -71.46 -49.9 11.22 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.309 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 46.2 Cg_endo -68.83 -53.73 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.131 1.888 . . . . 0.0 112.372 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 45.8 t -161.41 112.63 1.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.145 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 5.9 m -87.56 141.64 28.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.612 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 83.9 p -113.24 158.37 20.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.132 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 65.2 m 56.31 87.31 0.14 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.113 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.31 -62.0 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.562 2.174 . . . . 0.0 112.334 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.548 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 20.8 t70 -97.64 -48.79 0.23 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.808 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 52.7 Cg_exo -55.47 131.64 47.41 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.085 1.857 . . . . 0.0 112.426 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 165' ' ' ASP . 40.7 t -134.66 -56.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 65.0 m -153.97 30.91 0.45 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.492 ' HA ' ' H ' ' B' ' 181' ' ' CYS . 47.6 t -68.67 143.91 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.001 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.609 ' H ' ' HA ' ' B' ' 181' ' ' CYS . 32.9 t 58.96 25.69 14.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.18 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -81.85 -55.34 4.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -166.85 64.71 0.79 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.339 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.61 ' HB3' ' H ' ' B' ' 183' ' ' GLY . 8.8 Cg_endo -50.57 -72.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.829 2.353 . . . . 0.0 112.594 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 55.66 -139.77 41.93 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.481 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.35 113.66 3.38 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.445 2.097 . . . . 0.0 112.219 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 95.5 p 51.21 -166.4 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.208 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -170.82 -169.27 33.67 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.458 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -112.43 -68.78 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -154.27 -2.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.756 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.9 p -117.62 -159.17 0.73 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.8 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' CYS . . . . . 0.609 ' HA ' ' H ' ' B' ' 170' ' ' SER . 76.3 m 61.61 -173.51 0.14 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.7 m -100.06 -12.99 19.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' GLY . . . . . 0.61 ' H ' ' HB3' ' B' ' 173' ' ' PRO . . . -111.22 117.53 4.57 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.541 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 73.4 p -139.95 1.48 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 111.271 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.86 -69.98 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.015 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.342 179.975 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.832 0.349 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -105.59 123.06 47.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -80.66 107.43 13.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.489 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -133.98 155.92 49.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.608 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.598 HG22 ' HG ' ' B' ' 142' ' ' LEU . 22.4 t -76.22 -44.6 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.674 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.41 -27.29 64.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.752 0.311 . . . . 0.0 110.458 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -66.52 -41.13 89.26 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -64.57 -34.84 79.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.263 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.54 -46.26 86.78 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.464 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -56.78 -37.17 70.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.425 ' O ' HG23 ' A' ' 133' ' ' VAL . 78.8 t80 -69.51 -31.87 70.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.858 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.468 HD22 HD21 ' B' ' 138' ' ' LEU . 44.2 tp -62.46 -52.25 64.27 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.6 -34.9 76.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.646 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -56.91 -45.42 82.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.896 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 HD12 ' A' ' 178' ' ' LEU . 96.0 t -63.34 -47.28 92.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.517 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 139' ' ' SER . 87.2 tttt -64.54 -19.71 65.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.11 -39.15 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.461 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.4 mm100 -70.36 -67.26 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.441 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -56.81 -34.75 68.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.38 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.58 47.49 2.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.611 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.478 ' HA ' ' HG3' ' A' ' 134' ' ' LYS . 46.8 m 60.84 18.18 8.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.472 0.177 . . . . 0.0 111.323 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 45.2 mt-30 -54.56 109.11 1.37 Allowed Pre-proline 0 CA--C 1.529 0.162 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.755 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 140' ' ' GLN . 14.1 Cg_exo -69.4 2.89 2.94 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.742 2.295 . . . . 0.0 112.555 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -84.2 -52.88 5.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.177 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.8 t -86.76 -35.83 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.232 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -59.62 -59.05 6.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.984 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -56.51 -45.27 81.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -33.75 75.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.87 -60.02 3.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.3 -34.93 76.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.25 -51.45 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.492 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.439 HD12 HD22 ' A' ' 171' ' ' LEU . 8.0 mt -55.09 -47.47 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.362 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.615 ' HE2' HD12 ' B' ' 141' ' ' LEU . 79.6 mmm -52.83 -42.62 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.927 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.402 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.55 -35.32 72.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.131 0.491 . . . . 0.0 109.779 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -78.88 -38.83 36.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.568 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HG2' HG23 ' B' ' 136' ' ' ILE . 59.0 tptt -65.6 -24.33 67.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.7 t -103.22 8.95 38.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.141 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 62.51 106.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.85 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.2 m -158.21 -53.58 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.423 HD11 HG23 ' A' ' 150' ' ' ILE . 36.5 pt -113.59 15.37 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 164' ' ' VAL . 6.8 m-20 50.5 -165.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.587 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 88.2 m -76.37 -51.58 2.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.923 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 161' ' ' THR . 9.9 Cg_endo -53.21 -35.0 71.94 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.166 1.911 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.04 87.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 160' ' ' ASP . 57.9 t -70.95 -45.27 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.079 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.11 -44.44 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.223 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.8 p -65.94 -58.84 4.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.437 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -54.22 -54.38 40.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.481 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.66 -37.57 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.647 0.261 . . . . 0.0 110.975 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -57.65 -47.78 81.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.841 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -83.77 -11.73 56.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 150' ' ' ILE . 21.5 tp -78.87 -18.74 53.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.192 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -109.58 30.96 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.252 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.51 112.45 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.816 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 141.53 -47.07 0.86 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -117.81 94.97 47.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.421 0.153 . . . . 0.0 110.947 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.35 -4.76 14.4 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.424 2.083 . . . . 0.0 112.382 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.35 -57.02 5.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -57.61 -38.19 74.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -68.42 -38.42 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.4 ttm -63.15 -46.0 89.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.762 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.49 -30.97 63.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.318 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -40.06 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.29 -21.82 66.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.2 m -70.05 -33.62 72.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -66.0 -50.31 64.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.435 ' HA ' ' HB3' ' B' ' 145' ' ' SER . 90.2 mt -51.18 143.84 16.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 53.1 Cg_exo -56.43 111.92 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.474 2.116 . . . . 0.0 112.016 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.3 Cg_endo -62.49 150.26 88.1 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.42 2.08 . . . . 0.0 112.36 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.32 -1.267 . . . . 0.0 112.511 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 78.8 p -95.24 -44.72 7.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 68.1 p -116.5 132.0 56.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.043 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -160.87 -53.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 tp -73.14 147.78 44.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HG2' ' B' ' 134' ' ' GLU . 66.8 m -64.62 167.01 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.241 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -75.44 -47.88 25.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.278 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.81 19.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.63 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.587 ' HG2' ' HB2' ' B' ' 131' ' ' SER . 19.6 mm-40 -71.12 -57.08 4.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 66.1 mtm -63.51 -23.98 67.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.479 HG23 ' HG2' ' A' ' 155' ' ' LYS . 84.2 mt -75.47 -51.3 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.651 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.44 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -57.34 -50.12 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.055 0.455 . . . . 0.0 110.077 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.566 HD13 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -60.67 -40.82 93.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.58 62.13 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.15 -34.74 90.48 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.63 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.615 HD12 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -59.28 -56.09 26.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.989 0.423 . . . . 0.0 110.74 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.598 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -70.16 -21.13 63.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -82.16 -26.59 33.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 49.3 ttp -81.72 -38.63 25.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.678 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 68.0 p -119.72 95.86 4.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.74 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -138.39 -52.25 0.59 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.342 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' B' ' 153' ' ' CYS . . . 59.18 21.69 53.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.758 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.1 3.39 8.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.907 0.384 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.65 ' O ' HG22 ' B' ' 150' ' ' THR . 52.4 tt0 -152.52 131.8 12.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.534 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.65 HG22 ' O ' ' B' ' 149' ' ' GLN . 0.7 OUTLIER 57.3 147.7 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 123.727 0.642 . . . . 0.0 111.63 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' B' ' 155' ' ' ALA . 3.5 Cg_endo -46.91 112.67 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.848 2.365 . . . . 0.0 112.984 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -155.21 -81.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.76 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' CYS . . . . . 0.55 ' HB3' ' HA3' ' B' ' 147' ' ' GLY . 52.6 t -87.86 -74.21 0.46 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 31.3 m -79.22 -20.37 12.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.206 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' B' ' 151' ' ' PRO . . . 60.22 -171.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.146 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.9 m -68.53 172.35 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' B' ' 161' ' ' THR . 48.0 t -156.35 -5.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.77 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.702 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 89.4 mt -111.37 -53.31 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.51 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.702 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 60.2 Cg_endo -72.81 -62.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.966 1.777 . . . . 0.0 112.527 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.43 ' H ' ' HG2' ' B' ' 159' ' ' PRO . 79.5 p -92.99 -54.62 3.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.992 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.669 HG22 ' H ' ' B' ' 163' ' ' CYS . 7.2 m 66.23 146.33 0.04 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.184 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 47.7 t -93.78 -18.42 22.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.872 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' CYS . . . . . 0.669 ' H ' HG22 ' B' ' 161' ' ' THR . 12.6 p -158.65 86.92 2.32 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.48 -44.21 3.47 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.295 1.997 . . . . 0.0 111.854 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -160.48 68.64 2.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.561 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.424 ' HG3' ' HB2' ' B' ' 163' ' ' CYS . 53.9 Cg_endo -69.18 171.6 13.55 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.547 2.165 . . . . 0.0 112.345 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 61.8 t -143.36 97.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.316 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 38.4 t 59.33 18.09 6.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.218 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 66.1 t 61.61 94.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.103 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 45.5 t -166.02 -77.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.54 -88.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.255 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -166.34 94.68 0.76 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.028 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.75 -171.95 0.62 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.449 2.099 . . . . 0.0 112.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -83.64 172.64 50.52 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.827 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.57 114.07 3.63 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.74 2.293 . . . . 0.0 112.385 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 33.1 t 60.25 176.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.051 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 99.2 -10.34 61.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 56.85 97.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.894 0.378 . . . . 0.0 111.411 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -161.18 141.65 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.83 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -94.34 113.04 24.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 51.8 t 59.57 -88.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.071 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 43.5 t 59.62 -83.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.272 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 102.45 157.76 25.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 51.3 p -138.1 -49.77 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.352 . . . . 0.0 111.12 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -95.39 5.28 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.042 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.189 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.736 0.303 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -93.85 -18.12 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.15 119.99 23.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -138.96 148.51 43.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.585 HG22 ' HG ' ' B' ' 142' ' ' LEU . 36.0 t -63.42 -46.91 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.301 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 -31.48 64.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.468 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.3 -39.49 92.58 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.03 -38.7 92.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.609 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.25 -43.21 99.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.17 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -58.81 -40.54 84.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -62.85 -36.15 82.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.994 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.474 HD22 HD21 ' B' ' 138' ' ' LEU . 40.8 tp -62.67 -46.8 86.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.142 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.59 -35.19 78.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.139 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -62.38 -43.06 99.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.245 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.65 -38.42 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.683 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -67.09 -33.5 75.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.721 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -71.21 -51.03 27.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.391 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.61 -67.42 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.559 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -78.51 76.26 5.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.634 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.26 -54.93 2.45 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.37 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.4 m -78.33 7.95 5.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.935 0.398 . . . . 0.0 110.506 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -120.55 72.77 21.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.562 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.2 -7.94 21.27 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.561 2.174 . . . . 0.0 112.233 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -68.9 -59.37 3.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.885 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.22 -37.64 23.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.555 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.15 -59.43 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -58.63 -40.28 82.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.488 ' HB3' HD11 ' A' ' 171' ' ' LEU . 10.2 m-20 -64.85 -34.78 79.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.01 -60.37 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.231 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.45 -40.55 94.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.299 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.46 -47.49 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 109.671 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mt -56.17 -45.93 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.065 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.6 mmm -55.23 -40.33 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.25 -36.38 82.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.23 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.75 -42.69 97.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.19 -23.14 41.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.345 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -69.5 -56.27 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.8 m -73.47 -83.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.7 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -175.6 102.37 0.08 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -156.05 -77.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.8 pt -107.24 171.35 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.249 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -101.28 -176.34 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.596 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 30.6 m -57.08 -50.54 87.61 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.0 Cg_exo -53.61 -32.89 66.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.037 1.824 . . . . 0.0 112.065 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.73 -35.99 66.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.239 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.13 -45.22 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 165' ' ' ILE . 1.9 mp -65.86 -44.7 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.15 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.0 m -61.7 -55.96 24.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.385 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.55 -55.6 32.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.323 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.34 -33.21 30.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -64.33 -49.84 70.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.661 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -78.5 -11.63 59.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 146' ' ' ASP . 3.4 tp -74.82 -45.45 43.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -91.21 27.81 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.987 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.57 104.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.53 -44.18 0.73 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.436 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -117.37 98.37 51.78 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.413 0.149 . . . . 0.0 110.803 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.15 -9.41 26.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.385 2.057 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.46 -56.99 9.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -57.64 -42.01 82.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.663 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.13 -37.79 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.5 ttm -64.6 -43.65 93.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.721 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.31 -23.37 75.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.09 -46.64 33.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 111.037 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.99 -23.14 63.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 79.4 m -66.36 -35.78 81.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -59.41 -43.55 92.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.31 150.43 79.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 24.7 Cg_exo -62.85 124.19 13.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.432 2.088 . . . . 0.0 112.012 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.42 151.65 66.92 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.338 2.026 . . . . 0.0 112.414 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.38 -1.234 . . . . 0.0 112.462 -179.907 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.731 0.3 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.1 t -102.31 127.66 49.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 61.7 p -106.98 146.12 31.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.309 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -122.52 -24.62 4.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.731 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.99 177.4 4.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -87.73 150.28 23.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.705 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.02 -34.78 75.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.78 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.28 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.443 ' O ' HD23 ' B' ' 138' ' ' LEU . 43.5 mt-10 -74.75 -42.05 58.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.16 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtm -66.21 -32.75 74.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.081 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.3 mt -75.19 -53.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.16 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.465 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.64 -48.85 74.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.474 HD21 HD22 ' A' ' 130' ' ' LEU . 4.3 mm? -63.09 -39.89 96.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.45 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.64 -51.97 44.0 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.33 -29.25 74.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.919 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.471 HD13 HD13 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -61.16 -56.65 18.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.798 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.585 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -73.67 -19.71 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.683 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -80.11 -26.67 39.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.278 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 53.4 ttp -84.02 -41.38 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.798 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 46.4 m -79.46 81.7 5.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.204 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -137.88 -69.08 0.45 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.145 0.498 . . . . 0.0 110.174 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.65 98.96 2.31 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.418 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -108.24 -63.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 0.0 111.06 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.567 ' HG2' ' H ' ' B' ' 150' ' ' THR . 10.0 tt0 -94.54 -179.7 4.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.591 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.769 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.1 OUTLIER -62.31 -43.31 84.85 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.769 ' HD3' HG23 ' B' ' 150' ' ' THR . 41.7 Cg_endo -66.15 -68.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.729 1.619 . . . . 0.0 112.223 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ASN . . . . . 0.426 ' H ' ' HG2' ' B' ' 151' ' ' PRO . 8.0 p30 -155.39 -173.73 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.505 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -66.24 86.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.82 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 p -172.08 145.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.18 135.89 40.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.123 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 51.0 m -137.85 162.94 32.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.8 p -130.59 13.21 5.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.667 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 4.3 pp -97.71 -28.32 0.25 Allowed Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 37.1 Cg_endo -66.54 -67.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.378 1.385 . . . . 0.0 112.628 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 55.2 m -147.24 -14.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.167 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 13.0 m -76.4 142.64 41.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 78.1 p -131.52 4.45 4.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.01 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 77.2 m 58.76 78.19 0.36 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.02 -42.12 6.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.435 2.09 . . . . 0.0 111.79 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -168.37 72.13 0.84 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.747 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.74 30.59 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.725 2.283 . . . . 0.0 112.719 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 41.8 t -93.15 -65.52 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.988 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t -122.07 -34.28 3.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 39.2 t 65.35 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.334 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 76.0 p -79.86 176.4 9.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.806 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.48 -44.04 12.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -151.66 136.59 10.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.773 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.98 -54.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.267 1.978 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.75 178.28 35.01 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.491 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.52 -52.51 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.549 2.166 . . . . 0.0 112.439 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 79.5 p -113.45 121.86 45.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.994 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 173.89 -153.06 16.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.541 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -82.99 156.65 23.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 111.04 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -80.8 81.26 7.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.808 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 48.2 t -169.49 160.88 9.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 85.9 m -100.82 117.41 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 46.4 t -137.43 -77.84 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 61.18 49.64 75.82 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.46 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 5.3 t -99.24 -29.06 13.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.695 0.283 . . . . 0.0 111.379 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -118.77 -47.79 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.086 -0.959 . . . . 0.0 111.25 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.66 0.267 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 63.37 14.15 7.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.87 -73.07 0.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.471 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 63.41 150.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.57 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.8 t -95.86 -26.0 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -58.85 -41.56 87.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.547 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.82 -33.06 75.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -65.42 -41.95 93.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.324 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.42 -44.4 94.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.055 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -55.95 -41.58 74.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 133' ' ' VAL . 43.5 t80 -64.46 -36.94 85.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.715 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 148' ' ' LEU . 19.3 tp -59.96 -45.09 93.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.76 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.29 -37.59 87.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.037 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -60.89 -40.86 94.64 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 178' ' ' LEU . 58.2 t -65.21 -52.97 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.039 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 135' ' ' LEU . 7.2 tt -71.96 -57.75 4.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.853 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -51.94 -60.82 2.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 140' ' ' GLN . 76.0 m-85 -61.23 -67.22 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.63 -85.77 0.06 OUTLIER Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.64 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.6 t -65.38 -7.19 12.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.848 0.356 . . . . 0.0 110.977 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 137' ' ' PHE . 44.7 mt-30 -117.42 75.63 9.03 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.71 -2.5 11.45 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.65 2.234 . . . . 0.0 112.554 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -68.06 -29.14 68.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.978 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.48 -49.8 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.48 -52.53 63.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.668 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.01 -38.81 80.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.684 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.527 ' HB3' HD21 ' A' ' 171' ' ' LEU . 8.8 t70 -65.12 -31.79 73.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.485 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.78 -59.65 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.736 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 130' ' ' LEU . 6.9 mp -63.22 -29.98 71.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.05 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.92 -51.75 66.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 159' ' ' ILE . 10.0 mt -54.54 -48.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.656 ' HE2' HD23 ' B' ' 141' ' ' LEU . 82.4 mmm -53.01 -46.17 68.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.04 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.065 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.05 -37.9 84.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.03 -46.4 84.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.334 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HD3' ' HA2' ' B' ' 140' ' ' GLY . 29.2 mmmt -74.6 -17.94 60.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.678 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.1 t -97.63 11.75 35.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.488 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 62.91 99.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.121 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -161.37 -60.52 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.811 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 150' ' ' ILE . 35.5 pt -116.34 153.45 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.157 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.06 -179.89 6.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.596 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 89.6 m -55.18 -50.75 84.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.799 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.9 Cg_endo -55.72 -39.73 89.37 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.184 1.923 . . . . 0.0 112.148 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.14 -40.68 99.45 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.25 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.39 -42.93 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.12 -43.04 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.422 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.9 t -65.32 -55.14 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.619 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.12 -50.22 74.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.88 -43.05 87.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 87.6 p -60.91 -45.2 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.732 0.301 . . . . 0.0 111.018 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -79.82 -11.71 59.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 146' ' ' ASP . 13.9 tp -72.83 -35.0 67.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.653 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -96.52 33.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -52.42 129.8 29.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.007 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.8 -38.1 3.48 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.254 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -112.22 94.85 27.96 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.407 0.146 . . . . 0.0 110.753 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.59 -4.45 15.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.47 2.113 . . . . 0.0 112.657 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -68.08 -49.04 63.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.036 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.611 HD12 HG22 ' A' ' 133' ' ' VAL . 3.2 mm? -66.41 -35.34 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.12 -44.11 91.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.8 ttm -67.61 -37.39 82.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.23 -35.5 77.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -76.79 -34.39 57.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.725 0.298 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -64.65 -22.73 67.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.1 m -71.12 -37.38 72.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.135 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -57.51 -45.9 84.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.2 150.24 32.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 31.6 Cg_endo -64.55 113.3 2.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.349 2.033 . . . . 0.0 112.173 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 28.2 Cg_endo -62.37 155.05 59.71 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.354 2.036 . . . . 0.0 112.258 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.514 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.765 0.317 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 59.6 m -141.15 141.43 34.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 28.2 m -135.18 133.47 39.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.777 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -131.89 -31.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.404 HD12 ' N ' ' B' ' 130' ' ' LEU . 7.7 mp -99.88 147.6 25.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.122 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 43.8 t -79.48 175.63 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.862 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.8 -53.78 35.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.88 -25.35 19.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.43 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 15.7 mm-40 -71.66 -56.27 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.2 mtm -64.02 -25.74 68.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.629 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 99.7 mt -76.19 -53.23 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.429 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -56.54 -50.57 71.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.309 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.526 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 4.6 mm? -58.69 -52.66 64.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.459 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.64 29.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 109.65 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' GLY . . . . . 0.595 ' HA2' ' HD3' ' A' ' 155' ' ' LYS . . . -67.02 -50.95 42.71 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.876 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.656 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -69.13 -46.26 68.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.229 0.515 . . . . 0.0 111.198 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.591 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.7 mm? -58.59 -33.5 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.993 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -83.99 -31.58 25.43 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.855 0.359 . . . . 0.0 111.011 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 59.1 ttp -73.19 -23.97 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.049 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 64.0 m -86.52 -0.5 56.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.388 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.0 -8.45 5.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.753 0.311 . . . . 0.0 110.981 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.57 115.24 1.09 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.523 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.78 -37.1 86.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.336 . . . . 0.0 110.95 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -141.84 -48.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.554 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 2.7 t -89.65 149.63 42.61 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.711 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.9 -28.54 2.13 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.582 2.188 . . . . 0.0 112.581 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ASN . . . . . 0.422 ' O ' HG22 ' B' ' 154' ' ' VAL . 4.5 p30 -132.62 107.96 8.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.484 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 53.0 t -49.85 99.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.353 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.422 HG22 ' O ' ' B' ' 152' ' ' ASN . 35.8 m -144.65 15.19 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.932 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 63.84 100.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.833 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 52.7 m -63.99 153.42 37.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.317 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' SER . . . . . 0.569 ' HA ' ' HB ' ' B' ' 161' ' ' THR . 62.2 p -166.95 0.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.817 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.858 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 3.2 mm? -114.21 -52.36 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.308 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.858 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 3.4 Cg_exo -39.14 -74.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.913 2.409 . . . . 0.0 113.433 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 56.9 m -141.41 -1.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.675 0.274 . . . . 0.0 111.489 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.569 ' HB ' ' HA ' ' B' ' 157' ' ' SER . 28.3 m -59.48 -27.67 66.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.932 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 48.7 m -117.18 -168.7 1.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.578 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' B' ' 166' ' ' PRO . 77.3 m -56.32 110.24 2.21 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.816 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.71 -53.64 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.313 2.008 . . . . 0.0 112.474 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.556 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 19.6 t70 -92.73 -48.56 0.3 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.599 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 51.7 Cg_exo -53.86 123.3 13.1 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.028 1.818 . . . . 0.0 112.336 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.18 141.97 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.121 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.1 m -68.97 99.41 1.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 64.4 t -131.14 109.33 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.033 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 71.4 p -105.73 -60.8 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -161.33 1.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.789 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 56.85 85.54 0.19 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.899 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' B' ' 183' ' ' GLY . 73.5 Cg_endo -91.27 -65.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.747 2.298 . . . . 0.0 112.941 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.94 -179.14 33.57 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.547 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.23 123.07 10.99 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.572 2.181 . . . . 0.0 112.198 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 80.6 p -163.76 125.19 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.731 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.8 -127.09 22.09 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.41 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -140.7 14.9 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.647 0.261 . . . . 0.0 111.302 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -82.84 179.71 7.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.331 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 76.4 p -85.98 -2.43 58.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.181 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 24.2 p -65.36 111.84 3.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 46.2 t 177.94 113.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.977 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' B' ' 173' ' ' PRO . . . -81.21 131.01 10.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.282 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 7.6 t -98.5 -7.75 27.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 111.031 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -140.5 -57.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.937 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.259 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.773 0.321 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -81.15 125.54 30.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.794 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.66 116.27 15.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.674 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -132.45 173.11 11.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.578 HG22 ' HG ' ' B' ' 142' ' ' LEU . 40.0 t -89.99 -35.06 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.32 -34.03 70.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.59 -38.32 86.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 0.0 110.058 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.403 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -65.55 -43.01 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.319 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 123' ' ' VAL . 4.4 mm? -63.15 -34.93 78.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.072 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.3 t -62.56 -48.52 79.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.692 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.47 HD11 HD21 ' A' ' 148' ' ' LEU . 28.8 tp -61.01 -50.58 72.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.65 -25.81 68.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.536 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -65.11 -41.56 94.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.913 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.1 t -70.2 -45.92 73.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.852 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -57.02 -44.66 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.423 ' O ' HD13 ' A' ' 135' ' ' LEU . 3.3 tm? -69.36 -36.28 76.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -55.83 -70.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.063 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -65.6 -72.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.71 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.49 -76.62 1.49 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.923 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 54.1 m -58.85 -16.62 18.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.602 0.239 . . . . 0.0 111.437 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -116.7 81.29 11.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.79 -12.33 24.17 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.509 2.139 . . . . 0.0 112.027 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -69.67 -40.29 76.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.636 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.4 t -60.12 -56.62 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.27 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -53.14 34.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.179 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -54.45 -52.81 60.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.413 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -52.41 -42.05 63.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.399 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -60.12 -56.99 14.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.6 mp -63.91 -25.7 68.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -62.95 -49.38 74.98 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.81 -47.78 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.703 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 76.9 mmm -54.04 -37.06 63.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.774 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -71.8 -32.73 67.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.28 -44.0 89.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.876 0.369 . . . . 0.0 110.02 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.25 -42.86 87.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.936 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' B' ' 136' ' ' ILE . 12.1 tmtt? -62.7 -40.14 96.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.167 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 90.5 p -85.85 13.75 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 64.63 102.37 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.195 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -153.1 -64.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.79 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.2 pt -111.9 168.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -90.8 177.08 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.597 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 27.6 m -57.52 -50.94 85.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.893 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.1 Cg_exo -54.83 -33.12 80.13 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.022 1.814 . . . . 0.0 112.194 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.02 -37.54 83.18 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.25 -45.5 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.97 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.299 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -69.6 -58.31 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.652 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.43 -48.05 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.89 -29.26 69.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.204 0.526 . . . . 0.0 109.758 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -84.09 -18.76 35.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.167 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.29 -43.85 22.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -93.81 30.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.19 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -58.29 -28.29 64.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.25 -48.53 68.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.628 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -116.87 93.56 41.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.406 0.146 . . . . 0.0 110.772 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.79 -14.65 28.01 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.61 2.206 . . . . 0.0 112.645 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.18 -55.82 29.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -56.28 -33.51 65.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.63 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.53 -48.3 78.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.49 -30.73 73.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -71.22 -36.3 71.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 110.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.06 -16.96 62.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.0 m -71.63 -39.82 70.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.177 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -58.23 -49.56 76.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.991 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.82 151.78 11.16 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.521 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 27.8 Cg_endo -62.73 135.46 52.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.333 2.022 . . . . 0.0 112.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 37.4 Cg_exo -59.93 150.6 77.19 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.445 2.097 . . . . 0.0 112.36 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.615 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.78 0.324 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 79.9 p -156.02 -30.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 73.0 p -85.87 -19.73 30.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.063 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -112.29 101.56 9.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.533 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 87.8 mt -109.81 -175.59 2.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.017 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 47.6 t -59.22 155.29 14.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.974 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.73 -42.52 86.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.65 -27.83 66.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.562 ' HA ' HD23 ' A' ' 148' ' ' LEU . 45.2 mt-10 -77.26 -46.13 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.3 ttm -64.52 -36.41 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.021 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 155' ' ' LYS . 86.2 mt -74.23 -53.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.13 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.28 -46.71 69.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.112 0.482 . . . . 0.0 110.257 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -67.31 -35.28 79.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.427 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.82 -53.87 51.41 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.77 73.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 138' ' ' LEU . 0.8 OUTLIER -64.19 -56.56 13.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.424 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.578 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.6 mm? -70.8 -21.16 62.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.466 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -82.74 -26.5 31.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 58.6 ttp -80.96 -38.99 26.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 60.3 p -60.51 -19.17 56.14 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.013 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -108.21 -69.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.41 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 164.84 -83.75 0.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.524 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.69 -69.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.568 ' HG2' HG22 ' B' ' 150' ' ' THR . 26.1 tt0 -72.16 -58.97 2.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.752 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.5 OUTLIER -177.69 -36.13 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.752 ' HD3' HG23 ' B' ' 150' ' ' THR . 72.4 Cg_endo -83.88 -165.3 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.631 1.554 . . . . 0.0 112.066 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -64.66 106.88 1.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.675 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 28.9 t 64.19 169.88 0.17 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.779 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 13.3 p -56.13 -23.83 16.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.127 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.49 154.66 28.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.223 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.5 m -130.78 154.64 47.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 79.4 p -146.66 -24.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.501 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 83.4 mt -63.29 -49.92 77.17 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 64.0 Cg_endo -72.83 -152.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.09 1.86 . . . . 0.0 112.222 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 32.8 t -81.53 29.49 0.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 59.5 m 63.01 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.444 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 47.2 t -108.35 134.64 50.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.069 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' B' ' 166' ' ' PRO . 79.2 m 58.56 91.81 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.34 -43.42 1.48 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.304 2.003 . . . . 0.0 112.551 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 14.9 t70 -91.38 -49.37 0.33 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.564 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 33.6 Cg_exo -59.38 114.41 2.02 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.103 1.869 . . . . 0.0 112.289 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.519 HG23 ' H ' ' B' ' 169' ' ' VAL . 34.4 m -93.39 176.21 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 33.6 t -100.94 18.83 18.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.755 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.519 ' H ' HG23 ' B' ' 167' ' ' VAL . 59.2 t -118.49 120.4 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 35.6 t -105.31 174.07 6.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.778 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.13 174.46 1.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.014 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.52 147.65 98.73 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.723 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.91 -176.46 3.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.474 2.116 . . . . 0.0 112.223 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.87 -83.11 1.69 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.158 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.03 137.52 24.22 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.602 2.201 . . . . 0.0 112.3 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.0 t -62.54 114.37 3.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.716 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -149.16 -175.96 22.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.55 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.18 13.03 24.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.878 0.371 . . . . 0.0 110.721 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -80.22 7.16 9.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.026 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 71.1 m 61.03 -85.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.525 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -115.77 153.24 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.237 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 40.5 t 59.52 103.3 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.17 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -109.32 -8.99 26.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.295 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 45.0 m -68.41 111.16 4.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -166.25 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.304 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.765 0.317 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.488 ' N ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -140.7 162.91 34.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 55.97 89.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.537 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 17.3 tppt? -105.86 152.55 23.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.668 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.665 HG22 ' HG ' ' B' ' 142' ' ' LEU . 38.4 t -77.55 -35.35 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.297 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.537 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 35.8 tt0 -56.35 -35.7 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 122' ' ' LYS . 4.4 m-20 -65.3 -39.86 93.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 109.711 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.44 77.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.012 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.59 -51.25 66.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.829 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -55.39 -36.4 66.35 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 133' ' ' VAL . 86.4 t80 -67.98 -32.21 72.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.804 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.516 HD13 HD21 ' B' ' 138' ' ' LEU . 38.1 tp -64.74 -43.16 94.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.887 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.19 -40.52 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.292 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -58.55 -45.94 87.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.601 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 129' ' ' TYR . 92.6 t -63.65 -41.0 91.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.614 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.02 -27.98 69.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.4 -61.2 1.86 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.739 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -53.84 -50.28 66.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -97.3 72.46 2.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.561 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.62 -60.45 1.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.382 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.5 p -72.9 -5.62 39.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.939 0.4 . . . . 0.0 110.517 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -123.93 86.44 53.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.32 13.51 2.71 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.66 2.24 . . . . 0.0 112.432 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -75.72 -56.3 4.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.04 -44.84 92.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.319 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.21 -57.92 10.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.101 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -55.87 -42.44 75.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.298 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.07 -32.59 73.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -68.8 -59.55 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.2 mp -61.26 -31.12 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.195 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.12 -52.12 57.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.4 mt -54.08 -45.04 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.559 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 76.2 mmm -55.52 -48.93 73.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.51 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.26 -35.68 67.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.427 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.75 -43.72 92.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.973 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.65 -34.5 78.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.8 tptp -77.22 -27.55 53.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.389 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 18.24 12.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.59 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 62.43 96.92 0.04 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.838 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.2 m -155.59 -46.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.08 178.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -113.37 -173.35 2.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 93.6 m -58.55 -50.01 90.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.658 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.7 Cg_exo -56.58 -32.49 90.32 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.031 1.82 . . . . 0.0 112.037 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.0 -44.19 68.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.55 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.4 t -65.18 -44.36 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.65 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.453 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -61.2 -58.04 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.578 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -53.19 -56.48 16.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.91 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.4 t -57.65 -34.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.644 0.259 . . . . 0.0 111.321 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.2 t -60.34 -50.4 73.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.835 0.35 . . . . 0.0 110.805 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -80.11 -11.78 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.45 -38.72 65.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.726 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -97.3 23.72 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.808 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -54.49 106.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.63 -32.44 1.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.288 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -129.54 100.84 19.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.413 0.149 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.31 -0.08 9.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.413 2.075 . . . . 0.0 112.548 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.36 -58.75 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.5 mm? -60.54 -39.18 86.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.86 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.21 -42.87 93.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.87 76.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -81.42 -33.6 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.826 0.346 . . . . 0.0 111.115 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -63.13 -26.42 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.1 m -67.87 -37.91 82.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.138 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -56.86 -50.85 71.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.59 156.81 15.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 43.2 Cg_endo -66.98 144.81 71.63 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.251 1.967 . . . . 0.0 112.0 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 51.6 Cg_exo -54.48 164.22 3.12 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.398 2.066 . . . . 0.0 112.496 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.374 -1.236 . . . . 0.0 112.468 179.842 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 51.6 m 59.12 18.76 6.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.927 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 34.4 p -117.13 -11.01 10.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.17 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -84.28 -0.34 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.455 HD12 ' N ' ' B' ' 130' ' ' LEU . 6.5 mp -83.49 148.63 27.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 81.5 p -62.47 160.87 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.986 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.1 -36.86 85.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.48 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.471 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.425 ' HA ' HD23 ' A' ' 148' ' ' LEU . 46.2 mt-10 -76.8 -49.99 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 58.4 ttp -63.66 -33.33 75.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.5 mt -76.35 -51.75 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.152 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.559 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -57.34 -47.78 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.028 0.442 . . . . 0.0 110.446 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.82 -50.07 73.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.524 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.71 -46.66 40.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.055 0.455 . . . . 0.0 109.96 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.93 -32.95 85.88 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.767 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' B' ' 138' ' ' LEU . 55.8 mt -62.42 -55.01 31.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.308 . . . . 0.0 111.028 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.665 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -68.92 -22.37 64.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -86.32 -26.49 24.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.37 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 161' ' ' THR . 15.7 tmm? -88.21 -24.79 23.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 55.0 m -76.26 -1.23 25.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.545 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -131.31 -30.53 1.71 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.812 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' B' ' 153' ' ' CYS . . . 127.68 -80.78 0.36 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.584 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.549 ' HB2' HG12 ' B' ' 154' ' ' VAL . 38.0 tt0 -131.59 -59.18 0.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -151.78 -89.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.223 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.542 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 4.9 t -102.83 -30.31 0.21 Allowed Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' B' ' 150' ' ' THR . 97.1 Cg_endo -82.58 149.32 14.51 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.594 1.529 . . . . 0.0 112.506 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.49 108.27 0.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.56 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' CYS . . . . . 0.537 ' HA ' ' HA3' ' B' ' 147' ' ' GLY . 52.0 t 65.44 149.64 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.064 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' B' ' 148' ' ' GLU . 27.4 m -45.32 141.27 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.328 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -153.92 -27.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.285 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.432 ' HB2' ' HG3' ' B' ' 159' ' ' PRO . 46.5 m -86.25 171.15 11.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.984 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 44.2 t -142.79 2.78 1.39 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.674 ' N ' ' CD ' ' B' ' 159' ' ' PRO . 0.0 OUTLIER -122.36 6.69 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' B' ' 158' ' ' LEU . 96.8 Cg_endo -84.19 -42.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 121.611 1.541 . . . . 0.0 112.227 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 75.8 p -162.5 4.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 3.1 m -82.39 11.54 5.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 49.0 m -84.5 17.85 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 13.0 p -106.55 93.25 8.18 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.12 -57.19 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.253 1.968 . . . . 0.0 111.97 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.15 66.35 0.39 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.818 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.93 118.53 5.74 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.38 2.053 . . . . 0.0 112.102 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 30.7 m -123.68 177.97 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.359 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.6 m -82.64 135.09 35.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.19 -26.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 63.6 m -153.13 16.42 0.55 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.285 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.88 147.57 52.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.723 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.62 119.83 66.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.93 -179.24 2.85 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.201 1.934 . . . . 0.0 112.217 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -70.31 -160.5 3.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.0 97.95 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.465 2.11 . . . . 0.0 112.226 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 80.4 p -172.39 -173.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.808 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -113.66 -98.38 2.3 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.475 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -97.25 117.37 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.745 0.307 . . . . 0.0 110.77 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -138.36 -79.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.993 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 40.1 t -170.43 -76.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 26.6 p -171.31 130.14 0.73 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 33.2 t 60.35 175.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.302 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -149.42 -26.67 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.224 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 80.6 p -76.3 -4.43 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 111.147 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -142.18 117.43 10.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.178 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -148.17 106.99 3.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.8 tt -128.18 119.0 24.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.722 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -123.0 176.45 6.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.809 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.607 HG22 ' HG ' ' B' ' 142' ' ' LEU . 26.9 t -83.6 -35.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.95 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.88 -27.44 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.78 -44.41 81.41 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -66.56 -29.48 69.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.9 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 mt -63.51 -54.96 28.1 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.936 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -55.88 -37.07 68.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 133' ' ' VAL . 84.3 t80 -64.0 -34.22 77.51 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.667 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.725 HD13 HD21 ' B' ' 138' ' ' LEU . 28.6 tp -65.56 -42.43 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.86 -38.54 88.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.081 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -59.93 -52.52 65.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.627 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 129' ' ' TYR . 46.5 t -59.18 -39.2 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -76.86 -17.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tt -75.16 -56.58 4.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.5 -52.5 45.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.11 33.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.189 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.93 4.27 31.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.769 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.6 p -116.41 -6.92 11.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 0.0 110.784 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -132.75 91.32 30.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.3 -11.29 31.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.568 2.179 . . . . 0.0 112.196 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.32 -46.33 73.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.55 -52.49 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.84 -57.43 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -55.8 -32.86 63.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.154 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.63 -52.28 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -56.2 -56.18 24.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' B' ' 134' ' ' GLU . 8.8 mp -58.83 -37.77 77.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.514 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.67 -42.45 88.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 159' ' ' ILE . 13.9 mt -57.18 -49.71 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.027 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.482 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 83.5 mmm -52.76 -42.58 65.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.487 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 10.3 mtmp? -64.55 -35.63 81.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.209 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.0 -33.44 75.42 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -79.4 -28.42 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.861 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 152' ' ' LYS . 27.6 mmtt -71.46 -59.48 2.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.64 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.2 m -63.27 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -179.32 104.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -165.39 -69.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.197 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 150' ' ' ILE . 40.7 pt -116.23 158.08 16.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.217 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 164' ' ' VAL . 6.2 m-20 -100.86 -172.19 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 84.8 m -52.56 -51.96 68.32 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.265 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.6 Cg_endo -58.56 -38.38 89.96 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.168 1.912 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.61 -42.21 93.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 168' ' ' VAL . 94.5 t -64.27 -45.44 96.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.761 0.315 . . . . 0.0 111.26 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.38 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.482 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.1 m -62.01 -54.46 41.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.567 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 164' ' ' VAL . 87.2 t -58.32 -35.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 69.0 m -64.82 -39.96 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -82.55 -13.89 55.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.97 -49.27 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -96.63 25.22 5.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.183 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.42 -26.22 60.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.947 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.0 -32.71 85.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.409 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -125.81 102.41 28.63 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 120.369 0.128 . . . . 0.0 110.988 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.34 -3.37 9.86 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.435 2.09 . . . . 0.0 112.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.86 -53.78 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -61.15 -35.77 78.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -67.29 -47.97 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.8 ttp -57.46 -42.76 83.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.695 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.27 -32.46 62.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.389 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -67.95 -31.63 71.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 110.574 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -67.35 -23.87 65.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 35.0 m -65.57 -40.68 93.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -57.42 -50.85 71.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.34 146.22 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 23.4 Cg_endo -62.05 114.26 2.23 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.398 2.065 . . . . 0.0 111.977 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 15.6 Cg_endo -57.28 161.16 11.85 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.461 2.107 . . . . 0.0 112.347 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.548 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.826 0.346 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.2 t -105.64 -17.09 14.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.749 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 8.3 t -139.98 145.52 37.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' TRP . . . . . 0.412 ' HB2' ' H ' ' B' ' 130' ' ' LEU . 0.4 OUTLIER -117.72 -159.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.788 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.412 ' H ' ' HB2' ' B' ' 129' ' ' TRP . 54.0 mt -53.44 162.93 0.69 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.284 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.403 ' O ' ' HE2' ' B' ' 135' ' ' MET . 87.1 p -61.96 161.09 11.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.866 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' B' ' 135' ' ' MET . 11.1 pt-20 -75.1 -33.47 61.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.509 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.551 ' HA ' HD23 ' A' ' 148' ' ' LEU . 13.0 pt-20 -76.45 -41.59 46.85 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' B' ' 132' ' ' GLU . 22.3 ptp -63.29 -33.31 75.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.0 mt -76.48 -53.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.482 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -53.83 -51.01 64.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.725 HD21 HD13 ' A' ' 130' ' ' LEU . 3.9 mt -61.62 -43.67 98.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.02 -37.16 52.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.69 -37.58 76.77 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.598 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.584 HD13 ' HA ' ' B' ' 138' ' ' LEU . 1.5 mp -56.84 -56.03 26.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.046 0.45 . . . . 0.0 110.018 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.607 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -68.52 -24.13 64.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.466 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -75.45 -27.5 58.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.194 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' MET . . . . . 0.442 ' SD ' HG23 ' A' ' 161' ' ' THR . 12.7 ttm -79.46 -40.42 29.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 80.4 p -60.66 -29.95 69.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -137.47 -126.72 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.95 27.16 69.31 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.33 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -139.52 117.36 11.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.677 0.275 . . . . 0.0 110.601 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 61.69 -167.68 0.19 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.772 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 2.8 t 37.35 90.82 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.326 0 O-C-N 123.463 0.477 . . . . 0.0 111.854 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -38.21 105.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.879 2.386 . . . . 0.0 113.069 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.7 -67.38 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.664 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 51.5 t -110.04 -17.4 13.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.028 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.07 -88.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.264 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -167.79 110.46 0.63 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.194 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 67.3 m -156.69 158.85 37.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.1 t -159.95 -21.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.626 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.523 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 62.7 tp -81.02 -50.33 0.99 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.666 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 41.6 Cg_endo -66.94 -78.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.912 1.741 . . . . 0.0 112.449 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 66.4 m -160.97 106.83 1.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.811 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -142.72 -61.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 49.1 m -69.82 162.11 28.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 15.6 p -156.8 72.3 4.74 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.39 -44.19 7.01 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.518 2.145 . . . . 0.0 111.794 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -165.96 76.07 1.24 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.674 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.15 123.91 11.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.64 2.227 . . . . 0.0 112.564 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.35 -50.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 40.0 t -163.89 6.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.669 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.634 ' HA ' ' HG3' ' B' ' 173' ' ' PRO . 9.3 p -73.23 145.26 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.033 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 33.8 t 65.63 6.08 3.65 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.146 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.48 -66.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.364 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ASP . . . . . 0.615 ' N ' ' HD3' ' B' ' 173' ' ' PRO . 4.9 p-10 -166.55 43.67 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.627 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.634 ' HG3' ' HA ' ' B' ' 169' ' ' VAL . 43.0 Cg_endo -92.36 -176.43 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.497 2.132 . . . . 0.0 112.75 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.58 -69.08 0.45 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.464 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.06 -45.23 24.75 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.712 2.275 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 53.1 m -70.71 131.07 43.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 92.74 -163.94 27.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.605 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -148.94 -51.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.918 0.39 . . . . 0.0 110.696 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -107.54 -61.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.731 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 58.0 m -72.73 83.11 1.16 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 20.1 p -175.7 154.24 1.54 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.726 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.9 m -105.32 -76.37 0.61 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.627 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 118.81 -152.55 17.3 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.473 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 82.4 p -97.2 -49.73 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.738 0.304 . . . . 0.0 111.434 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -123.69 -61.41 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.03 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.296 -179.889 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.717 0.294 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -93.55 6.9 46.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.51 98.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.598 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -95.52 168.37 10.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.256 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.672 HG22 ' HG ' ' B' ' 142' ' ' LEU . 41.8 t -95.11 -27.65 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.77 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -59.58 -35.35 74.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -68.33 -39.03 82.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.923 0.392 . . . . 0.0 110.539 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -63.99 -44.72 91.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.487 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.479 HD23 HG12 ' A' ' 123' ' ' VAL . 4.5 mm? -61.55 -40.79 95.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.174 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -58.96 -42.16 89.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.8 -40.56 93.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.852 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.451 HD22 HD21 ' B' ' 138' ' ' LEU . 26.2 tp -59.47 -41.56 90.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.191 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.47 -43.09 99.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.56 -41.19 85.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.26 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.93 -46.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.866 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -64.61 -25.55 68.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -72.73 -59.54 2.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.177 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -61.87 -56.37 20.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -83.71 30.56 0.49 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.336 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.0 -25.08 69.12 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.866 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -87.81 -22.22 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.05 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -121.91 98.12 45.44 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.26 13.58 2.18 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.451 2.101 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -75.01 -61.57 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.65 -37.27 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.278 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -65.23 -57.66 7.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -56.43 -35.51 67.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.142 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.57 -36.48 73.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.014 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -64.58 -58.36 6.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.971 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.8 mp -60.39 -42.72 96.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.76 -44.86 74.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.117 0.484 . . . . 0.0 109.714 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.06 -47.95 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.235 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.454 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -54.96 -42.41 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.548 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -61.72 -39.64 92.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.262 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.11 -39.74 91.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.066 0.46 . . . . 0.0 109.874 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.81 -21.7 57.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.878 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -86.31 -22.87 26.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.63 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 62.7 m -104.01 16.35 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 61.43 93.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.984 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.8 m -147.6 -61.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.668 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 pt -114.54 155.07 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.407 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 1.1 p30 -83.17 171.75 13.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.621 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 63.5 m -53.67 -51.57 75.14 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.624 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 51.6 Cg_exo -53.03 -32.16 57.08 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.923 1.749 . . . . 0.0 111.896 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.09 62.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.207 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.4 t -66.93 -43.81 89.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.739 0.304 . . . . 0.0 110.813 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -66.1 -43.61 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.171 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.1 p -65.42 -54.06 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.375 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -55.78 -51.26 68.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.309 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.76 -36.16 69.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 t -59.39 -45.74 90.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.524 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -84.09 -11.58 56.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.6 tp -75.96 -26.34 56.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -109.29 30.48 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.57 118.28 4.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.06 -54.84 0.77 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.198 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -109.03 95.72 18.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.76 0.88 4.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.506 2.137 . . . . 0.0 112.643 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.72 -56.02 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.006 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.9 mm? -58.52 -37.7 76.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.7 mt -71.07 -37.78 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.74 -38.64 91.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.13 -28.62 40.38 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.649 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -68.99 -40.98 78.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.8 -21.27 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 m -66.38 -39.96 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.309 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -60.7 -40.37 91.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.26 152.0 44.68 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.614 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 29.1 Cg_endo -63.63 111.12 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.313 2.009 . . . . 0.0 112.091 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.2 Cg_endo -62.87 145.26 94.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.339 2.026 . . . . 0.0 112.188 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.396 -1.224 . . . . 0.0 112.546 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.782 0.325 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 74.9 p -94.81 116.35 28.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.785 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 67.5 p -65.2 116.03 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -74.73 -3.97 34.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.786 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.457 HD12 ' N ' ' B' ' 130' ' ' LEU . 7.2 mp -91.38 173.95 7.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.64 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 59.4 m -93.35 164.35 13.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.724 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.47 -36.56 63.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.783 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.1 -28.74 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.89 -42.87 60.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.6 tpp -65.44 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.41 -52.28 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.48 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -52.47 -47.0 66.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.091 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 130' ' ' LEU . 4.2 mm? -64.74 -38.72 91.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.276 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.39 -46.76 62.95 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.31 -31.42 71.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.584 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.48 HD12 ' O ' ' B' ' 137' ' ' ALA . 0.1 OUTLIER -59.02 -54.95 41.29 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 110.399 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.672 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -73.51 -21.63 60.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.83 -26.3 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.356 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 53.8 ttp -87.51 -34.75 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m -60.3 -17.29 41.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.689 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -127.03 -17.56 4.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.015 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -102.08 50.95 0.92 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.523 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -118.57 125.11 49.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.738 0.304 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.65 ' O ' HG22 ' B' ' 150' ' ' THR . 54.5 tt0 63.03 169.74 0.14 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.838 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.65 HG22 ' O ' ' B' ' 149' ' ' GLN . 0.7 OUTLIER 58.56 146.68 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 123.289 0.635 . . . . 0.0 111.857 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.1 114.22 1.63 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.379 2.053 . . . . 0.0 112.133 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -157.66 -81.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.804 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 29.8 t -152.44 20.96 0.63 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.221 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.52 -27.36 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.903 0.382 . . . . 0.0 111.102 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -163.7 106.63 0.97 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.252 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 49.7 m -133.13 112.13 11.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.719 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 81.1 p -135.85 -7.21 2.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.786 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.501 ' HB3' ' HD3' ' B' ' 159' ' ' PRO . 47.6 tp -86.27 -49.54 0.51 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.307 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' B' ' 158' ' ' LEU . 91.4 Cg_endo -78.86 -1.38 11.55 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.143 1.895 . . . . 0.0 112.064 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 47.4 t 56.98 93.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.959 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 56.7 m -88.37 -51.22 5.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.14 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 59.1 m -119.68 -71.26 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 69.1 m 55.03 73.88 0.81 Allowed Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.47 31.75 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.598 2.199 . . . . 0.0 112.112 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 23.9 t70 58.69 72.36 0.85 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.603 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.81 142.95 84.76 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.583 2.188 . . . . 0.0 112.339 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 47.9 t -74.13 144.85 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 59.2 m -58.76 114.06 2.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.91 -27.65 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 45.0 t -106.31 153.54 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.941 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -100.16 -29.12 12.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.767 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -144.74 92.33 5.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.582 ' HB3' ' H ' ' B' ' 182' ' ' SER . 57.5 Cg_endo -70.49 -42.42 2.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.126 . . . . 0.0 112.142 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.39 -159.99 10.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.447 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.12 173.34 11.44 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.527 2.151 . . . . 0.0 112.311 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.0 t -71.42 103.76 3.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -175.32 -7.09 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.345 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.28 173.54 11.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -118.1 166.23 12.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 70.3 m 58.08 -176.1 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.135 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 27.2 p -90.05 145.04 25.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.582 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 47.0 t -158.3 3.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -88.56 -47.4 4.3 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.394 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 35.5 p 49.11 -89.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 122.518 0.327 . . . . 0.0 111.786 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -122.9 -50.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.746 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.399 -0.81 . . . . 0.0 111.202 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 121' ' ' LEU . 16.0 ptm180 -154.75 -10.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.975 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.416 ' H ' ' H ' ' A' ' 120' ' ' ARG . 5.5 tt 63.44 109.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.62 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -113.48 145.48 41.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.265 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.671 HG22 ' HG ' ' B' ' 142' ' ' LEU . 48.7 t -64.03 -31.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.519 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -56.98 -35.87 69.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.17 -37.83 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.11 86.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.119 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.91 -49.3 73.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -55.06 -36.61 65.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 133' ' ' VAL . 64.9 t80 -67.68 -33.55 75.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.83 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.5 tp -62.3 -48.62 79.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.024 0.44 . . . . 0.0 110.041 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.54 -38.54 91.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -57.97 -44.78 87.29 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 110.296 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.537 HG22 HD12 ' A' ' 178' ' ' LEU . 89.2 t -61.88 -48.11 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -68.22 -15.93 63.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.56 -54.87 6.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.48 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.8 mm100 -52.0 -65.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.435 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -61.91 -64.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.816 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.57 -87.19 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.735 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.7 m -64.72 -9.33 19.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 111.037 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -119.01 77.52 15.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.541 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.0 4.56 6.88 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.643 2.228 . . . . 0.0 112.54 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -62.21 -38.9 90.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.705 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t -72.34 -39.03 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.121 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.26 -55.28 36.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.048 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -54.94 -42.0 71.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.22 -32.04 73.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.201 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.18 -60.53 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.077 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -61.86 -38.75 89.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.004 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.18 -46.14 83.08 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.535 HD12 HD22 ' A' ' 171' ' ' LEU . 3.2 mt -56.99 -45.49 83.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.855 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.566 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 77.4 mmm -55.03 -40.19 69.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.658 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.35 -37.77 88.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.218 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.06 -39.88 93.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 109.856 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.4 -37.46 63.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.818 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HG2' HG23 ' B' ' 136' ' ' ILE . 22.0 tptm -65.93 -27.44 68.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.383 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 92.7 p -102.33 -154.76 0.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.905 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -102.89 87.61 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.812 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.4 t -148.56 -70.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.57 167.21 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.677 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.3 -170.49 1.67 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 56.8 m -53.58 -52.31 68.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.745 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 161' ' ' THR . 10.1 Cg_endo -53.25 -36.39 77.73 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.033 1.822 . . . . 0.0 111.883 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.05 -38.59 88.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.13 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.42 -45.2 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.23 -49.0 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.43 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -62.66 -59.24 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.717 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -52.82 -54.33 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.605 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.25 -35.34 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.676 0.274 . . . . 0.0 111.235 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.3 t -61.3 -46.51 90.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -83.96 -11.79 56.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.535 HD22 HD12 ' A' ' 150' ' ' ILE . 19.1 tp -77.94 -24.76 48.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -113.0 25.68 11.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.65 103.51 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 144.65 -25.97 1.96 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.557 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -125.47 95.12 41.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.388 0.137 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -7.36 21.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.387 2.058 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.88 -54.26 10.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -60.79 -41.92 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.9 mt -63.8 -49.58 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 57.0 ttp -58.89 -35.82 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.6 -20.56 63.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.434 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.99 -41.31 36.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -62.39 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 89.4 m -63.75 -35.9 82.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' B' ' 145' ' ' SER . 97.0 m-85 -65.15 -52.03 57.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' B' ' 145' ' ' SER . 77.2 mt -54.78 148.59 26.27 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 51.3 Cg_exo -54.57 145.44 58.66 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.428 2.085 . . . . 0.0 112.108 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 53.0 Cg_exo -55.22 166.52 2.29 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.364 2.043 . . . . 0.0 112.402 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.443 -1.198 . . . . 0.0 112.441 -179.923 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 56.6 m . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.793 0.33 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 45.1 t -101.77 2.87 38.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.41 HG22 ' HB2' ' B' ' 130' ' ' LEU . 27.7 m -75.71 -22.52 56.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.999 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 60.33 18.06 7.68 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.061 0.457 . . . . 0.0 110.72 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.473 ' HG ' ' H ' ' B' ' 131' ' ' SER . 17.2 tp -105.25 170.39 7.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.771 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.473 ' H ' ' HG ' ' B' ' 130' ' ' LEU . 78.3 p -85.5 161.92 19.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.8 -37.37 81.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.203 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.24 94.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.725 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 148' ' ' LEU . 39.3 mt-10 -70.97 -39.17 72.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.17 -34.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.501 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.6 mt -75.7 -52.81 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.061 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.566 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -54.24 -48.52 71.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 110.574 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.625 ' HA ' HD12 ' B' ' 141' ' ' LEU . 3.7 mm? -63.9 -43.79 94.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.258 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.13 -47.28 45.65 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.44 -36.66 92.88 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.891 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' B' ' 138' ' ' LEU . 56.9 mt -59.51 -55.32 36.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.919 0.39 . . . . 0.0 110.901 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.671 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -72.76 -18.76 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.332 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.343 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 44.7 ttp -81.76 -39.35 24.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.354 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.489 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.6 p -110.12 76.55 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.882 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' B' ' 153' ' ' CYS . 13.0 pt20 -130.79 -10.1 3.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.122 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -99.43 64.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.547 ' HG2' ' HG2' ' B' ' 149' ' ' GLN . 0.3 OUTLIER -59.38 -31.13 68.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.0 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.547 ' HG2' ' HG2' ' B' ' 148' ' ' GLU . 86.1 mm-40 -112.24 -157.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.782 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.521 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 1.1 t -70.97 -32.01 2.24 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' B' ' 150' ' ' THR . 2.9 Cg_exo -76.38 -161.56 0.14 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.953 1.769 . . . . 0.0 112.067 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -133.13 136.25 45.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.988 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' B' ' 146' ' ' GLN . 35.5 t 60.28 9.08 1.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.337 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.698 HG22 ' H ' ' B' ' 156' ' ' SER . 7.6 p -172.28 159.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.815 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ALA . . . . . 0.408 ' N ' HG22 ' B' ' 154' ' ' VAL . . . -100.83 -7.36 23.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.351 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.698 ' H ' HG22 ' B' ' 154' ' ' VAL . 92.5 p 51.6 -169.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.281 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.8 p -171.0 -31.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.479 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 62.4 tp -65.77 -51.15 50.55 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.643 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 58.3 Cg_endo -71.6 -56.72 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.021 1.814 . . . . 0.0 112.344 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 55.1 m -148.6 101.05 3.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 33.3 m -62.31 148.78 44.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.157 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 45.9 t -65.2 138.08 58.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.973 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 22.6 p 38.54 73.07 0.82 Allowed Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.61 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.81 -43.16 46.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.553 2.168 . . . . 0.0 111.863 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -154.63 69.52 5.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.481 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.48 137.86 48.15 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.527 2.152 . . . . 0.0 112.526 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.413 HG12 ' N ' ' B' ' 168' ' ' SER . 11.2 t -115.31 158.83 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.631 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.413 ' N ' HG12 ' B' ' 167' ' ' VAL . 48.3 t -55.43 101.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.937 0.399 . . . . 0.0 111.142 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 94.1 t -144.43 135.68 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.826 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 46.9 t -112.47 142.43 45.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.06 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.87 110.95 22.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.691 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 21.4 t70 57.07 88.72 0.12 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.015 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' B' ' 181' ' ' CYS . 58.3 Cg_endo -71.67 -169.51 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.46 2.107 . . . . 0.0 112.241 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.63 165.73 40.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.448 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.24 -25.81 42.56 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.614 2.209 . . . . 0.0 112.185 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 47.8 t -158.38 112.98 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.843 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.93 -48.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.603 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -142.24 152.27 42.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.748 0.309 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.71 -19.79 66.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.325 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 79.4 p -131.53 -176.84 4.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' CYS . . . . . 0.445 ' HA ' ' HG3' ' B' ' 173' ' ' PRO . 28.2 p -59.63 154.25 18.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.766 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 66.7 p -159.11 -61.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.38 21.8 76.92 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.561 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 82.1 p -76.26 -46.5 27.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -154.24 140.28 18.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.955 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.264 179.783 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.761 0.315 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -70.05 157.02 38.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.844 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.33 118.5 23.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -137.18 128.17 27.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.918 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.608 HG22 ' HG ' ' B' ' 142' ' ' LEU . 30.2 t -67.02 -28.72 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.63 -39.06 79.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.779 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.51 -36.8 84.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 109.969 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -61.77 -45.22 94.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.174 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.082 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -56.99 -38.59 73.26 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 133' ' ' VAL . 67.3 t80 -64.98 -40.67 95.33 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.731 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.32 -36.06 74.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.26 -39.84 74.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.01 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -57.87 -39.21 77.27 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.869 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 178' ' ' LEU . 47.4 t -72.51 -38.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -68.28 -20.58 64.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.288 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.21 -55.9 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.57 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -74.76 -59.9 2.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.168 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -83.46 24.91 0.79 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.13 -26.08 68.85 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.498 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.4 m -90.36 5.49 47.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -114.11 87.2 12.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.68 -7.26 18.41 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.357 2.038 . . . . 0.0 112.034 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -84.27 -62.34 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.451 HG13 HD23 ' A' ' 171' ' ' LEU . 17.0 t -57.68 -44.9 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.596 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.49 -56.78 16.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.908 0.385 . . . . 0.0 110.568 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.8 -36.28 76.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.544 ' HB3' HD11 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -68.85 -31.58 70.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -69.65 -59.7 2.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -38.26 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.496 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 15.1 t70 -58.22 -50.12 74.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -53.74 -44.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.196 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.543 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 75.7 mmm -58.2 -39.66 79.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 55.2 mtmt -67.02 -31.17 71.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.115 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.57 -42.73 86.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.69 -21.82 60.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.818 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.48 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.5 tptp -82.31 -34.61 28.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.9 t -95.2 18.99 11.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 64.04 98.86 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -153.08 -61.92 0.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.567 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.37 172.42 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 164' ' ' VAL . 12.1 m-20 -100.37 -178.33 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.135 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 87.5 m -60.22 -50.04 87.88 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.603 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 53.1 Cg_exo -55.51 -32.95 84.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.964 1.776 . . . . 0.0 111.939 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.49 -40.49 59.66 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.235 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 168' ' ' VAL . 94.4 t -64.9 -45.27 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.94 -49.87 77.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.308 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.4 p -58.89 -53.2 61.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -54.3 -52.31 61.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.397 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 164' ' ' VAL . 81.8 t -61.7 -31.13 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.752 0.311 . . . . 0.0 111.007 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.1 m -64.41 -45.36 87.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.781 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -82.25 -16.5 49.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 146' ' ' ASP . 1.2 tp -76.03 -42.53 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -95.94 15.6 20.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -51.61 120.09 4.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.46 -45.68 0.78 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.36 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -120.45 100.7 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.46 0.172 . . . . 0.0 110.758 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.41 -11.27 13.14 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.489 2.126 . . . . 0.0 112.707 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.5 -64.74 0.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 133' ' ' VAL . 4.8 mp -57.7 -27.12 62.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.64 -55.06 24.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.1 ttp -64.2 -40.96 97.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.008 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.15 -30.97 79.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.59 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.04 -35.85 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -63.72 -30.7 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.7 m -55.76 -51.91 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -53.52 -44.48 69.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.91 154.09 39.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 19.5 Cg_endo -60.01 146.91 94.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.369 2.046 . . . . 0.0 112.126 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 31.4 Cg_exo -61.42 142.41 95.39 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.327 2.018 . . . . 0.0 112.105 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.423 -1.209 . . . . 0.0 112.57 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 54.2 m -104.92 175.21 5.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.946 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 26.2 m 65.32 130.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.205 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -156.51 -29.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.73 162.67 15.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.502 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 43.9 t -66.1 170.8 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.999 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -67.13 -48.76 67.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.99 14.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 11.1 mm-40 -72.28 -54.95 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.772 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 51.8 ttm -64.63 -25.89 68.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.48 HG23 ' HG2' ' A' ' 155' ' ' LYS . 93.5 mt -73.55 -53.43 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.543 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -57.24 -47.77 80.54 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.509 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.682 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.08 -45.69 93.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.543 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.38 49.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.09 -34.36 89.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.867 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' B' ' 138' ' ' LEU . 58.4 mt -61.25 -56.13 24.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.895 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.608 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -69.13 -21.97 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -82.71 -26.25 32.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.556 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -80.47 -39.23 28.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.542 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 77.8 p -59.2 -19.49 45.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.637 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -119.23 -15.36 9.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.846 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -71.26 -19.28 77.34 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.795 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 62.97 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.611 0.243 . . . . 0.0 111.29 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -136.58 -45.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.969 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 5.8 t -82.94 143.54 46.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.055 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.95 -16.79 29.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.411 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.46 6.69 48.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 70.1 m 65.68 144.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.102 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 47.1 t 61.59 104.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.339 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.28 120.64 12.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 53.9 m -144.01 155.36 43.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 55.4 m -91.9 -1.35 57.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.55 ' HB3' ' HD3' ' B' ' 159' ' ' PRO . 44.9 tp -74.44 -48.3 5.46 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' B' ' 158' ' ' LEU . 52.6 Cg_exo -54.93 -72.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.191 1.928 . . . . 0.0 112.542 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.417 ' H ' ' H ' ' B' ' 161' ' ' THR . 80.0 p -163.84 -9.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.197 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.581 HG22 ' H ' ' B' ' 163' ' ' CYS . 25.3 m 65.39 148.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.242 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 57.6 m -132.32 6.83 4.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' CYS . . . . . 0.581 ' H ' HG22 ' B' ' 161' ' ' THR . 63.6 m -128.94 80.12 73.37 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.19 30.52 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.675 2.25 . . . . 0.0 112.062 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.2 t70 58.69 66.95 2.25 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.861 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.52 129.47 5.0 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.664 2.243 . . . . 0.0 112.239 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 20.6 t -125.69 96.58 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.123 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 94.1 p 50.01 22.09 0.84 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.394 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 35.9 m -80.82 154.46 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.326 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 47.6 t -156.37 -16.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.828 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.41 ' H ' ' H ' ' B' ' 172' ' ' ASP . 9.7 tp10 -159.48 -9.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.692 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 172' ' ' ASP . . . . . 0.41 ' H ' ' H ' ' B' ' 171' ' ' GLU . 20.4 t70 65.34 124.9 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.038 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.85 179.06 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.307 2.005 . . . . 0.0 112.246 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.03 -143.04 10.87 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.445 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.82 -29.55 63.51 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.645 2.23 . . . . 0.0 112.643 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.7 m -128.75 167.64 16.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.027 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -125.93 153.73 18.52 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.423 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -152.59 119.99 5.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.693 0.282 . . . . 0.0 111.137 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 59.99 -86.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.493 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 78.3 p -115.93 -47.49 2.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 71.6 m -60.89 99.99 0.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.007 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.1 t -162.11 115.2 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.653 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.04 -134.83 8.67 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.6 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 4.8 t -151.48 -32.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -158.08 -47.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.28 -179.928 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.607 0.241 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 65.34 130.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.187 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -62.12 103.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.413 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.621 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 16.4 tppt? -132.06 145.29 51.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.63 HG13 ' HG ' ' B' ' 142' ' ' LEU . 58.9 t -71.41 -32.04 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.621 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 36.8 tt0 -57.67 -39.21 76.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.934 0.397 . . . . 0.0 110.504 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.808 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.4 -41.51 98.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.132 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.73 -44.23 96.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.84 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.5 m -55.74 -40.03 71.95 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 133' ' ' VAL . 40.8 t80 -65.63 -34.52 78.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.086 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.583 HD22 HD21 ' B' ' 138' ' ' LEU . 28.2 tp -61.96 -48.58 79.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.241 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.36 -31.46 72.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.17 -43.61 94.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.614 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 129' ' ' TYR . 91.0 t -67.19 -47.83 80.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 134' ' ' LYS . 10.9 tmtt? -58.2 -39.14 78.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.8 -31.98 63.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.779 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -54.26 -55.78 24.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.35 -62.79 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.536 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.1 -80.46 0.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.861 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.2 m -58.41 -19.51 36.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.323 . . . . 0.0 111.159 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -122.1 81.39 43.82 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.962 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.31 6.36 3.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.767 2.311 . . . . 0.0 112.197 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -65.92 -56.21 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.216 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -50.46 -36.81 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.474 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.66 -57.93 10.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.448 . . . . 0.0 110.661 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -57.56 -33.47 68.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' HD11 ' A' ' 171' ' ' LEU . 58.0 m-20 -62.43 -49.52 75.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.31 -58.14 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.273 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.14 -30.24 70.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.709 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.0 -55.1 36.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.172 0.511 . . . . 0.0 109.709 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mt -54.46 -46.33 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.247 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.761 ' HE2' HD23 ' B' ' 141' ' ' LEU . 69.1 mmm -52.95 -42.91 65.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.681 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -64.66 -39.05 93.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.611 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.75 -40.82 89.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.547 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -77.61 -38.6 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.507 ' HG2' HG23 ' B' ' 136' ' ' ILE . 61.0 tptt -62.54 -30.58 71.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.78 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.4 m -89.64 -83.29 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.783 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -178.17 94.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.521 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.1 m -157.37 -73.01 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -103.48 -178.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.319 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 164' ' ' VAL . 20.9 m-20 -120.23 -175.25 2.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.559 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.0 m -54.58 -51.53 77.74 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.807 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.4 Cg_endo -58.31 -37.03 96.95 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.081 1.854 . . . . 0.0 112.037 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.273 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 160' ' ' ASP . 87.0 t -68.39 -45.15 82.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 110.957 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.23 -45.76 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.485 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.6 p -64.68 -55.81 17.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.835 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -57.66 -53.27 60.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.793 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.66 -41.1 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.787 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 85.2 p -60.77 -44.37 96.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.551 0.215 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -82.59 -12.02 58.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 146' ' ' ASP . 19.0 tp -70.2 -39.18 75.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.566 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -92.83 33.04 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -52.4 112.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 132.01 -46.65 1.05 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.551 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -114.37 95.59 40.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.433 0.158 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.81 3.55 5.41 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.5 2.134 . . . . 0.0 112.376 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -69.83 -60.64 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 178' ' ' LEU . 3.3 mm? -60.29 -35.66 76.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.547 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.17 -49.86 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.784 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.7 ttp -59.29 -38.8 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.68 -25.82 73.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.386 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -77.32 -34.88 55.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.724 0.297 . . . . 0.0 111.06 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -65.54 -16.98 64.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.2 m -70.32 -34.15 72.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.226 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -62.75 -43.62 98.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.57 155.72 27.4 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.847 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.77 129.09 25.08 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.523 2.149 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.21 171.89 11.94 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.391 2.061 . . . . 0.0 112.252 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.491 -179.953 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.716 0.293 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 29.9 t 59.93 176.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.164 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 5.7 t -80.2 144.94 32.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -137.26 -20.64 1.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.966 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' B' ' 130' ' ' LEU . 0.8 OUTLIER -57.82 164.76 2.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 50.0 m -65.95 -178.31 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.434 ' O ' HG13 ' B' ' 136' ' ' ILE . 39.9 mt-10 -74.41 -41.62 60.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.103 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.87 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.498 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -67.71 -46.68 71.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.0 -28.51 69.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.201 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.507 HG23 ' HG2' ' A' ' 155' ' ' LYS . 96.5 mt -74.91 -53.91 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.86 73.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.106 0.479 . . . . 0.0 110.138 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 130' ' ' LEU . 4.4 mm? -56.71 -52.54 64.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.243 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.69 -31.66 26.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.67 -51.46 47.07 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.001 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.761 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -68.4 -47.08 68.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.207 0.504 . . . . 0.0 111.338 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.63 ' HG ' HG13 ' A' ' 123' ' ' VAL . 3.6 mm? -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.548 0.213 . . . . 0.0 111.32 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -86.15 -28.56 23.89 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.66 0.267 . . . . 0.0 111.382 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -73.51 -25.78 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.482 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 78.6 p -70.9 -18.07 62.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -111.89 -20.17 12.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.57 -68.97 0.21 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.703 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -158.83 -69.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.715 0.293 . . . . 0.0 110.983 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -68.0 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.592 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 3.5 t -64.24 147.09 97.32 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.88 -20.44 6.95 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.745 2.296 . . . . 0.0 113.269 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -131.19 112.16 12.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.783 0.325 . . . . 0.0 111.203 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 74.0 m 59.7 -155.12 0.36 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.752 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.03 133.66 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 111.061 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.53 -22.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.174 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 64.2 m -73.36 156.59 38.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.2 p -166.18 6.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.794 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.593 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 6.9 mp -91.99 -50.37 0.3 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.671 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.593 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 25.9 Cg_endo -61.76 -76.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.088 1.858 . . . . 0.0 112.615 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 47.0 t -72.23 -44.93 62.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.893 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 49.9 m 63.36 -82.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.382 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 47.7 t -133.97 141.8 47.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.013 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 16.3 p -120.2 80.62 28.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -85.69 -8.54 8.21 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.853 2.369 . . . . 0.0 112.973 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.571 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 20.2 t70 -83.07 -53.23 0.6 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.577 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 90.9 Cg_endo -81.62 86.1 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.98 1.786 . . . . 0.0 112.356 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.6 -68.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.816 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 33.5 t -165.67 12.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.788 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.03 147.87 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.117 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' B' ' 181' ' ' CYS . 77.7 p -156.51 113.31 3.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -167.6 -177.17 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.15 119.22 75.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.707 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.13 -54.88 2.25 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.325 2.017 . . . . 0.0 112.327 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -148.97 -84.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.424 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.92 -176.49 2.11 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.574 2.183 . . . . 0.0 112.175 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 67.5 m -74.02 123.78 24.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -154.02 -164.47 12.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.41 -3.3 1.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -73.71 176.25 6.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.1 p -79.5 -176.06 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 181' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' B' ' 170' ' ' SER . 46.4 t -60.14 125.27 23.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.2 m -140.04 3.0 1.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.067 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -84.65 173.16 49.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 92.3 m 58.42 96.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.7 0.286 . . . . 0.0 111.327 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.2 t70 66.87 90.72 0.09 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.126 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.442 -179.391 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.697 0.284 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 59.56 96.2 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.984 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 99.1 mt 58.73 -173.74 0.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -160.17 140.64 11.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.733 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.627 HG22 ' HG ' ' B' ' 142' ' ' LEU . 25.1 t -67.94 -26.28 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.68 -42.31 88.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.035 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -64.96 -33.17 75.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -63.44 -50.12 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.48 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.27 -41.59 89.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.257 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.0 t -55.78 -42.46 75.58 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.37 -35.46 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.01 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.65 -46.0 88.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.746 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.78 -40.3 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.886 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.405 ' HG3' ' NE2' ' A' ' 136' ' ' GLN . 7.6 tp60 -55.34 -42.94 74.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.153 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.63 -47.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.48 -25.08 65.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.654 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.4 tp -75.47 -65.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.295 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 132' ' ' GLN . 2.8 mp0 -52.01 -45.7 64.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.388 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -93.16 38.17 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.48 150.75 33.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.523 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.5 t 60.34 11.69 3.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.791 0.329 . . . . 0.0 111.052 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.43 80.09 28.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.693 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.04 9.78 3.2 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.712 2.275 . . . . 0.0 112.56 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -66.09 -61.1 2.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.19 -34.6 57.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.66 -55.88 29.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.982 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -56.05 -49.97 72.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.53 -36.57 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.79 -60.63 2.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.827 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.365 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -48.78 80.02 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.36 -48.0 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.082 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.403 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 81.2 mmm -53.24 -44.67 68.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.615 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.425 ' HG3' HG21 ' B' ' 136' ' ' ILE . 3.0 ttmp? -61.59 -37.28 83.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.543 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.11 -41.12 96.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 0.0 109.895 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -70.35 -41.61 72.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.468 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.547 ' HG2' HG23 ' B' ' 136' ' ' ILE . 28.6 tptp -65.37 -29.21 69.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.3 t -89.09 -85.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.793 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -178.5 101.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.611 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -165.34 -69.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.974 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.94 175.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.337 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.78 -171.95 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.972 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.533 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 61.3 m -53.53 -51.99 70.99 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.671 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 161' ' ' THR . 22.3 Cg_endo -61.68 -34.01 84.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.835 1.69 . . . . 0.0 111.686 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.67 93.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.089 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.72 -45.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.84 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.105 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -67.08 -56.6 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -55.59 -49.21 73.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.227 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.7 t -62.9 -34.56 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.564 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.3 t -59.34 -47.65 84.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.487 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.77 -15.68 56.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.5 tp -77.81 -31.01 51.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -118.99 24.55 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.33 -23.3 62.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.144 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -59.55 -32.51 73.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.804 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.32 108.31 10.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.525 0.163 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.33 -15.13 48.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.393 2.062 . . . . 0.0 112.425 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.93 -52.95 63.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.849 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.9 mm? -58.65 -33.93 70.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.572 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.31 -46.72 94.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.8 tpp -61.59 -48.06 82.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -26.05 72.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.547 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -78.81 -37.41 40.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.643 0.259 . . . . 0.0 111.111 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.62 -30.49 71.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.024 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.9 m -60.85 -39.7 90.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' B' ' 145' ' ' SER . 59.6 m-85 -58.46 -52.0 67.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.33 149.05 21.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.658 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 21.8 Cg_endo -60.8 140.56 91.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.357 2.038 . . . . 0.0 111.944 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.37 154.51 58.18 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.355 2.036 . . . . 0.0 112.281 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.561 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.813 0.34 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 55.6 m -138.88 163.57 31.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 5.9 t -142.73 -29.12 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.378 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -74.72 -32.89 62.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.04 179.18 7.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.857 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 89.5 p -104.49 -169.88 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.945 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.04 -38.52 79.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.185 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.53 68.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.512 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.545 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.9 OUTLIER -69.58 -47.9 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.189 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.1 ttm -60.69 -31.53 70.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.547 HG23 ' HG2' ' A' ' 155' ' ' LYS . 77.0 mt -76.57 -53.18 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.347 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.88 -47.63 70.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.634 HD13 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -66.69 -38.33 86.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.06 -53.17 45.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.011 0.434 . . . . 0.0 109.837 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.54 -31.0 79.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.589 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.634 HD13 HD13 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -58.34 -56.07 26.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 179.211 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.705 HD11 ' HB2' ' A' ' 126' ' ' ALA . 3.1 mm? -75.7 -17.3 59.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -83.12 -26.17 31.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.736 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 62.5 ttp -91.09 -32.25 15.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 57.3 m -80.09 14.67 1.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.397 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.407 ' HG3' ' N ' ' B' ' 147' ' ' GLY . 12.4 pt20 -126.25 -131.86 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.474 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' B' ' 146' ' ' GLN . . . 62.64 91.32 0.02 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.651 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -68.86 -60.67 2.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.772 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -140.34 16.33 2.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.5 t -171.22 145.63 1.89 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.66 127.03 17.62 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.358 2.039 . . . . 0.0 112.128 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 64.29 119.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.932 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 77.9 m -51.37 115.84 1.78 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.956 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 13.6 p -151.51 -17.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 62.59 108.3 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.273 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 49.9 m -125.13 165.87 17.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' B' ' 161' ' ' THR . 48.7 m -151.03 5.72 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.652 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 62.3 tp -99.89 -50.09 0.2 Allowed Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.791 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.652 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 41.7 Cg_endo -67.36 -64.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.066 1.844 . . . . 0.0 112.643 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 85.8 p -98.71 -25.02 14.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.453 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.525 HG22 ' H ' ' B' ' 163' ' ' CYS . 20.6 m 66.21 146.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.094 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 74.0 p -136.72 14.73 3.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.372 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 163' ' ' CYS . . . . . 0.525 ' H ' HG22 ' B' ' 161' ' ' THR . 78.7 m 61.57 101.78 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.096 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.1 -52.3 6.07 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.588 2.192 . . . . 0.0 113.077 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 17.0 t70 -93.08 -49.9 0.28 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 35.5 Cg_exo -60.9 98.67 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.08 1.854 . . . . 0.0 112.329 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 47.6 t -137.59 -66.53 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.27 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 44.0 t -167.38 2.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.169 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 13.6 p -66.37 142.84 16.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.061 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 51.8 m -107.03 -171.69 1.93 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.088 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.56 151.56 51.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 24.5 t70 55.24 86.43 0.17 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.118 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.495 ' HB3' ' H ' ' B' ' 182' ' ' SER . 54.3 Cg_endo -69.58 -47.75 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.589 2.193 . . . . 0.0 112.409 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.25 -155.38 21.34 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.584 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.26 -23.49 20.85 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.403 2.069 . . . . 0.0 112.354 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 50.6 m -149.29 126.45 11.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -175.14 29.16 0.08 OUTLIER Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.764 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 55.51 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.663 0.268 . . . . 0.0 111.282 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -151.06 -12.44 0.22 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.936 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.3 p -87.19 150.88 23.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 181' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' B' ' 173' ' ' PRO . 27.0 p -78.24 147.0 34.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 50.2 m -147.86 18.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.776 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.28 -33.57 71.02 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.617 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 56.9 m -75.87 112.8 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.688 0.28 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.46 -36.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.216 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.717 0.294 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 62.36 175.1 0.14 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.966 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.58 91.97 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.955 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -137.0 127.32 26.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.64 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.2 t -57.57 -40.29 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.677 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.22 -40.72 74.51 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.691 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.76 -37.24 86.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.197 0.522 . . . . 0.0 109.727 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -61.53 -41.81 97.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.987 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.04 -42.24 98.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.976 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m -55.47 -43.39 75.48 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.4 t80 -61.66 -38.13 86.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.1 tp -58.86 -44.59 91.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.992 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.25 -37.05 85.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.932 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.27 -35.61 80.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.399 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 178' ' ' LEU . 85.3 t -67.32 -55.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.857 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.09 -40.05 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.729 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.64 -37.98 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.145 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.475 ' HG2' HD21 ' A' ' 178' ' ' LEU . 5.8 tp-100 -57.86 -61.04 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.989 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 140' ' ' GLN . 92.6 m-85 -76.82 -1.62 29.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.17 -83.06 1.35 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.678 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.9 t -146.58 24.16 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.002 0.43 . . . . 0.0 110.44 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 137' ' ' PHE . 3.6 pm0 -46.42 118.78 4.95 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.52 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -92.87 -11.91 1.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.029 2.486 . . . . 0.0 111.797 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -84.67 -63.5 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.296 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.455 ' HB ' ' HG3' ' A' ' 140' ' ' GLN . 3.3 t -58.36 -50.2 79.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.267 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -52.76 -58.51 6.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.142 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -54.96 -42.45 72.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.391 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB3' HD11 ' A' ' 171' ' ' LEU . 63.0 m-20 -62.35 -38.16 88.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.464 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.61 -59.16 4.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.327 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -63.29 -34.29 77.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.299 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.12 -52.16 66.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.448 . . . . 0.0 109.836 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.2 mt -55.99 -48.32 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.482 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 71.1 mmm -55.38 -35.0 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.951 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -72.18 -34.18 68.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.28 -45.34 91.92 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -69.14 -33.05 72.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.892 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG2' HG23 ' B' ' 136' ' ' ILE . 61.3 tptt -74.8 -21.79 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.349 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.0 t -107.22 18.46 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.742 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 62.29 99.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.1 m -153.67 -65.29 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.09 165.38 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.96 -179.46 6.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.6 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 81.9 m -61.35 -50.06 85.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.63 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.31 -29.35 83.72 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.021 1.814 . . . . 0.0 111.912 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.8 -39.28 65.7 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.01 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.7 -44.16 79.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 110.996 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.43 -43.75 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.7 -56.01 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -54.5 39.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.23 -36.81 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -59.49 -49.39 77.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.818 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.31 -12.15 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 146' ' ' ASP . 12.4 tp -76.9 -19.83 56.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -125.62 29.18 6.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.986 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -55.6 -21.54 18.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.52 -53.08 46.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -120.37 98.03 48.73 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.399 0.142 . . . . 0.0 110.996 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.7 -14.98 23.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.467 2.111 . . . . 0.0 112.388 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.49 -54.33 48.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -57.21 -41.98 80.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.388 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.42 -35.85 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.812 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -63.8 -53.09 56.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.49 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.12 -22.88 72.82 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.235 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.451 ' HE1' HD21 ' B' ' 141' ' ' LEU . 83.9 t80 -72.77 -47.27 48.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.342 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.97 -20.86 65.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.4 m -60.79 -36.09 78.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.811 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -70.9 -49.1 49.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 75.8 mt -51.61 147.84 10.58 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.048 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.53 123.93 13.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 -170.32 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.313 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.305 -1.275 . . . . 0.0 112.511 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.695 0.283 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 81.8 p -102.54 142.67 33.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.806 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.418 HG22 ' H ' ' B' ' 130' ' ' LEU . 75.7 m -141.4 133.25 27.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -109.9 -1.46 17.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.45 HD12 ' N ' ' B' ' 130' ' ' LEU . 6.2 mp -101.18 147.76 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.984 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 49.6 m -74.76 -174.92 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.703 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.31 -35.33 71.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.052 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.94 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.498 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.564 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -71.95 -46.43 57.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtp -65.68 -31.34 72.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.435 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.409 HG23 ' HG2' ' A' ' 155' ' ' LYS . 88.7 mt -74.94 -53.73 15.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -55.5 -49.52 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.611 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -62.49 -42.94 99.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.666 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.35 59.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.92 80.1 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.582 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -60.77 -56.54 19.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.739 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.64 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -69.4 -22.12 63.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -82.02 -26.8 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -80.84 -40.19 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.888 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 79.4 p -104.22 98.4 8.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.149 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.404 ' HB2' ' SG ' ' B' ' 153' ' ' CYS . 8.5 mt-30 -108.76 -71.4 0.76 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.8 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.699 ' HA3' ' HB2' ' B' ' 152' ' ' ASN . . . -159.92 -69.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.553 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 51.89 73.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 111.174 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.576 ' HG2' HG22 ' B' ' 150' ' ' THR . 62.2 tt0 -175.84 -71.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.706 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.835 ' H ' ' HD2' ' B' ' 151' ' ' PRO . 4.0 t 177.04 -34.56 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.835 ' HD2' ' H ' ' B' ' 150' ' ' THR . 58.5 Cg_endo -70.83 -51.8 0.28 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.336 1.357 . . . . 0.0 112.152 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 152' ' ' ASN . . . . . 0.699 ' HB2' ' HA3' ' B' ' 147' ' ' GLY . 84.6 m-20 -86.56 -82.79 0.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.666 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 153' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' B' ' 146' ' ' GLN . 98.2 m -66.04 174.25 2.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.696 0.284 . . . . 0.0 110.753 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 32.2 m -131.78 11.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.455 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.91 -74.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.12 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 75.0 p 54.06 -177.17 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.48 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' SER . . . . . 0.533 ' HA ' ' HB ' ' B' ' 161' ' ' THR . 48.0 t -165.08 -29.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.815 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.618 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 3.8 mm? -60.7 -50.0 87.17 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.675 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 9.3 Cg_endo -51.21 -74.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.218 1.945 . . . . 0.0 112.44 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 79.0 p -170.71 14.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.665 0.269 . . . . 0.0 111.355 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' B' ' 157' ' ' SER . 45.7 m -61.47 -47.75 84.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.811 0.338 . . . . 0.0 110.846 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 39.2 t -140.9 120.76 13.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 82.1 m 56.18 80.84 0.27 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.298 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.64 -48.46 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.543 2.162 . . . . 0.0 112.215 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.534 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 26.0 t70 -103.51 -47.93 0.16 Allowed Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.653 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 35.0 Cg_exo -60.88 111.54 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.14 1.893 . . . . 0.0 112.506 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.69 -47.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 85.8 p -149.75 -21.24 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.789 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 60.7 t 60.68 -86.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.312 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 77.6 p -171.54 -61.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 110.764 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -135.74 179.99 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.799 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 18.8 t70 59.51 98.32 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.26 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.01 140.32 24.4 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.552 2.168 . . . . 0.0 112.581 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -149.92 -72.08 0.01 OUTLIER Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.479 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.55 -171.02 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.464 2.109 . . . . 0.0 112.114 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 80.3 p -85.78 156.11 20.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 166.67 -139.82 5.97 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.348 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -126.12 -63.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.782 0.325 . . . . 0.0 110.844 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -150.96 -178.57 6.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.624 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 44.1 t 59.03 103.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.29 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 20.4 p 43.32 32.91 0.53 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.658 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 53.8 m -152.71 111.94 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.961 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 160.88 91.82 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 4.7 t -73.81 -20.39 60.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.822 0.344 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -165.95 122.66 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.144 -0.932 . . . . 0.0 111.251 179.847 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.793 0.33 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.51 ' HA ' ' HE ' ' A' ' 120' ' ' ARG . 3.1 mmp_? -114.02 112.68 23.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.9 tp -109.15 122.3 46.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.782 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.83 175.04 5.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.531 HG22 ' HG ' ' B' ' 142' ' ' LEU . 49.1 t -82.05 -44.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.749 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.27 -24.85 45.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.05 -43.56 82.42 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.544 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -65.33 -35.59 81.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.475 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.86 -42.87 99.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.841 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -60.6 -42.51 96.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -58.79 -39.19 80.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.785 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.489 HD22 HD21 ' B' ' 138' ' ' LEU . 22.8 tp -58.75 -46.91 86.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.0 -37.03 78.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.438 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -59.6 -51.63 68.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.375 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.552 HG22 HD12 ' A' ' 178' ' ' LEU . 95.8 t -58.88 -39.88 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.67 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -69.0 -25.81 64.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.787 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.86 -53.57 12.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -60.9 -56.46 20.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -85.52 31.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.126 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.08 -28.8 67.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.481 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.8 p -85.88 -18.48 32.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.826 0.346 . . . . 0.0 110.779 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -130.55 87.21 50.72 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.875 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.36 10.12 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.477 2.118 . . . . 0.0 112.37 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -67.16 -58.5 4.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.04 -43.96 77.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.06 -52.16 66.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.686 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -58.4 -38.48 77.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.802 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.13 -31.56 71.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -66.44 -60.07 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.558 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.17 -30.52 71.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.04 -48.8 80.21 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.2 mt -56.05 -43.54 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.547 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.518 ' HB3' ' HA ' ' B' ' 137' ' ' ALA . 0.0 OUTLIER -53.38 -48.85 68.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.984 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -58.54 -41.6 85.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.084 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.84 -39.74 78.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.847 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.65 -22.97 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.851 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -84.58 -14.13 49.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.3 m -111.53 15.66 21.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 62.95 93.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.8 m -147.15 -49.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.28 171.57 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.939 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.569 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 5.3 t70 -111.2 -177.23 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.765 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 34.1 m -51.02 -50.58 74.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 33.1 Cg_exo -57.75 -37.09 97.84 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.898 1.732 . . . . 0.0 111.953 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.72 -37.91 89.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.506 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 160' ' ' ASP . 61.5 t -67.18 -45.17 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.756 0.313 . . . . 0.0 110.938 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.63 -43.85 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -66.26 -55.41 16.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.499 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -53.62 -53.9 45.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.345 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.9 -35.72 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 111.097 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 t -57.66 -50.34 73.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -79.34 -18.39 52.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 tp -68.49 -35.84 78.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.909 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -100.83 30.15 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.31 113.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 134.96 -32.07 2.63 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.463 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -126.07 93.3 43.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.514 0.197 . . . . 0.0 110.863 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.89 -3.46 12.81 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.474 2.116 . . . . 0.0 112.17 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.64 -53.9 19.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.552 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -64.59 -39.1 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.51 -49.47 84.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.743 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 51.9 ttm -61.01 -43.4 98.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.559 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.44 -25.59 72.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.352 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -78.13 -37.43 46.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.86 -20.2 65.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.3 m -70.63 -37.99 73.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.361 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -62.16 -43.0 99.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.33 153.73 36.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 28.5 Cg_endo -62.27 114.15 2.22 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.519 2.146 . . . . 0.0 112.245 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 37.1 Cg_endo -65.75 152.93 80.22 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.36 2.04 . . . . 0.0 112.231 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.553 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.613 0.244 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 56.8 m 65.61 132.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.061 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 69.8 p -119.99 -20.54 7.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.312 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -129.76 123.07 30.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 92.3 mt -128.57 -168.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.654 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 79.9 p -64.78 162.8 15.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.803 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.84 -40.48 83.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.308 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.66 65.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.423 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -75.82 -47.83 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 92.3 mmm -63.54 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -52.68 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.024 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.26 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 130' ' ' LEU . 4.5 mm? -62.99 -39.8 95.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.266 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.32 -47.11 55.91 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.84 -29.2 72.6 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.745 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.476 HD12 ' O ' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -62.47 -56.41 18.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 126' ' ' ALA . 3.0 mm? -70.73 -21.55 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.776 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -83.36 -26.78 30.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.902 0.382 . . . . 0.0 110.853 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' MET . . . . . 0.469 ' SD ' HG23 ' A' ' 161' ' ' THR . 10.1 tmm? -86.8 -25.37 24.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.151 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 66.9 m -68.01 -17.14 64.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.821 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' B' ' 147' ' ' GLY . 6.0 pt20 -137.45 -100.35 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.154 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.463 ' H ' ' HG3' ' B' ' 146' ' ' GLN . . . 55.42 41.75 81.38 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.627 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -149.91 103.96 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 52.24 70.66 0.54 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.2 t -178.11 145.46 0.53 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.57 93.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.251 1.967 . . . . 0.0 112.178 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -174.46 -77.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.062 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 14.0 p -55.38 -58.08 9.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.301 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 14.8 p -168.74 -23.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 111.235 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.35 163.87 6.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.053 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 49.6 m 59.25 101.0 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.104 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 78.8 p -104.13 4.25 33.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.995 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.553 ' HB2' ' HD3' ' B' ' 159' ' ' PRO . 97.9 mt -87.21 -48.88 0.47 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.728 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' B' ' 158' ' ' LEU . 50.2 Cg_exo -54.13 -66.43 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.141 1.894 . . . . 0.0 112.469 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 41.5 t -167.96 -3.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.823 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m 64.63 -81.98 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.214 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 79.3 p -170.06 156.57 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 64.1 m -130.61 96.44 23.73 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.38 -56.71 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.428 2.085 . . . . 0.0 112.536 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.553 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 14.5 t70 -93.15 -48.13 0.29 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.709 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 49.7 Cg_exo -56.18 -179.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.106 1.871 . . . . 0.0 112.608 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.429 HG22 ' O ' ' B' ' 167' ' ' VAL . 8.6 p -141.02 27.54 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.252 0.548 . . . . 0.0 109.874 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.519 ' O ' ' HB ' ' B' ' 169' ' ' VAL . 74.7 m 62.52 -85.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.401 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' B' ' 168' ' ' SER . 7.1 p 165.17 141.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 O-C-N 123.601 0.563 . . . . 0.0 110.936 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 50.7 m -82.16 167.93 18.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.798 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -121.12 14.38 11.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -124.94 77.69 66.18 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.023 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.73 -164.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.506 2.137 . . . . 0.0 112.351 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.23 -151.51 21.78 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.587 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.57 -36.15 15.54 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.585 2.19 . . . . 0.0 112.539 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 59.8 m -135.57 174.95 10.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.987 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 160.26 -173.22 36.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.269 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.07 -32.78 2.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.311 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 179' ' ' GLN . . . . . 0.443 ' CD ' ' H ' ' B' ' 179' ' ' GLN . 4.6 pm0 -103.24 -173.0 2.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.76 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 47.3 t -58.52 -50.33 74.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 27.9 p -100.36 -171.57 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.0 t -172.84 -41.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.936 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -98.31 70.47 0.64 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.491 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 82.2 p -102.06 -17.5 16.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 111.078 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -145.66 -29.78 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.407 HG23 ' O ' ' B' ' 186' ' ' THR . 3.7 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.295 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -121.91 114.49 21.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.8 tp -115.71 125.27 52.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.499 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 60.9 tptt -107.24 136.64 46.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.977 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.621 HG22 ' HG ' ' B' ' 142' ' ' LEU . 42.0 t -70.43 -33.06 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.499 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 37.4 tt0 -55.33 -36.51 66.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.32 -36.97 85.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.72 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -62.64 -43.02 99.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.089 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.06 -45.3 95.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.066 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.1 t -56.13 -38.16 70.44 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -67.52 -34.5 77.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.072 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.516 HD13 HD21 ' B' ' 138' ' ' LEU . 40.7 tp -61.95 -39.86 93.54 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.824 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.54 -38.55 74.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.177 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -57.2 -42.69 81.72 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.28 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.67 -38.92 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -61.14 -28.5 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.812 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.2 -51.33 7.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -54.75 -62.54 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.074 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.55 28.34 1.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.66 -29.65 74.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.6 p -81.73 -4.5 56.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.822 0.344 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -139.12 96.55 8.99 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.0 23.66 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.526 2.151 . . . . 0.0 112.342 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -83.69 -63.04 1.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.013 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.1 t -61.12 -51.13 76.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.629 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.23 -55.62 26.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.54 -43.64 84.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.003 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' HB3' HD21 ' A' ' 171' ' ' LEU . 9.8 t70 -67.45 -25.55 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.844 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -70.21 -59.65 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.2 -35.74 79.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.27 -46.83 88.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 109.843 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.59 -46.89 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.387 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.575 ' HE2' HD12 ' B' ' 141' ' ' LEU . 85.3 mmm -54.19 -48.9 70.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.847 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.3 -34.81 74.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.373 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.55 -38.08 88.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.96 -32.31 65.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.824 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -76.54 -23.14 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.845 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.6 t -98.36 10.36 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.574 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 63.77 95.6 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.043 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -149.65 -51.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.745 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.7 pt -123.46 172.02 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.068 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.92 -175.79 2.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.193 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.9 m -59.38 -51.38 81.82 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.667 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.5 Cg_endo -58.07 -31.42 93.05 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.037 1.825 . . . . 0.0 111.851 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.14 -45.39 62.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.114 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.17 -41.5 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.885 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.4 mt -62.34 -53.63 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.4 m -58.62 -55.67 32.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.766 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -51.74 -54.36 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.95 -35.83 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.428 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 71.0 m -59.4 -47.12 86.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.828 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -84.3 -11.92 55.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.182 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 146' ' ' ASP . 16.1 tp -76.5 -25.1 53.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.25 31.11 5.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.083 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.59 107.49 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.2 -47.0 0.57 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.632 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -124.58 103.57 31.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.01 -0.112 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.91 -9.56 25.28 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.381 2.054 . . . . 0.0 112.252 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -54.38 20.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -57.05 -44.88 83.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.731 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.68 -41.73 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.2 tpp -62.83 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.61 -30.53 74.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.339 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -72.21 -39.62 68.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.37 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -61.36 -25.92 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.3 m -63.33 -39.65 95.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 145' ' ' SER . 93.6 m-85 -57.54 -51.35 69.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.31 155.1 5.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.093 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 41.0 Cg_endo -66.94 117.36 4.72 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.428 2.085 . . . . 0.0 112.337 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 34.2 Cg_exo -61.21 135.04 55.82 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.407 2.071 . . . . 0.0 112.191 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.488 179.919 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.873 0.368 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 77.2 p -129.55 -176.4 3.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 57.1 m -73.46 135.5 44.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.114 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -96.01 -61.93 1.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.39 158.14 21.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.117 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.422 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 41.7 t -67.6 171.36 6.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.08 -46.96 69.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.3 -23.79 16.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.422 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 13.3 mm-40 -70.53 -58.1 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 110.953 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 79.7 mtp -63.99 -29.25 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.782 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.83 -53.47 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.293 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.481 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.68 -49.34 73.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 130' ' ' LEU . 4.4 mm? -61.7 -42.21 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.368 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.4 -46.75 56.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.36 -32.56 82.3 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.742 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.575 HD12 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -59.01 -54.02 51.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.621 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.8 mm? -76.22 -17.95 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.945 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -81.46 -30.63 33.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.41 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 56.7 ttp -83.98 -38.77 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 185' ' ' PHE . 74.7 p -64.26 -13.36 49.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.073 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -111.39 -10.65 14.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.784 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -128.41 80.1 0.36 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.626 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.88 -54.88 17.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 0.0 110.675 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' B' ' 151' ' ' PRO . 49.0 mt-30 -72.83 -163.5 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.755 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.518 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 2.0 t -87.13 -31.46 0.41 Allowed Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' B' ' 149' ' ' GLN . 71.8 Cg_endo -83.19 -74.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.529 1.486 . . . . 0.0 112.548 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 152' ' ' ASN . . . . . 0.463 ' H ' ' HG2' ' B' ' 151' ' ' PRO . 3.5 p-10 -174.01 132.28 0.41 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 36.4 t 61.59 169.53 0.11 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 35.7 m -85.59 5.19 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.87 124.28 30.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.066 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 85.0 p -154.91 130.55 9.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 36.1 t -156.27 8.11 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.616 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 4.0 mm? -100.32 -51.69 0.18 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.91 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.616 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 50.1 Cg_endo -69.23 -60.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.92 1.747 . . . . 0.0 112.78 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.456 ' C ' ' H ' ' B' ' 162' ' ' SER . 45.9 t -97.77 -25.18 15.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.28 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 25.3 m 71.83 -17.48 0.35 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.471 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' SER . . . . . 0.456 ' H ' ' C ' ' B' ' 160' ' ' SER . 41.2 t 57.43 98.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.87 0.367 . . . . 0.0 111.29 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 24.6 p -164.3 63.19 1.07 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.026 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.19 1.03 8.98 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.762 2.308 . . . . 0.0 112.646 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.496 ' N ' ' HD2' ' B' ' 166' ' ' PRO . 22.7 t70 -91.59 -51.19 0.3 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.713 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 165' ' ' ASP . 57.0 Cg_endo -70.31 115.92 4.39 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.969 1.779 . . . . 0.0 112.255 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.54 130.53 65.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.1 m -65.2 95.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 48.3 t -134.8 -28.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 32.7 t -151.02 11.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.811 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.8 -82.31 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -150.75 136.0 10.23 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.002 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.18 -161.47 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.542 2.162 . . . . 0.0 112.361 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.22 -77.6 1.28 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.44 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.67 112.15 2.64 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.571 2.18 . . . . 0.0 112.458 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 28.1 t 59.16 179.15 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -129.54 -171.08 12.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.446 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 56.57 23.26 7.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.72 0.295 . . . . 0.0 111.184 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -130.5 -57.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 53.7 m -131.14 -172.37 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 75.0 m -141.85 13.72 2.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 78.7 p -114.27 112.67 23.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.25 121.8 0.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.604 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 3.3 t -101.13 -36.58 8.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.059 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -164.25 -9.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.404 HG22 ' H ' ' B' ' 186' ' ' THR . 1.5 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.288 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.83 0.347 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -102.93 117.43 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 tp -150.69 140.72 22.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.031 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -120.38 145.18 47.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.56 HG22 ' HG ' ' B' ' 142' ' ' LEU . 32.4 t -74.78 -38.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.794 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -57.08 -27.62 61.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.825 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.29 -44.22 79.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -63.48 -31.75 73.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.575 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.62 -49.68 70.13 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.964 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.2 t -54.54 -39.26 67.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.34 -33.41 75.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.094 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.503 HD13 HD21 ' B' ' 138' ' ' LEU . 44.7 tp -61.28 -48.87 79.43 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.943 0.402 . . . . 0.0 110.001 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.8 -32.99 74.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.03 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -57.67 -46.75 83.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.23 -45.93 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -61.22 -22.61 64.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.54 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.1 tp -78.57 -58.62 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.982 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -55.37 -56.03 24.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.136 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -85.81 37.46 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.33 -27.38 67.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.674 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.3 p -85.66 -22.07 28.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.814 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -123.44 90.01 50.77 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.57 -13.57 13.29 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.536 2.157 . . . . 0.0 112.341 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -56.58 -35.53 68.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.4 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t -72.48 -33.12 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -63.3 -55.55 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -57.17 -37.51 72.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.451 ' HB3' HD11 ' A' ' 171' ' ' LEU . 3.6 m-20 -65.48 -38.5 89.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -64.48 -59.44 4.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.913 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -58.71 -38.9 79.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.827 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.518 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 22.1 t70 -56.18 -47.43 78.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.3 mt -56.0 -48.31 78.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.212 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.497 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.3 mmm -54.6 -38.43 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.693 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 56.2 mtmt -68.44 -35.78 78.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.47 -42.13 95.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.155 0.502 . . . . 0.0 109.667 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -77.25 -27.5 53.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.208 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' B' ' 136' ' ' ILE . 29.4 tptp -73.48 -28.5 61.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.2 m -98.69 -84.44 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -173.04 105.45 0.14 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.704 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.8 t -169.38 -69.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.239 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.402 HD13 ' HD2' ' A' ' 167' ' ' ARG . 47.2 pt -116.45 168.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.363 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 164' ' ' VAL . 9.2 m-20 -108.95 -172.57 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.552 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 55.3 m -51.53 -51.0 73.55 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.9 Cg_endo -60.11 -32.7 95.03 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.904 1.736 . . . . 0.0 111.694 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.75 -32.28 70.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 160' ' ' ASP . 57.5 t -73.85 -45.17 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.725 0.298 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.65 -41.78 93.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.9 m -68.31 -54.0 20.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.699 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.402 ' HD2' HD13 ' A' ' 159' ' ' ILE . 95.6 mtt180 -58.97 -44.41 91.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.563 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.79 -44.94 99.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 90.6 p -59.73 -36.46 76.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.911 0.386 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -84.15 -17.58 39.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.746 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 146' ' ' ASP . 15.8 tp -75.41 -36.81 60.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.25 28.86 5.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -55.46 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.38 -37.47 1.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.422 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -121.52 99.52 45.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 -1.67 11.45 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.458 2.105 . . . . 0.0 112.301 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.95 -60.27 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.4 mm? -60.71 -41.86 96.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.95 -39.42 82.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.718 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.4 ttm -62.23 -52.8 62.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.7 69.14 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.305 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.4 ' HE1' HD21 ' B' ' 141' ' ' LEU . 88.8 t80 -74.62 -37.42 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -67.42 -15.61 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.739 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 27.9 m -74.42 -38.37 63.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -57.43 -41.16 79.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.767 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 92.0 mt -59.76 154.92 44.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.77 117.55 5.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.407 2.071 . . . . 0.0 112.356 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.0 150.42 31.05 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.282 1.988 . . . . 0.0 112.248 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.495 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.723 0.297 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -111.2 135.65 51.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 4.1 t -160.92 149.06 15.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -106.65 -32.7 7.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.746 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.478 HD12 ' N ' ' B' ' 130' ' ' LEU . 6.5 mp -75.97 168.26 20.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.744 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.404 ' OG ' ' HG2' ' B' ' 134' ' ' GLU . 92.4 p -84.26 -176.26 6.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' B' ' 132' ' ' GLU . 0.1 OUTLIER -72.58 -42.2 64.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.191 -179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.21 66.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.159 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.454 ' HA ' HD23 ' A' ' 148' ' ' LEU . 5.4 mm-40 -64.0 -47.85 78.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.67 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 94.3 mmm -62.48 -27.59 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.11 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.442 HG23 ' HG2' ' A' ' 155' ' ' LYS . 81.1 mt -73.2 -53.49 18.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.119 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.408 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.02 -48.07 76.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 110.33 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.514 HD13 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -63.51 -37.72 88.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.385 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.26 -49.53 63.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.96 -33.9 88.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.545 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.514 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -59.08 -56.17 25.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.921 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.56 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -73.43 -17.33 61.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.44 -26.78 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.831 0.348 . . . . 0.0 110.891 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.0 ttp -86.13 -36.95 19.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.605 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 59.7 m -58.51 -18.76 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.691 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -119.5 -21.82 7.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.57 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -82.21 -102.07 0.43 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.512 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 53.98 78.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 54.79 93.61 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.254 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.483 ' H ' ' HB ' ' B' ' 154' ' ' VAL . 6.5 t -168.02 142.98 2.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.047 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.43 21.26 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.391 2.06 . . . . 0.0 112.496 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -102.61 -59.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.991 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 84.2 m -115.99 -41.59 3.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.007 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.483 ' HB ' ' H ' ' B' ' 150' ' ' THR . 67.2 t -71.61 144.93 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.084 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -109.56 108.2 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.3 m -100.99 -172.14 2.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.029 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 59.4 m -136.74 -17.14 1.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.256 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.447 ' HB2' ' HD3' ' B' ' 159' ' ' PRO . 3.9 mm? -82.42 -52.69 0.69 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.465 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' B' ' 158' ' ' LEU . 67.9 Cg_endo -74.5 -58.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.11 1.874 . . . . 0.0 112.534 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 43.8 t -158.91 118.55 3.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.751 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 67.9 m -60.38 -81.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 42.5 t -174.33 -60.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.726 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 52.8 t 56.2 76.6 0.48 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.11 37.21 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.709 2.273 . . . . 0.0 112.011 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 15.9 t70 62.82 76.59 0.37 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.765 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.42 124.75 12.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.495 2.13 . . . . 0.0 112.265 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.7 114.96 48.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.7 m 55.96 23.84 7.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.39 140.15 12.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.134 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 88.0 p -104.94 -177.33 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.702 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.15 -34.14 6.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' B' ' 173' ' ' PRO . 13.7 m-20 -141.87 103.76 5.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' B' ' 182' ' ' SER . 9.4 Cg_endo -52.13 -49.3 17.82 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.71 2.273 . . . . 0.0 112.59 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.41 -161.58 31.54 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.367 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.86 -66.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.591 2.194 . . . . 0.0 112.475 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 47.7 t -162.61 166.49 24.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.89 88.08 1.71 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 16.1 t70 60.67 103.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.789 0.328 . . . . 0.0 111.071 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.04 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 46.6 t 62.55 -84.39 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.776 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 27.9 p -170.11 179.98 3.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.578 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' B' ' 173' ' ' PRO . 41.0 t -56.84 103.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.398 . . . . 0.0 111.083 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 122.34 145.31 6.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.381 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 70.2 p -94.31 -44.66 7.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.798 0.332 . . . . 0.0 111.282 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -110.74 2.19 18.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.95 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.281 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.817 0.341 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -148.79 119.86 7.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.9 tp -78.39 97.99 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.0 tptp -100.03 155.62 17.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.752 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.585 HG22 ' HG ' ' B' ' 142' ' ' LEU . 72.6 t -58.84 -34.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 38.0 mt-10 -57.68 -23.61 52.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.01 -44.52 72.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.079 0.466 . . . . 0.0 109.819 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -66.5 -37.74 85.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.132 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 123' ' ' VAL . 4.4 mm? -62.12 -43.06 99.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.982 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.9 t -62.72 -38.87 92.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.709 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.96 -50.27 74.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.391 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.604 HD22 HD21 ' B' ' 138' ' ' LEU . 30.4 tp -57.59 -39.87 77.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.22 -39.49 94.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.51 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.98 -45.41 93.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.417 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.09 -41.13 89.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -68.0 -26.77 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.533 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.71 -51.83 15.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -63.53 -69.69 0.26 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.308 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 140' ' ' GLN . 83.2 m-85 -54.93 -35.74 64.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.66 -84.74 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.574 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.2 t -61.8 -70.07 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.536 0.207 . . . . 0.0 111.041 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 137' ' ' PHE . 9.0 pt20 35.49 64.04 2.15 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.933 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 140' ' ' GLN . 20.7 Cg_exo -65.86 -56.63 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.44 2.094 . . . . 0.0 112.2 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.05 -34.28 32.9 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.273 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 2.3 t -57.13 -52.99 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.462 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.03 -59.28 5.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.15 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -51.31 -51.95 49.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.96 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.13 -42.76 81.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -59.19 -60.68 3.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.838 0.351 . . . . 0.0 111.518 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.7 mp -61.58 -34.26 75.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.89 -44.55 96.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.0 -48.22 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.909 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.492 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -55.72 -47.76 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.377 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -56.8 -35.88 69.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.444 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.32 -39.63 92.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -66.97 -37.03 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.014 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' A' ' 155' ' ' LYS . 4.0 mmmp? -75.74 -27.55 58.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -91.76 14.34 15.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.455 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 62.99 93.59 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.315 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.4 m -150.77 -70.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.691 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.0 pt -104.95 166.9 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.103 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -103.67 -170.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.799 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 32.3 m -57.14 -51.03 84.71 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.8 Cg_endo -58.88 -27.86 85.61 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.018 1.812 . . . . 0.0 111.91 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.3 -42.32 50.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.53 -45.07 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.2 mt -64.19 -46.23 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.421 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.4 t -62.5 -57.71 10.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.583 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.6 -56.35 17.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.489 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 75.3 t -57.3 -35.46 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 t -61.74 -40.64 95.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.968 0.413 . . . . 0.0 110.139 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.8 -22.79 56.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 171' ' ' LEU . 2.7 tm? -72.44 -38.26 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -94.0 25.42 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.765 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 173' ' ' LYS . 4.6 ttmp? -53.08 137.8 32.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.99 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.75 88.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.61 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -139.11 85.33 15.9 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.615 0.245 . . . . 0.0 111.181 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.55 2.09 7.75 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.481 2.121 . . . . 0.0 112.36 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -72.59 -63.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.3 mm? -61.76 -31.75 71.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.97 -52.06 48.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.3 ttp -61.78 -31.86 72.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.25 -26.65 59.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.174 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -80.9 -31.54 35.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 0.0 111.004 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -62.86 -18.98 63.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.3 m -72.52 -37.04 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.946 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -61.58 -45.54 93.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' B' ' 145' ' ' SER . 94.9 mt -58.57 145.75 75.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.77 119.14 6.17 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.351 2.034 . . . . 0.0 112.186 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.27 139.0 80.83 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.362 2.041 . . . . 0.0 112.215 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.604 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 79.4 p -100.3 170.5 8.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 69.9 p -101.42 -19.8 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 63.8 -81.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.11 149.68 44.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.91 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 27.7 t -69.21 177.97 2.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.94 -43.38 68.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.88 -21.82 32.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.514 ' HA ' HD23 ' A' ' 148' ' ' LEU . 7.9 mm-40 -70.87 -61.72 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 80.0 mtp -60.53 -26.33 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.26 -50.28 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.489 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.25 -50.02 72.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 130' ' ' LEU . 4.6 mm? -61.94 -41.24 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.167 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -46.27 59.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.8 -35.45 90.92 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.644 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.572 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -58.45 -56.14 25.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.87 0.366 . . . . 0.0 110.756 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.585 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -69.6 -22.82 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -77.53 -27.13 51.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 57.6 ttp -83.44 -36.26 24.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.578 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' SER . . . . . 0.622 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.5 p -118.85 94.7 4.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.895 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -138.45 -53.27 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.009 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.88 -41.82 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.419 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 63.49 7.57 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.816 0.341 . . . . 0.0 111.034 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -159.48 -93.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.483 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.578 ' H ' ' CD ' ' B' ' 151' ' ' PRO . 5.1 t -116.13 -26.84 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.578 ' CD ' ' H ' ' B' ' 150' ' ' THR . 79.8 Cg_exo -45.31 -60.44 0.84 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.829 1.686 . . . . 0.0 113.131 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -146.32 -4.74 0.6 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.609 0.242 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 43.1 t -51.86 -70.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.015 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 31.4 m -139.09 -8.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.179 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 60.36 99.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.263 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.1 m -136.27 172.26 13.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 51.3 m -123.09 -13.65 7.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.73 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.495 ' HB2' ' HD3' ' B' ' 159' ' ' PRO . 76.4 mt -64.05 -48.76 77.01 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.418 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' B' ' 158' ' ' LEU . 80.8 Cg_endo -78.35 21.06 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.152 1.901 . . . . 0.0 112.502 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 48.4 t 64.21 117.3 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.315 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 73.6 m -76.19 -61.44 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.024 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 79.4 p -148.38 8.75 0.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 17.4 p -130.66 77.09 76.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.13 -27.94 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.774 2.316 . . . . 0.0 112.862 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 16.1 t70 -58.26 -51.44 81.78 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.524 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 73.4 Cg_endo -75.02 161.36 38.83 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.961 1.774 . . . . 0.0 112.068 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.587 HG23 ' H ' ' B' ' 168' ' ' SER . 1.4 m -139.67 -59.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.307 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.587 ' H ' HG23 ' B' ' 167' ' ' VAL . 47.4 t -173.8 -15.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.821 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.0 t 60.74 104.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.131 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 43.6 t -85.11 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -121.74 18.67 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 14.5 t70 65.79 139.42 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 173' ' ' PRO . . . . . 0.628 ' HB3' ' H ' ' B' ' 182' ' ' SER . 17.2 Cg_endo -57.35 127.81 27.01 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.574 2.183 . . . . 0.0 112.277 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.34 -82.76 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.742 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.38 -62.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.523 2.149 . . . . 0.0 112.494 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 41.4 t -157.87 164.79 36.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -155.85 121.48 1.1 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.37 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -92.03 -58.26 2.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -126.87 -18.03 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.157 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.3 p -102.73 178.43 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 20.6 p 43.26 -157.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.553 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.628 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 50.3 m -110.63 -50.11 2.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.995 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 183' ' ' GLY . . . . . 0.491 ' H ' ' HB3' ' B' ' 173' ' ' PRO . . . 77.85 137.09 1.01 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.466 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 40.0 p -103.89 14.86 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 111.399 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -90.47 -13.03 35.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.384 -179.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.914 0.388 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 22.0 t -87.78 -33.4 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.61 -37.87 74.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.4 -36.86 83.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -62.72 -44.49 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.376 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.58 -43.69 98.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.094 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -55.68 -39.57 71.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.4 t80 -65.72 -36.17 82.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.828 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.6 tp -61.04 -45.11 96.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.141 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.75 -39.0 93.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.237 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -59.56 -41.49 90.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.53 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 129' ' ' TYR . 59.8 t -67.02 -41.93 87.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.7 -26.43 67.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.412 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.2 -58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.657 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.648 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.37 -58.36 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -55.19 -40.12 70.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.518 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.35 -37.93 86.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.17 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.54 -59.86 4.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.5 mp -59.43 -39.76 84.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.224 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.44 -46.78 80.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 109.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.77 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.379 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.54 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 70.0 mmm -54.56 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.418 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.08 -37.5 75.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.589 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.81 -38.66 86.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.1 0.476 . . . . 0.0 109.801 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -78.6 -31.75 47.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.811 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' B' ' 136' ' ' ILE . 58.4 tptt -68.53 -26.3 65.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.5 t -98.57 -81.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.786 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -177.54 102.16 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -165.01 -66.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -113.86 178.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.527 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 164' ' ' VAL . 9.8 m-20 -112.53 -174.82 2.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 64.8 m -57.99 -51.96 77.93 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.727 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.6 Cg_endo -59.09 -28.65 88.41 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.919 1.746 . . . . 0.0 111.725 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.71 -40.01 65.98 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 160' ' ' ASP . 56.9 t -67.75 -44.38 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.778 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.12 -45.72 97.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.456 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.4 m -66.57 -54.98 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.631 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -54.72 -49.0 71.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.1 t -61.95 -39.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.718 0.294 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.9 t -58.3 -39.45 79.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.334 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.588 HE21 ' HA ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -84.12 -18.64 36.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.65 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.1 -21.35 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -111.13 26.63 10.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.913 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 0.5 OUTLIER -57.79 112.43 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.06 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 130.84 -30.31 3.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.589 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -120.97 90.08 46.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.394 0.14 . . . . 0.0 110.751 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.95 -6.48 18.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.579 2.186 . . . . 0.0 112.704 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -70.28 -59.83 2.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.6 mm? -56.62 -42.28 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.95 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.8 tpp -57.56 -42.34 82.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.828 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.42 -18.96 72.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.546 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -75.99 -40.4 53.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.616 0.246 . . . . 0.0 111.332 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -65.43 -20.37 66.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 m -62.28 -36.45 82.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -64.13 -49.65 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.8 mt -59.57 151.64 60.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.85 122.04 10.62 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.432 2.088 . . . . 0.0 112.099 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--N 1.348 0.521 0 C-N-CA 122.177 1.918 . . . . 0.0 112.384 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.813 0.339 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.14 74.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.594 ' HA ' HD23 ' A' ' 148' ' ' LEU . 1.1 pp20? -69.54 -29.98 67.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.229 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 47.5 ttp -68.78 -36.0 77.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.42 HG23 ' HG2' ' A' ' 155' ' ' LYS . 85.8 mt -74.99 -52.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.54 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -55.62 -46.06 77.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.975 0.416 . . . . 0.0 110.683 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.1 mm? -63.85 -46.26 85.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.89 -49.94 28.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.179 0.514 . . . . 0.0 109.76 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.76 -32.21 83.45 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.964 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' B' ' 138' ' ' LEU . 24.1 mt -61.38 -55.51 30.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.708 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 126' ' ' ALA . 3.1 mm? -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.1 -26.34 29.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.211 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.95 -38.26 28.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 54.8 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.082 179.681 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.724 HG22 ' HG ' ' B' ' 142' ' ' LEU . 19.9 t -70.99 -24.85 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.611 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -59.67 -43.52 93.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.634 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.92 -31.6 72.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.103 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.462 ' HB1' HD12 ' B' ' 138' ' ' LEU . . . -62.97 -53.55 52.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.521 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.14 -40.46 85.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.303 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -56.26 -40.93 74.99 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 133' ' ' VAL . 82.1 t80 -65.94 -36.45 83.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.001 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.472 HD22 HD21 ' B' ' 138' ' ' LEU . 28.6 tp -60.9 -44.82 96.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.196 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.78 -39.78 91.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.732 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.82 -47.83 81.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 178' ' ' LEU . 60.7 t -62.22 -47.52 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -70.84 -13.58 62.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.4 tp -81.08 -63.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.347 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.703 HE22 HD21 ' A' ' 178' ' ' LEU . 27.6 mt-30 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.533 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.848 0.356 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -58.84 -54.75 43.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.83 -39.34 77.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.217 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB3' HD11 ' A' ' 171' ' ' LEU . 28.4 m-20 -62.2 -40.66 96.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.006 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.92 -60.0 3.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -60.05 -34.83 73.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.207 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.84 -48.06 83.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.7 mt -55.83 -50.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.335 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.543 ' HE2' HD12 ' B' ' 141' ' ' LEU . 80.7 mmm -52.47 -44.4 65.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.02 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -63.04 -36.33 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.19 -39.77 95.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.598 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -78.58 -33.03 47.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 155' ' ' LYS . 9.2 tmtt? -64.81 -43.42 93.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.264 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.1 m -78.79 -84.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -176.7 96.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -152.63 -79.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -103.23 -178.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 m-20 -113.72 -179.23 3.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.9 m -53.84 -50.83 81.64 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.46 -39.37 91.73 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.015 1.81 . . . . 0.0 112.04 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.33 84.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.378 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 160' ' ' ASP . 93.3 t -68.48 -45.34 82.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.94 -44.26 97.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.587 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.4 m -67.05 -55.87 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.562 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 30.8 ttm180 -56.96 -43.26 81.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.397 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.28 -34.12 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.355 . . . . 0.0 110.881 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.4 t -64.35 -41.4 96.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 1.3 pp0? -84.19 -18.91 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 146' ' ' ASP . 20.0 tp -63.45 -38.95 93.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -89.59 30.98 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.6 99.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.28 -33.44 1.34 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.147 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -132.7 88.82 37.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.474 0.178 . . . . 0.0 110.714 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.467 ' HA ' HD12 ' A' ' 179' ' ' ILE . 38.0 Cg_exo -60.75 -7.19 7.0 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.599 2.199 . . . . 0.0 112.653 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.65 -55.94 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.175 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.703 HD21 HE22 ' A' ' 136' ' ' GLN . 3.2 mm? -59.09 -38.36 79.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.402 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 176' ' ' PRO . 62.6 mt -62.28 -45.35 98.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.7 tpp -62.8 -34.79 78.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.507 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.45 64.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -66.39 -40.82 89.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.81 -18.27 64.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.5 m -74.29 -41.07 61.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.94 -41.02 90.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.593 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.455 HD23 ' OG ' ' B' ' 145' ' ' SER . 85.6 mt -59.91 145.91 83.21 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.686 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 31.5 Cg_exo -59.51 116.06 3.03 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.476 2.118 . . . . 0.0 112.078 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.3 Cg_endo . . . . . 0 C--N 1.348 0.54 0 C-N-CA 122.448 2.099 . . . . 0.0 112.495 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.601 0.239 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.84 -24.61 16.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.512 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.551 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -76.07 -57.47 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 23.3 ptp -60.94 -29.01 69.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -75.48 -51.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.414 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.08 -49.34 74.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 110.106 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -60.87 -42.43 97.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.823 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.575 ' HA ' HD21 ' B' ' 142' ' ' LEU . . . -50.0 -44.81 51.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.11 72.63 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.52 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -61.95 -56.58 17.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.724 ' HG ' HG22 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.0 -15.03 58.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.782 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -82.07 -27.22 33.05 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 54.5 ttp -86.18 -40.42 15.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 14.7 m . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.787 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.746 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.4 tptp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.739 0.304 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.626 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.9 t -56.77 -27.69 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.061 0.457 . . . . 0.0 110.573 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.746 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 42.3 tt0 -57.71 -32.74 67.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.519 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -67.88 -31.88 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.014 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -69.63 -44.05 71.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.12 -44.97 94.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.242 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.6 p -57.93 -40.39 80.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 133' ' ' VAL . 48.3 t80 -63.78 -35.3 80.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.497 HD22 HD21 ' B' ' 138' ' ' LEU . 22.3 tp -61.06 -43.66 98.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.803 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.581 HE21 ' HA ' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -58.95 -40.98 86.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.389 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 HD12 ' A' ' 178' ' ' LEU . 97.8 t -64.04 -52.63 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -63.03 -21.59 66.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -52.41 8.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.272 -179.767 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.927 0.394 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -63.78 -57.38 10.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.44 -41.63 76.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.635 ' HB3' HD21 ' A' ' 171' ' ' LEU . 9.9 t70 -70.06 -28.1 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.066 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.65 -60.1 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.29 -36.51 80.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.6 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -59.47 -45.16 92.41 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.8 mt -56.94 -44.74 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.588 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 90.5 mmm -55.99 -40.16 72.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.261 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 2.4 mmmp? -61.28 -43.34 99.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -56.19 -46.45 79.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -70.56 -23.15 62.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.687 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -86.18 -12.6 49.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 80.7 p -117.05 20.98 13.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.838 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 62.08 94.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 65.6 m -150.38 -62.41 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.725 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.14 168.29 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -97.83 -179.55 4.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.574 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 27.6 m -54.99 -52.06 74.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.1 Cg_endo -56.3 -30.15 79.44 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.073 1.849 . . . . 0.0 111.786 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.7 58.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.094 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.89 -45.38 80.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.286 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.78 -38.87 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.7 t -62.24 -58.54 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -58.4 -48.39 80.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.198 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.31 -36.4 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.6 t -62.67 -44.14 97.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.408 . . . . 0.0 109.938 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.08 -12.73 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.376 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 146' ' ' ASP . 14.6 tp -84.29 -33.26 24.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -99.86 14.49 30.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -52.61 105.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.46 -39.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.405 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -124.87 95.93 41.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.459 0.171 . . . . 0.0 110.713 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.3 -21.75 72.65 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.677 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.27 -49.06 77.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.192 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -57.31 -45.88 83.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.717 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -67.32 -29.06 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.3 mtt -69.06 -36.0 77.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -88.17 -19.32 53.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.271 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -77.95 -44.03 28.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.62 -19.79 62.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.822 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 23.3 m -66.04 -44.36 84.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -57.68 -47.67 81.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.614 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.58 156.73 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.789 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 32.5 Cg_exo -57.73 155.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.39 2.06 . . . . 0.0 112.243 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.0 112.311 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.742 0.306 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -21.34 6.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.668 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -67.58 -69.04 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 24.4 ptm -63.76 -25.83 68.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.985 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.26 -53.58 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.588 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -56.97 -48.31 78.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.688 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -59.4 -46.71 87.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.332 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.57 -44.88 47.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.991 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.66 -36.44 93.15 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.079 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' B' ' 138' ' ' LEU . 54.1 mt -62.66 -56.61 16.16 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.915 0.388 . . . . 0.0 111.118 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.626 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -65.75 -23.81 66.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.145 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -84.38 -27.2 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.047 0.451 . . . . 0.0 110.705 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 44.8 ttp -74.87 -42.03 58.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.984 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . 0.544 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 77.9 p . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.913 0.387 . . . . 0.0 111.338 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 123' ' ' VAL . 48.7 tptt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.692 0.282 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.593 HG22 ' HG ' ' B' ' 142' ' ' LEU . 25.3 t -68.65 -36.75 75.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.96 -28.87 64.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.073 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -66.54 -44.19 83.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -62.04 -34.04 75.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.279 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.31 -43.02 95.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.371 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -57.68 -39.28 76.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.0 -30.58 69.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.781 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.471 HD13 HD21 ' B' ' 138' ' ' LEU . 34.0 tp -65.6 -40.94 93.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.048 0.452 . . . . 0.0 110.001 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.43 -40.34 81.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.235 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -57.63 -46.86 83.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.44 -46.71 94.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.774 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -60.53 -26.62 67.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.681 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.6 tp -76.8 -62.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.507 -179.41 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.922 0.391 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.62 -54.28 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.818 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -59.79 -42.98 94.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.378 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -61.53 -36.19 79.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.339 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -66.18 -59.44 3.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' B' ' 134' ' ' GLU . 8.2 mp -60.66 -30.11 69.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.974 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -63.33 -50.22 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -55.63 -51.5 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.493 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 70.8 mmm -53.01 -44.24 67.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.587 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.502 ' HE2' HD12 ' B' ' 136' ' ' ILE . 44.1 tttm -59.61 -38.19 80.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.78 -46.68 86.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.2 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -61.24 -42.76 99.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' B' ' 136' ' ' ILE . 60.6 tptt -70.81 -24.5 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.515 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -97.7 19.05 14.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 61.3 93.13 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.3 t -149.76 -68.57 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.4 pt -111.89 171.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 164' ' ' VAL . 5.3 m-20 -96.29 175.48 6.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.582 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 49.5 m -54.31 -51.17 80.19 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.559 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.36 -33.63 96.54 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.085 1.857 . . . . 0.0 111.878 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.94 -36.83 82.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 160' ' ' ASP . 60.6 t -70.33 -45.19 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.82 -39.01 83.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.4 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.2 m -67.91 -55.71 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.041 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -55.18 -47.18 75.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.004 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -61.76 -39.75 84.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.686 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.6 t -59.31 -39.26 82.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -84.32 -18.1 37.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.884 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.5 tp -77.97 -29.88 50.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.74 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.24 24.05 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -55.8 108.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.92 -41.97 0.8 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.586 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -125.38 103.46 29.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.422 0.153 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.67 -0.14 8.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.075 . . . . 0.0 112.237 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -59.84 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.042 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.7 mm? -58.3 -38.93 78.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.587 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.32 -44.03 94.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.764 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.43 -39.47 83.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.79 66.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.11 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -74.73 -38.38 62.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 110.771 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -70.38 -19.06 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 51.9 m -69.94 -33.48 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.135 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -61.09 -49.95 75.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' B' ' 145' ' ' SER . 62.3 mt -53.84 145.62 30.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.8 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.95 141.11 79.12 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.377 2.051 . . . . 0.0 112.209 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.349 0.565 0 C-N-CA 122.42 2.08 . . . . 0.0 112.17 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.797 0.332 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.4 84.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.48 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -69.28 -28.33 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.812 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -35.7 72.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.502 HD12 ' HE2' ' A' ' 152' ' ' LYS . 73.0 mt -76.28 -50.35 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -56.55 -50.38 72.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.113 0.482 . . . . 0.0 110.197 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.585 HD13 HD13 ' B' ' 141' ' ' LEU . 4.2 mm? -62.25 -41.98 98.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.93 -47.73 43.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.92 -39.82 98.51 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.942 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.585 HD13 HD13 ' B' ' 138' ' ' LEU . 0.3 OUTLIER -56.09 -56.15 24.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.593 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -65.28 -24.78 67.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.478 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -77.27 -26.66 52.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 110.051 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 30.0 mtm -75.64 -38.57 58.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.929 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 73.4 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.835 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.8 tptt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.662 0.268 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.598 HG22 ' HG ' ' B' ' 142' ' ' LEU . 22.4 t -76.22 -44.6 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.674 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.41 -27.29 64.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.752 0.311 . . . . 0.0 110.458 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -66.52 -41.13 89.26 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -64.57 -34.84 79.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.263 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.54 -46.26 86.78 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.464 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -56.78 -37.17 70.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.425 ' O ' HG23 ' A' ' 133' ' ' VAL . 78.8 t80 -69.51 -31.87 70.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.858 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.468 HD22 HD21 ' B' ' 138' ' ' LEU . 44.2 tp -62.46 -52.25 64.27 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.6 -34.9 76.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.646 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -56.91 -45.42 82.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.896 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 HD12 ' A' ' 178' ' ' LEU . 96.0 t -63.34 -47.28 92.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.517 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.54 -19.71 65.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.11 -39.15 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.461 ' HG3' HD21 ' A' ' 178' ' ' LEU . 30.8 mm-40 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.441 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.75 0.31 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -59.62 -59.05 6.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.984 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -56.51 -45.27 81.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -33.75 75.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.87 -60.02 3.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.3 -34.93 76.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.25 -51.45 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.492 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.439 HD12 HD22 ' A' ' 171' ' ' LEU . 8.0 mt -55.09 -47.47 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.362 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.615 ' HE2' HD12 ' B' ' 141' ' ' LEU . 79.6 mmm -52.83 -42.62 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.927 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.402 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.55 -35.32 72.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.131 0.491 . . . . 0.0 109.779 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -78.88 -38.83 36.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.568 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HG2' HG23 ' B' ' 136' ' ' ILE . 59.0 tptt -65.6 -24.33 67.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.7 t -103.22 8.95 38.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.141 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 62.51 106.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.85 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.2 m -158.21 -53.58 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.423 HD11 HG23 ' A' ' 150' ' ' ILE . 36.5 pt -113.59 15.37 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 164' ' ' VAL . 6.8 m-20 50.5 -165.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.587 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 88.2 m -76.37 -51.58 2.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.923 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 161' ' ' THR . 9.9 Cg_endo -53.21 -35.0 71.94 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.166 1.911 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.04 87.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 160' ' ' ASP . 57.9 t -70.95 -45.27 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.079 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.11 -44.44 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.223 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.8 p -65.94 -58.84 4.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.437 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.528 ' HA ' HE21 ' A' ' 170' ' ' GLN . 95.3 mtt180 -54.22 -54.38 40.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.481 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.66 -37.57 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.647 0.261 . . . . 0.0 110.975 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -57.65 -47.78 81.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.841 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.528 HE21 ' HA ' ' A' ' 167' ' ' ARG . 30.0 pt20 -83.77 -11.73 56.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 150' ' ' ILE . 21.5 tp -78.87 -18.74 53.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.192 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -109.58 30.96 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.252 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.51 112.45 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.816 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 141.53 -47.07 0.86 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -117.81 94.97 47.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.421 0.153 . . . . 0.0 110.947 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.35 -4.76 14.4 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.424 2.083 . . . . 0.0 112.382 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.35 -57.02 5.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -57.61 -38.19 74.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -68.42 -38.42 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.4 ttm -63.15 -46.0 89.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.762 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.49 -30.97 63.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.318 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -40.06 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.29 -21.82 66.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.2 m -70.05 -33.62 72.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -66.0 -50.31 64.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.435 ' HA ' ' HB3' ' B' ' 145' ' ' SER . 90.2 mt -51.18 143.84 16.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 53.1 Cg_exo -56.43 111.92 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.474 2.116 . . . . 0.0 112.016 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.3 Cg_endo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.42 2.08 . . . . 0.0 112.36 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.794 0.33 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.81 19.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.63 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -71.12 -57.08 4.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 66.1 mtm -63.51 -23.98 67.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.479 HG23 ' HG2' ' A' ' 155' ' ' LYS . 84.2 mt -75.47 -51.3 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.651 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.44 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -57.34 -50.12 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.055 0.455 . . . . 0.0 110.077 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.566 HD13 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -60.67 -40.82 93.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.58 62.13 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.15 -34.74 90.48 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.63 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.615 HD12 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -59.28 -56.09 26.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.989 0.423 . . . . 0.0 110.74 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.598 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -70.16 -21.13 63.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -82.16 -26.59 33.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 49.3 ttp -81.72 -38.63 25.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.678 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 68.0 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.74 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.72 0.295 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.585 HG22 ' HG ' ' B' ' 142' ' ' LEU . 36.0 t -63.42 -46.91 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.301 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 -31.48 64.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.468 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.3 -39.49 92.58 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.03 -38.7 92.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.609 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.25 -43.21 99.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.17 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -58.81 -40.54 84.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -62.85 -36.15 82.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.994 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.474 HD22 HD21 ' B' ' 138' ' ' LEU . 40.8 tp -62.67 -46.8 86.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.142 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.59 -35.19 78.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.139 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -62.38 -43.06 99.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.245 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.65 -38.42 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.683 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -67.09 -33.5 75.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.721 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -71.21 -51.03 27.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.391 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.559 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.529 0.149 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.15 -59.43 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -58.63 -40.28 82.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.488 ' HB3' HD11 ' A' ' 171' ' ' LEU . 10.2 m-20 -64.85 -34.78 79.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.01 -60.37 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.231 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.45 -40.55 94.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.299 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.46 -47.49 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 109.671 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mt -56.17 -45.93 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.065 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.6 mmm -55.23 -40.33 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.25 -36.38 82.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.23 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.75 -42.69 97.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.19 -23.14 41.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.345 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -69.5 -56.27 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.8 m -73.47 -83.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.7 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -175.6 102.37 0.08 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -156.05 -77.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.8 pt -107.24 171.35 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.249 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -101.28 -176.34 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.596 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 30.6 m -57.08 -50.54 87.61 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.0 Cg_exo -53.61 -32.89 66.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.037 1.824 . . . . 0.0 112.065 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.73 -35.99 66.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.239 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.13 -45.22 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 165' ' ' ILE . 1.9 mp -65.86 -44.7 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.15 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.0 m -61.7 -55.96 24.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.385 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.55 -55.6 32.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.323 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.34 -33.21 30.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -64.33 -49.84 70.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.661 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -78.5 -11.63 59.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 146' ' ' ASP . 3.4 tp -74.82 -45.45 43.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -91.21 27.81 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.987 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.57 104.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.53 -44.18 0.73 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.436 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -117.37 98.37 51.78 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.413 0.149 . . . . 0.0 110.803 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.15 -9.41 26.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.385 2.057 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.46 -56.99 9.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -57.64 -42.01 82.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.663 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.13 -37.79 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.5 ttm -64.6 -43.65 93.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.721 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.31 -23.37 75.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.09 -46.64 33.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 111.037 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.99 -23.14 63.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 79.4 m -66.36 -35.78 81.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -59.41 -43.55 92.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.31 150.43 79.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 24.7 Cg_exo -62.85 124.19 13.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.432 2.088 . . . . 0.0 112.012 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 C--N 1.348 0.538 0 C-N-CA 122.338 2.026 . . . . 0.0 112.414 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.732 0.301 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.78 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.28 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.443 ' O ' HD23 ' B' ' 138' ' ' LEU . 43.5 mt-10 -74.75 -42.05 58.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.16 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtm -66.21 -32.75 74.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.081 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.3 mt -75.19 -53.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.16 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.465 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.64 -48.85 74.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.474 HD21 HD22 ' A' ' 130' ' ' LEU . 4.3 mm? -63.09 -39.89 96.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.45 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.64 -51.97 44.0 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.33 -29.25 74.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.919 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.471 HD13 HD13 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -61.16 -56.65 18.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.798 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.585 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -73.67 -19.71 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.683 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -80.11 -26.67 39.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.278 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 53.4 ttp -84.02 -41.38 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.798 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 46.4 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.204 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.078 0.466 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.8 t -95.86 -26.0 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -58.85 -41.56 87.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.547 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.82 -33.06 75.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -65.42 -41.95 93.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.324 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.42 -44.4 94.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.055 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -55.95 -41.58 74.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 133' ' ' VAL . 43.5 t80 -64.46 -36.94 85.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.715 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 148' ' ' LEU . 19.3 tp -59.96 -45.09 93.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.76 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.29 -37.59 87.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.037 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -60.89 -40.86 94.64 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 178' ' ' LEU . 58.2 t -65.21 -52.97 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.039 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 135' ' ' LEU . 7.2 tt -71.96 -57.75 4.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.853 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.455 ' NE2' HD21 ' A' ' 178' ' ' LEU . 48.2 mt-30 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.48 -52.53 63.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.668 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.01 -38.81 80.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.684 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.527 ' HB3' HD21 ' A' ' 171' ' ' LEU . 8.8 t70 -65.12 -31.79 73.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.485 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.78 -59.65 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.736 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 130' ' ' LEU . 6.9 mp -63.22 -29.98 71.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.05 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.92 -51.75 66.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 159' ' ' ILE . 10.0 mt -54.54 -48.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.656 ' HE2' HD23 ' B' ' 141' ' ' LEU . 82.4 mmm -53.01 -46.17 68.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.04 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.065 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.05 -37.9 84.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.03 -46.4 84.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.334 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HD3' ' HA2' ' B' ' 140' ' ' GLY . 29.2 mmmt -74.6 -17.94 60.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.678 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.1 t -97.63 11.75 35.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.488 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 62.91 99.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.121 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -161.37 -60.52 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.811 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 150' ' ' ILE . 35.5 pt -116.34 153.45 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.157 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.06 -179.89 6.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.596 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 89.6 m -55.18 -50.75 84.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.799 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.9 Cg_endo -55.72 -39.73 89.37 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.184 1.923 . . . . 0.0 112.148 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.14 -40.68 99.45 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.25 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.39 -42.93 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.12 -43.04 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.422 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.9 t -65.32 -55.14 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.619 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.12 -50.22 74.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.88 -43.05 87.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 87.6 p -60.91 -45.2 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.732 0.301 . . . . 0.0 111.018 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -79.82 -11.71 59.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 146' ' ' ASP . 13.9 tp -72.83 -35.0 67.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.653 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -96.52 33.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -52.42 129.8 29.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.007 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.8 -38.1 3.48 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.254 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -112.22 94.85 27.96 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.407 0.146 . . . . 0.0 110.753 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.59 -4.45 15.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.47 2.113 . . . . 0.0 112.657 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -68.08 -49.04 63.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.036 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.611 HD12 HG22 ' A' ' 133' ' ' VAL . 3.2 mm? -66.41 -35.34 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.12 -44.11 91.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.8 ttm -67.61 -37.39 82.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.23 -35.5 77.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -76.79 -34.39 57.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.725 0.298 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -64.65 -22.73 67.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.1 m -71.12 -37.38 72.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.135 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -57.51 -45.9 84.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.2 150.24 32.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 31.6 Cg_endo -64.55 113.3 2.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.349 2.033 . . . . 0.0 112.173 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 28.2 Cg_endo . . . . . 0 C--N 1.35 0.632 0 C-N-CA 122.354 2.036 . . . . 0.0 112.258 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 CA--C 1.526 0.049 0 CA-C-O 120.647 0.26 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.88 -25.35 19.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.43 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.441 ' O ' HD23 ' B' ' 138' ' ' LEU . 15.7 mm-40 -71.66 -56.27 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.2 mtm -64.02 -25.74 68.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.629 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 99.7 mt -76.19 -53.23 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.429 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -56.54 -50.57 71.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.309 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.526 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 4.6 mm? -58.69 -52.66 64.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.459 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.64 29.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 109.65 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . 0.595 ' HA2' ' HD3' ' A' ' 155' ' ' LYS . . . -67.02 -50.95 42.71 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.876 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.656 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -69.13 -46.26 68.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.229 0.515 . . . . 0.0 111.198 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.591 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.7 mm? -58.59 -33.5 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.993 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -83.99 -31.58 25.43 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.855 0.359 . . . . 0.0 111.011 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 59.1 ttp -73.19 -23.97 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.049 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.388 -179.548 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.802 0.334 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.578 HG22 ' HG ' ' B' ' 142' ' ' LEU . 40.0 t -89.99 -35.06 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.32 -34.03 70.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.59 -38.32 86.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 0.0 110.058 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.403 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -65.55 -43.01 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.319 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 123' ' ' VAL . 4.4 mm? -63.15 -34.93 78.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.072 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.3 t -62.56 -48.52 79.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.692 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.47 HD11 HD21 ' A' ' 148' ' ' LEU . 28.8 tp -61.01 -50.58 72.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.65 -25.81 68.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.536 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -65.11 -41.56 94.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.913 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.1 t -70.2 -45.92 73.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.852 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -57.02 -44.66 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.423 ' O ' HD13 ' A' ' 135' ' ' LEU . 3.3 tm? -69.36 -36.28 76.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.063 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.852 0.358 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -53.14 34.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.179 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -54.45 -52.81 60.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.413 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -52.41 -42.05 63.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.399 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -60.12 -56.99 14.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.6 mp -63.91 -25.7 68.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -62.95 -49.38 74.98 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.81 -47.78 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.703 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 76.9 mmm -54.04 -37.06 63.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.774 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -71.8 -32.73 67.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.28 -44.0 89.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.876 0.369 . . . . 0.0 110.02 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.25 -42.86 87.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.936 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' B' ' 136' ' ' ILE . 12.1 tmtt? -62.7 -40.14 96.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.167 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 90.5 p -85.85 13.75 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 64.63 102.37 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.195 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -153.1 -64.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.79 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.2 pt -111.9 168.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -90.8 177.08 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.597 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 27.6 m -57.52 -50.94 85.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.893 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.1 Cg_exo -54.83 -33.12 80.13 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.022 1.814 . . . . 0.0 112.194 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.02 -37.54 83.18 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.25 -45.5 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.97 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.299 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -69.6 -58.31 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.652 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.43 -48.05 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.89 -29.26 69.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.204 0.526 . . . . 0.0 109.758 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -84.09 -18.76 35.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.167 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.29 -43.85 22.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -93.81 30.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.19 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -58.29 -28.29 64.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.25 -48.53 68.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.628 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -116.87 93.56 41.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.406 0.146 . . . . 0.0 110.772 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.79 -14.65 28.01 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.61 2.206 . . . . 0.0 112.645 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.18 -55.82 29.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -56.28 -33.51 65.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.63 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.53 -48.3 78.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.49 -30.73 73.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -71.22 -36.3 71.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 110.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.06 -16.96 62.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.0 m -71.63 -39.82 70.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.177 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -58.23 -49.56 76.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.991 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.82 151.78 11.16 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.521 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 27.8 Cg_endo -62.73 135.46 52.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.333 2.022 . . . . 0.0 112.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 37.4 Cg_exo . . . . . 0 C--N 1.351 0.694 0 C-N-CA 122.445 2.097 . . . . 0.0 112.36 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.65 -27.83 66.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.562 ' HA ' HD23 ' A' ' 148' ' ' LEU . 45.2 mt-10 -77.26 -46.13 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.3 ttm -64.52 -36.41 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.021 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 155' ' ' LYS . 86.2 mt -74.23 -53.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.13 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.28 -46.71 69.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.112 0.482 . . . . 0.0 110.257 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -67.31 -35.28 79.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.427 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.82 -53.87 51.41 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.77 73.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 138' ' ' LEU . 0.8 OUTLIER -64.19 -56.56 13.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.424 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.578 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.6 mm? -70.8 -21.16 62.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.466 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -82.74 -26.5 31.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 58.6 ttp -80.96 -38.99 26.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.013 179.628 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.537 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 17.3 tppt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.778 0.323 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.665 HG22 ' HG ' ' B' ' 142' ' ' LEU . 38.4 t -77.55 -35.35 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.297 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.537 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 35.8 tt0 -56.35 -35.7 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 122' ' ' LYS . 4.4 m-20 -65.3 -39.86 93.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 109.711 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.44 77.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.012 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.59 -51.25 66.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.829 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -55.39 -36.4 66.35 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 133' ' ' VAL . 86.4 t80 -67.98 -32.21 72.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.804 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.516 HD13 HD21 ' B' ' 138' ' ' LEU . 38.1 tp -64.74 -43.16 94.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.887 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.19 -40.52 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.292 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -58.55 -45.94 87.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.601 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 129' ' ' TYR . 92.6 t -63.65 -41.0 91.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.614 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.02 -27.98 69.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.4 -61.2 1.86 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.739 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.791 0.329 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.21 -57.92 10.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.101 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -55.87 -42.44 75.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.298 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.07 -32.59 73.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -68.8 -59.55 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.2 mp -61.26 -31.12 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.195 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.12 -52.12 57.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.4 mt -54.08 -45.04 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.559 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 76.2 mmm -55.52 -48.93 73.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.51 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.26 -35.68 67.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.427 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.75 -43.72 92.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.973 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.65 -34.5 78.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.8 tptp -77.22 -27.55 53.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.389 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 18.24 12.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.59 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 62.43 96.92 0.04 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.838 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.2 m -155.59 -46.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.08 178.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -113.37 -173.35 2.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 93.6 m -58.55 -50.01 90.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.658 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.7 Cg_exo -56.58 -32.49 90.32 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.031 1.82 . . . . 0.0 112.037 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.0 -44.19 68.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.55 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.4 t -65.18 -44.36 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.65 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.453 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -61.2 -58.04 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.578 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -53.19 -56.48 16.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.91 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.4 t -57.65 -34.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.644 0.259 . . . . 0.0 111.321 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.2 t -60.34 -50.4 73.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.835 0.35 . . . . 0.0 110.805 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.11 -11.78 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.45 -38.72 65.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.726 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -97.3 23.72 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.808 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -54.49 106.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.63 -32.44 1.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.288 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -129.54 100.84 19.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.413 0.149 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.31 -0.08 9.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.413 2.075 . . . . 0.0 112.548 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.36 -58.75 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.5 mm? -60.54 -39.18 86.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.86 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.21 -42.87 93.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.87 76.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -81.42 -33.6 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.826 0.346 . . . . 0.0 111.115 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -63.13 -26.42 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.1 m -67.87 -37.91 82.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.138 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -56.86 -50.85 71.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.59 156.81 15.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 43.2 Cg_endo -66.98 144.81 71.63 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.251 1.967 . . . . 0.0 112.0 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 51.6 Cg_exo . . . . . 0 C--N 1.348 0.522 0 C-N-CA 122.398 2.066 . . . . 0.0 112.496 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.709 0.29 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.48 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.471 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.425 ' HA ' HD23 ' A' ' 148' ' ' LEU . 46.2 mt-10 -76.8 -49.99 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 58.4 ttp -63.66 -33.33 75.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.5 mt -76.35 -51.75 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.152 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.559 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -57.34 -47.78 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.028 0.442 . . . . 0.0 110.446 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.82 -50.07 73.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.524 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.71 -46.66 40.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.055 0.455 . . . . 0.0 109.96 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.93 -32.95 85.88 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.767 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' B' ' 138' ' ' LEU . 55.8 mt -62.42 -55.01 31.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.308 . . . . 0.0 111.028 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.665 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -68.92 -22.37 64.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -86.32 -26.49 24.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.37 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 161' ' ' THR . 15.7 tmm? -88.21 -24.79 23.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.545 179.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.771 0.32 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.607 HG22 ' HG ' ' B' ' 142' ' ' LEU . 26.9 t -83.6 -35.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.95 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.88 -27.44 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.78 -44.41 81.41 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -66.56 -29.48 69.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.9 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 mt -63.51 -54.96 28.1 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.936 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -55.88 -37.07 68.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 133' ' ' VAL . 84.3 t80 -64.0 -34.22 77.51 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.667 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.725 HD13 HD21 ' B' ' 138' ' ' LEU . 28.6 tp -65.56 -42.43 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.86 -38.54 88.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.081 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 -52.52 65.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.627 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 129' ' ' TYR . 46.5 t -59.18 -39.2 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -76.86 -17.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tt -75.16 -56.58 4.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.419 ' NE2' HD21 ' A' ' 178' ' ' LEU . 25.0 mt-30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.793 0.33 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.84 -57.43 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -55.8 -32.86 63.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.154 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.63 -52.28 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -56.2 -56.18 24.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' B' ' 134' ' ' GLU . 8.8 mp -58.83 -37.77 77.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.514 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.67 -42.45 88.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 159' ' ' ILE . 13.9 mt -57.18 -49.71 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.027 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.482 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 83.5 mmm -52.76 -42.58 65.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.487 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 10.3 mtmp? -64.55 -35.63 81.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.209 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.0 -33.44 75.42 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -79.4 -28.42 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.861 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 152' ' ' LYS . 27.6 mmtt -71.46 -59.48 2.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.64 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.2 m -63.27 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -179.32 104.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -165.39 -69.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.197 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 150' ' ' ILE . 40.7 pt -116.23 158.08 16.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.217 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 164' ' ' VAL . 6.2 m-20 -100.86 -172.19 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 84.8 m -52.56 -51.96 68.32 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.265 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.6 Cg_endo -58.56 -38.38 89.96 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.168 1.912 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.61 -42.21 93.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 168' ' ' VAL . 94.5 t -64.27 -45.44 96.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.761 0.315 . . . . 0.0 111.26 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.38 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.482 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.1 m -62.01 -54.46 41.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.567 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 164' ' ' VAL . 87.2 t -58.32 -35.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 69.0 m -64.82 -39.96 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.55 -13.89 55.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.97 -49.27 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -96.63 25.22 5.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.183 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.42 -26.22 60.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.947 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.0 -32.71 85.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.409 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -125.81 102.41 28.63 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 120.369 0.128 . . . . 0.0 110.988 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.34 -3.37 9.86 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.435 2.09 . . . . 0.0 112.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.86 -53.78 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -61.15 -35.77 78.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -67.29 -47.97 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.8 ttp -57.46 -42.76 83.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.695 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.27 -32.46 62.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.389 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -67.95 -31.63 71.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 110.574 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -67.35 -23.87 65.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 35.0 m -65.57 -40.68 93.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -57.42 -50.85 71.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.34 146.22 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 23.4 Cg_endo -62.05 114.26 2.23 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.398 2.065 . . . . 0.0 111.977 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 15.6 Cg_endo . . . . . 0 C--N 1.35 0.621 0 C-N-CA 122.461 2.107 . . . . 0.0 112.347 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' B' ' 135' ' ' MET . 11.1 pt-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.551 ' HA ' HD23 ' A' ' 148' ' ' LEU . 13.0 pt-20 -76.45 -41.59 46.85 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' B' ' 132' ' ' GLU . 22.3 ptp -63.29 -33.31 75.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.0 mt -76.48 -53.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.482 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -53.83 -51.01 64.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.725 HD21 HD13 ' A' ' 130' ' ' LEU . 3.9 mt -61.62 -43.67 98.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.02 -37.16 52.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.69 -37.58 76.77 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.598 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.584 HD13 ' HA ' ' B' ' 138' ' ' LEU . 1.5 mp -56.84 -56.03 26.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.046 0.45 . . . . 0.0 110.018 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.607 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -68.52 -24.13 64.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.466 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -75.45 -27.5 58.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.194 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . 0.442 ' SD ' HG23 ' A' ' 161' ' ' THR . 12.7 ttm -79.46 -40.42 29.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.884 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.943 0.402 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.672 HG22 ' HG ' ' B' ' 142' ' ' LEU . 41.8 t -95.11 -27.65 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.77 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -59.58 -35.35 74.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -68.33 -39.03 82.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.923 0.392 . . . . 0.0 110.539 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -63.99 -44.72 91.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.487 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.479 HD23 HG12 ' A' ' 123' ' ' VAL . 4.5 mm? -61.55 -40.79 95.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.174 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -58.96 -42.16 89.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.8 -40.56 93.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.852 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.451 HD22 HD21 ' B' ' 138' ' ' LEU . 26.2 tp -59.47 -41.56 90.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.191 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.47 -43.09 99.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.56 -41.19 85.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.26 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.93 -46.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.866 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -64.61 -25.55 68.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -72.73 -59.54 2.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.177 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.419 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.756 0.312 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -65.23 -57.66 7.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -56.43 -35.51 67.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.142 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.57 -36.48 73.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.014 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -64.58 -58.36 6.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.971 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.8 mp -60.39 -42.72 96.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.76 -44.86 74.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.117 0.484 . . . . 0.0 109.714 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.06 -47.95 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.235 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.454 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -54.96 -42.41 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.548 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -61.72 -39.64 92.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.262 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.11 -39.74 91.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.066 0.46 . . . . 0.0 109.874 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.81 -21.7 57.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.878 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -86.31 -22.87 26.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.63 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 62.7 m -104.01 16.35 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 61.43 93.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.984 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.8 m -147.6 -61.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.668 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 pt -114.54 155.07 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.407 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 1.1 p30 -83.17 171.75 13.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.621 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 63.5 m -53.67 -51.57 75.14 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.624 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 51.6 Cg_exo -53.03 -32.16 57.08 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.923 1.749 . . . . 0.0 111.896 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.09 62.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.207 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.4 t -66.93 -43.81 89.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.739 0.304 . . . . 0.0 110.813 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -66.1 -43.61 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.171 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.1 p -65.42 -54.06 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.375 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.524 ' HA ' HE21 ' A' ' 170' ' ' GLN . 74.1 mtp180 -55.78 -51.26 68.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.309 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.76 -36.16 69.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 t -59.39 -45.74 90.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.524 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.524 HE21 ' HA ' ' A' ' 167' ' ' ARG . 28.0 pt20 -84.09 -11.58 56.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.6 tp -75.96 -26.34 56.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -109.29 30.48 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.57 118.28 4.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.06 -54.84 0.77 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.198 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -109.03 95.72 18.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.76 0.88 4.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.506 2.137 . . . . 0.0 112.643 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.72 -56.02 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.006 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.9 mm? -58.52 -37.7 76.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.7 mt -71.07 -37.78 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.74 -38.64 91.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.13 -28.62 40.38 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.649 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -68.99 -40.98 78.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.435 HD22 HD12 ' A' ' 186' ' ' LEU . 3.7 t-20 -63.8 -21.27 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 m -66.38 -39.96 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.309 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -60.7 -40.37 91.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.435 HD12 HD22 ' A' ' 183' ' ' ASN . 79.1 mt -58.26 152.0 44.68 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.614 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.419 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 29.1 Cg_endo -63.63 111.12 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.313 2.009 . . . . 0.0 112.091 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.2 Cg_endo . . . . . 0 C--N 1.35 0.631 0 C-N-CA 122.339 2.026 . . . . 0.0 112.188 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.83 0.348 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.1 -28.74 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.89 -42.87 60.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.6 tpp -65.44 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.41 -52.28 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.48 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -52.47 -47.0 66.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.091 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 130' ' ' LEU . 4.2 mm? -64.74 -38.72 91.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.276 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.39 -46.76 62.95 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.31 -31.42 71.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.584 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.48 HD12 ' O ' ' B' ' 137' ' ' ALA . 0.1 OUTLIER -59.02 -54.95 41.29 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 110.399 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.672 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -73.51 -21.63 60.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.83 -26.3 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.356 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 53.8 ttp -87.51 -34.75 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.689 179.662 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.86 0.362 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.671 HG22 ' HG ' ' B' ' 142' ' ' LEU . 48.7 t -64.03 -31.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.519 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -56.98 -35.87 69.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.17 -37.83 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.11 86.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.119 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.91 -49.3 73.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -55.06 -36.61 65.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 133' ' ' VAL . 64.9 t80 -67.68 -33.55 75.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.83 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.5 tp -62.3 -48.62 79.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.024 0.44 . . . . 0.0 110.041 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.54 -38.54 91.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 132' ' ' GLN . 7.9 tt0 -57.97 -44.78 87.29 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 110.296 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.537 HG22 HD12 ' A' ' 178' ' ' LEU . 89.2 t -61.88 -48.11 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -68.22 -15.93 63.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.56 -54.87 6.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.48 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.8 mm100 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.435 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.803 0.335 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.26 -55.28 36.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.048 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -54.94 -42.0 71.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.22 -32.04 73.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.201 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.18 -60.53 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.077 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -61.86 -38.75 89.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.004 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.18 -46.14 83.08 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.535 HD12 HD22 ' A' ' 171' ' ' LEU . 3.2 mt -56.99 -45.49 83.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.855 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.566 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 77.4 mmm -55.03 -40.19 69.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.658 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.35 -37.77 88.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.218 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.06 -39.88 93.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 109.856 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.4 -37.46 63.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.818 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HG2' HG23 ' B' ' 136' ' ' ILE . 22.0 tptm -65.93 -27.44 68.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.383 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 92.7 p -102.33 -154.76 0.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.905 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -102.89 87.61 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.812 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.4 t -148.56 -70.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.57 167.21 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.677 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.3 -170.49 1.67 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 56.8 m -53.58 -52.31 68.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.745 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 161' ' ' THR . 10.1 Cg_endo -53.25 -36.39 77.73 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.033 1.822 . . . . 0.0 111.883 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.05 -38.59 88.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.13 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.42 -45.2 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.23 -49.0 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.43 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -62.66 -59.24 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.717 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -52.82 -54.33 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.605 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.25 -35.34 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.676 0.274 . . . . 0.0 111.235 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.3 t -61.3 -46.51 90.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -83.96 -11.79 56.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.535 HD22 HD12 ' A' ' 150' ' ' ILE . 19.1 tp -77.94 -24.76 48.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -113.0 25.68 11.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.65 103.51 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 144.65 -25.97 1.96 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.557 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -125.47 95.12 41.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.388 0.137 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -7.36 21.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.387 2.058 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.88 -54.26 10.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -60.79 -41.92 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.9 mt -63.8 -49.58 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 57.0 ttp -58.89 -35.82 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.6 -20.56 63.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.434 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.99 -41.31 36.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.39 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 89.4 m -63.75 -35.9 82.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' B' ' 145' ' ' SER . 97.0 m-85 -65.15 -52.03 57.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' B' ' 145' ' ' SER . 77.2 mt -54.78 148.59 26.27 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 51.3 Cg_exo -54.57 145.44 58.66 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.428 2.085 . . . . 0.0 112.108 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 53.0 Cg_exo . . . . . 0 C--N 1.348 0.509 0 C-N-CA 122.364 2.043 . . . . 0.0 112.402 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.804 0.335 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.24 94.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.725 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 148' ' ' LEU . 39.3 mt-10 -70.97 -39.17 72.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.17 -34.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.501 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.6 mt -75.7 -52.81 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.061 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.566 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -54.24 -48.52 71.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 110.574 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.625 ' HA ' HD12 ' B' ' 141' ' ' LEU . 3.7 mm? -63.9 -43.79 94.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.258 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.13 -47.28 45.65 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.44 -36.66 92.88 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.891 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' B' ' 138' ' ' LEU . 56.9 mt -59.51 -55.32 36.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.919 0.39 . . . . 0.0 110.901 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.671 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -72.76 -18.76 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.332 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.343 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 44.7 ttp -81.76 -39.35 24.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.354 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . 0.489 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.6 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.882 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.849 0.357 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.608 HG22 ' HG ' ' B' ' 142' ' ' LEU . 30.2 t -67.02 -28.72 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.63 -39.06 79.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.779 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.51 -36.8 84.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 109.969 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -61.77 -45.22 94.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.174 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.082 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -56.99 -38.59 73.26 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 133' ' ' VAL . 67.3 t80 -64.98 -40.67 95.33 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.731 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.32 -36.06 74.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.26 -39.84 74.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.01 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -57.87 -39.21 77.27 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.869 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 178' ' ' LEU . 47.4 t -72.51 -38.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -68.28 -20.58 64.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.288 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.21 -55.9 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.57 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.168 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.451 HG13 HD23 ' A' ' 171' ' ' LEU . 17.0 t . . . . . 0 C--O 1.231 0.094 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.49 -56.78 16.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.908 0.385 . . . . 0.0 110.568 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.8 -36.28 76.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.544 ' HB3' HD11 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -68.85 -31.58 70.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -69.65 -59.7 2.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -38.26 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.496 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 15.1 t70 -58.22 -50.12 74.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -53.74 -44.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.196 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.543 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 75.7 mmm -58.2 -39.66 79.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 55.2 mtmt -67.02 -31.17 71.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.115 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.57 -42.73 86.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.69 -21.82 60.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.818 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.48 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.5 tptp -82.31 -34.61 28.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.9 t -95.2 18.99 11.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 64.04 98.86 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -153.08 -61.92 0.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.567 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.37 172.42 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 164' ' ' VAL . 12.1 m-20 -100.37 -178.33 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.135 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 87.5 m -60.22 -50.04 87.88 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.603 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 53.1 Cg_exo -55.51 -32.95 84.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.964 1.776 . . . . 0.0 111.939 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.49 -40.49 59.66 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.235 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 168' ' ' VAL . 94.4 t -64.9 -45.27 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.94 -49.87 77.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.308 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.4 p -58.89 -53.2 61.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -54.3 -52.31 61.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.397 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 164' ' ' VAL . 81.8 t -61.7 -31.13 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.752 0.311 . . . . 0.0 111.007 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.1 m -64.41 -45.36 87.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.781 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -82.25 -16.5 49.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 146' ' ' ASP . 1.2 tp -76.03 -42.53 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -95.94 15.6 20.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -51.61 120.09 4.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.46 -45.68 0.78 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.36 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -120.45 100.7 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.46 0.172 . . . . 0.0 110.758 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.41 -11.27 13.14 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.489 2.126 . . . . 0.0 112.707 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.5 -64.74 0.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 133' ' ' VAL . 4.8 mp -57.7 -27.12 62.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.64 -55.06 24.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.1 ttp -64.2 -40.96 97.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.008 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.15 -30.97 79.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.59 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.04 -35.85 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -63.72 -30.7 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.7 m -55.76 -51.91 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -53.52 -44.48 69.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.91 154.09 39.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 19.5 Cg_endo -60.01 146.91 94.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.369 2.046 . . . . 0.0 112.126 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 31.4 Cg_exo . . . . . 0 C--N 1.348 0.52 0 C-N-CA 122.327 2.018 . . . . 0.0 112.105 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.787 0.327 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.99 14.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -72.28 -54.95 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.772 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 51.8 ttm -64.63 -25.89 68.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.48 HG23 ' HG2' ' A' ' 155' ' ' LYS . 93.5 mt -73.55 -53.43 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.543 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -57.24 -47.77 80.54 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.509 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.682 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.08 -45.69 93.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.543 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.38 49.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.09 -34.36 89.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.867 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' B' ' 138' ' ' LEU . 58.4 mt -61.25 -56.13 24.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.895 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.608 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -69.13 -21.97 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -82.71 -26.25 32.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.556 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -80.47 -39.23 28.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.542 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.637 179.516 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.621 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 16.4 tppt? . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.893 0.377 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.63 HG13 ' HG ' ' B' ' 142' ' ' LEU . 58.9 t -71.41 -32.04 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.621 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 36.8 tt0 -57.67 -39.21 76.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.934 0.397 . . . . 0.0 110.504 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.808 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.4 -41.51 98.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.132 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.73 -44.23 96.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.84 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.5 m -55.74 -40.03 71.95 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 133' ' ' VAL . 40.8 t80 -65.63 -34.52 78.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.086 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.583 HD22 HD21 ' B' ' 138' ' ' LEU . 28.2 tp -61.96 -48.58 79.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.241 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.36 -31.46 72.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.17 -43.61 94.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.614 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 129' ' ' TYR . 91.0 t -67.19 -47.83 80.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 134' ' ' LYS . 10.9 tmtt? -58.2 -39.14 78.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.8 -31.98 63.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.779 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 -179.717 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.744 0.307 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.66 -57.93 10.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.448 . . . . 0.0 110.661 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -57.56 -33.47 68.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' HD11 ' A' ' 171' ' ' LEU . 58.0 m-20 -62.43 -49.52 75.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.31 -58.14 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.273 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.14 -30.24 70.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.709 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.0 -55.1 36.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.172 0.511 . . . . 0.0 109.709 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mt -54.46 -46.33 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.247 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.761 ' HE2' HD23 ' B' ' 141' ' ' LEU . 69.1 mmm -52.95 -42.91 65.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.681 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -64.66 -39.05 93.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.611 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.75 -40.82 89.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.547 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -77.61 -38.6 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.507 ' HG2' HG23 ' B' ' 136' ' ' ILE . 61.0 tptt -62.54 -30.58 71.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.78 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.4 m -89.64 -83.29 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.783 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -178.17 94.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.521 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.1 m -157.37 -73.01 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -103.48 -178.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.319 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 164' ' ' VAL . 20.9 m-20 -120.23 -175.25 2.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.559 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.0 m -54.58 -51.53 77.74 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.807 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.4 Cg_endo -58.31 -37.03 96.95 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.081 1.854 . . . . 0.0 112.037 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.273 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 160' ' ' ASP . 87.0 t -68.39 -45.15 82.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 110.957 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.23 -45.76 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.485 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.6 p -64.68 -55.81 17.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.835 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.596 ' HA ' HE21 ' A' ' 170' ' ' GLN . 99.5 mtt180 -57.66 -53.27 60.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.793 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.66 -41.1 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.787 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 85.2 p -60.77 -44.37 96.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.551 0.215 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.596 HE21 ' HA ' ' A' ' 167' ' ' ARG . 30.0 pt20 -82.59 -12.02 58.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 146' ' ' ASP . 19.0 tp -70.2 -39.18 75.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.566 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -92.83 33.04 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -52.4 112.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 132.01 -46.65 1.05 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.551 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -114.37 95.59 40.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.433 0.158 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.81 3.55 5.41 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.5 2.134 . . . . 0.0 112.376 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -69.83 -60.64 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 178' ' ' LEU . 3.3 mm? -60.29 -35.66 76.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.547 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.17 -49.86 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.784 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.7 ttp -59.29 -38.8 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.68 -25.82 73.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.386 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -77.32 -34.88 55.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.724 0.297 . . . . 0.0 111.06 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -65.54 -16.98 64.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.2 m -70.32 -34.15 72.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.226 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -62.75 -43.62 98.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.57 155.72 27.4 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.847 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.77 129.09 25.08 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.523 2.149 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.349 0.572 0 C-N-CA 122.391 2.061 . . . . 0.0 112.252 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.434 ' O ' HG13 ' B' ' 136' ' ' ILE . 39.9 mt-10 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.649 0.262 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.87 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.498 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -67.71 -46.68 71.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.0 -28.51 69.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.201 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.507 HG23 ' HG2' ' A' ' 155' ' ' LYS . 96.5 mt -74.91 -53.91 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.86 73.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.106 0.479 . . . . 0.0 110.138 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 130' ' ' LEU . 4.4 mm? -56.71 -52.54 64.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.243 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.69 -31.66 26.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.67 -51.46 47.07 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.001 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.761 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -68.4 -47.08 68.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.207 0.504 . . . . 0.0 111.338 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.63 ' HG ' HG13 ' A' ' 123' ' ' VAL . 3.6 mm? -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.548 0.213 . . . . 0.0 111.32 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -86.15 -28.56 23.89 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.66 0.267 . . . . 0.0 111.382 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -73.51 -25.78 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.482 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.793 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.694 0.283 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.627 HG22 ' HG ' ' B' ' 142' ' ' LEU . 25.1 t -67.94 -26.28 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.68 -42.31 88.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.035 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -64.96 -33.17 75.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -63.44 -50.12 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.48 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.27 -41.59 89.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.257 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.0 t -55.78 -42.46 75.58 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.37 -35.46 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.01 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.65 -46.0 88.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.746 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.78 -40.3 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.886 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.405 ' HG3' ' NE2' ' A' ' 136' ' ' GLN . 7.6 tp60 -55.34 -42.94 74.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.153 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.63 -47.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.48 -25.08 65.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.654 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.4 tp -75.47 -65.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.295 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 132' ' ' GLN . 2.8 mp0 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.388 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.834 0.349 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.66 -55.88 29.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.982 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -56.05 -49.97 72.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.53 -36.57 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.79 -60.63 2.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.827 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.365 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -48.78 80.02 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.36 -48.0 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.082 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.403 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 81.2 mmm -53.24 -44.67 68.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.615 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.425 ' HG3' HG21 ' B' ' 136' ' ' ILE . 3.0 ttmp? -61.59 -37.28 83.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.543 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.11 -41.12 96.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 0.0 109.895 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -70.35 -41.61 72.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.468 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.547 ' HG2' HG23 ' B' ' 136' ' ' ILE . 28.6 tptp -65.37 -29.21 69.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.3 t -89.09 -85.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.793 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -178.5 101.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.611 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -165.34 -69.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.974 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.94 175.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.337 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.78 -171.95 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.972 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.533 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 61.3 m -53.53 -51.99 70.99 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.671 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 161' ' ' THR . 22.3 Cg_endo -61.68 -34.01 84.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.835 1.69 . . . . 0.0 111.686 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.67 93.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.089 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.72 -45.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.84 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.105 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -67.08 -56.6 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -55.59 -49.21 73.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.227 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.7 t -62.9 -34.56 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.564 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.3 t -59.34 -47.65 84.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.487 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.77 -15.68 56.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.5 tp -77.81 -31.01 51.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -118.99 24.55 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.33 -23.3 62.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.144 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -59.55 -32.51 73.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.804 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.32 108.31 10.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.525 0.163 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.33 -15.13 48.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.393 2.062 . . . . 0.0 112.425 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.93 -52.95 63.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.849 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.9 mm? -58.65 -33.93 70.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.572 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.31 -46.72 94.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.8 tpp -61.59 -48.06 82.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -26.05 72.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.547 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -78.81 -37.41 40.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.643 0.259 . . . . 0.0 111.111 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.62 -30.49 71.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.024 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.9 m -60.85 -39.7 90.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' B' ' 145' ' ' SER . 59.6 m-85 -58.46 -52.0 67.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.33 149.05 21.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.658 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 21.8 Cg_endo -60.8 140.56 91.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.357 2.038 . . . . 0.0 111.944 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo . . . . . 0 C--N 1.347 0.498 0 C-N-CA 122.355 2.036 . . . . 0.0 112.281 -179.746 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.705 0.288 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.53 68.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.512 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.545 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.9 OUTLIER -69.58 -47.9 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.189 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.1 ttm -60.69 -31.53 70.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.547 HG23 ' HG2' ' A' ' 155' ' ' LYS . 77.0 mt -76.57 -53.18 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.347 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.88 -47.63 70.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.634 HD13 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -66.69 -38.33 86.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.06 -53.17 45.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.011 0.434 . . . . 0.0 109.837 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.54 -31.0 79.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.589 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.634 HD13 HD13 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -58.34 -56.07 26.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 179.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.705 HD11 ' HB2' ' A' ' 126' ' ' ALA . 3.1 mm? -75.7 -17.3 59.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -83.12 -26.17 31.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.736 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 62.5 ttp -91.09 -32.25 15.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 57.3 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.397 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.4 tptt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.821 0.343 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.64 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.2 t -57.57 -40.29 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.677 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.22 -40.72 74.51 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.691 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.76 -37.24 86.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.197 0.522 . . . . 0.0 109.727 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -61.53 -41.81 97.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.987 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.04 -42.24 98.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.976 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m -55.47 -43.39 75.48 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.4 t80 -61.66 -38.13 86.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.1 tp -58.86 -44.59 91.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.992 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.25 -37.05 85.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.932 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.27 -35.61 80.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.399 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 178' ' ' LEU . 85.3 t -67.32 -55.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.857 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.09 -40.05 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.729 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.64 -37.98 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.145 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.475 ' HG2' HD21 ' A' ' 178' ' ' LEU . 5.8 tp-100 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.989 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.784 0.326 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -52.76 -58.51 6.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.142 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -54.96 -42.45 72.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.391 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB3' HD11 ' A' ' 171' ' ' LEU . 63.0 m-20 -62.35 -38.16 88.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.464 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.61 -59.16 4.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.327 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -63.29 -34.29 77.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.299 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.12 -52.16 66.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.448 . . . . 0.0 109.836 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.2 mt -55.99 -48.32 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.482 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 71.1 mmm -55.38 -35.0 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.951 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -72.18 -34.18 68.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.28 -45.34 91.92 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -69.14 -33.05 72.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.892 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG2' HG23 ' B' ' 136' ' ' ILE . 61.3 tptt -74.8 -21.79 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.349 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.0 t -107.22 18.46 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.742 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 62.29 99.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.1 m -153.67 -65.29 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.09 165.38 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.96 -179.46 6.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.6 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 81.9 m -61.35 -50.06 85.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.63 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.31 -29.35 83.72 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.021 1.814 . . . . 0.0 111.912 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.8 -39.28 65.7 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.01 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.7 -44.16 79.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 110.996 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.43 -43.75 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.7 -56.01 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -54.5 39.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.23 -36.81 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -59.49 -49.39 77.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.818 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -80.31 -12.15 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 146' ' ' ASP . 12.4 tp -76.9 -19.83 56.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -125.62 29.18 6.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.986 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -55.6 -21.54 18.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.52 -53.08 46.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -120.37 98.03 48.73 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.399 0.142 . . . . 0.0 110.996 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.7 -14.98 23.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.467 2.111 . . . . 0.0 112.388 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.49 -54.33 48.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -57.21 -41.98 80.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.388 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.42 -35.85 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.812 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -63.8 -53.09 56.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.49 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.12 -22.88 72.82 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.235 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.451 ' HE1' HD21 ' B' ' 141' ' ' LEU . 83.9 t80 -72.77 -47.27 48.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.342 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.97 -20.86 65.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.4 m -60.79 -36.09 78.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.811 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -70.9 -49.1 49.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 75.8 mt -51.61 147.84 10.58 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.048 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.53 123.93 13.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.313 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.732 0.301 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.94 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.498 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.564 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -71.95 -46.43 57.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtp -65.68 -31.34 72.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.435 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.409 HG23 ' HG2' ' A' ' 155' ' ' LYS . 88.7 mt -74.94 -53.73 15.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -55.5 -49.52 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.611 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -62.49 -42.94 99.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.666 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.35 59.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.92 80.1 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.582 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -60.77 -56.54 19.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.739 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.64 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -69.4 -22.12 63.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.02 -26.8 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -80.84 -40.19 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.888 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.149 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.687 0.279 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.531 HG22 ' HG ' ' B' ' 142' ' ' LEU . 49.1 t -82.05 -44.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.749 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.27 -24.85 45.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.05 -43.56 82.42 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.544 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -65.33 -35.59 81.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.475 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.86 -42.87 99.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.841 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -60.6 -42.51 96.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -58.79 -39.19 80.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.785 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.489 HD22 HD21 ' B' ' 138' ' ' LEU . 22.8 tp -58.75 -46.91 86.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.0 -37.03 78.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.438 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.557 ' HG3' HE22 ' A' ' 136' ' ' GLN . 5.7 tp-100 -59.6 -51.63 68.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.375 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.552 HG22 HD12 ' A' ' 178' ' ' LEU . 95.8 t -58.88 -39.88 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.67 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -69.0 -25.81 64.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.787 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.86 -53.57 12.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.557 HE22 ' HG3' ' A' ' 132' ' ' GLN . 2.4 mp0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.847 0.355 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.06 -52.16 66.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.686 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -58.4 -38.48 77.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.802 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.13 -31.56 71.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -66.44 -60.07 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.558 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.17 -30.52 71.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.04 -48.8 80.21 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.2 mt -56.05 -43.54 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.547 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.518 ' HB3' ' HA ' ' B' ' 137' ' ' ALA . 0.0 OUTLIER -53.38 -48.85 68.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.984 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -58.54 -41.6 85.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.084 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.84 -39.74 78.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.847 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.65 -22.97 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.851 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -84.58 -14.13 49.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.3 m -111.53 15.66 21.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 62.95 93.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.8 m -147.15 -49.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.28 171.57 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.939 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.569 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 5.3 t70 -111.2 -177.23 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.765 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 34.1 m -51.02 -50.58 74.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 33.1 Cg_exo -57.75 -37.09 97.84 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.898 1.732 . . . . 0.0 111.953 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.72 -37.91 89.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.506 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 160' ' ' ASP . 61.5 t -67.18 -45.17 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.756 0.313 . . . . 0.0 110.938 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.63 -43.85 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -66.26 -55.41 16.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.499 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -53.62 -53.9 45.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.345 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.9 -35.72 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 111.097 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 t -57.66 -50.34 73.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -79.34 -18.39 52.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 tp -68.49 -35.84 78.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.909 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -100.83 30.15 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.31 113.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 134.96 -32.07 2.63 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.463 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -126.07 93.3 43.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.514 0.197 . . . . 0.0 110.863 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.89 -3.46 12.81 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.474 2.116 . . . . 0.0 112.17 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.64 -53.9 19.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.552 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -64.59 -39.1 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.51 -49.47 84.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.743 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 51.9 ttm -61.01 -43.4 98.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.559 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.44 -25.59 72.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.352 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -78.13 -37.43 46.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.86 -20.2 65.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.3 m -70.63 -37.99 73.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.361 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -62.16 -43.0 99.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.33 153.73 36.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 28.5 Cg_endo -62.27 114.15 2.22 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.519 2.146 . . . . 0.0 112.245 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 37.1 Cg_endo . . . . . 0 C--N 1.348 0.523 0 C-N-CA 122.36 2.04 . . . . 0.0 112.231 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 CA--C 1.524 -0.036 0 CA-C-O 120.682 0.277 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.66 65.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.423 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -75.82 -47.83 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 92.3 mmm -63.54 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -52.68 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.024 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.26 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 130' ' ' LEU . 4.5 mm? -62.99 -39.8 95.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.266 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.32 -47.11 55.91 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.84 -29.2 72.6 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.745 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.476 HD12 ' O ' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -62.47 -56.41 18.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 126' ' ' ALA . 3.0 mm? -70.73 -21.55 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.776 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -83.36 -26.78 30.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.902 0.382 . . . . 0.0 110.853 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . 0.469 ' SD ' HG23 ' A' ' 161' ' ' THR . 10.1 tmm? -86.8 -25.37 24.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.151 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.821 179.288 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.499 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 60.9 tptt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.837 0.351 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.621 HG22 ' HG ' ' B' ' 142' ' ' LEU . 42.0 t -70.43 -33.06 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.499 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 37.4 tt0 -55.33 -36.51 66.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.32 -36.97 85.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.72 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -62.64 -43.02 99.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.089 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.06 -45.3 95.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.066 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.1 t -56.13 -38.16 70.44 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -67.52 -34.5 77.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.072 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.516 HD13 HD21 ' B' ' 138' ' ' LEU . 40.7 tp -61.95 -39.86 93.54 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.824 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.54 -38.55 74.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.177 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -57.2 -42.69 81.72 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.28 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.67 -38.92 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -61.14 -28.5 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.812 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.2 -51.33 7.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.074 -179.707 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.603 0.24 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.23 -55.62 26.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.54 -43.64 84.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.003 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.582 ' HB3' HD21 ' A' ' 171' ' ' LEU . 9.8 t70 -67.45 -25.55 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.844 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -70.21 -59.65 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.2 -35.74 79.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.27 -46.83 88.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 109.843 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.59 -46.89 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.387 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.575 ' HE2' HD12 ' B' ' 141' ' ' LEU . 85.3 mmm -54.19 -48.9 70.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.847 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.3 -34.81 74.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.373 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.55 -38.08 88.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.96 -32.31 65.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.824 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -76.54 -23.14 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.845 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.6 t -98.36 10.36 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.574 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 63.77 95.6 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.043 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -149.65 -51.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.745 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.7 pt -123.46 172.02 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.068 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.92 -175.79 2.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.193 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.9 m -59.38 -51.38 81.82 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.667 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.5 Cg_endo -58.07 -31.42 93.05 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.037 1.825 . . . . 0.0 111.851 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.14 -45.39 62.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.114 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.17 -41.5 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.885 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.4 mt -62.34 -53.63 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.4 m -58.62 -55.67 32.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.766 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -51.74 -54.36 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.95 -35.83 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.428 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 71.0 m -59.4 -47.12 86.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.828 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -84.3 -11.92 55.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.182 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 146' ' ' ASP . 16.1 tp -76.5 -25.1 53.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.25 31.11 5.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.083 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.59 107.49 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.2 -47.0 0.57 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.632 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -124.58 103.57 31.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.01 -0.112 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.91 -9.56 25.28 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.381 2.054 . . . . 0.0 112.252 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -54.38 20.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -57.05 -44.88 83.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.731 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.68 -41.73 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.2 tpp -62.83 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.61 -30.53 74.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.339 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -72.21 -39.62 68.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.37 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.36 -25.92 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.3 m -63.33 -39.65 95.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 145' ' ' SER . 93.6 m-85 -57.54 -51.35 69.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.31 155.1 5.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.093 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 41.0 Cg_endo -66.94 117.36 4.72 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.428 2.085 . . . . 0.0 112.337 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 34.2 Cg_exo . . . . . 0 C--N 1.35 0.607 0 C-N-CA 122.407 2.071 . . . . 0.0 112.191 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.765 0.317 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.3 -23.79 16.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -70.53 -58.1 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 79.7 mtp -63.99 -29.25 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.782 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.83 -53.47 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.293 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.481 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.68 -49.34 73.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 130' ' ' LEU . 4.4 mm? -61.7 -42.21 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.368 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.4 -46.75 56.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.36 -32.56 82.3 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.742 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.575 HD12 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -59.01 -54.02 51.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.621 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.8 mm? -76.22 -17.95 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.945 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' B' ' 143' ' ' GLN . 1.0 OUTLIER -81.46 -30.63 33.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.41 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 56.7 ttp -83.98 -38.77 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 185' ' ' PHE . 74.7 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.073 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.821 0.344 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.56 HG22 ' HG ' ' B' ' 142' ' ' LEU . 32.4 t -74.78 -38.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.794 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -57.08 -27.62 61.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.825 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.29 -44.22 79.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -63.48 -31.75 73.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.575 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.62 -49.68 70.13 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.964 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.2 t -54.54 -39.26 67.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.34 -33.41 75.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.094 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.503 HD13 HD21 ' B' ' 138' ' ' LEU . 44.7 tp -61.28 -48.87 79.43 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.943 0.402 . . . . 0.0 110.001 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.8 -32.99 74.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.03 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -57.67 -46.75 83.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.23 -45.93 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -61.22 -22.61 64.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.54 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.1 tp -78.57 -58.62 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.982 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.488 HE21 ' HA ' ' A' ' 136' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.136 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -63.3 -55.55 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -57.17 -37.51 72.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.451 ' HB3' HD11 ' A' ' 171' ' ' LEU . 3.6 m-20 -65.48 -38.5 89.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -64.48 -59.44 4.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.913 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -58.71 -38.9 79.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.827 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.518 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 22.1 t70 -56.18 -47.43 78.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.3 mt -56.0 -48.31 78.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.212 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.497 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.3 mmm -54.6 -38.43 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.693 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 56.2 mtmt -68.44 -35.78 78.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.47 -42.13 95.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.155 0.502 . . . . 0.0 109.667 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -77.25 -27.5 53.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.208 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' B' ' 136' ' ' ILE . 29.4 tptp -73.48 -28.5 61.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.2 m -98.69 -84.44 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -173.04 105.45 0.14 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.704 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.8 t -169.38 -69.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.239 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.402 HD13 ' HD2' ' A' ' 167' ' ' ARG . 47.2 pt -116.45 168.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.363 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 164' ' ' VAL . 9.2 m-20 -108.95 -172.57 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.552 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 55.3 m -51.53 -51.0 73.55 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.9 Cg_endo -60.11 -32.7 95.03 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.904 1.736 . . . . 0.0 111.694 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.75 -32.28 70.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 160' ' ' ASP . 57.5 t -73.85 -45.17 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.725 0.298 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.65 -41.78 93.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.9 m -68.31 -54.0 20.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.699 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.402 ' HD2' HD13 ' A' ' 159' ' ' ILE . 95.6 mtt180 -58.97 -44.41 91.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.563 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.79 -44.94 99.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 90.6 p -59.73 -36.46 76.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.911 0.386 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -84.15 -17.58 39.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.746 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 146' ' ' ASP . 15.8 tp -75.41 -36.81 60.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.25 28.86 5.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -55.46 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.38 -37.47 1.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.422 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -121.52 99.52 45.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 -1.67 11.45 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.458 2.105 . . . . 0.0 112.301 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.95 -60.27 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.4 mm? -60.71 -41.86 96.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.95 -39.42 82.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.718 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.4 ttm -62.23 -52.8 62.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.7 69.14 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.305 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.4 ' HE1' HD21 ' B' ' 141' ' ' LEU . 88.8 t80 -74.62 -37.42 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -67.42 -15.61 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.739 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 27.9 m -74.42 -38.37 63.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -57.43 -41.16 79.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.767 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 92.0 mt -59.76 154.92 44.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.77 117.55 5.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.407 2.071 . . . . 0.0 112.356 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--N 1.349 0.604 0 C-N-CA 122.282 1.988 . . . . 0.0 112.248 179.798 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.703 0.287 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.21 66.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.159 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.454 ' HA ' HD23 ' A' ' 148' ' ' LEU . 5.4 mm-40 -64.0 -47.85 78.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.67 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 94.3 mmm -62.48 -27.59 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.11 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.442 HG23 ' HG2' ' A' ' 155' ' ' LYS . 81.1 mt -73.2 -53.49 18.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.119 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.408 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.02 -48.07 76.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 110.33 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.514 HD13 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -63.51 -37.72 88.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.385 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.26 -49.53 63.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.96 -33.9 88.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.545 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.514 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -59.08 -56.17 25.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.921 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.56 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -73.43 -17.33 61.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.44 -26.78 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.831 0.348 . . . . 0.0 110.891 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.0 ttp -86.13 -36.95 19.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.605 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 59.7 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.691 179.628 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.0 tptp . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.717 0.294 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.585 HG22 ' HG ' ' B' ' 142' ' ' LEU . 72.6 t -58.84 -34.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 38.0 mt-10 -57.68 -23.61 52.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.01 -44.52 72.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.079 0.466 . . . . 0.0 109.819 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -66.5 -37.74 85.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.132 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 123' ' ' VAL . 4.4 mm? -62.12 -43.06 99.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.982 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.9 t -62.72 -38.87 92.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.709 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.96 -50.27 74.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.391 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.604 HD22 HD21 ' B' ' 138' ' ' LEU . 30.4 tp -57.59 -39.87 77.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.22 -39.49 94.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.51 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.98 -45.41 93.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.417 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.09 -41.13 89.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -68.0 -26.77 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.533 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.71 -51.83 15.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.308 -179.663 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 171' ' ' LEU . 2.3 t . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.75 0.31 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.03 -59.28 5.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.15 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -51.31 -51.95 49.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.96 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.13 -42.76 81.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -59.19 -60.68 3.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.838 0.351 . . . . 0.0 111.518 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.7 mp -61.58 -34.26 75.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.89 -44.55 96.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.0 -48.22 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.909 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.492 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -55.72 -47.76 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.377 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -56.8 -35.88 69.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.444 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.32 -39.63 92.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -66.97 -37.03 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.014 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' A' ' 155' ' ' LYS . 4.0 mmmp? -75.74 -27.55 58.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -91.76 14.34 15.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.455 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 62.99 93.59 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.315 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.4 m -150.77 -70.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.691 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.0 pt -104.95 166.9 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.103 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -103.67 -170.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.799 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 32.3 m -57.14 -51.03 84.71 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.8 Cg_endo -58.88 -27.86 85.61 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.018 1.812 . . . . 0.0 111.91 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.3 -42.32 50.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.53 -45.07 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.2 mt -64.19 -46.23 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.421 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.4 t -62.5 -57.71 10.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.583 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.6 -56.35 17.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.489 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 75.3 t -57.3 -35.46 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 t -61.74 -40.64 95.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.968 0.413 . . . . 0.0 110.139 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.8 -22.79 56.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 171' ' ' LEU . 2.7 tm? -72.44 -38.26 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -94.0 25.42 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.765 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 173' ' ' LYS . 4.6 ttmp? -53.08 137.8 32.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.99 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.75 88.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.61 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -139.11 85.33 15.9 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.615 0.245 . . . . 0.0 111.181 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.55 2.09 7.75 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.481 2.121 . . . . 0.0 112.36 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -72.59 -63.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.3 mm? -61.76 -31.75 71.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.97 -52.06 48.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.3 ttp -61.78 -31.86 72.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.25 -26.65 59.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.174 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -80.9 -31.54 35.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 0.0 111.004 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -62.86 -18.98 63.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.3 m -72.52 -37.04 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.946 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -61.58 -45.54 93.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' B' ' 145' ' ' SER . 94.9 mt -58.57 145.75 75.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.77 119.14 6.17 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.351 2.034 . . . . 0.0 112.186 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo . . . . . 0 C--N 1.35 0.641 0 C-N-CA 122.362 2.041 . . . . 0.0 112.215 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.79 0.328 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.88 -21.82 32.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.514 ' HA ' HD23 ' A' ' 148' ' ' LEU . 7.9 mm-40 -70.87 -61.72 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 80.0 mtp -60.53 -26.33 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.26 -50.28 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.489 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.25 -50.02 72.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 130' ' ' LEU . 4.6 mm? -61.94 -41.24 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.167 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -46.27 59.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.8 -35.45 90.92 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.644 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.572 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -58.45 -56.14 25.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.87 0.366 . . . . 0.0 110.756 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.585 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -69.6 -22.82 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -77.53 -27.13 51.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 57.6 ttp -83.44 -36.26 24.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.578 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 145' ' ' SER . . . . . 0.622 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.5 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.895 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -118.94 -55.08 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.92 -49.25 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.14 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? 65.97 133.08 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 22.0 t -87.78 -33.4 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.61 -37.87 74.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.4 -36.86 83.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -62.72 -44.49 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.376 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.58 -43.69 98.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.094 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -55.68 -39.57 71.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.4 t80 -65.72 -36.17 82.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.828 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.6 tp -61.04 -45.11 96.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.141 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.75 -39.0 93.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.237 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -59.56 -41.49 90.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.53 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 129' ' ' TYR . 59.8 t -67.02 -41.93 87.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.7 -26.43 67.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.412 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.5 tp -73.2 -58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.657 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -57.1 -54.39 47.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.95 33.36 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.174 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.12 -28.41 68.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.604 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.0 m -89.97 -8.13 52.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -134.25 79.34 55.8 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.74 3.89 2.95 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.792 2.328 . . . . 0.0 112.438 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.12 -56.15 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.8 -34.57 25.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.269 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.37 -58.36 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -55.19 -40.12 70.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.518 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.35 -37.93 86.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.17 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -63.54 -59.86 4.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.5 mp -59.43 -39.76 84.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.224 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.44 -46.78 80.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 109.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.77 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.379 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.54 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 70.0 mmm -54.56 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.418 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.08 -37.5 75.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.589 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.81 -38.66 86.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.1 0.476 . . . . 0.0 109.801 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -78.6 -31.75 47.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.811 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' B' ' 136' ' ' ILE . 58.4 tptt -68.53 -26.3 65.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.65 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.5 t -98.57 -81.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.786 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -177.54 102.16 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -165.01 -66.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.0 pt -113.86 178.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.527 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 164' ' ' VAL . 9.8 m-20 -112.53 -174.82 2.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 64.8 m -57.99 -51.96 77.93 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.727 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.6 Cg_endo -59.09 -28.65 88.41 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.919 1.746 . . . . 0.0 111.725 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.71 -40.01 65.98 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 160' ' ' ASP . 56.9 t -67.75 -44.38 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.778 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.9 mt -63.12 -45.72 97.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.456 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.4 m -66.57 -54.98 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.631 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -54.72 -49.0 71.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.1 t -61.95 -39.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.718 0.294 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.9 t -58.3 -39.45 79.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.334 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.588 ' HA ' HE21 ' A' ' 170' ' ' GLN . 0.1 OUTLIER -84.12 -18.64 36.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.65 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.1 -21.35 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -111.13 26.63 10.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.913 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 0.5 OUTLIER -57.79 112.43 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.06 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 130.84 -30.31 3.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.589 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -120.97 90.08 46.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.394 0.14 . . . . 0.0 110.751 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.95 -6.48 18.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.579 2.186 . . . . 0.0 112.704 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -70.28 -59.83 2.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.6 mm? -56.62 -42.28 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.95 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.8 tpp -57.56 -42.34 82.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.828 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.42 -18.96 72.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.546 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -75.99 -40.4 53.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.616 0.246 . . . . 0.0 111.332 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -65.43 -20.37 66.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 m -62.28 -36.45 82.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -64.13 -49.65 71.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.8 mt -59.57 151.64 60.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.529 ' HG3' ' HG2' ' B' ' 148' ' ' GLU . 18.7 Cg_endo -60.85 122.04 10.62 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.432 2.088 . . . . 0.0 112.099 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.52 -169.84 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.177 1.918 . . . . 0.0 112.384 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.459 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.891 0.377 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.3 t -99.36 112.14 24.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.972 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 70.1 p -96.88 125.97 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -108.53 -164.01 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.67 -173.31 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.981 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 47.0 t -48.46 153.62 0.74 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.195 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.74 -27.11 61.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.841 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.14 74.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.594 ' HA ' HD23 ' A' ' 148' ' ' LEU . 1.1 pp20? -69.54 -29.98 67.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.229 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 47.5 ttp -68.78 -36.0 77.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.42 HG23 ' HG2' ' A' ' 155' ' ' LYS . 85.8 mt -74.99 -52.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.54 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -55.62 -46.06 77.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.975 0.416 . . . . 0.0 110.683 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.1 mm? -63.85 -46.26 85.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.89 -49.94 28.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.179 0.514 . . . . 0.0 109.76 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.76 -32.21 83.45 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.964 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' B' ' 138' ' ' LEU . 24.1 mt -61.38 -55.51 30.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.708 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 126' ' ' ALA . 3.1 mm? -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.1 -26.34 29.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.211 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.95 -38.26 28.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 54.8 m -64.69 -11.29 34.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.082 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -127.43 -12.32 5.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.84 61.14 4.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.639 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.529 ' HG2' ' HG3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -147.93 12.96 1.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.659 0.266 . . . . 0.0 111.257 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -142.75 -88.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.288 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.766 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.1 OUTLIER -114.43 -34.73 0.1 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.766 ' HD3' HG23 ' B' ' 150' ' ' THR . 83.1 Cg_exo -49.21 -55.11 4.46 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.825 1.683 . . . . 0.0 112.727 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -121.37 -55.41 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.011 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 31.5 t -65.81 169.34 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.798 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.53 108.58 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -165.99 142.84 5.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 10.8 t 60.09 99.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 53.7 m -86.33 7.92 23.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.548 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 3.1 mm? -76.91 -51.3 2.19 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.649 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 27.9 Cg_endo -61.75 -75.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.134 1.889 . . . . 0.0 112.504 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 45.4 t -163.89 100.82 0.88 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 32.5 m -134.8 -42.3 0.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 45.8 t -90.92 -6.11 54.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 84.5 m -130.6 77.78 75.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.255 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.96 -50.41 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.567 2.178 . . . . 0.0 112.007 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -166.17 65.76 0.96 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.688 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.14 173.11 1.43 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.491 2.128 . . . . 0.0 112.221 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.66 -14.22 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.2 m 58.2 88.2 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.573 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 9.8 p -162.63 142.45 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 48.3 t -151.79 158.37 43.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.771 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -61.43 143.32 56.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.566 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' B' ' 182' ' ' SER . 5.6 m-20 -49.74 105.93 0.57 Allowed Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' B' ' 181' ' ' CYS . 56.3 Cg_endo -93.3 -66.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.839 2.359 . . . . 0.0 112.894 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.44 -157.54 15.38 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.574 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.49 104.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.629 2.219 . . . . 0.0 112.817 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 83.6 p -166.36 21.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.746 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.62 148.24 8.65 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.502 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.69 20.05 4.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.781 0.324 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.42 -75.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.069 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.2 p -165.52 19.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.956 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . 0.561 ' HB2' ' HD3' ' B' ' 173' ' ' PRO . 14.7 p -145.99 108.29 4.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.958 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' B' ' 172' ' ' ASP . 47.6 t -179.37 68.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 51.9 -106.39 0.33 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.908 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 74.4 m -154.12 -42.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.953 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -157.13 -22.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.31 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -99.3 163.74 12.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.782 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.26 168.92 16.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -133.89 130.08 37.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.724 HG22 ' HG ' ' B' ' 142' ' ' LEU . 19.9 t -70.99 -24.85 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.611 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -59.67 -43.52 93.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.634 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.92 -31.6 72.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.103 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.462 ' HB1' HD12 ' B' ' 138' ' ' LEU . . . -62.97 -53.55 52.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.521 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.14 -40.46 85.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.303 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -56.26 -40.93 74.99 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 133' ' ' VAL . 82.1 t80 -65.94 -36.45 83.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.001 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.472 HD22 HD21 ' B' ' 138' ' ' LEU . 28.6 tp -60.9 -44.82 96.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.196 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.78 -39.78 91.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.732 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.82 -47.83 81.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 178' ' ' LEU . 60.7 t -62.22 -47.52 92.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -70.84 -13.58 62.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.4 tp -81.08 -63.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.347 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.703 HE22 HD21 ' A' ' 178' ' ' LEU . 27.6 mt-30 -50.77 -58.39 6.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.533 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -58.0 -68.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.684 0.278 . . . . 0.0 110.796 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.94 -85.55 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.761 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -63.91 -10.61 21.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.666 0.269 . . . . 0.0 111.153 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -119.1 77.44 16.36 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.66 2.06 8.81 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.67 2.247 . . . . 0.0 112.391 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -62.25 -60.37 3.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.9 t -53.66 -35.47 26.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -58.84 -54.75 43.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.83 -39.34 77.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.217 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB3' HD11 ' A' ' 171' ' ' LEU . 28.4 m-20 -62.2 -40.66 96.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.006 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.92 -60.0 3.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -60.05 -34.83 73.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.207 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.84 -48.06 83.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.7 mt -55.83 -50.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.335 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.543 ' HE2' HD12 ' B' ' 141' ' ' LEU . 80.7 mmm -52.47 -44.4 65.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.02 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -63.04 -36.33 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.19 -39.77 95.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.598 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -78.58 -33.03 47.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 155' ' ' LYS . 9.2 tmtt? -64.81 -43.42 93.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.264 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.1 m -78.79 -84.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -176.7 96.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -152.63 -79.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -103.23 -178.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 164' ' ' VAL . 7.4 m-20 -113.72 -179.23 3.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.9 m -53.84 -50.83 81.64 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.46 -39.37 91.73 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.015 1.81 . . . . 0.0 112.04 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.33 84.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.378 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 160' ' ' ASP . 93.3 t -68.48 -45.34 82.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.94 -44.26 97.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.587 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.4 m -67.05 -55.87 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.562 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 30.8 ttm180 -56.96 -43.26 81.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.397 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.28 -34.12 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.355 . . . . 0.0 110.881 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.4 t -64.35 -41.4 96.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 1.3 pp0? -84.19 -18.91 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 146' ' ' ASP . 20.0 tp -63.45 -38.95 93.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -89.59 30.98 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.6 99.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.28 -33.44 1.34 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.147 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -132.7 88.82 37.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.474 0.178 . . . . 0.0 110.714 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.467 ' HA ' HD12 ' A' ' 179' ' ' ILE . 38.0 Cg_exo -60.75 -7.19 7.0 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.599 2.199 . . . . 0.0 112.653 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.65 -55.94 16.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.175 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.703 HD21 HE22 ' A' ' 136' ' ' GLN . 3.2 mm? -59.09 -38.36 79.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.402 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 176' ' ' PRO . 62.6 mt -62.28 -45.35 98.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.818 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.7 tpp -62.8 -34.79 78.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.507 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.45 64.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -66.39 -40.82 89.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -64.81 -18.27 64.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.5 m -74.29 -41.07 61.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.94 -41.02 90.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.593 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.455 HD23 ' OG ' ' B' ' 145' ' ' SER . 85.6 mt -59.91 145.91 83.21 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.686 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 31.5 Cg_exo -59.51 116.06 3.03 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.476 2.118 . . . . 0.0 112.078 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.3 Cg_endo -62.93 139.64 75.0 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.448 2.099 . . . . 0.0 112.495 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.333 179.791 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.683 0.278 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 55.2 m 59.24 -173.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 8.6 t -168.79 -26.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.255 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 30.0 t90 -63.01 -31.89 73.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.004 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.412 ' HB2' ' HG2' ' B' ' 134' ' ' GLU . 2.4 pt? -63.65 134.39 55.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 66.2 m -71.16 -175.59 1.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.56 -39.43 81.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.178 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.84 -24.61 16.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.512 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.551 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -76.07 -57.47 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 23.3 ptp -60.94 -29.01 69.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -75.48 -51.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.414 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.08 -49.34 74.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 110.106 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -60.87 -42.43 97.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.823 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.575 ' HA ' HD21 ' B' ' 142' ' ' LEU . . . -50.0 -44.81 51.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.11 72.63 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.52 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -61.95 -56.58 17.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.724 ' HG ' HG22 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.0 -15.03 58.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.782 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -82.07 -27.22 33.05 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 54.5 ttp -86.18 -40.42 15.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 14.7 m -89.86 85.34 6.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.787 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -133.65 -70.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.432 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.77 79.45 0.21 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 187' ' ' PRO . 11.7 tp10 -83.67 104.98 14.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.948 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 58.18 20.31 6.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.241 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.2 t -132.78 139.57 35.01 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.018 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.76 95.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.401 2.067 . . . . 0.0 112.352 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -160.76 -61.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -92.25 -83.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.71 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 p -175.55 -23.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.686 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.28 109.17 1.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 48.8 m -152.58 168.65 24.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.719 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.8 p -153.27 -25.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.451 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 7.2 mp -73.96 -50.49 5.37 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.326 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 75.7 Cg_endo -76.21 6.04 4.18 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.172 1.914 . . . . 0.0 112.368 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 52.5 m 64.31 113.95 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.216 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 22.5 m -58.53 147.19 32.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 49.8 m -123.79 170.58 10.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.227 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 73.8 m -138.39 80.55 27.27 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.11 -10.92 6.65 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.835 2.357 . . . . 0.0 112.541 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.554 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 20.9 t70 -92.31 -48.36 0.31 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.865 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 6.7 Cg_exo -74.6 22.66 0.39 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.483 2.122 . . . . 0.0 112.854 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.2 -67.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 111.007 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.9 m -153.11 12.1 0.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.76 -71.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.207 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 47.7 t -131.05 -33.91 1.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.65 99.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.39 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' B' ' 173' ' ' PRO . 27.5 t70 57.05 94.97 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.207 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.695 ' HB3' ' H ' ' B' ' 182' ' ' SER . 33.9 Cg_endo -64.59 -27.9 61.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.457 2.105 . . . . 0.0 112.141 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.72 -75.69 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.321 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.0 -169.85 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.66 2.24 . . . . 0.0 112.203 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 60.3 m -94.27 141.15 28.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.15 87.86 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.56 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.53 108.5 3.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.95 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -159.29 -65.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -149.04 173.24 13.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -94.63 139.55 31.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.692 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.695 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 62.2 m -134.91 6.61 3.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.014 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -96.44 84.25 0.82 Allowed Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.562 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 80.9 p -105.03 -2.71 24.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 111.001 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.72 -48.15 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.206 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.842 0.354 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -72.06 -17.18 62.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.753 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.82 103.09 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.965 0.412 . . . . 0.0 110.531 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.746 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.4 tptp -100.11 138.91 36.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.617 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.626 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.9 t -56.77 -27.69 26.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.061 0.457 . . . . 0.0 110.573 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.746 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 42.3 tt0 -57.71 -32.74 67.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.519 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -67.88 -31.88 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.114 0.483 . . . . 0.0 110.014 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -69.63 -44.05 71.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mp -63.12 -44.97 94.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.242 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 90.6 p -57.93 -40.39 80.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 133' ' ' VAL . 48.3 t80 -63.78 -35.3 80.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.497 HD22 HD21 ' B' ' 138' ' ' LEU . 22.3 tp -61.06 -43.66 98.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.803 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.581 ' HA ' HE21 ' A' ' 132' ' ' GLN . 0.0 OUTLIER -58.95 -40.98 86.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.389 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 HD12 ' A' ' 178' ' ' LEU . 97.8 t -64.04 -52.63 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -63.03 -21.59 66.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -52.41 8.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -54.01 -71.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.272 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -59.5 -72.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.786 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.0 0.15 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.9 p -59.56 -15.23 16.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -115.1 80.78 7.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.98 6.99 4.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.525 2.15 . . . . 0.0 112.4 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -74.42 -32.6 62.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.969 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.88 -41.2 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -63.78 -57.38 10.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.44 -41.63 76.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.635 ' HB3' HD21 ' A' ' 171' ' ' LEU . 9.9 t70 -70.06 -28.1 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.066 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.65 -60.1 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.29 -36.51 80.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.6 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -59.47 -45.16 92.41 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.8 mt -56.94 -44.74 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.588 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 90.5 mmm -55.99 -40.16 72.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.261 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 2.4 mmmp? -61.28 -43.34 99.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -56.19 -46.45 79.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -70.56 -23.15 62.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.687 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -86.18 -12.6 49.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 80.7 p -117.05 20.98 13.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.838 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 62.08 94.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 65.6 m -150.38 -62.41 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.725 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.14 168.29 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -97.83 -179.55 4.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.574 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 27.6 m -54.99 -52.06 74.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.1 Cg_endo -56.3 -30.15 79.44 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.073 1.849 . . . . 0.0 111.786 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.74 -35.7 58.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.094 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.89 -45.38 80.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.286 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.78 -38.87 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.7 t -62.24 -58.54 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -58.4 -48.39 80.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.198 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.31 -36.4 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.6 t -62.67 -44.14 97.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.408 . . . . 0.0 109.938 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.08 -12.73 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.376 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 146' ' ' ASP . 14.6 tp -84.29 -33.26 24.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -99.86 14.49 30.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -52.61 105.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.46 -39.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.405 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -124.87 95.93 41.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.459 0.171 . . . . 0.0 110.713 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.3 -21.75 72.65 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.677 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.27 -49.06 77.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.192 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -57.31 -45.88 83.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.717 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -67.32 -29.06 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.3 mtt -69.06 -36.0 77.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.6 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -88.17 -19.32 53.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.271 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -77.95 -44.03 28.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.62 -19.79 62.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.822 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 23.3 m -66.04 -44.36 84.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.066 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -57.68 -47.67 81.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.614 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.58 156.73 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.789 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 32.5 Cg_exo -57.73 155.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.39 2.06 . . . . 0.0 112.243 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.69 157.16 48.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.0 112.311 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.431 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 76.4 p . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.3 t -121.73 -36.21 3.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.075 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 72.5 p -77.91 100.04 6.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.188 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -149.89 -60.17 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.464 ' HB3' ' HG3' ' B' ' 134' ' ' GLU . 72.1 mt -73.45 167.76 20.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.758 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.506 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 39.6 t -63.53 167.0 6.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.775 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -65.32 -51.25 61.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -21.34 6.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.668 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 17.3 mm-40 -67.58 -69.04 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 24.4 ptm -63.76 -25.83 68.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.985 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.26 -53.58 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.588 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -56.97 -48.31 78.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.688 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -59.4 -46.71 87.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.332 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.57 -44.88 47.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.991 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.66 -36.44 93.15 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.079 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' B' ' 138' ' ' LEU . 54.1 mt -62.66 -56.61 16.16 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.915 0.388 . . . . 0.0 111.118 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.626 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -65.75 -23.81 66.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.145 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -84.38 -27.2 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.047 0.451 . . . . 0.0 110.705 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 44.8 ttp -74.87 -42.03 58.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.984 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.544 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 77.9 p -71.02 -39.9 72.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.913 0.387 . . . . 0.0 111.338 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.524 ' HB2' ' HA ' ' B' ' 153' ' ' CYS . 0.2 OUTLIER -134.15 -80.47 0.46 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.364 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' B' ' 146' ' ' GLN . . . 176.51 -63.81 0.1 OUTLIER Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.613 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 59.11 21.93 9.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -67.43 -41.27 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.913 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.1 OUTLIER -167.4 -40.35 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.913 ' HD3' HG23 ' B' ' 150' ' ' THR . 79.6 Cg_endo -84.31 -104.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.701 1.6 . . . . 0.0 112.29 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -177.11 93.39 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' B' ' 146' ' ' GLN . 24.3 t 63.77 11.26 5.74 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -98.21 4.34 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 64.39 -81.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.219 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 75.9 p -143.44 139.05 29.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 44.4 t -147.38 -43.13 0.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.773 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.513 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 95.3 mt -74.44 -51.09 4.46 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.664 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 43.5 Cg_endo -67.73 -57.28 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.978 1.785 . . . . 0.0 112.416 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 47.7 t -162.92 107.29 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 18.3 m -76.78 -22.11 54.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.852 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 45.1 t -60.26 163.3 5.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 82.7 m 56.68 79.52 0.33 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.831 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.99 -60.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.472 2.115 . . . . 0.0 112.225 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -150.25 70.76 9.2 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.662 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.02 155.44 60.78 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.61 2.207 . . . . 0.0 112.271 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.39 6.91 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.056 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 52.6 m 57.65 98.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.064 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.11 79.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.663 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 60.7 m -133.41 -15.23 2.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.724 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -138.67 8.04 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -125.48 90.52 50.51 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.151 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.519 ' HG3' ' HB ' ' B' ' 184' ' ' THR . 58.9 Cg_endo -72.42 161.27 44.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.398 2.066 . . . . 0.0 112.163 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.45 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.79 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.96 152.08 24.52 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.531 2.154 . . . . 0.0 112.55 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.7 m 58.19 -178.9 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.365 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -150.7 94.92 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.47 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -93.46 -73.82 0.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 111.01 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -167.94 -37.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -138.53 153.07 48.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.757 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 17.2 p 44.57 27.68 0.26 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.656 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 47.6 t -165.68 108.28 0.79 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 59.99 63.14 5.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.313 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . 0.519 ' HB ' ' HG3' ' B' ' 173' ' ' PRO . 60.8 m -109.48 -34.91 6.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 111.282 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -138.47 6.97 2.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.081 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.306 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.662 0.268 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 55.69 30.39 15.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.729 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 121' ' ' LEU . 0.4 OUTLIER 61.05 97.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.645 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 123' ' ' VAL . 48.7 tptt -132.27 166.96 20.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.607 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.593 HG22 ' HG ' ' B' ' 142' ' ' LEU . 25.3 t -68.65 -36.75 75.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.96 -28.87 64.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.073 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -66.54 -44.19 83.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -62.04 -34.04 75.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.279 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.31 -43.02 95.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.371 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -57.68 -39.28 76.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -69.0 -30.58 69.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.781 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.471 HD13 HD21 ' B' ' 138' ' ' LEU . 34.0 tp -65.6 -40.94 93.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.048 0.452 . . . . 0.0 110.001 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.43 -40.34 81.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.235 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -57.63 -46.86 83.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.44 -46.71 94.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.774 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -60.53 -26.62 67.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.681 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.6 tp -76.8 -62.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -51.21 -50.32 59.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.507 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -89.39 41.62 1.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.324 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.07 -20.06 70.57 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.512 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 t -97.34 -10.74 25.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.887 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -130.35 78.94 73.47 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.803 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.66 -13.75 39.83 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.428 2.085 . . . . 0.0 112.227 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -61.84 -52.06 65.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.016 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.65 -38.0 33.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.62 -54.28 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.818 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -59.79 -42.98 94.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.378 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -61.53 -36.19 79.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.339 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -66.18 -59.44 3.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' B' ' 134' ' ' GLU . 8.2 mp -60.66 -30.11 69.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.974 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -63.33 -50.22 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -55.63 -51.5 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.493 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 70.8 mmm -53.01 -44.24 67.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.587 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.502 ' HE2' HD12 ' B' ' 136' ' ' ILE . 44.1 tttm -59.61 -38.19 80.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.664 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.78 -46.68 86.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.2 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -61.24 -42.76 99.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' B' ' 136' ' ' ILE . 60.6 tptt -70.81 -24.5 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.515 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -97.7 19.05 14.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 61.3 93.13 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.3 t -149.76 -68.57 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.4 pt -111.89 171.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 164' ' ' VAL . 5.3 m-20 -96.29 175.48 6.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.582 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 49.5 m -54.31 -51.17 80.19 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.559 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.36 -33.63 96.54 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.085 1.857 . . . . 0.0 111.878 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.94 -36.83 82.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 160' ' ' ASP . 60.6 t -70.33 -45.19 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.82 -39.01 83.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.4 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.2 m -67.91 -55.71 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.041 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -55.18 -47.18 75.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.004 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -61.76 -39.75 84.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.686 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.6 t -59.31 -39.26 82.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.389 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -84.32 -18.1 37.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.884 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.5 tp -77.97 -29.88 50.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.74 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.24 24.05 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -55.8 108.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.92 -41.97 0.8 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.586 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -125.38 103.46 29.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.422 0.153 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.67 -0.14 8.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.075 . . . . 0.0 112.237 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -59.84 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.042 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.7 mm? -58.3 -38.93 78.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.587 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.32 -44.03 94.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.764 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.43 -39.47 83.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.79 66.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.11 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -74.73 -38.38 62.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 110.771 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -70.38 -19.06 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 51.9 m -69.94 -33.48 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.135 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -61.09 -49.95 75.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' B' ' 145' ' ' SER . 62.3 mt -53.84 145.62 30.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.8 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.95 141.11 79.12 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.377 2.051 . . . . 0.0 112.209 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.7 145.65 58.9 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.42 2.08 . . . . 0.0 112.17 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.512 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.768 0.318 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 78.6 p -84.43 177.89 7.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 5.7 t -90.4 -38.43 13.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 20.4 t90 58.04 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.8 mt -92.27 176.31 6.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.971 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 134' ' ' GLU . 45.7 t -59.71 154.02 18.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.725 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.41 -30.52 60.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.162 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.4 84.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.48 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -69.28 -28.33 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.812 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -35.7 72.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.502 HD12 ' HE2' ' A' ' 152' ' ' LYS . 73.0 mt -76.28 -50.35 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -56.55 -50.38 72.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.113 0.482 . . . . 0.0 110.197 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.585 HD13 HD13 ' B' ' 141' ' ' LEU . 4.2 mm? -62.25 -41.98 98.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.094 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.93 -47.73 43.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.92 -39.82 98.51 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.942 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.585 HD13 HD13 ' B' ' 138' ' ' LEU . 0.3 OUTLIER -56.09 -56.15 24.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.593 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -65.28 -24.78 67.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.478 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -77.27 -26.66 52.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 110.051 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 30.0 mtm -75.64 -38.57 58.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.929 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 73.4 p -118.69 106.33 12.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.835 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' B' ' 147' ' ' GLY . 3.0 pt20 -132.49 -83.83 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.409 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.475 ' H ' ' HG3' ' B' ' 146' ' ' GLN . . . -145.98 -111.9 0.73 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.647 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -108.98 -74.19 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.616 0.246 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' B' ' 149' ' ' GLN . 1.7 mp0 -127.58 -71.35 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 110.772 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.2 t -65.14 145.07 99.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.05 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.2 149.93 11.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.601 2.201 . . . . 0.0 112.564 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.93 47.51 14.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.899 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' B' ' 147' ' ' GLY . 77.6 m 58.53 -174.48 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.091 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.73 109.94 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.045 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -152.29 -43.45 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.175 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 57.0 m 64.38 115.1 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.313 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 49.5 m -142.1 -39.26 0.37 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.656 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.544 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 3.6 mm? -71.46 -49.9 11.22 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.309 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 46.2 Cg_endo -68.83 -53.73 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.131 1.888 . . . . 0.0 112.372 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 45.8 t -161.41 112.63 1.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.145 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 5.9 m -87.56 141.64 28.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.612 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 83.9 p -113.24 158.37 20.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.132 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 65.2 m 56.31 87.31 0.14 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.113 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.31 -62.0 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.562 2.174 . . . . 0.0 112.334 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.548 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 20.8 t70 -97.64 -48.79 0.23 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.808 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 52.7 Cg_exo -55.47 131.64 47.41 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.085 1.857 . . . . 0.0 112.426 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 165' ' ' ASP . 40.7 t -134.66 -56.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 65.0 m -153.97 30.91 0.45 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.492 ' HA ' ' H ' ' B' ' 181' ' ' CYS . 47.6 t -68.67 143.91 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.001 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.609 ' H ' ' HA ' ' B' ' 181' ' ' CYS . 32.9 t 58.96 25.69 14.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.18 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -81.85 -55.34 4.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -166.85 64.71 0.79 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.339 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.61 ' HB3' ' H ' ' B' ' 183' ' ' GLY . 8.8 Cg_endo -50.57 -72.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.829 2.353 . . . . 0.0 112.594 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 55.66 -139.77 41.93 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.481 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.35 113.66 3.38 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.445 2.097 . . . . 0.0 112.219 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 95.5 p 51.21 -166.4 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.208 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -170.82 -169.27 33.67 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.458 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -112.43 -68.78 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -154.27 -2.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.756 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.9 p -117.62 -159.17 0.73 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.8 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . 0.609 ' HA ' ' H ' ' B' ' 170' ' ' SER . 76.3 m 61.61 -173.51 0.14 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.7 m -100.06 -12.99 19.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . 0.61 ' H ' ' HB3' ' B' ' 173' ' ' PRO . . . -111.22 117.53 4.57 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.541 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 73.4 p -139.95 1.48 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 111.271 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.86 -69.98 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.015 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.342 179.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.832 0.349 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -105.59 123.06 47.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -80.66 107.43 13.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.489 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -133.98 155.92 49.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.608 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.598 HG22 ' HG ' ' B' ' 142' ' ' LEU . 22.4 t -76.22 -44.6 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.674 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.41 -27.29 64.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.752 0.311 . . . . 0.0 110.458 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -66.52 -41.13 89.26 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -64.57 -34.84 79.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.263 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.54 -46.26 86.78 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.464 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -56.78 -37.17 70.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.425 ' O ' HG23 ' A' ' 133' ' ' VAL . 78.8 t80 -69.51 -31.87 70.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.858 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.468 HD22 HD21 ' B' ' 138' ' ' LEU . 44.2 tp -62.46 -52.25 64.27 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.6 -34.9 76.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.646 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -56.91 -45.42 82.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.896 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 HD12 ' A' ' 178' ' ' LEU . 96.0 t -63.34 -47.28 92.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.517 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 139' ' ' SER . 87.2 tttt -64.54 -19.71 65.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.11 -39.15 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.461 ' HG3' HD21 ' A' ' 178' ' ' LEU . 30.8 mm-40 -70.36 -67.26 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.441 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.445 ' HB3' HE21 ' A' ' 140' ' ' GLN . 96.4 m-85 -56.81 -34.75 68.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.38 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.58 47.49 2.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.611 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.478 ' HA ' ' HG3' ' A' ' 134' ' ' LYS . 46.8 m 60.84 18.18 8.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.472 0.177 . . . . 0.0 111.323 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 137' ' ' PHE . 40.5 mt-30 -54.56 109.11 1.37 Allowed Pre-proline 0 CA--C 1.529 0.162 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.755 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 140' ' ' GLN . 14.1 Cg_exo -69.4 2.89 2.94 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.742 2.295 . . . . 0.0 112.555 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -84.2 -52.88 5.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.177 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.8 t -86.76 -35.83 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.232 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -59.62 -59.05 6.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.984 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -56.51 -45.27 81.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -33.75 75.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -66.87 -60.02 3.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.3 -34.93 76.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.25 -51.45 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.492 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.439 HD12 HD22 ' A' ' 171' ' ' LEU . 8.0 mt -55.09 -47.47 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.362 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.615 ' HE2' HD12 ' B' ' 141' ' ' LEU . 79.6 mmm -52.83 -42.62 65.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.927 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.402 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.55 -35.32 72.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.131 0.491 . . . . 0.0 109.779 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -78.88 -38.83 36.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.568 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HG2' HG23 ' B' ' 136' ' ' ILE . 59.0 tptt -65.6 -24.33 67.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.691 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.7 t -103.22 8.95 38.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.141 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 62.51 106.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.85 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.2 m -158.21 -53.58 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.423 HD11 HG23 ' A' ' 150' ' ' ILE . 36.5 pt -113.59 15.37 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 164' ' ' VAL . 6.8 m-20 50.5 -165.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.587 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 88.2 m -76.37 -51.58 2.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.923 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 161' ' ' THR . 9.9 Cg_endo -53.21 -35.0 71.94 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.166 1.911 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.04 87.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 160' ' ' ASP . 57.9 t -70.95 -45.27 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.079 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.11 -44.44 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.223 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.8 p -65.94 -58.84 4.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.437 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.528 ' HA ' HE21 ' A' ' 170' ' ' GLN . 95.3 mtt180 -54.22 -54.38 40.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.481 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.66 -37.57 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.647 0.261 . . . . 0.0 110.975 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -57.65 -47.78 81.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.841 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.528 HE21 ' HA ' ' A' ' 167' ' ' ARG . 30.0 pt20 -83.77 -11.73 56.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 150' ' ' ILE . 21.5 tp -78.87 -18.74 53.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.192 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -109.58 30.96 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.252 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -60.51 112.45 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.816 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 141.53 -47.07 0.86 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -117.81 94.97 47.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.421 0.153 . . . . 0.0 110.947 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.35 -4.76 14.4 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.424 2.083 . . . . 0.0 112.382 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.35 -57.02 5.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -57.61 -38.19 74.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.741 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -68.42 -38.42 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.4 ttm -63.15 -46.0 89.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.762 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.49 -30.97 63.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.318 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -40.06 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.29 -21.82 66.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.2 m -70.05 -33.62 72.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -66.0 -50.31 64.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.704 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.435 ' HA ' ' HB3' ' B' ' 145' ' ' SER . 90.2 mt -51.18 143.84 16.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 53.1 Cg_exo -56.43 111.92 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.474 2.116 . . . . 0.0 112.016 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.3 Cg_endo -62.49 150.26 88.1 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.42 2.08 . . . . 0.0 112.36 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.32 -1.267 . . . . 0.0 112.511 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 78.8 p -95.24 -44.72 7.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 68.1 p -116.5 132.0 56.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.043 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -160.87 -53.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 tp -73.14 147.78 44.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HG2' ' B' ' 134' ' ' GLU . 66.8 m -64.62 167.01 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.241 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -75.44 -47.88 25.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.278 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.81 19.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.63 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.587 ' HG2' ' HB2' ' B' ' 131' ' ' SER . 19.6 mm-40 -71.12 -57.08 4.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 66.1 mtm -63.51 -23.98 67.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.479 HG23 ' HG2' ' A' ' 155' ' ' LYS . 84.2 mt -75.47 -51.3 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.651 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.44 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -57.34 -50.12 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.055 0.455 . . . . 0.0 110.077 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.566 HD13 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -60.67 -40.82 93.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.27 -45.58 62.13 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.15 -34.74 90.48 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.63 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.615 HD12 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -59.28 -56.09 26.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.989 0.423 . . . . 0.0 110.74 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.598 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -70.16 -21.13 63.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -82.16 -26.59 33.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 49.3 ttp -81.72 -38.63 25.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.678 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 186' ' ' LEU . 68.0 p -119.72 95.86 4.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.74 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -138.39 -52.25 0.59 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.342 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' B' ' 153' ' ' CYS . . . 59.18 21.69 53.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.758 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.1 3.39 8.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.907 0.384 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.65 ' O ' HG22 ' B' ' 150' ' ' THR . 8.6 tt0 -152.52 131.8 12.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.534 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.65 HG22 ' O ' ' B' ' 149' ' ' GLN . 0.7 OUTLIER 57.3 147.7 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 123.727 0.642 . . . . 0.0 111.63 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' B' ' 155' ' ' ALA . 3.5 Cg_endo -46.91 112.67 0.53 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.848 2.365 . . . . 0.0 112.984 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -155.21 -81.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.76 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . 0.55 ' HB3' ' HA3' ' B' ' 147' ' ' GLY . 52.6 t -87.86 -74.21 0.46 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 31.3 m -79.22 -20.37 12.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.206 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' B' ' 151' ' ' PRO . . . 60.22 -171.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.146 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.9 m -68.53 172.35 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' B' ' 161' ' ' THR . 48.0 t -156.35 -5.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.77 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.702 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 89.4 mt -111.37 -53.31 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.51 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.702 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 60.2 Cg_endo -72.81 -62.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.966 1.777 . . . . 0.0 112.527 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.43 ' H ' ' HG2' ' B' ' 159' ' ' PRO . 79.5 p -92.99 -54.62 3.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.992 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.669 HG22 ' H ' ' B' ' 163' ' ' CYS . 7.2 m 66.23 146.33 0.04 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.184 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 47.7 t -93.78 -18.42 22.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.872 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . 0.669 ' H ' HG22 ' B' ' 161' ' ' THR . 12.6 p -158.65 86.92 2.32 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.48 -44.21 3.47 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.295 1.997 . . . . 0.0 111.854 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -160.48 68.64 2.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.561 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.424 ' HG3' ' HB2' ' B' ' 163' ' ' CYS . 53.9 Cg_endo -69.18 171.6 13.55 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.547 2.165 . . . . 0.0 112.345 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 61.8 t -143.36 97.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.316 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 38.4 t 59.33 18.09 6.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.218 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 66.1 t 61.61 94.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.103 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 45.5 t -166.02 -77.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.54 -88.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.255 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -166.34 94.68 0.76 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.028 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.75 -171.95 0.62 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.449 2.099 . . . . 0.0 112.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -83.64 172.64 50.52 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.827 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.57 114.07 3.63 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.74 2.293 . . . . 0.0 112.385 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 33.1 t 60.25 176.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.051 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 99.2 -10.34 61.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 56.85 97.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.894 0.378 . . . . 0.0 111.411 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -161.18 141.65 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.83 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -94.34 113.04 24.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 51.8 t 59.57 -88.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.071 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 43.5 t 59.62 -83.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.272 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 102.45 157.76 25.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 51.3 p -138.1 -49.77 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.352 . . . . 0.0 111.12 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -95.39 5.28 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.042 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.189 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.736 0.303 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -93.85 -18.12 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.15 119.99 23.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -138.96 148.51 43.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.585 HG22 ' HG ' ' B' ' 142' ' ' LEU . 36.0 t -63.42 -46.91 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.301 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -56.9 -31.48 64.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.468 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.3 -39.49 92.58 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.03 -38.7 92.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.609 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.25 -43.21 99.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.17 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -58.81 -40.54 84.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -62.85 -36.15 82.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.994 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.474 HD22 HD21 ' B' ' 138' ' ' LEU . 40.8 tp -62.67 -46.8 86.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.142 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.59 -35.19 78.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.139 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.551 ' HA ' HE21 ' A' ' 132' ' ' GLN . 0.0 OUTLIER -62.38 -43.06 99.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.245 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.65 -38.42 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.683 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -67.09 -33.5 75.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.721 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -71.21 -51.03 27.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.391 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.61 -67.42 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.559 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -78.51 76.26 5.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.634 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.26 -54.93 2.45 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.37 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.4 m -78.33 7.95 5.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.935 0.398 . . . . 0.0 110.506 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.478 HE21 ' HB2' ' A' ' 142' ' ' GLN . 53.1 tp60 -120.55 72.77 21.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.562 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.2 -7.94 21.27 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.561 2.174 . . . . 0.0 112.233 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.478 ' HB2' HE21 ' A' ' 140' ' ' GLN . 80.7 mt-30 -68.9 -59.37 3.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.885 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.22 -37.64 23.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.555 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.15 -59.43 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -58.63 -40.28 82.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.488 ' HB3' HD11 ' A' ' 171' ' ' LEU . 10.2 m-20 -64.85 -34.78 79.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.01 -60.37 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.231 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.45 -40.55 94.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.299 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.46 -47.49 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 109.671 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mt -56.17 -45.93 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.065 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.6 mmm -55.23 -40.33 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.764 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.25 -36.38 82.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.23 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.75 -42.69 97.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.043 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.19 -23.14 41.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.345 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -69.5 -56.27 7.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.8 m -73.47 -83.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.7 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -175.6 102.37 0.08 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.8 m -156.05 -77.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.8 pt -107.24 171.35 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.249 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -101.28 -176.34 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.596 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 30.6 m -57.08 -50.54 87.61 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.0 Cg_exo -53.61 -32.89 66.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.037 1.824 . . . . 0.0 112.065 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.73 -35.99 66.7 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.239 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.13 -45.22 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 165' ' ' ILE . 1.9 mp -65.86 -44.7 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.15 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.0 m -61.7 -55.96 24.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.385 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -57.55 -55.6 32.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.323 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.34 -33.21 30.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -64.33 -49.84 70.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.661 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -78.5 -11.63 59.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 146' ' ' ASP . 3.4 tp -74.82 -45.45 43.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -91.21 27.81 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.987 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.57 104.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.53 -44.18 0.73 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.436 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -117.37 98.37 51.78 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.413 0.149 . . . . 0.0 110.803 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.15 -9.41 26.25 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.385 2.057 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.46 -56.99 9.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -57.64 -42.01 82.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.663 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.13 -37.79 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.5 ttm -64.6 -43.65 93.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.721 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.31 -23.37 75.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.504 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.09 -46.64 33.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 111.037 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.99 -23.14 63.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 79.4 m -66.36 -35.78 81.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -59.41 -43.55 92.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.31 150.43 79.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 24.7 Cg_exo -62.85 124.19 13.62 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.432 2.088 . . . . 0.0 112.012 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.42 151.65 66.92 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.338 2.026 . . . . 0.0 112.414 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.38 -1.234 . . . . 0.0 112.462 -179.907 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.731 0.3 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.1 t -102.31 127.66 49.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 61.7 p -106.98 146.12 31.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.309 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -122.52 -24.62 4.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.731 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.99 177.4 4.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -87.73 150.28 23.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.705 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.02 -34.78 75.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.78 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.28 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.443 ' O ' HD23 ' B' ' 138' ' ' LEU . 43.5 mt-10 -74.75 -42.05 58.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.16 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtm -66.21 -32.75 74.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.081 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.3 mt -75.19 -53.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.16 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.465 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.64 -48.85 74.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.474 HD21 HD22 ' A' ' 130' ' ' LEU . 4.3 mm? -63.09 -39.89 96.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.45 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.64 -51.97 44.0 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.33 -29.25 74.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.919 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.471 HD13 HD13 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -61.16 -56.65 18.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.974 0.416 . . . . 0.0 110.798 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.585 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -73.67 -19.71 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.683 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -80.11 -26.67 39.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.278 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 53.4 ttp -84.02 -41.38 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.798 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 46.4 m -79.46 81.7 5.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.204 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -137.88 -69.08 0.45 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.145 0.498 . . . . 0.0 110.174 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.65 98.96 2.31 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.418 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -108.24 -63.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.747 0.308 . . . . 0.0 111.06 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.567 ' HG2' ' H ' ' B' ' 150' ' ' THR . 10.0 tt0 -94.54 -179.7 4.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.591 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.769 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.1 OUTLIER -62.31 -43.31 84.85 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.769 ' HD3' HG23 ' B' ' 150' ' ' THR . 41.7 Cg_endo -66.15 -68.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.729 1.619 . . . . 0.0 112.223 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . 0.426 ' H ' ' HG2' ' B' ' 151' ' ' PRO . 3.7 p-10 -155.39 -173.73 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.505 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -66.24 86.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.82 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 p -172.08 145.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.18 135.89 40.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.123 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 51.0 m -137.85 162.94 32.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.8 p -130.59 13.21 5.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.667 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 4.3 pp -97.71 -28.32 0.25 Allowed Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 37.1 Cg_endo -66.54 -67.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.378 1.385 . . . . 0.0 112.628 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 55.2 m -147.24 -14.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.167 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 13.0 m -76.4 142.64 41.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 78.1 p -131.52 4.45 4.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.01 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 77.2 m 58.76 78.19 0.36 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.02 -42.12 6.58 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.435 2.09 . . . . 0.0 111.79 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -168.37 72.13 0.84 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.747 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.74 30.59 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.725 2.283 . . . . 0.0 112.719 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 41.8 t -93.15 -65.52 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.988 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t -122.07 -34.28 3.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 39.2 t 65.35 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.334 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 76.0 p -79.86 176.4 9.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.806 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.48 -44.04 12.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -151.66 136.59 10.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.773 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.98 -54.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.267 1.978 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.75 178.28 35.01 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.491 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.52 -52.51 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.549 2.166 . . . . 0.0 112.439 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 79.5 p -113.45 121.86 45.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.994 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 173.89 -153.06 16.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.541 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -82.99 156.65 23.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 111.04 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -80.8 81.26 7.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.808 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 48.2 t -169.49 160.88 9.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 85.9 m -100.82 117.41 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 46.4 t -137.43 -77.84 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 61.18 49.64 75.82 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.46 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 5.3 t -99.24 -29.06 13.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.695 0.283 . . . . 0.0 111.379 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -118.77 -47.79 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.086 -0.959 . . . . 0.0 111.25 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.66 0.267 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 63.37 14.15 7.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.87 -73.07 0.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.471 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 63.41 150.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.57 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.8 t -95.86 -26.0 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.426 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -58.85 -41.56 87.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.547 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.82 -33.06 75.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -65.42 -41.95 93.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.324 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.42 -44.4 94.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.055 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -55.95 -41.58 74.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 133' ' ' VAL . 43.5 t80 -64.46 -36.94 85.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.715 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 148' ' ' LEU . 19.3 tp -59.96 -45.09 93.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.76 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.29 -37.59 87.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.037 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -60.89 -40.86 94.64 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 178' ' ' LEU . 58.2 t -65.21 -52.97 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.039 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 135' ' ' LEU . 7.2 tt -71.96 -57.75 4.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.853 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.455 ' NE2' HD21 ' A' ' 178' ' ' LEU . 48.2 mt-30 -51.94 -60.82 2.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 140' ' ' GLN . 76.0 m-85 -61.23 -67.22 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.63 -85.77 0.06 OUTLIER Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.64 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.6 t -65.38 -7.19 12.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.848 0.356 . . . . 0.0 110.977 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 137' ' ' PHE . 44.7 mt-30 -117.42 75.63 9.03 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.71 -2.5 11.45 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.65 2.234 . . . . 0.0 112.554 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -68.06 -29.14 68.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.978 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.48 -49.8 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.48 -52.53 63.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.668 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.01 -38.81 80.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.684 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.527 ' HB3' HD21 ' A' ' 171' ' ' LEU . 8.8 t70 -65.12 -31.79 73.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.485 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.78 -59.65 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.736 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 130' ' ' LEU . 6.9 mp -63.22 -29.98 71.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.05 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.92 -51.75 66.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 159' ' ' ILE . 10.0 mt -54.54 -48.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.656 ' HE2' HD23 ' B' ' 141' ' ' LEU . 82.4 mmm -53.01 -46.17 68.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.04 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.065 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.05 -37.9 84.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -64.03 -46.4 84.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.334 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HD3' ' HA2' ' B' ' 140' ' ' GLY . 29.2 mmmt -74.6 -17.94 60.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.678 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.1 t -97.63 11.75 35.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.488 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 62.91 99.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.121 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -161.37 -60.52 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.811 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 150' ' ' ILE . 35.5 pt -116.34 153.45 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.157 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.06 -179.89 6.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.596 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 89.6 m -55.18 -50.75 84.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.799 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 161' ' ' THR . 13.9 Cg_endo -55.72 -39.73 89.37 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.184 1.923 . . . . 0.0 112.148 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -63.14 -40.68 99.45 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.25 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.39 -42.93 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.5 mt -62.12 -43.04 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.422 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.9 t -65.32 -55.14 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.619 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.12 -50.22 74.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.88 -43.05 87.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.714 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 87.6 p -60.91 -45.2 95.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.732 0.301 . . . . 0.0 111.018 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -79.82 -11.71 59.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 146' ' ' ASP . 13.9 tp -72.83 -35.0 67.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.653 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -96.52 33.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -52.42 129.8 29.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.007 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.8 -38.1 3.48 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.254 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -112.22 94.85 27.96 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.407 0.146 . . . . 0.0 110.753 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.59 -4.45 15.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.47 2.113 . . . . 0.0 112.657 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -68.08 -49.04 63.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.036 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.611 HD12 HG22 ' A' ' 133' ' ' VAL . 3.2 mm? -66.41 -35.34 80.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.12 -44.11 91.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.8 ttm -67.61 -37.39 82.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.23 -35.5 77.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -76.79 -34.39 57.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.725 0.298 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -64.65 -22.73 67.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.715 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.1 m -71.12 -37.38 72.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.135 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -57.51 -45.9 84.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.2 150.24 32.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 31.6 Cg_endo -64.55 113.3 2.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.349 2.033 . . . . 0.0 112.173 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 28.2 Cg_endo -62.37 155.05 59.71 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.354 2.036 . . . . 0.0 112.258 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.514 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.765 0.317 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 59.6 m -141.15 141.43 34.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 28.2 m -135.18 133.47 39.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.777 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -131.89 -31.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.404 HD12 ' N ' ' B' ' 130' ' ' LEU . 7.7 mp -99.88 147.6 25.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.122 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 43.8 t -79.48 175.63 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.862 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.8 -53.78 35.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.88 -25.35 19.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.43 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 15.7 mm-40 -71.66 -56.27 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.2 mtm -64.02 -25.74 68.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.629 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 99.7 mt -76.19 -53.23 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.429 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -56.54 -50.57 71.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.309 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.526 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 4.6 mm? -58.69 -52.66 64.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.459 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.64 29.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 109.65 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . 0.595 ' HA2' ' HD3' ' A' ' 155' ' ' LYS . . . -67.02 -50.95 42.71 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.876 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.656 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.3 OUTLIER -69.13 -46.26 68.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.229 0.515 . . . . 0.0 111.198 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.591 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.7 mm? -58.59 -33.5 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.993 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -83.99 -31.58 25.43 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.855 0.359 . . . . 0.0 111.011 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 59.1 ttp -73.19 -23.97 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.049 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 64.0 m -86.52 -0.5 56.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.388 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.0 -8.45 5.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.753 0.311 . . . . 0.0 110.981 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.57 115.24 1.09 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.523 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.78 -37.1 86.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.336 . . . . 0.0 110.95 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -141.84 -48.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.554 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 2.7 t -89.65 149.63 42.61 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.711 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.9 -28.54 2.13 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.582 2.188 . . . . 0.0 112.581 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . 0.422 ' O ' HG22 ' B' ' 154' ' ' VAL . 4.5 p30 -132.62 107.96 8.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.484 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 53.0 t -49.85 99.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.353 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.422 HG22 ' O ' ' B' ' 152' ' ' ASN . 35.8 m -144.65 15.19 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.932 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 63.84 100.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.833 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 52.7 m -63.99 153.42 37.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.317 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . 0.569 ' HA ' ' HB ' ' B' ' 161' ' ' THR . 62.2 p -166.95 0.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.817 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.858 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 3.2 mm? -114.21 -52.36 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.308 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.858 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 3.4 Cg_exo -39.14 -74.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.913 2.409 . . . . 0.0 113.433 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 56.9 m -141.41 -1.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.675 0.274 . . . . 0.0 111.489 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.569 ' HB ' ' HA ' ' B' ' 157' ' ' SER . 28.3 m -59.48 -27.67 66.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.932 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 48.7 m -117.18 -168.7 1.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.578 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' B' ' 166' ' ' PRO . 77.3 m -56.32 110.24 2.21 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.816 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.71 -53.64 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.313 2.008 . . . . 0.0 112.474 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.556 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 19.6 t70 -92.73 -48.56 0.3 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.599 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 51.7 Cg_exo -53.86 123.3 13.1 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.028 1.818 . . . . 0.0 112.336 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.18 141.97 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.121 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.1 m -68.97 99.41 1.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 64.4 t -131.14 109.33 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.033 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 71.4 p -105.73 -60.8 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -161.33 1.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.789 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 56.85 85.54 0.19 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.899 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' B' ' 183' ' ' GLY . 73.5 Cg_endo -91.27 -65.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.747 2.298 . . . . 0.0 112.941 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.94 -179.14 33.57 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.547 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.23 123.07 10.99 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.572 2.181 . . . . 0.0 112.198 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 80.6 p -163.76 125.19 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.731 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.8 -127.09 22.09 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.41 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -140.7 14.9 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.647 0.261 . . . . 0.0 111.302 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . 0.491 ' NE2' ' H ' ' B' ' 179' ' ' GLN . 1.7 mp0 -82.84 179.71 7.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.331 . . . . 0.0 110.994 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 76.4 p -85.98 -2.43 58.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.181 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 24.2 p -65.36 111.84 3.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 46.2 t 177.94 113.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.977 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' B' ' 173' ' ' PRO . . . -81.21 131.01 10.09 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.282 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 7.6 t -98.5 -7.75 27.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 111.031 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -140.5 -57.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.937 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.259 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.773 0.321 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -81.15 125.54 30.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.794 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.66 116.27 15.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.674 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -132.45 173.11 11.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.578 HG22 ' HG ' ' B' ' 142' ' ' LEU . 40.0 t -89.99 -35.06 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.32 -34.03 70.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.59 -38.32 86.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 0.0 110.058 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.403 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -65.55 -43.01 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.319 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 123' ' ' VAL . 4.4 mm? -63.15 -34.93 78.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.072 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.3 t -62.56 -48.52 79.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -60.32 -32.0 70.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.692 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.47 HD11 HD21 ' A' ' 148' ' ' LEU . 28.8 tp -61.01 -50.58 72.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.65 -25.81 68.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.536 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -65.11 -41.56 94.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.913 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.1 t -70.2 -45.92 73.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.852 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -57.02 -44.66 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.423 ' O ' HD13 ' A' ' 135' ' ' LEU . 3.3 tm? -69.36 -36.28 76.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -55.83 -70.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.063 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -65.6 -72.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.71 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.49 -76.62 1.49 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.923 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 54.1 m -58.85 -16.62 18.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.602 0.239 . . . . 0.0 111.437 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -116.7 81.29 11.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.79 -12.33 24.17 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.509 2.139 . . . . 0.0 112.027 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -69.67 -40.29 76.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.636 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.4 t -60.12 -56.62 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.27 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -50.86 -53.14 34.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.179 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -54.45 -52.81 60.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.413 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -52.41 -42.05 63.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.399 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -60.12 -56.99 14.81 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.6 mp -63.91 -25.7 68.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -62.95 -49.38 74.98 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.81 -47.78 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.703 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 76.9 mmm -54.04 -37.06 63.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.774 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -71.8 -32.73 67.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.28 -44.0 89.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.876 0.369 . . . . 0.0 110.02 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.25 -42.86 87.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.936 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' B' ' 136' ' ' ILE . 12.1 tmtt? -62.7 -40.14 96.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.167 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 90.5 p -85.85 13.75 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 64.63 102.37 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.195 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -153.1 -64.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.79 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.2 pt -111.9 168.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -90.8 177.08 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.597 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 27.6 m -57.52 -50.94 85.31 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.893 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 52.1 Cg_exo -54.83 -33.12 80.13 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.022 1.814 . . . . 0.0 112.194 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.02 -37.54 83.18 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.25 -45.5 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.97 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.299 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -69.6 -58.31 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.652 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.43 -48.05 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.89 -29.26 69.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.204 0.526 . . . . 0.0 109.758 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -84.09 -18.76 35.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.167 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.29 -43.85 22.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.648 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -93.81 30.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.19 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -58.29 -28.29 64.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.25 -48.53 68.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.628 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -116.87 93.56 41.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.406 0.146 . . . . 0.0 110.772 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.79 -14.65 28.01 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.61 2.206 . . . . 0.0 112.645 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.18 -55.82 29.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -56.28 -33.51 65.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.63 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.53 -48.3 78.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.49 -30.73 73.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -71.22 -36.3 71.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 110.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.06 -16.96 62.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.0 m -71.63 -39.82 70.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.177 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -58.23 -49.56 76.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.991 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.82 151.78 11.16 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.521 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 27.8 Cg_endo -62.73 135.46 52.53 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.333 2.022 . . . . 0.0 112.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 37.4 Cg_exo -59.93 150.6 77.19 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.445 2.097 . . . . 0.0 112.36 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.615 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.78 0.324 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 79.9 p -156.02 -30.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 73.0 p -85.87 -19.73 30.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.063 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -112.29 101.56 9.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.533 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 87.8 mt -109.81 -175.59 2.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.017 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 47.6 t -59.22 155.29 14.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.974 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.73 -42.52 86.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.65 -27.83 66.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.562 ' HA ' HD23 ' A' ' 148' ' ' LEU . 45.2 mt-10 -77.26 -46.13 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.3 ttm -64.52 -36.41 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.021 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 155' ' ' LYS . 86.2 mt -74.23 -53.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.13 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.28 -46.71 69.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.112 0.482 . . . . 0.0 110.257 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -67.31 -35.28 79.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.427 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.82 -53.87 51.41 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.77 73.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.249 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 138' ' ' LEU . 0.8 OUTLIER -64.19 -56.56 13.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.424 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.578 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.6 mm? -70.8 -21.16 62.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.466 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -82.74 -26.5 31.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 58.6 ttp -80.96 -38.99 26.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 60.3 p -60.51 -19.17 56.14 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.013 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -108.21 -69.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.41 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 164.84 -83.75 0.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.524 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.69 -69.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.568 ' HG2' HG22 ' B' ' 150' ' ' THR . 26.1 tt0 -72.16 -58.97 2.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.752 HG23 ' HD3' ' B' ' 151' ' ' PRO . 0.5 OUTLIER -177.69 -36.13 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.752 ' HD3' HG23 ' B' ' 150' ' ' THR . 72.4 Cg_endo -83.88 -165.3 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.631 1.554 . . . . 0.0 112.066 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -64.66 106.88 1.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.675 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 28.9 t 64.19 169.88 0.17 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.779 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 13.3 p -56.13 -23.83 16.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.127 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.49 154.66 28.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.223 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.5 m -130.78 154.64 47.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 79.4 p -146.66 -24.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.501 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 83.4 mt -63.29 -49.92 77.17 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 64.0 Cg_endo -72.83 -152.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.09 1.86 . . . . 0.0 112.222 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 32.8 t -81.53 29.49 0.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 59.5 m 63.01 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.444 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 47.2 t -108.35 134.64 50.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.069 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' B' ' 166' ' ' PRO . 79.2 m 58.56 91.81 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.34 -43.42 1.48 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.304 2.003 . . . . 0.0 112.551 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 14.9 t70 -91.38 -49.37 0.33 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.564 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 33.6 Cg_exo -59.38 114.41 2.02 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.103 1.869 . . . . 0.0 112.289 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.519 HG23 ' H ' ' B' ' 169' ' ' VAL . 34.4 m -93.39 176.21 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 33.6 t -100.94 18.83 18.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.755 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.519 ' H ' HG23 ' B' ' 167' ' ' VAL . 59.2 t -118.49 120.4 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.063 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 35.6 t -105.31 174.07 6.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.778 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.13 174.46 1.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.014 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.52 147.65 98.73 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.723 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.91 -176.46 3.24 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.474 2.116 . . . . 0.0 112.223 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.87 -83.11 1.69 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.158 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.03 137.52 24.22 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.602 2.201 . . . . 0.0 112.3 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.0 t -62.54 114.37 3.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.716 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -149.16 -175.96 22.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.55 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.18 13.03 24.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.878 0.371 . . . . 0.0 110.721 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . 0.418 ' NE2' ' HA2' ' B' ' 183' ' ' GLY . 26.2 mt-30 -80.22 7.16 9.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.026 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 71.1 m 61.03 -85.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.525 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -115.77 153.24 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.237 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 40.5 t 59.52 103.3 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.17 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' B' ' 179' ' ' GLN . . . -109.32 -8.99 26.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.295 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 45.0 m -68.41 111.16 4.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -166.25 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.304 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.765 0.317 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.488 ' N ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -140.7 162.91 34.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 55.97 89.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.537 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 17.3 tppt? -105.86 152.55 23.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.668 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.665 HG22 ' HG ' ' B' ' 142' ' ' LEU . 38.4 t -77.55 -35.35 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.297 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.537 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 35.8 tt0 -56.35 -35.7 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 122' ' ' LYS . 4.4 m-20 -65.3 -39.86 93.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 109.711 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.44 77.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.012 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.59 -51.25 66.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.829 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -55.39 -36.4 66.35 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 133' ' ' VAL . 86.4 t80 -67.98 -32.21 72.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.804 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.516 HD13 HD21 ' B' ' 138' ' ' LEU . 38.1 tp -64.74 -43.16 94.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.887 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.19 -40.52 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.292 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -58.55 -45.94 87.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.601 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 129' ' ' TYR . 92.6 t -63.65 -41.0 91.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.614 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.02 -27.98 69.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.7 tp -71.4 -61.2 1.86 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.739 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -53.84 -50.28 66.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -97.3 72.46 2.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.561 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.62 -60.45 1.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.382 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.5 p -72.9 -5.62 39.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.939 0.4 . . . . 0.0 110.517 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -123.93 86.44 53.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.32 13.51 2.71 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.66 2.24 . . . . 0.0 112.432 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -75.72 -56.3 4.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.04 -44.84 92.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.319 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.21 -57.92 10.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.101 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -55.87 -42.44 75.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.298 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.07 -32.59 73.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -68.8 -59.55 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.2 mp -61.26 -31.12 70.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.195 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -65.12 -52.12 57.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.4 mt -54.08 -45.04 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.559 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 76.2 mmm -55.52 -48.93 73.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.51 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.26 -35.68 67.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.427 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.75 -43.72 92.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.973 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.65 -34.5 78.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.8 tptp -77.22 -27.55 53.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.389 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 18.24 12.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.59 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 62.43 96.92 0.04 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.838 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.2 m -155.59 -46.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.08 178.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -113.37 -173.35 2.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 93.6 m -58.55 -50.01 90.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.658 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.7 Cg_exo -56.58 -32.49 90.32 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.031 1.82 . . . . 0.0 112.037 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.0 -44.19 68.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.55 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.4 t -65.18 -44.36 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.65 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.453 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.8 t -61.2 -58.04 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.578 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -53.19 -56.48 16.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.91 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.4 t -57.65 -34.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.644 0.259 . . . . 0.0 111.321 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.2 t -60.34 -50.4 73.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.835 0.35 . . . . 0.0 110.805 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.11 -11.78 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.45 -38.72 65.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.726 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -97.3 23.72 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.808 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -54.49 106.16 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.63 -32.44 1.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.288 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -129.54 100.84 19.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.413 0.149 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.31 -0.08 9.19 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.413 2.075 . . . . 0.0 112.548 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.36 -58.75 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.5 mm? -60.54 -39.18 86.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.86 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.21 -42.87 93.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.87 76.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -81.42 -33.6 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.826 0.346 . . . . 0.0 111.115 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -63.13 -26.42 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.1 m -67.87 -37.91 82.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.138 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -56.86 -50.85 71.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.59 156.81 15.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 43.2 Cg_endo -66.98 144.81 71.63 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.251 1.967 . . . . 0.0 112.0 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 51.6 Cg_exo -54.48 164.22 3.12 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.398 2.066 . . . . 0.0 112.496 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.374 -1.236 . . . . 0.0 112.468 179.842 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 51.6 m 59.12 18.76 6.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.927 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 34.4 p -117.13 -11.01 10.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.17 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -84.28 -0.34 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.455 HD12 ' N ' ' B' ' 130' ' ' LEU . 6.5 mp -83.49 148.63 27.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 81.5 p -62.47 160.87 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.986 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.1 -36.86 85.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.48 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.471 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.425 ' HA ' HD23 ' A' ' 148' ' ' LEU . 46.2 mt-10 -76.8 -49.99 14.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 58.4 ttp -63.66 -33.33 75.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.5 mt -76.35 -51.75 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.152 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.559 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -57.34 -47.78 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.028 0.442 . . . . 0.0 110.446 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.82 -50.07 73.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.524 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.71 -46.66 40.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.055 0.455 . . . . 0.0 109.96 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.93 -32.95 85.88 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.767 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' B' ' 138' ' ' LEU . 55.8 mt -62.42 -55.01 31.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.308 . . . . 0.0 111.028 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.665 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -68.92 -22.37 64.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -86.32 -26.49 24.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.37 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 161' ' ' THR . 15.7 tmm? -88.21 -24.79 23.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 55.0 m -76.26 -1.23 25.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.545 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -131.31 -30.53 1.71 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.812 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' B' ' 153' ' ' CYS . . . 127.68 -80.78 0.36 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.584 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.549 ' HB2' HG12 ' B' ' 154' ' ' VAL . 38.0 tt0 -131.59 -59.18 0.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -151.78 -89.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.223 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.542 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 4.9 t -102.83 -30.31 0.21 Allowed Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' B' ' 150' ' ' THR . 97.1 Cg_endo -82.58 149.32 14.51 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.594 1.529 . . . . 0.0 112.506 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.49 108.27 0.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.56 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . 0.537 ' HA ' ' HA3' ' B' ' 147' ' ' GLY . 52.0 t 65.44 149.64 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.064 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' B' ' 148' ' ' GLU . 27.4 m -45.32 141.27 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.328 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -153.92 -27.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.285 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.432 ' HB2' ' HG3' ' B' ' 159' ' ' PRO . 46.5 m -86.25 171.15 11.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.984 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 44.2 t -142.79 2.78 1.39 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.674 ' N ' ' CD ' ' B' ' 159' ' ' PRO . 0.0 OUTLIER -122.36 6.69 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' B' ' 158' ' ' LEU . 96.8 Cg_endo -84.19 -42.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 121.611 1.541 . . . . 0.0 112.227 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 75.8 p -162.5 4.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 3.1 m -82.39 11.54 5.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 49.0 m -84.5 17.85 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 13.0 p -106.55 93.25 8.18 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.12 -57.19 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.253 1.968 . . . . 0.0 111.97 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.15 66.35 0.39 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.818 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.93 118.53 5.74 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.38 2.053 . . . . 0.0 112.102 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 30.7 m -123.68 177.97 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.359 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 51.6 m -82.64 135.09 35.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.19 -26.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 63.6 m -153.13 16.42 0.55 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.285 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.88 147.57 52.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.723 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.62 119.83 66.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.93 -179.24 2.85 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.201 1.934 . . . . 0.0 112.217 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -70.31 -160.5 3.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.0 97.95 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.465 2.11 . . . . 0.0 112.226 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 80.4 p -172.39 -173.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.808 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -113.66 -98.38 2.3 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.475 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -97.25 117.37 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.745 0.307 . . . . 0.0 110.77 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -138.36 -79.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.993 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 40.1 t -170.43 -76.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 26.6 p -171.31 130.14 0.73 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 33.2 t 60.35 175.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.302 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -149.42 -26.67 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.224 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 80.6 p -76.3 -4.43 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 111.147 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -142.18 117.43 10.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.178 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -148.17 106.99 3.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.8 tt -128.18 119.0 24.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.722 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -123.0 176.45 6.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.809 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.607 HG22 ' HG ' ' B' ' 142' ' ' LEU . 26.9 t -83.6 -35.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.95 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.88 -27.44 60.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.78 -44.41 81.41 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -66.56 -29.48 69.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.9 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 mt -63.51 -54.96 28.1 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.936 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -55.88 -37.07 68.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 133' ' ' VAL . 84.3 t80 -64.0 -34.22 77.51 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.667 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.725 HD13 HD21 ' B' ' 138' ' ' LEU . 28.6 tp -65.56 -42.43 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -61.86 -38.54 88.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.081 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.93 -52.52 65.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.627 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 129' ' ' TYR . 46.5 t -59.18 -39.2 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -76.86 -17.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tt -75.16 -56.58 4.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.419 ' NE2' HD21 ' A' ' 178' ' ' LEU . 25.0 mt-30 -66.5 -52.5 45.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.11 33.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.189 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.93 4.27 31.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.769 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.6 p -116.41 -6.92 11.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 0.0 110.784 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -132.75 91.32 30.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.3 -11.29 31.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.568 2.179 . . . . 0.0 112.196 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.32 -46.33 73.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.55 -52.49 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.84 -57.43 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -55.8 -32.86 63.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.154 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.63 -52.28 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -56.2 -56.18 24.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' B' ' 134' ' ' GLU . 8.8 mp -58.83 -37.77 77.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.514 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.67 -42.45 88.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 159' ' ' ILE . 13.9 mt -57.18 -49.71 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.027 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.482 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 83.5 mmm -52.76 -42.58 65.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.487 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 10.3 mtmp? -64.55 -35.63 81.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.209 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.0 -33.44 75.42 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -79.4 -28.42 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.861 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 152' ' ' LYS . 27.6 mmtt -71.46 -59.48 2.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.64 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.2 m -63.27 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -179.32 104.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.744 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -165.39 -69.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.197 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 150' ' ' ILE . 40.7 pt -116.23 158.08 16.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.217 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 164' ' ' VAL . 6.2 m-20 -100.86 -172.19 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 84.8 m -52.56 -51.96 68.32 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.265 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.6 Cg_endo -58.56 -38.38 89.96 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.168 1.912 . . . . 0.0 112.35 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.61 -42.21 93.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 168' ' ' VAL . 94.5 t -64.27 -45.44 96.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.761 0.315 . . . . 0.0 111.26 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.38 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.482 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.1 m -62.01 -54.46 41.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.371 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.567 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 164' ' ' VAL . 87.2 t -58.32 -35.7 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 69.0 m -64.82 -39.96 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.55 -13.89 55.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.97 -49.27 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -96.63 25.22 5.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.183 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.42 -26.22 60.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.947 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -65.0 -32.71 85.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.409 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -125.81 102.41 28.63 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 120.369 0.128 . . . . 0.0 110.988 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.34 -3.37 9.86 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.435 2.09 . . . . 0.0 112.375 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.86 -53.78 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -61.15 -35.77 78.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -67.29 -47.97 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.8 ttp -57.46 -42.76 83.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.695 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.27 -32.46 62.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.389 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -67.95 -31.63 71.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 110.574 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -67.35 -23.87 65.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 35.0 m -65.57 -40.68 93.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -57.42 -50.85 71.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.34 146.22 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 23.4 Cg_endo -62.05 114.26 2.23 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.398 2.065 . . . . 0.0 111.977 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 15.6 Cg_endo -57.28 161.16 11.85 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.461 2.107 . . . . 0.0 112.347 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.548 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.826 0.346 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 47.2 t -105.64 -17.09 14.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.749 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 8.3 t -139.98 145.52 37.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . 0.412 ' HB2' ' H ' ' B' ' 130' ' ' LEU . 0.4 OUTLIER -117.72 -159.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.788 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.412 ' H ' ' HB2' ' B' ' 129' ' ' TRP . 54.0 mt -53.44 162.93 0.69 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.284 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.403 ' O ' ' HE2' ' B' ' 135' ' ' MET . 87.1 p -61.96 161.09 11.15 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.866 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' B' ' 135' ' ' MET . 11.1 pt-20 -75.1 -33.47 61.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.509 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.551 ' HA ' HD23 ' A' ' 148' ' ' LEU . 13.0 pt-20 -76.45 -41.59 46.85 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' B' ' 132' ' ' GLU . 22.3 ptp -63.29 -33.31 75.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.0 mt -76.48 -53.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.482 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -53.83 -51.01 64.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.346 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.725 HD21 HD13 ' A' ' 130' ' ' LEU . 3.9 mt -61.62 -43.67 98.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.02 -37.16 52.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.69 -37.58 76.77 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.598 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.584 HD13 ' HA ' ' B' ' 138' ' ' LEU . 1.5 mp -56.84 -56.03 26.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.046 0.45 . . . . 0.0 110.018 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.607 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -68.52 -24.13 64.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.466 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -75.45 -27.5 58.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.194 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . 0.442 ' SD ' HG23 ' A' ' 161' ' ' THR . 12.7 ttm -79.46 -40.42 29.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 80.4 p -60.66 -29.95 69.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -137.47 -126.72 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.763 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.95 27.16 69.31 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.33 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -139.52 117.36 11.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.677 0.275 . . . . 0.0 110.601 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 61.69 -167.68 0.19 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.772 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 2.8 t 37.35 90.82 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.326 0 O-C-N 123.463 0.477 . . . . 0.0 111.854 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -38.21 105.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.879 2.386 . . . . 0.0 113.069 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.7 -67.38 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.664 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 51.5 t -110.04 -17.4 13.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.028 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.07 -88.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.264 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -167.79 110.46 0.63 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.194 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 67.3 m -156.69 158.85 37.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.1 t -159.95 -21.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.626 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.523 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 62.7 tp -81.02 -50.33 0.99 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.666 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 41.6 Cg_endo -66.94 -78.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.912 1.741 . . . . 0.0 112.449 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 66.4 m -160.97 106.83 1.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.811 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -142.72 -61.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 49.1 m -69.82 162.11 28.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 15.6 p -156.8 72.3 4.74 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.39 -44.19 7.01 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.518 2.145 . . . . 0.0 111.794 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -165.96 76.07 1.24 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.674 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.15 123.91 11.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.64 2.227 . . . . 0.0 112.564 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.35 -50.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 40.0 t -163.89 6.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.669 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.634 ' HA ' ' HG3' ' B' ' 173' ' ' PRO . 9.3 p -73.23 145.26 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.033 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 33.8 t 65.63 6.08 3.65 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.146 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.48 -66.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.364 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . 0.615 ' N ' ' HD3' ' B' ' 173' ' ' PRO . 4.9 p-10 -166.55 43.67 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.627 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.634 ' HG3' ' HA ' ' B' ' 169' ' ' VAL . 43.0 Cg_endo -92.36 -176.43 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.497 2.132 . . . . 0.0 112.75 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.58 -69.08 0.45 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.464 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.06 -45.23 24.75 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.712 2.275 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 53.1 m -70.71 131.07 43.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 92.74 -163.94 27.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.605 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -148.94 -51.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.918 0.39 . . . . 0.0 110.696 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -107.54 -61.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.731 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 58.0 m -72.73 83.11 1.16 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.073 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 20.1 p -175.7 154.24 1.54 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.726 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.9 m -105.32 -76.37 0.61 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.627 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 118.81 -152.55 17.3 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.473 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 82.4 p -97.2 -49.73 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.738 0.304 . . . . 0.0 111.434 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -123.69 -61.41 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.03 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.296 -179.889 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.717 0.294 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -93.55 6.9 46.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.51 98.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.598 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -95.52 168.37 10.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.256 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.672 HG22 ' HG ' ' B' ' 142' ' ' LEU . 41.8 t -95.11 -27.65 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.77 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -59.58 -35.35 74.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -68.33 -39.03 82.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.923 0.392 . . . . 0.0 110.539 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -63.99 -44.72 91.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.487 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.479 HD23 HG12 ' A' ' 123' ' ' VAL . 4.5 mm? -61.55 -40.79 95.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.174 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -58.96 -42.16 89.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.8 -40.56 93.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.852 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.451 HD22 HD21 ' B' ' 138' ' ' LEU . 26.2 tp -59.47 -41.56 90.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.191 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.47 -43.09 99.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.56 -41.19 85.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.26 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.93 -46.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.866 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -64.61 -25.55 68.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -72.73 -59.54 2.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.177 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -61.87 -56.37 20.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -83.71 30.56 0.49 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.336 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.0 -25.08 69.12 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.866 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -87.81 -22.22 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.05 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.91 98.12 45.44 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.26 13.58 2.18 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.451 2.101 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -75.01 -61.57 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.65 -37.27 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.278 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -65.23 -57.66 7.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -56.43 -35.51 67.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.142 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.57 -36.48 73.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.014 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -64.58 -58.36 6.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.971 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.8 mp -60.39 -42.72 96.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.76 -44.86 74.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.117 0.484 . . . . 0.0 109.714 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.06 -47.95 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.235 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.454 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -54.96 -42.41 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.548 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -61.72 -39.64 92.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.262 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.11 -39.74 91.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.066 0.46 . . . . 0.0 109.874 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.81 -21.7 57.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.878 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -86.31 -22.87 26.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.63 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 62.7 m -104.01 16.35 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 61.43 93.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.984 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.8 m -147.6 -61.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.668 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 pt -114.54 155.07 15.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.407 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 1.1 p30 -83.17 171.75 13.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.621 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 63.5 m -53.67 -51.57 75.14 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.624 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 51.6 Cg_exo -53.03 -32.16 57.08 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.923 1.749 . . . . 0.0 111.896 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.09 62.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.207 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.4 t -66.93 -43.81 89.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.739 0.304 . . . . 0.0 110.813 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -66.1 -43.61 92.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.171 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.1 p -65.42 -54.06 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.375 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.524 ' HA ' HE21 ' A' ' 170' ' ' GLN . 74.1 mtp180 -55.78 -51.26 68.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.309 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.76 -36.16 69.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 t -59.39 -45.74 90.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.524 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.524 HE21 ' HA ' ' A' ' 167' ' ' ARG . 28.0 pt20 -84.09 -11.58 56.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.6 tp -75.96 -26.34 56.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -109.29 30.48 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.57 118.28 4.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.06 -54.84 0.77 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.198 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -109.03 95.72 18.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.76 0.88 4.32 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.506 2.137 . . . . 0.0 112.643 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.72 -56.02 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.006 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.9 mm? -58.52 -37.7 76.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.7 mt -71.07 -37.78 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.2 ttp -63.74 -38.64 91.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.13 -28.62 40.38 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.649 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -68.99 -40.98 78.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.435 HD22 HD12 ' A' ' 186' ' ' LEU . 3.7 t-20 -63.8 -21.27 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 m -66.38 -39.96 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.309 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -60.7 -40.37 91.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.435 HD12 HD22 ' A' ' 183' ' ' ASN . 79.1 mt -58.26 152.0 44.68 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.614 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 29.1 Cg_endo -63.63 111.12 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.313 2.009 . . . . 0.0 112.091 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 29.2 Cg_endo -62.87 145.26 94.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.339 2.026 . . . . 0.0 112.188 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.396 -1.224 . . . . 0.0 112.546 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.782 0.325 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 74.9 p -94.81 116.35 28.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.785 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 67.5 p -65.2 116.03 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -74.73 -3.97 34.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.786 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.457 HD12 ' N ' ' B' ' 130' ' ' LEU . 7.2 mp -91.38 173.95 7.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.64 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 59.4 m -93.35 164.35 13.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.724 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.47 -36.56 63.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.783 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.1 -28.74 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -73.89 -42.87 60.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.6 tpp -65.44 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.41 -52.28 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.48 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -52.47 -47.0 66.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.091 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 130' ' ' LEU . 4.2 mm? -64.74 -38.72 91.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.276 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.39 -46.76 62.95 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.31 -31.42 71.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.584 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.48 HD12 ' O ' ' B' ' 137' ' ' ALA . 0.1 OUTLIER -59.02 -54.95 41.29 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 110.399 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.672 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -73.51 -21.63 60.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.83 -26.3 49.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.356 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 53.8 ttp -87.51 -34.75 18.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m -60.3 -17.29 41.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.689 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -127.03 -17.56 4.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.015 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -102.08 50.95 0.92 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.523 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -118.57 125.11 49.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.738 0.304 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.65 ' O ' HG22 ' B' ' 150' ' ' THR . 54.5 tt0 63.03 169.74 0.14 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.838 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.65 HG22 ' O ' ' B' ' 149' ' ' GLN . 0.7 OUTLIER 58.56 146.68 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 123.289 0.635 . . . . 0.0 111.857 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.1 114.22 1.63 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.379 2.053 . . . . 0.0 112.133 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -157.66 -81.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.804 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 29.8 t -152.44 20.96 0.63 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.221 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.52 -27.36 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.903 0.382 . . . . 0.0 111.102 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -163.7 106.63 0.97 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.252 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 49.7 m -133.13 112.13 11.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.719 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 81.1 p -135.85 -7.21 2.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.786 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.501 ' HB3' ' HD3' ' B' ' 159' ' ' PRO . 47.6 tp -86.27 -49.54 0.51 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.307 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' B' ' 158' ' ' LEU . 91.4 Cg_endo -78.86 -1.38 11.55 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.143 1.895 . . . . 0.0 112.064 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 47.4 t 56.98 93.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.959 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 56.7 m -88.37 -51.22 5.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.14 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 59.1 m -119.68 -71.26 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 69.1 m 55.03 73.88 0.81 Allowed Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.47 31.75 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.598 2.199 . . . . 0.0 112.112 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 23.9 t70 58.69 72.36 0.85 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.603 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.81 142.95 84.76 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.583 2.188 . . . . 0.0 112.339 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 47.9 t -74.13 144.85 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 59.2 m -58.76 114.06 2.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.91 -27.65 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 45.0 t -106.31 153.54 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.941 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -100.16 -29.12 12.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.767 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -144.74 92.33 5.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.582 ' HB3' ' H ' ' B' ' 182' ' ' SER . 57.5 Cg_endo -70.49 -42.42 2.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.126 . . . . 0.0 112.142 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.39 -159.99 10.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.447 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.12 173.34 11.44 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.527 2.151 . . . . 0.0 112.311 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.0 t -71.42 103.76 3.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -175.32 -7.09 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.345 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -144.28 173.54 11.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -118.1 166.23 12.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 70.3 m 58.08 -176.1 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.135 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 27.2 p -90.05 145.04 25.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.582 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 47.0 t -158.3 3.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -88.56 -47.4 4.3 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.394 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 35.5 p 49.11 -89.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 122.518 0.327 . . . . 0.0 111.786 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -122.9 -50.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.746 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.399 -0.81 . . . . 0.0 111.202 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 121' ' ' LEU . 16.0 ptm180 -154.75 -10.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.975 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.416 ' H ' ' H ' ' A' ' 120' ' ' ARG . 5.5 tt 63.44 109.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.62 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -113.48 145.48 41.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.265 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.671 HG22 ' HG ' ' B' ' 142' ' ' LEU . 48.7 t -64.03 -31.98 55.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.519 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -56.98 -35.87 69.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.17 -37.83 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.11 86.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.119 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.91 -49.3 73.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -55.06 -36.61 65.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 133' ' ' VAL . 64.9 t80 -67.68 -33.55 75.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.83 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.5 tp -62.3 -48.62 79.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.024 0.44 . . . . 0.0 110.041 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.54 -38.54 91.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 132' ' ' GLN . 7.9 tt0 -57.97 -44.78 87.29 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 110.296 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.537 HG22 HD12 ' A' ' 178' ' ' LEU . 89.2 t -61.88 -48.11 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -68.22 -15.93 63.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.56 -54.87 6.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.48 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.8 mm100 -52.0 -65.49 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.435 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -61.91 -64.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.816 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.57 -87.19 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.735 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.7 m -64.72 -9.33 19.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 111.037 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 142' ' ' GLN . 55.7 tp60 -119.01 77.52 15.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.541 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.0 4.56 6.88 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.643 2.228 . . . . 0.0 112.54 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.471 ' HB3' HE21 ' A' ' 140' ' ' GLN . 22.5 tm0? -62.21 -38.9 90.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.705 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t -72.34 -39.03 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.121 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.26 -55.28 36.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.048 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -54.94 -42.0 71.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.22 -32.04 73.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.201 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.18 -60.53 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.077 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -61.86 -38.75 89.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.004 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.18 -46.14 83.08 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.535 HD12 HD22 ' A' ' 171' ' ' LEU . 3.2 mt -56.99 -45.49 83.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.855 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.566 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 77.4 mmm -55.03 -40.19 69.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.658 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.35 -37.77 88.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.218 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.06 -39.88 93.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.06 0.457 . . . . 0.0 109.856 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.4 -37.46 63.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.818 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HG2' HG23 ' B' ' 136' ' ' ILE . 22.0 tptm -65.93 -27.44 68.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.383 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 92.7 p -102.33 -154.76 0.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.905 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -102.89 87.61 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.812 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.4 t -148.56 -70.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.3 pt -124.57 167.21 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.677 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.3 -170.49 1.67 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.633 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 56.8 m -53.58 -52.31 68.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.745 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 161' ' ' THR . 10.1 Cg_endo -53.25 -36.39 77.73 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.033 1.822 . . . . 0.0 111.883 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.05 -38.59 88.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.13 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.42 -45.2 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.23 -49.0 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.43 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -62.66 -59.24 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.717 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -52.82 -54.33 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.605 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.25 -35.34 52.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.676 0.274 . . . . 0.0 111.235 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.3 t -61.3 -46.51 90.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -83.96 -11.79 56.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.986 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.535 HD22 HD12 ' A' ' 150' ' ' ILE . 19.1 tp -77.94 -24.76 48.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -113.0 25.68 11.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.65 103.51 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 144.65 -25.97 1.96 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.557 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -125.47 95.12 41.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.388 0.137 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.91 -7.36 21.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.387 2.058 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.88 -54.26 10.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -60.79 -41.92 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.9 mt -63.8 -49.58 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 57.0 ttp -58.89 -35.82 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.6 -20.56 63.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.434 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.99 -41.31 36.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -62.39 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 89.4 m -63.75 -35.9 82.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' B' ' 145' ' ' SER . 97.0 m-85 -65.15 -52.03 57.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.839 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' B' ' 145' ' ' SER . 77.2 mt -54.78 148.59 26.27 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 51.3 Cg_exo -54.57 145.44 58.66 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.428 2.085 . . . . 0.0 112.108 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 53.0 Cg_exo -55.22 166.52 2.29 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.364 2.043 . . . . 0.0 112.402 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.443 -1.198 . . . . 0.0 112.441 -179.923 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 56.6 m . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.793 0.33 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 45.1 t -101.77 2.87 38.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.41 HG22 ' HB2' ' B' ' 130' ' ' LEU . 27.7 m -75.71 -22.52 56.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.999 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 60.33 18.06 7.68 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.061 0.457 . . . . 0.0 110.72 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.473 ' HG ' ' H ' ' B' ' 131' ' ' SER . 17.2 tp -105.25 170.39 7.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.771 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.473 ' H ' ' HG ' ' B' ' 130' ' ' LEU . 78.3 p -85.5 161.92 19.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.8 -37.37 81.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.203 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.24 94.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.725 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 148' ' ' LEU . 39.3 mt-10 -70.97 -39.17 72.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.17 -34.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.501 HG23 ' HG2' ' A' ' 155' ' ' LYS . 61.6 mt -75.7 -52.81 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.061 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.566 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -54.24 -48.52 71.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 110.574 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.625 ' HA ' HD12 ' B' ' 141' ' ' LEU . 3.7 mm? -63.9 -43.79 94.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.258 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.13 -47.28 45.65 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.44 -36.66 92.88 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.891 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' B' ' 138' ' ' LEU . 56.9 mt -59.51 -55.32 36.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.919 0.39 . . . . 0.0 110.901 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.671 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -72.76 -18.76 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.332 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.343 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 44.7 ttp -81.76 -39.35 24.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.354 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.489 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.6 p -110.12 76.55 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.882 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' B' ' 153' ' ' CYS . 13.0 pt20 -130.79 -10.1 3.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.122 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -99.43 64.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.547 ' HG2' ' HG2' ' B' ' 149' ' ' GLN . 0.3 OUTLIER -59.38 -31.13 68.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.0 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.547 ' HG2' ' HG2' ' B' ' 148' ' ' GLU . 15.2 mm100 -112.24 -157.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.782 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.521 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 1.1 t -70.97 -32.01 2.24 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' B' ' 150' ' ' THR . 2.9 Cg_exo -76.38 -161.56 0.14 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.953 1.769 . . . . 0.0 112.067 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -133.13 136.25 45.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.988 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' B' ' 146' ' ' GLN . 35.5 t 60.28 9.08 1.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.337 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.698 HG22 ' H ' ' B' ' 156' ' ' SER . 7.6 p -172.28 159.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.815 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . 0.408 ' N ' HG22 ' B' ' 154' ' ' VAL . . . -100.83 -7.36 23.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.351 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.698 ' H ' HG22 ' B' ' 154' ' ' VAL . 92.5 p 51.6 -169.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.281 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.8 p -171.0 -31.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.479 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 62.4 tp -65.77 -51.15 50.55 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.643 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 58.3 Cg_endo -71.6 -56.72 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.021 1.814 . . . . 0.0 112.344 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 55.1 m -148.6 101.05 3.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 33.3 m -62.31 148.78 44.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.157 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 45.9 t -65.2 138.08 58.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.973 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 22.6 p 38.54 73.07 0.82 Allowed Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.61 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.81 -43.16 46.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.553 2.168 . . . . 0.0 111.863 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -154.63 69.52 5.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.481 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.48 137.86 48.15 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.527 2.152 . . . . 0.0 112.526 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.413 HG12 ' N ' ' B' ' 168' ' ' SER . 11.2 t -115.31 158.83 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.631 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.413 ' N ' HG12 ' B' ' 167' ' ' VAL . 48.3 t -55.43 101.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.937 0.399 . . . . 0.0 111.142 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 94.1 t -144.43 135.68 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.826 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 46.9 t -112.47 142.43 45.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.06 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.87 110.95 22.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.691 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 21.4 t70 57.07 88.72 0.12 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.015 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' B' ' 181' ' ' CYS . 58.3 Cg_endo -71.67 -169.51 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.46 2.107 . . . . 0.0 112.241 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.63 165.73 40.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.448 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.24 -25.81 42.56 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.614 2.209 . . . . 0.0 112.185 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 47.8 t -158.38 112.98 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.843 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.93 -48.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.603 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -142.24 152.27 42.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.748 0.309 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.71 -19.79 66.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.325 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 79.4 p -131.53 -176.84 4.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . 0.445 ' HA ' ' HG3' ' B' ' 173' ' ' PRO . 28.2 p -59.63 154.25 18.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.766 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 66.7 p -159.11 -61.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.38 21.8 76.92 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.561 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 82.1 p -76.26 -46.5 27.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -154.24 140.28 18.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.955 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.264 179.783 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.761 0.315 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -70.05 157.02 38.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.844 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.33 118.5 23.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -137.18 128.17 27.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.918 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.608 HG22 ' HG ' ' B' ' 142' ' ' LEU . 30.2 t -67.02 -28.72 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.63 -39.06 79.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.779 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.51 -36.8 84.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 109.969 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -61.77 -45.22 94.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.174 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.082 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -56.99 -38.59 73.26 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 133' ' ' VAL . 67.3 t80 -64.98 -40.67 95.33 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.731 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.32 -36.06 74.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.26 -39.84 74.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.01 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -57.87 -39.21 77.27 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.869 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 178' ' ' LEU . 47.4 t -72.51 -38.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -68.28 -20.58 64.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.288 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.21 -55.9 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.57 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -74.76 -59.9 2.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.168 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -83.46 24.91 0.79 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.13 -26.08 68.85 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.498 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.4 m -90.36 5.49 47.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -114.11 87.2 12.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.68 -7.26 18.41 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.357 2.038 . . . . 0.0 112.034 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -84.27 -62.34 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.451 HG13 HD23 ' A' ' 171' ' ' LEU . 17.0 t -57.68 -44.9 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.596 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.49 -56.78 16.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.908 0.385 . . . . 0.0 110.568 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.8 -36.28 76.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.544 ' HB3' HD11 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -68.85 -31.58 70.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -69.65 -59.7 2.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.26 -38.26 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.496 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 15.1 t70 -58.22 -50.12 74.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -53.74 -44.73 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.196 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.543 ' HE2' ' O ' ' B' ' 137' ' ' ALA . 75.7 mmm -58.2 -39.66 79.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.859 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 55.2 mtmt -67.02 -31.17 71.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.115 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.57 -42.73 86.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.69 -21.82 60.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.818 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.48 ' HG2' HG23 ' B' ' 136' ' ' ILE . 27.5 tptp -82.31 -34.61 28.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.9 t -95.2 18.99 11.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 64.04 98.86 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -153.08 -61.92 0.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.567 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.37 172.42 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 164' ' ' VAL . 12.1 m-20 -100.37 -178.33 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.135 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 87.5 m -60.22 -50.04 87.88 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.603 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 53.1 Cg_exo -55.51 -32.95 84.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.964 1.776 . . . . 0.0 111.939 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.49 -40.49 59.66 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.235 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 168' ' ' VAL . 94.4 t -64.9 -45.27 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.94 -49.87 77.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.308 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.4 p -58.89 -53.2 61.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -54.3 -52.31 61.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.397 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 164' ' ' VAL . 81.8 t -61.7 -31.13 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.752 0.311 . . . . 0.0 111.007 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.1 m -64.41 -45.36 87.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.781 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -82.25 -16.5 49.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 146' ' ' ASP . 1.2 tp -76.03 -42.53 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -95.94 15.6 20.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -51.61 120.09 4.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.46 -45.68 0.78 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.36 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -120.45 100.7 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.46 0.172 . . . . 0.0 110.758 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.41 -11.27 13.14 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.489 2.126 . . . . 0.0 112.707 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.5 -64.74 0.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 133' ' ' VAL . 4.8 mp -57.7 -27.12 62.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.64 -55.06 24.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 58.1 ttp -64.2 -40.96 97.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.008 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.15 -30.97 79.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.59 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.04 -35.85 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.907 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -63.72 -30.7 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.7 m -55.76 -51.91 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -53.52 -44.48 69.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.91 154.09 39.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 19.5 Cg_endo -60.01 146.91 94.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.369 2.046 . . . . 0.0 112.126 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 31.4 Cg_exo -61.42 142.41 95.39 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.327 2.018 . . . . 0.0 112.105 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.423 -1.209 . . . . 0.0 112.57 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 54.2 m -104.92 175.21 5.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.946 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 26.2 m 65.32 130.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.205 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -156.51 -29.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.73 162.67 15.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.502 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 43.9 t -66.1 170.8 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.999 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -67.13 -48.76 67.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.99 14.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 11.1 mm-40 -72.28 -54.95 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.772 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 51.8 ttm -64.63 -25.89 68.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.0 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.48 HG23 ' HG2' ' A' ' 155' ' ' LYS . 93.5 mt -73.55 -53.43 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.543 ' O ' ' HE2' ' A' ' 151' ' ' MET . . . -57.24 -47.77 80.54 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.509 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.682 ' HA ' HD12 ' B' ' 141' ' ' LEU . 4.2 mm? -61.08 -45.69 93.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.543 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.38 49.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.09 -34.36 89.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.867 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' B' ' 138' ' ' LEU . 58.4 mt -61.25 -56.13 24.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.895 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.608 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.0 mm? -69.13 -21.97 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -82.71 -26.25 32.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.556 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -80.47 -39.23 28.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.542 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 77.8 p -59.2 -19.49 45.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.637 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -119.23 -15.36 9.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.846 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -71.26 -19.28 77.34 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.795 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 62.97 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.611 0.243 . . . . 0.0 111.29 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -136.58 -45.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.969 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 5.8 t -82.94 143.54 46.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.055 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.95 -16.79 29.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.39 2.06 . . . . 0.0 112.411 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.46 6.69 48.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 70.1 m 65.68 144.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.102 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 47.1 t 61.59 104.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.339 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.28 120.64 12.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 53.9 m -144.01 155.36 43.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 55.4 m -91.9 -1.35 57.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.55 ' HB3' ' HD3' ' B' ' 159' ' ' PRO . 44.9 tp -74.44 -48.3 5.46 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' B' ' 158' ' ' LEU . 52.6 Cg_exo -54.93 -72.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.191 1.928 . . . . 0.0 112.542 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.417 ' H ' ' H ' ' B' ' 161' ' ' THR . 80.0 p -163.84 -9.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.197 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.581 HG22 ' H ' ' B' ' 163' ' ' CYS . 25.3 m 65.39 148.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.242 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 57.6 m -132.32 6.83 4.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . 0.581 ' H ' HG22 ' B' ' 161' ' ' THR . 63.6 m -128.94 80.12 73.37 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.19 30.52 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.675 2.25 . . . . 0.0 112.062 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.2 t70 58.69 66.95 2.25 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.861 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.52 129.47 5.0 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.664 2.243 . . . . 0.0 112.239 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 20.6 t -125.69 96.58 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.123 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 94.1 p 50.01 22.09 0.84 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.394 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 35.9 m -80.82 154.46 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.326 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 47.6 t -156.37 -16.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.828 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.41 ' H ' ' H ' ' B' ' 172' ' ' ASP . 9.7 tp10 -159.48 -9.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.692 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . 0.41 ' H ' ' H ' ' B' ' 171' ' ' GLU . 20.4 t70 65.34 124.9 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.038 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.85 179.06 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.307 2.005 . . . . 0.0 112.246 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.03 -143.04 10.87 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.445 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.82 -29.55 63.51 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.645 2.23 . . . . 0.0 112.643 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 48.7 m -128.75 167.64 16.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.027 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -125.93 153.73 18.52 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.423 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -152.59 119.99 5.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.693 0.282 . . . . 0.0 111.137 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 59.99 -86.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.493 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 78.3 p -115.93 -47.49 2.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 71.6 m -60.89 99.99 0.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.007 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.1 t -162.11 115.2 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.653 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.04 -134.83 8.67 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.6 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 4.8 t -151.48 -32.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -158.08 -47.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.28 -179.928 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.607 0.241 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 65.34 130.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.187 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -62.12 103.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.413 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.621 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 16.4 tppt? -132.06 145.29 51.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.63 HG13 ' HG ' ' B' ' 142' ' ' LEU . 58.9 t -71.41 -32.04 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.621 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 36.8 tt0 -57.67 -39.21 76.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.934 0.397 . . . . 0.0 110.504 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.808 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.4 -41.51 98.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.132 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.73 -44.23 96.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.84 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.5 m -55.74 -40.03 71.95 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 133' ' ' VAL . 40.8 t80 -65.63 -34.52 78.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.086 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.583 HD22 HD21 ' B' ' 138' ' ' LEU . 28.2 tp -61.96 -48.58 79.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.241 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.36 -31.46 72.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.17 -43.61 94.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.614 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 129' ' ' TYR . 91.0 t -67.19 -47.83 80.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 134' ' ' LYS . 10.9 tmtt? -58.2 -39.14 78.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.8 -31.98 63.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.779 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -54.26 -55.78 24.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.35 -62.79 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.536 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.1 -80.46 0.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.861 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.2 m -58.41 -19.51 36.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.323 . . . . 0.0 111.159 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -122.1 81.39 43.82 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.962 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.31 6.36 3.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.767 2.311 . . . . 0.0 112.197 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -65.92 -56.21 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.216 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -50.46 -36.81 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.474 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.66 -57.93 10.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.448 . . . . 0.0 110.661 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -57.56 -33.47 68.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' HD11 ' A' ' 171' ' ' LEU . 58.0 m-20 -62.43 -49.52 75.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.31 -58.14 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.273 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.14 -30.24 70.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.709 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.0 -55.1 36.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.172 0.511 . . . . 0.0 109.709 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mt -54.46 -46.33 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.247 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.761 ' HE2' HD23 ' B' ' 141' ' ' LEU . 69.1 mmm -52.95 -42.91 65.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.681 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -64.66 -39.05 93.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.611 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.75 -40.82 89.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.547 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -77.61 -38.6 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.507 ' HG2' HG23 ' B' ' 136' ' ' ILE . 61.0 tptt -62.54 -30.58 71.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.78 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 55.4 m -89.64 -83.29 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.783 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -178.17 94.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.521 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.1 m -157.37 -73.01 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -103.48 -178.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.319 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 164' ' ' VAL . 20.9 m-20 -120.23 -175.25 2.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.559 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.0 m -54.58 -51.53 77.74 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.807 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.4 Cg_endo -58.31 -37.03 96.95 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.081 1.854 . . . . 0.0 112.037 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.273 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 160' ' ' ASP . 87.0 t -68.39 -45.15 82.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 110.957 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.23 -45.76 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.485 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.6 p -64.68 -55.81 17.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.835 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.596 ' HA ' HE21 ' A' ' 170' ' ' GLN . 99.5 mtt180 -57.66 -53.27 60.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.793 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.66 -41.1 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.787 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 85.2 p -60.77 -44.37 96.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.551 0.215 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.596 HE21 ' HA ' ' A' ' 167' ' ' ARG . 30.0 pt20 -82.59 -12.02 58.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 146' ' ' ASP . 19.0 tp -70.2 -39.18 75.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.566 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -92.83 33.04 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -52.4 112.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 132.01 -46.65 1.05 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.551 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -114.37 95.59 40.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.433 0.158 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.81 3.55 5.41 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.5 2.134 . . . . 0.0 112.376 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -69.83 -60.64 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 178' ' ' LEU . 3.3 mm? -60.29 -35.66 76.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.547 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.17 -49.86 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.784 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.7 ttp -59.29 -38.8 81.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.68 -25.82 73.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.386 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -77.32 -34.88 55.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.724 0.297 . . . . 0.0 111.06 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -65.54 -16.98 64.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.2 m -70.32 -34.15 72.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.226 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -62.75 -43.62 98.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.57 155.72 27.4 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.847 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.77 129.09 25.08 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.523 2.149 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.21 171.89 11.94 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.391 2.061 . . . . 0.0 112.252 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.491 -179.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.716 0.293 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 29.9 t 59.93 176.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.164 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 5.7 t -80.2 144.94 32.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -137.26 -20.64 1.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.966 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' B' ' 130' ' ' LEU . 0.8 OUTLIER -57.82 164.76 2.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 50.0 m -65.95 -178.31 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.434 ' O ' HG13 ' B' ' 136' ' ' ILE . 39.9 mt-10 -74.41 -41.62 60.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.103 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.87 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.498 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -67.71 -46.68 71.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.0 -28.51 69.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.201 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.507 HG23 ' HG2' ' A' ' 155' ' ' LYS . 96.5 mt -74.91 -53.91 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.252 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.86 73.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.106 0.479 . . . . 0.0 110.138 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 130' ' ' LEU . 4.4 mm? -56.71 -52.54 64.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.243 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.69 -31.66 26.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.67 -51.46 47.07 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.001 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.761 HD23 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -68.4 -47.08 68.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.207 0.504 . . . . 0.0 111.338 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.63 ' HG ' HG13 ' A' ' 123' ' ' VAL . 3.6 mm? -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.548 0.213 . . . . 0.0 111.32 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -86.15 -28.56 23.89 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.66 0.267 . . . . 0.0 111.382 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -73.51 -25.78 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.482 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 78.6 p -70.9 -18.07 62.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.899 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -111.89 -20.17 12.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.57 -68.97 0.21 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.703 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -158.83 -69.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.715 0.293 . . . . 0.0 110.983 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -68.0 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.592 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 3.5 t -64.24 147.09 97.32 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.88 -20.44 6.95 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.745 2.296 . . . . 0.0 113.269 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -131.19 112.16 12.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.783 0.325 . . . . 0.0 111.203 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 74.0 m 59.7 -155.12 0.36 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.752 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.03 133.66 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 111.061 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.53 -22.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.174 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 64.2 m -73.36 156.59 38.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 80.2 p -166.18 6.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.794 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.593 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 6.9 mp -91.99 -50.37 0.3 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.671 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.593 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 25.9 Cg_endo -61.76 -76.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.088 1.858 . . . . 0.0 112.615 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 47.0 t -72.23 -44.93 62.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.893 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 49.9 m 63.36 -82.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.382 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 47.7 t -133.97 141.8 47.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.013 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 16.3 p -120.2 80.62 28.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -85.69 -8.54 8.21 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.853 2.369 . . . . 0.0 112.973 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.571 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 20.2 t70 -83.07 -53.23 0.6 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.577 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 90.9 Cg_endo -81.62 86.1 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.98 1.786 . . . . 0.0 112.356 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.6 -68.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.816 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 33.5 t -165.67 12.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.788 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.03 147.87 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.117 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' B' ' 181' ' ' CYS . 77.7 p -156.51 113.31 3.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -167.6 -177.17 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.15 119.22 75.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.707 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.13 -54.88 2.25 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.325 2.017 . . . . 0.0 112.327 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -148.97 -84.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.424 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.92 -176.49 2.11 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.574 2.183 . . . . 0.0 112.175 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 67.5 m -74.02 123.78 24.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -154.02 -164.47 12.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.41 -3.3 1.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -73.71 176.25 6.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.1 p -79.5 -176.06 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' B' ' 170' ' ' SER . 46.4 t -60.14 125.27 23.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.2 m -140.04 3.0 1.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.067 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -84.65 173.16 49.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 92.3 m 58.42 96.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.7 0.286 . . . . 0.0 111.327 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.2 t70 66.87 90.72 0.09 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.126 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.442 -179.391 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.697 0.284 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 59.56 96.2 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.984 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 99.1 mt 58.73 -173.74 0.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -160.17 140.64 11.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.733 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.627 HG22 ' HG ' ' B' ' 142' ' ' LEU . 25.1 t -67.94 -26.28 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.68 -42.31 88.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.035 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -64.96 -33.17 75.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -63.44 -50.12 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.48 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.27 -41.59 89.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.257 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.0 t -55.78 -42.46 75.58 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.37 -35.46 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.01 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.65 -46.0 88.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.746 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.78 -40.3 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.886 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.405 ' HG3' ' NE2' ' A' ' 136' ' ' GLN . 7.6 tp60 -55.34 -42.94 74.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.153 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.63 -47.8 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.48 -25.08 65.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.654 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.4 tp -75.47 -65.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.295 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 132' ' ' GLN . 2.8 mp0 -52.01 -45.7 64.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.388 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -93.16 38.17 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.48 150.75 33.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.523 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.5 t 60.34 11.69 3.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.791 0.329 . . . . 0.0 111.052 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.43 80.09 28.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.693 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.04 9.78 3.2 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.712 2.275 . . . . 0.0 112.56 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -66.09 -61.1 2.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.19 -34.6 57.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.66 -55.88 29.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.982 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -56.05 -49.97 72.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.53 -36.57 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -66.79 -60.63 2.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.827 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.0 mp -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.365 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -48.78 80.02 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.36 -48.0 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.082 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.403 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 81.2 mmm -53.24 -44.67 68.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.615 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.425 ' HG3' HG21 ' B' ' 136' ' ' ILE . 3.0 ttmp? -61.59 -37.28 83.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.543 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.11 -41.12 96.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 0.0 109.895 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -70.35 -41.61 72.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.468 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.547 ' HG2' HG23 ' B' ' 136' ' ' ILE . 28.6 tptp -65.37 -29.21 69.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.3 t -89.09 -85.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.793 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -178.5 101.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.611 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -165.34 -69.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.974 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.94 175.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.337 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.78 -171.95 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.972 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.533 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 61.3 m -53.53 -51.99 70.99 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.671 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 161' ' ' THR . 22.3 Cg_endo -61.68 -34.01 84.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.835 1.69 . . . . 0.0 111.686 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.67 93.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.089 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.72 -45.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.84 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.105 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -67.08 -56.6 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -55.59 -49.21 73.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.227 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.7 t -62.9 -34.56 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.564 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.3 t -59.34 -47.65 84.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.487 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.77 -15.68 56.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.516 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.5 tp -77.81 -31.01 51.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -118.99 24.55 10.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.33 -23.3 62.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.144 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -59.55 -32.51 73.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.804 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.32 108.31 10.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.525 0.163 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.33 -15.13 48.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.393 2.062 . . . . 0.0 112.425 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.93 -52.95 63.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.849 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.9 mm? -58.65 -33.93 70.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.572 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.31 -46.72 94.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.8 tpp -61.59 -48.06 82.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -26.05 72.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.547 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -78.81 -37.41 40.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.643 0.259 . . . . 0.0 111.111 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.62 -30.49 71.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.024 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 88.9 m -60.85 -39.7 90.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' B' ' 145' ' ' SER . 59.6 m-85 -58.46 -52.0 67.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.33 149.05 21.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.658 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 145' ' ' SER . 21.8 Cg_endo -60.8 140.56 91.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.357 2.038 . . . . 0.0 111.944 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.37 154.51 58.18 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.355 2.036 . . . . 0.0 112.281 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.561 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.813 0.34 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 55.6 m -138.88 163.57 31.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 5.9 t -142.73 -29.12 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.378 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -74.72 -32.89 62.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.04 179.18 7.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.857 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 89.5 p -104.49 -169.88 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.945 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.04 -38.52 79.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.185 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.53 68.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.512 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.545 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.9 OUTLIER -69.58 -47.9 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.189 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 54.1 ttm -60.69 -31.53 70.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.547 HG23 ' HG2' ' A' ' 155' ' ' LYS . 77.0 mt -76.57 -53.18 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.347 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -53.88 -47.63 70.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.1 0.476 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.634 HD13 HD13 ' B' ' 141' ' ' LEU . 4.5 mm? -66.69 -38.33 86.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.06 -53.17 45.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.011 0.434 . . . . 0.0 109.837 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.54 -31.0 79.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.589 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.634 HD13 HD13 ' B' ' 138' ' ' LEU . 0.1 OUTLIER -58.34 -56.07 26.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.886 179.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.705 HD11 ' HB2' ' A' ' 126' ' ' ALA . 3.1 mm? -75.7 -17.3 59.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -83.12 -26.17 31.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.736 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 62.5 ttp -91.09 -32.25 15.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 187' ' ' PRO . 57.3 m -80.09 14.67 1.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.397 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.407 ' HG3' ' N ' ' B' ' 147' ' ' GLY . 4.1 pt20 -126.25 -131.86 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.474 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' B' ' 146' ' ' GLN . . . 62.64 91.32 0.02 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.651 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -68.86 -60.67 2.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.772 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -140.34 16.33 2.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.5 t -171.22 145.63 1.89 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.66 127.03 17.62 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.358 2.039 . . . . 0.0 112.128 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 15.2 m120 64.29 119.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.932 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 77.9 m -51.37 115.84 1.78 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.956 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 13.6 p -151.51 -17.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 62.59 108.3 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.273 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 49.9 m -125.13 165.87 17.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' B' ' 161' ' ' THR . 48.7 m -151.03 5.72 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.652 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 62.3 tp -99.89 -50.09 0.2 Allowed Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.791 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.652 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 41.7 Cg_endo -67.36 -64.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.066 1.844 . . . . 0.0 112.643 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 85.8 p -98.71 -25.02 14.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.453 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.525 HG22 ' H ' ' B' ' 163' ' ' CYS . 20.6 m 66.21 146.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.094 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 74.0 p -136.72 14.73 3.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.372 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . 0.525 ' H ' HG22 ' B' ' 161' ' ' THR . 78.7 m 61.57 101.78 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.096 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.1 -52.3 6.07 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.588 2.192 . . . . 0.0 113.077 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 17.0 t70 -93.08 -49.9 0.28 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 35.5 Cg_exo -60.9 98.67 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.08 1.854 . . . . 0.0 112.329 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 47.6 t -137.59 -66.53 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.27 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 44.0 t -167.38 2.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.169 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 13.6 p -66.37 142.84 16.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.061 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 51.8 m -107.03 -171.69 1.93 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.088 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.56 151.56 51.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 24.5 t70 55.24 86.43 0.17 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.118 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.495 ' HB3' ' H ' ' B' ' 182' ' ' SER . 54.3 Cg_endo -69.58 -47.75 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.589 2.193 . . . . 0.0 112.409 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.25 -155.38 21.34 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.584 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.26 -23.49 20.85 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.403 2.069 . . . . 0.0 112.354 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 50.6 m -149.29 126.45 11.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -175.14 29.16 0.08 OUTLIER Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.764 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 55.51 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.663 0.268 . . . . 0.0 111.282 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -151.06 -12.44 0.22 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.936 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.3 p -87.19 150.88 23.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' B' ' 173' ' ' PRO . 27.0 p -78.24 147.0 34.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 50.2 m -147.86 18.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.776 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.28 -33.57 71.02 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.617 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 56.9 m -75.87 112.8 12.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.688 0.28 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.46 -36.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.216 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.717 0.294 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 62.36 175.1 0.14 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.966 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.58 91.97 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.955 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -137.0 127.32 26.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.64 HG22 ' HG ' ' B' ' 142' ' ' LEU . 61.2 t -57.57 -40.29 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.677 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.22 -40.72 74.51 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.691 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.76 -37.24 86.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.197 0.522 . . . . 0.0 109.727 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -61.53 -41.81 97.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.987 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.04 -42.24 98.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.976 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m -55.47 -43.39 75.48 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.4 t80 -61.66 -38.13 86.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.1 tp -58.86 -44.59 91.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.992 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.25 -37.05 85.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.932 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.27 -35.61 80.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.399 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 178' ' ' LEU . 85.3 t -67.32 -55.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.857 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.09 -40.05 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.729 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.64 -37.98 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.145 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.475 ' HG2' HD21 ' A' ' 178' ' ' LEU . 5.8 tp-100 -57.86 -61.04 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.989 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 140' ' ' GLN . 92.6 m-85 -76.82 -1.62 29.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.17 -83.06 1.35 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.678 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.9 t -146.58 24.16 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.002 0.43 . . . . 0.0 110.44 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 137' ' ' PHE . 3.6 pm0 -46.42 118.78 4.95 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.52 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -92.87 -11.91 1.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.029 2.486 . . . . 0.0 111.797 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -84.67 -63.5 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.296 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.455 ' HB ' ' HG3' ' A' ' 140' ' ' GLN . 3.3 t -58.36 -50.2 79.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.267 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -52.76 -58.51 6.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.142 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -54.96 -42.45 72.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.391 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB3' HD11 ' A' ' 171' ' ' LEU . 63.0 m-20 -62.35 -38.16 88.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.464 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.61 -59.16 4.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.327 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.9 mp -63.29 -34.29 77.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.299 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.12 -52.16 66.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.042 0.448 . . . . 0.0 109.836 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.2 mt -55.99 -48.32 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.482 ' HB2' ' HB1' ' B' ' 137' ' ' ALA . 71.1 mmm -55.38 -35.0 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.951 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -72.18 -34.18 68.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.28 -45.34 91.92 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -69.14 -33.05 72.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.892 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG2' HG23 ' B' ' 136' ' ' ILE . 61.3 tptt -74.8 -21.79 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.349 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.0 t -107.22 18.46 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.742 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 62.29 99.15 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.1 m -153.67 -65.29 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.4 pt -112.09 165.38 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.96 -179.46 6.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.6 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 81.9 m -61.35 -50.06 85.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.63 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 161' ' ' THR . 15.4 Cg_endo -57.31 -29.35 83.72 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.021 1.814 . . . . 0.0 111.912 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.8 -39.28 65.7 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.01 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.7 -44.16 79.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 110.996 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.43 -43.75 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.7 -56.01 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -54.5 39.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.23 -36.81 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.143 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -59.49 -49.39 77.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.818 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -80.31 -12.15 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 146' ' ' ASP . 12.4 tp -76.9 -19.83 56.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -125.62 29.18 6.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.986 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -55.6 -21.54 18.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.52 -53.08 46.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -120.37 98.03 48.73 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.399 0.142 . . . . 0.0 110.996 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.7 -14.98 23.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.467 2.111 . . . . 0.0 112.388 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.49 -54.33 48.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -57.21 -41.98 80.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.388 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.42 -35.85 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.812 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -63.8 -53.09 56.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.49 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.12 -22.88 72.82 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.235 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.451 ' HE1' HD21 ' B' ' 141' ' ' LEU . 83.9 t80 -72.77 -47.27 48.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.817 0.342 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.97 -20.86 65.67 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 17.4 m -60.79 -36.09 78.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.811 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -70.9 -49.1 49.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 75.8 mt -51.61 147.84 10.58 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.048 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.53 123.93 13.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 -170.32 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.313 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.305 -1.275 . . . . 0.0 112.511 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.695 0.283 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 81.8 p -102.54 142.67 33.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.806 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.418 HG22 ' H ' ' B' ' 130' ' ' LEU . 75.7 m -141.4 133.25 27.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -109.9 -1.46 17.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.45 HD12 ' N ' ' B' ' 130' ' ' LEU . 6.2 mp -101.18 147.76 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.984 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 49.6 m -74.76 -174.92 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.703 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.31 -35.33 71.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.052 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.94 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.498 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.564 ' HA ' HD23 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -71.95 -46.43 57.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 71.3 mtp -65.68 -31.34 72.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.435 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.409 HG23 ' HG2' ' A' ' 155' ' ' LYS . 88.7 mt -74.94 -53.73 15.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 151' ' ' MET . . . -55.5 -49.52 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.611 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 141' ' ' LEU . 4.4 mm? -62.49 -42.94 99.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.666 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.35 59.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.54 -31.92 80.1 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.582 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -60.77 -56.54 19.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.739 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.64 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.9 mm? -69.4 -22.12 63.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.02 -26.8 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -80.84 -40.19 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.888 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 79.4 p -104.22 98.4 8.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.149 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.404 ' HB2' ' SG ' ' B' ' 153' ' ' CYS . 8.5 mt-30 -108.76 -71.4 0.76 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.8 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.699 ' HA3' ' HB2' ' B' ' 152' ' ' ASN . . . -159.92 -69.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.553 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 51.89 73.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 111.174 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.576 ' HG2' HG22 ' B' ' 150' ' ' THR . 62.2 tt0 -175.84 -71.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.706 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.835 ' H ' ' HD2' ' B' ' 151' ' ' PRO . 4.0 t 177.04 -34.56 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.835 ' HD2' ' H ' ' B' ' 150' ' ' THR . 58.5 Cg_endo -70.83 -51.8 0.28 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.336 1.357 . . . . 0.0 112.152 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . 0.699 ' HB2' ' HA3' ' B' ' 147' ' ' GLY . 84.6 m-20 -86.56 -82.79 0.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.666 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' B' ' 146' ' ' GLN . 98.2 m -66.04 174.25 2.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.696 0.284 . . . . 0.0 110.753 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 32.2 m -131.78 11.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.455 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.91 -74.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.12 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 75.0 p 54.06 -177.17 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.48 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . 0.533 ' HA ' ' HB ' ' B' ' 161' ' ' THR . 48.0 t -165.08 -29.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.815 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.618 ' N ' ' HD2' ' B' ' 159' ' ' PRO . 3.8 mm? -60.7 -50.0 87.17 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.675 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' B' ' 158' ' ' LEU . 9.3 Cg_endo -51.21 -74.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.218 1.945 . . . . 0.0 112.44 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 79.0 p -170.71 14.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.665 0.269 . . . . 0.0 111.355 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' B' ' 157' ' ' SER . 45.7 m -61.47 -47.75 84.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.811 0.338 . . . . 0.0 110.846 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 39.2 t -140.9 120.76 13.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 82.1 m 56.18 80.84 0.27 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.298 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.64 -48.46 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.543 2.162 . . . . 0.0 112.215 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.534 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 26.0 t70 -103.51 -47.93 0.16 Allowed Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.653 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 35.0 Cg_exo -60.88 111.54 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.14 1.893 . . . . 0.0 112.506 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.69 -47.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 85.8 p -149.75 -21.24 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.789 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 60.7 t 60.68 -86.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.312 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 77.6 p -171.54 -61.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 110.764 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -135.74 179.99 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.799 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 18.8 t70 59.51 98.32 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.26 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.01 140.32 24.4 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.552 2.168 . . . . 0.0 112.581 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -149.92 -72.08 0.01 OUTLIER Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.479 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.55 -171.02 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.464 2.109 . . . . 0.0 112.114 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 80.3 p -85.78 156.11 20.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 166.67 -139.82 5.97 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.348 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -126.12 -63.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.782 0.325 . . . . 0.0 110.844 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -150.96 -178.57 6.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.624 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 44.1 t 59.03 103.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.29 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 20.4 p 43.32 32.91 0.53 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.658 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 53.8 m -152.71 111.94 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.961 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 160.88 91.82 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 4.7 t -73.81 -20.39 60.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.822 0.344 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -165.95 122.66 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.144 -0.932 . . . . 0.0 111.251 179.847 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.793 0.33 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.51 ' HA ' ' HE ' ' A' ' 120' ' ' ARG . 3.1 mmp_? -114.02 112.68 23.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.9 tp -109.15 122.3 46.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.782 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.83 175.04 5.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.531 HG22 ' HG ' ' B' ' 142' ' ' LEU . 49.1 t -82.05 -44.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.749 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.27 -24.85 45.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.05 -43.56 82.42 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.544 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -65.33 -35.59 81.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.475 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.86 -42.87 99.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.841 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -60.6 -42.51 96.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -58.79 -39.19 80.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.785 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.489 HD22 HD21 ' B' ' 138' ' ' LEU . 22.8 tp -58.75 -46.91 86.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.675 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.0 -37.03 78.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.438 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.557 ' HG3' HE22 ' A' ' 136' ' ' GLN . 5.7 tp-100 -59.6 -51.63 68.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.375 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.552 HG22 HD12 ' A' ' 178' ' ' LEU . 95.8 t -58.88 -39.88 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.67 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -69.0 -25.81 64.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.787 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.86 -53.57 12.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.557 HE22 ' HG3' ' A' ' 132' ' ' GLN . 2.4 mp0 -60.9 -56.46 20.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -85.52 31.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.126 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.08 -28.8 67.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.481 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.8 p -85.88 -18.48 32.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.826 0.346 . . . . 0.0 110.779 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -130.55 87.21 50.72 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.875 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.36 10.12 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.477 2.118 . . . . 0.0 112.37 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.16 -58.5 4.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.04 -43.96 77.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.06 -52.16 66.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.686 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -58.4 -38.48 77.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.802 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.13 -31.56 71.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -66.44 -60.07 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.558 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.17 -30.52 71.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.04 -48.8 80.21 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.2 mt -56.05 -43.54 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.547 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.518 ' HB3' ' HA ' ' B' ' 137' ' ' ALA . 0.0 OUTLIER -53.38 -48.85 68.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.984 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -58.54 -41.6 85.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.084 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.84 -39.74 78.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.847 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.65 -22.97 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.851 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -84.58 -14.13 49.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 54.3 m -111.53 15.66 21.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 62.95 93.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.8 m -147.15 -49.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.48 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 pt -126.28 171.57 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.939 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.569 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 5.3 t70 -111.2 -177.23 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.765 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 34.1 m -51.02 -50.58 74.21 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 33.1 Cg_exo -57.75 -37.09 97.84 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.898 1.732 . . . . 0.0 111.953 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.72 -37.91 89.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.506 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 160' ' ' ASP . 61.5 t -67.18 -45.17 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.756 0.313 . . . . 0.0 110.938 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.63 -43.85 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -66.26 -55.41 16.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.499 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -53.62 -53.9 45.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.345 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.9 -35.72 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 111.097 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 t -57.66 -50.34 73.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -79.34 -18.39 52.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 tp -68.49 -35.84 78.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.909 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -100.83 30.15 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.31 113.54 2.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 134.96 -32.07 2.63 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.463 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -126.07 93.3 43.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.514 0.197 . . . . 0.0 110.863 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.89 -3.46 12.81 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.474 2.116 . . . . 0.0 112.17 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.64 -53.9 19.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.552 HD12 HG22 ' A' ' 133' ' ' VAL . 3.6 mm? -64.59 -39.1 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.51 -49.47 84.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.743 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 51.9 ttm -61.01 -43.4 98.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.559 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.44 -25.59 72.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.352 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -78.13 -37.43 46.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.86 -20.2 65.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.3 m -70.63 -37.99 73.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.361 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -62.16 -43.0 99.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.33 153.73 36.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 28.5 Cg_endo -62.27 114.15 2.22 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.519 2.146 . . . . 0.0 112.245 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 37.1 Cg_endo -65.75 152.93 80.22 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.36 2.04 . . . . 0.0 112.231 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.553 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.613 0.244 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 56.8 m 65.61 132.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.061 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 69.8 p -119.99 -20.54 7.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.312 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -129.76 123.07 30.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 92.3 mt -128.57 -168.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.654 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 79.9 p -64.78 162.8 15.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.803 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.84 -40.48 83.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.308 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -31.66 65.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.423 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -75.82 -47.83 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 92.3 mmm -63.54 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -52.68 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.024 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 151' ' ' MET . . . -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.26 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 130' ' ' LEU . 4.5 mm? -62.99 -39.8 95.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.266 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.32 -47.11 55.91 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.84 -29.2 72.6 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.745 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.476 HD12 ' O ' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -62.47 -56.41 18.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 126' ' ' ALA . 3.0 mm? -70.73 -21.55 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.776 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -83.36 -26.78 30.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.902 0.382 . . . . 0.0 110.853 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . 0.469 ' SD ' HG23 ' A' ' 161' ' ' THR . 10.1 tmm? -86.8 -25.37 24.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.151 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 66.9 m -68.01 -17.14 64.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.821 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' B' ' 147' ' ' GLY . 1.6 pt20 -137.45 -100.35 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.154 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.463 ' H ' ' HG3' ' B' ' 146' ' ' GLN . . . 55.42 41.75 81.38 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.627 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -149.91 103.96 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 52.24 70.66 0.54 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 4.2 t -178.11 145.46 0.53 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.57 93.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.251 1.967 . . . . 0.0 112.178 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -174.46 -77.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.062 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 14.0 p -55.38 -58.08 9.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.301 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 14.8 p -168.74 -23.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 111.235 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.35 163.87 6.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.053 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 49.6 m 59.25 101.0 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.104 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 78.8 p -104.13 4.25 33.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.995 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.553 ' HB2' ' HD3' ' B' ' 159' ' ' PRO . 97.9 mt -87.21 -48.88 0.47 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.728 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' B' ' 158' ' ' LEU . 50.2 Cg_exo -54.13 -66.43 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.141 1.894 . . . . 0.0 112.469 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 41.5 t -167.96 -3.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.823 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m 64.63 -81.98 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.214 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 79.3 p -170.06 156.57 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 64.1 m -130.61 96.44 23.73 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.38 -56.71 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.428 2.085 . . . . 0.0 112.536 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.553 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 14.5 t70 -93.15 -48.13 0.29 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.709 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 49.7 Cg_exo -56.18 -179.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.106 1.871 . . . . 0.0 112.608 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.429 HG22 ' O ' ' B' ' 167' ' ' VAL . 8.6 p -141.02 27.54 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.252 0.548 . . . . 0.0 109.874 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.519 ' O ' ' HB ' ' B' ' 169' ' ' VAL . 74.7 m 62.52 -85.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.401 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' B' ' 168' ' ' SER . 7.1 p 165.17 141.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 O-C-N 123.601 0.563 . . . . 0.0 110.936 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 50.7 m -82.16 167.93 18.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.798 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -121.12 14.38 11.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -124.94 77.69 66.18 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.023 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.73 -164.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.506 2.137 . . . . 0.0 112.351 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.23 -151.51 21.78 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.587 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.57 -36.15 15.54 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.585 2.19 . . . . 0.0 112.539 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 59.8 m -135.57 174.95 10.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.987 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 160.26 -173.22 36.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.269 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.07 -32.78 2.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.311 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . 0.443 ' CD ' ' H ' ' B' ' 179' ' ' GLN . 4.6 pm0 -103.24 -173.0 2.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.76 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 47.3 t -58.52 -50.33 74.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 27.9 p -100.36 -171.57 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.0 t -172.84 -41.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.936 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . -98.31 70.47 0.64 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.491 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 82.2 p -102.06 -17.5 16.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 111.078 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -145.66 -29.78 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.407 HG23 ' O ' ' B' ' 186' ' ' THR . 3.7 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.295 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -121.91 114.49 21.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.8 tp -115.71 125.27 52.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.499 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 60.9 tptt -107.24 136.64 46.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.977 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.621 HG22 ' HG ' ' B' ' 142' ' ' LEU . 42.0 t -70.43 -33.06 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.499 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 37.4 tt0 -55.33 -36.51 66.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.592 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.32 -36.97 85.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.72 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' B' ' 142' ' ' LEU . . . -62.64 -43.02 99.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.089 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.06 -45.3 95.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.066 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.1 t -56.13 -38.16 70.44 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -67.52 -34.5 77.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.072 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.516 HD13 HD21 ' B' ' 138' ' ' LEU . 40.7 tp -61.95 -39.86 93.54 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.824 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.54 -38.55 74.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.177 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -57.2 -42.69 81.72 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.28 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.67 -38.92 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -61.14 -28.5 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.812 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.2 -51.33 7.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -54.75 -62.54 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.074 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.55 28.34 1.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.66 -29.65 74.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.6 p -81.73 -4.5 56.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.822 0.344 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -139.12 96.55 8.99 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.0 23.66 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.526 2.151 . . . . 0.0 112.342 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -83.69 -63.04 1.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.013 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.1 t -61.12 -51.13 76.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.629 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.23 -55.62 26.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.54 -43.64 84.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.003 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.582 ' HB3' HD21 ' A' ' 171' ' ' LEU . 9.8 t70 -67.45 -25.55 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.844 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -70.21 -59.65 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 mp -62.2 -35.74 79.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.27 -46.83 88.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 109.843 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.59 -46.89 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.387 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.575 ' HE2' HD12 ' B' ' 141' ' ' LEU . 85.3 mmm -54.19 -48.9 70.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.847 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.3 -34.81 74.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.373 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.55 -38.08 88.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.96 -32.31 65.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.824 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -76.54 -23.14 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.845 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.6 t -98.36 10.36 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.574 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 63.77 95.6 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.043 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -149.65 -51.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.745 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.7 pt -123.46 172.02 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.068 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.92 -175.79 2.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.193 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.9 m -59.38 -51.38 81.82 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.667 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.5 Cg_endo -58.07 -31.42 93.05 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.037 1.825 . . . . 0.0 111.851 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.14 -45.39 62.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.114 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.17 -41.5 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.885 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 86.4 mt -62.34 -53.63 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.4 m -58.62 -55.67 32.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.766 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -51.74 -54.36 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.95 -35.83 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.428 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 71.0 m -59.4 -47.12 86.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.828 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -84.3 -11.92 55.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.182 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 146' ' ' ASP . 16.1 tp -76.5 -25.1 53.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.651 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.25 31.11 5.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.083 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.59 107.49 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.2 -47.0 0.57 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.632 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -124.58 103.57 31.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.01 -0.112 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.91 -9.56 25.28 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.381 2.054 . . . . 0.0 112.252 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -54.38 20.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.8 mm? -57.05 -44.88 83.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.731 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.68 -41.73 89.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 50.2 tpp -62.83 -43.35 99.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -67.61 -30.53 74.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.339 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -72.21 -39.62 68.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.37 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.36 -25.92 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.936 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.3 m -63.33 -39.65 95.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 145' ' ' SER . 93.6 m-85 -57.54 -51.35 69.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.31 155.1 5.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.093 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 41.0 Cg_endo -66.94 117.36 4.72 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.428 2.085 . . . . 0.0 112.337 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 187' ' ' PRO . 34.2 Cg_exo -61.21 135.04 55.82 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.407 2.071 . . . . 0.0 112.191 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.488 179.919 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.873 0.368 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 77.2 p -129.55 -176.4 3.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 57.1 m -73.46 135.5 44.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.114 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -96.01 -61.93 1.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.39 158.14 21.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.117 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.422 ' HB3' ' HG2' ' B' ' 134' ' ' GLU . 41.7 t -67.6 171.36 6.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.08 -46.96 69.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.3 -23.79 16.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.422 ' HG2' ' HB3' ' B' ' 131' ' ' SER . 13.3 mm-40 -70.53 -58.1 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 110.953 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 79.7 mtp -63.99 -29.25 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.782 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 78.7 mt -74.83 -53.47 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.293 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.481 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -55.68 -49.34 73.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 130' ' ' LEU . 4.4 mm? -61.7 -42.21 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.368 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.4 -46.75 56.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.36 -32.56 82.3 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.742 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.575 HD12 ' HE2' ' A' ' 151' ' ' MET . 0.2 OUTLIER -59.01 -54.02 51.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.621 ' HG ' HG22 ' A' ' 123' ' ' VAL . 2.8 mm? -76.22 -17.95 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.945 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' B' ' 143' ' ' GLN . 1.0 OUTLIER -81.46 -30.63 33.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.41 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 56.7 ttp -83.98 -38.77 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.576 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 185' ' ' PHE . 74.7 p -64.26 -13.36 49.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.073 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -111.39 -10.65 14.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.784 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -128.41 80.1 0.36 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.626 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.88 -54.88 17.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 0.0 110.675 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' B' ' 151' ' ' PRO . 44.8 mt-30 -72.83 -163.5 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.755 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.518 ' N ' ' CD ' ' B' ' 151' ' ' PRO . 2.0 t -87.13 -31.46 0.41 Allowed Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' B' ' 149' ' ' GLN . 71.8 Cg_endo -83.19 -74.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.529 1.486 . . . . 0.0 112.548 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . 0.463 ' H ' ' HG2' ' B' ' 151' ' ' PRO . 3.5 p-10 -174.01 132.28 0.41 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 36.4 t 61.59 169.53 0.11 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 35.7 m -85.59 5.19 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.87 124.28 30.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.066 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 85.0 p -154.91 130.55 9.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 36.1 t -156.27 8.11 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.616 ' H ' ' HD2' ' B' ' 159' ' ' PRO . 4.0 mm? -100.32 -51.69 0.18 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.91 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.616 ' HD2' ' H ' ' B' ' 158' ' ' LEU . 50.1 Cg_endo -69.23 -60.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.92 1.747 . . . . 0.0 112.78 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.456 ' C ' ' H ' ' B' ' 162' ' ' SER . 45.9 t -97.77 -25.18 15.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.28 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 25.3 m 71.83 -17.48 0.35 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.471 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . 0.456 ' H ' ' C ' ' B' ' 160' ' ' SER . 41.2 t 57.43 98.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.87 0.367 . . . . 0.0 111.29 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 24.6 p -164.3 63.19 1.07 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.026 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.19 1.03 8.98 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.762 2.308 . . . . 0.0 112.646 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.496 ' N ' ' HD2' ' B' ' 166' ' ' PRO . 22.7 t70 -91.59 -51.19 0.3 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.713 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 165' ' ' ASP . 57.0 Cg_endo -70.31 115.92 4.39 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.969 1.779 . . . . 0.0 112.255 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.54 130.53 65.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.1 m -65.2 95.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 48.3 t -134.8 -28.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 32.7 t -151.02 11.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.811 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.8 -82.31 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -150.75 136.0 10.23 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.002 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.18 -161.47 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.542 2.162 . . . . 0.0 112.361 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.22 -77.6 1.28 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.44 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.67 112.15 2.64 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.571 2.18 . . . . 0.0 112.458 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 28.1 t 59.16 179.15 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -129.54 -171.08 12.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.446 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 56.57 23.26 7.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.72 0.295 . . . . 0.0 111.184 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -130.5 -57.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 53.7 m -131.14 -172.37 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 75.0 m -141.85 13.72 2.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 78.7 p -114.27 112.67 23.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.25 121.8 0.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.604 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 3.3 t -101.13 -36.58 8.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.059 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -164.25 -9.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.404 HG22 ' H ' ' B' ' 186' ' ' THR . 1.5 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.288 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.83 0.347 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -102.93 117.43 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 tp -150.69 140.72 22.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.031 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -120.38 145.18 47.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.56 HG22 ' HG ' ' B' ' 142' ' ' LEU . 32.4 t -74.78 -38.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.794 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -57.08 -27.62 61.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.825 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.29 -44.22 79.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -63.48 -31.75 73.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.575 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.62 -49.68 70.13 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.964 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.2 t -54.54 -39.26 67.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -67.34 -33.41 75.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.094 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.503 HD13 HD21 ' B' ' 138' ' ' LEU . 44.7 tp -61.28 -48.87 79.43 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.943 0.402 . . . . 0.0 110.001 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.8 -32.99 74.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.03 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -57.67 -46.75 83.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.248 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.23 -45.93 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -61.22 -22.61 64.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.54 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.1 tp -78.57 -58.62 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.982 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.488 ' HA ' HE21 ' A' ' 136' ' ' GLN . 0.1 OUTLIER -55.37 -56.03 24.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.136 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -85.81 37.46 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.33 -27.38 67.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.674 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.3 p -85.66 -22.07 28.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.814 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -123.44 90.01 50.77 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.57 -13.57 13.29 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.536 2.157 . . . . 0.0 112.341 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -56.58 -35.53 68.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.4 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t -72.48 -33.12 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -63.3 -55.55 23.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -57.17 -37.51 72.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.451 ' HB3' HD11 ' A' ' 171' ' ' LEU . 3.6 m-20 -65.48 -38.5 89.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -64.48 -59.44 4.32 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.913 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' B' ' 134' ' ' GLU . 7.7 mp -58.71 -38.9 79.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.827 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.518 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 22.1 t70 -56.18 -47.43 78.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.3 mt -56.0 -48.31 78.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.212 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.497 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.3 mmm -54.6 -38.43 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.693 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 149' ' ' ASP . 56.2 mtmt -68.44 -35.78 78.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.47 -42.13 95.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.155 0.502 . . . . 0.0 109.667 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -77.25 -27.5 53.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.208 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' B' ' 136' ' ' ILE . 29.4 tptp -73.48 -28.5 61.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.2 m -98.69 -84.44 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -173.04 105.45 0.14 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.704 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.8 t -169.38 -69.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.239 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.402 HD13 ' HD2' ' A' ' 167' ' ' ARG . 47.2 pt -116.45 168.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.363 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 164' ' ' VAL . 9.2 m-20 -108.95 -172.57 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.552 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 55.3 m -51.53 -51.0 73.55 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 161' ' ' THR . 19.9 Cg_endo -60.11 -32.7 95.03 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.904 1.736 . . . . 0.0 111.694 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.75 -32.28 70.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 160' ' ' ASP . 57.5 t -73.85 -45.17 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.725 0.298 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.65 -41.78 93.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.9 m -68.31 -54.0 20.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.699 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.402 ' HD2' HD13 ' A' ' 159' ' ' ILE . 95.6 mtt180 -58.97 -44.41 91.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.563 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.79 -44.94 99.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 90.6 p -59.73 -36.46 76.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.911 0.386 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -84.15 -17.58 39.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.746 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 146' ' ' ASP . 15.8 tp -75.41 -36.81 60.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.25 28.86 5.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -55.46 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.38 -37.47 1.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.422 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -121.52 99.52 45.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 -1.67 11.45 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.458 2.105 . . . . 0.0 112.301 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.95 -60.27 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.4 mm? -60.71 -41.86 96.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.95 -39.42 82.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.718 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.4 ttm -62.23 -52.8 62.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.7 69.14 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.305 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.4 ' HE1' HD21 ' B' ' 141' ' ' LEU . 88.8 t80 -74.62 -37.42 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -67.42 -15.61 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.739 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 27.9 m -74.42 -38.37 63.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -57.43 -41.16 79.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.767 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 92.0 mt -59.76 154.92 44.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.77 117.55 5.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.407 2.071 . . . . 0.0 112.356 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.0 150.42 31.05 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.282 1.988 . . . . 0.0 112.248 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.495 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.723 0.297 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -111.2 135.65 51.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 4.1 t -160.92 149.06 15.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -106.65 -32.7 7.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.746 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.478 HD12 ' N ' ' B' ' 130' ' ' LEU . 6.5 mp -75.97 168.26 20.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.744 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.404 ' OG ' ' HG2' ' B' ' 134' ' ' GLU . 92.4 p -84.26 -176.26 6.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' B' ' 132' ' ' GLU . 0.1 OUTLIER -72.58 -42.2 64.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.191 -179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.21 66.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.159 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.454 ' HA ' HD23 ' A' ' 148' ' ' LEU . 5.4 mm-40 -64.0 -47.85 78.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.67 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 94.3 mmm -62.48 -27.59 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.11 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.442 HG23 ' HG2' ' A' ' 155' ' ' LYS . 81.1 mt -73.2 -53.49 18.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.119 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.408 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.02 -48.07 76.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 110.33 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.514 HD13 HD13 ' B' ' 141' ' ' LEU . 4.6 mm? -63.51 -37.72 88.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.385 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.26 -49.53 63.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.96 -33.9 88.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.545 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.514 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -59.08 -56.17 25.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.921 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.56 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.1 mm? -73.43 -17.33 61.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.44 -26.78 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.831 0.348 . . . . 0.0 110.891 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 55.0 ttp -86.13 -36.95 19.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.605 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 59.7 m -58.51 -18.76 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.691 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -119.5 -21.82 7.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.57 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -82.21 -102.07 0.43 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.512 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 53.98 78.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 54.79 93.61 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.254 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.483 ' H ' ' HB ' ' B' ' 154' ' ' VAL . 6.5 t -168.02 142.98 2.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.047 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.43 21.26 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.391 2.06 . . . . 0.0 112.496 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -102.61 -59.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.991 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 84.2 m -115.99 -41.59 3.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.007 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.483 ' HB ' ' H ' ' B' ' 150' ' ' THR . 67.2 t -71.61 144.93 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.084 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -109.56 108.2 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.3 m -100.99 -172.14 2.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.029 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 59.4 m -136.74 -17.14 1.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.256 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.447 ' HB2' ' HD3' ' B' ' 159' ' ' PRO . 3.9 mm? -82.42 -52.69 0.69 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.465 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' B' ' 158' ' ' LEU . 67.9 Cg_endo -74.5 -58.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.11 1.874 . . . . 0.0 112.534 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 43.8 t -158.91 118.55 3.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.751 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 67.9 m -60.38 -81.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 42.5 t -174.33 -60.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.726 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 52.8 t 56.2 76.6 0.48 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.11 37.21 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.709 2.273 . . . . 0.0 112.011 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 15.9 t70 62.82 76.59 0.37 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.765 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.42 124.75 12.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.495 2.13 . . . . 0.0 112.265 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.7 114.96 48.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.7 m 55.96 23.84 7.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.39 140.15 12.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.134 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 88.0 p -104.94 -177.33 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.702 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.15 -34.14 6.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' B' ' 173' ' ' PRO . 13.7 m-20 -141.87 103.76 5.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' B' ' 182' ' ' SER . 9.4 Cg_endo -52.13 -49.3 17.82 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.71 2.273 . . . . 0.0 112.59 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.41 -161.58 31.54 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.367 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.86 -66.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.591 2.194 . . . . 0.0 112.475 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 47.7 t -162.61 166.49 24.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.89 88.08 1.71 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 16.1 t70 60.67 103.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.789 0.328 . . . . 0.0 111.071 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.04 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 46.6 t 62.55 -84.39 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.776 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 27.9 p -170.11 179.98 3.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.578 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' B' ' 173' ' ' PRO . 41.0 t -56.84 103.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.398 . . . . 0.0 111.083 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . . . . . . . . . . . 122.34 145.31 6.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.381 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 70.2 p -94.31 -44.66 7.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.798 0.332 . . . . 0.0 111.282 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -110.74 2.19 18.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.95 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.281 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.817 0.341 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -148.79 119.86 7.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.9 tp -78.39 97.99 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' A' ' 124' ' ' GLU . 29.0 tptp -100.03 155.62 17.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.752 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.585 HG22 ' HG ' ' B' ' 142' ' ' LEU . 72.6 t -58.84 -34.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 38.0 mt-10 -57.68 -23.61 52.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.01 -44.52 72.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.079 0.466 . . . . 0.0 109.819 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' B' ' 142' ' ' LEU . . . -66.5 -37.74 85.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.132 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 123' ' ' VAL . 4.4 mm? -62.12 -43.06 99.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.982 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.9 t -62.72 -38.87 92.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.709 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.96 -50.27 74.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.391 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.604 HD22 HD21 ' B' ' 138' ' ' LEU . 30.4 tp -57.59 -39.87 77.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.22 -39.49 94.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.51 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.98 -45.41 93.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.417 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.729 HG12 HE22 ' A' ' 140' ' ' GLN . 47.3 t -62.09 -41.13 89.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -68.0 -26.77 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.533 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.0 tt -73.71 -51.83 15.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -63.53 -69.69 0.26 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.308 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 140' ' ' GLN . 83.2 m-85 -54.93 -35.74 64.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.66 -84.74 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.574 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.2 t -61.8 -70.07 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.536 0.207 . . . . 0.0 111.041 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.729 HE22 HG12 ' A' ' 133' ' ' VAL . 3.6 pt20 35.49 64.04 2.15 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.933 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 140' ' ' GLN . 20.7 Cg_exo -65.86 -56.63 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.44 2.094 . . . . 0.0 112.2 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.05 -34.28 32.9 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.273 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 140' ' ' GLN . 2.3 t -57.13 -52.99 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.462 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.03 -59.28 5.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.15 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -51.31 -51.95 49.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.96 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.13 -42.76 81.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -59.19 -60.68 3.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.838 0.351 . . . . 0.0 111.518 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' B' ' 134' ' ' GLU . 6.7 mp -61.58 -34.26 75.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.036 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.89 -44.55 96.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.0 -48.22 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.909 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.492 ' HE2' HD12 ' B' ' 141' ' ' LEU . 82.8 mmm -55.72 -47.76 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.377 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -56.8 -35.88 69.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.444 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.32 -39.63 92.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -66.97 -37.03 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.014 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' A' ' 155' ' ' LYS . 4.0 mmmp? -75.74 -27.55 58.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.469 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -91.76 14.34 15.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.455 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 62.99 93.59 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.315 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.4 m -150.77 -70.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.691 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.0 pt -104.95 166.9 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.103 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -103.67 -170.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.799 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 32.3 m -57.14 -51.03 84.71 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.8 Cg_endo -58.88 -27.86 85.61 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.018 1.812 . . . . 0.0 111.91 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.3 -42.32 50.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.53 -45.07 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.2 mt -64.19 -46.23 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.421 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.4 t -62.5 -57.71 10.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.583 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.6 -56.35 17.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.489 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 75.3 t -57.3 -35.46 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 t -61.74 -40.64 95.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.968 0.413 . . . . 0.0 110.139 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -75.8 -22.79 56.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.222 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 171' ' ' LEU . 2.7 tm? -72.44 -38.26 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -94.0 25.42 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.765 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 173' ' ' LYS . 4.6 ttmp? -53.08 137.8 32.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.99 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.75 88.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.61 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -139.11 85.33 15.9 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.615 0.245 . . . . 0.0 111.181 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.55 2.09 7.75 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.481 2.121 . . . . 0.0 112.36 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -72.59 -63.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 178' ' ' LEU . 3.3 mm? -61.76 -31.75 71.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.594 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.97 -52.06 48.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.3 ttp -61.78 -31.86 72.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.25 -26.65 59.29 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.174 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -80.9 -31.54 35.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 0.0 111.004 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -62.86 -18.98 63.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.3 m -72.52 -37.04 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.946 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -61.58 -45.54 93.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' B' ' 145' ' ' SER . 94.9 mt -58.57 145.75 75.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.77 119.14 6.17 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.351 2.034 . . . . 0.0 112.186 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.27 139.0 80.83 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.362 2.041 . . . . 0.0 112.215 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.604 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 79.4 p -100.3 170.5 8.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 69.9 p -101.42 -19.8 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 63.8 -81.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.11 149.68 44.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.91 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 27.7 t -69.21 177.97 2.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.94 -43.38 68.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.88 -21.82 32.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.514 ' HA ' HD23 ' A' ' 148' ' ' LEU . 7.9 mm-40 -70.87 -61.72 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' MET . . . . . . . . . . . . . 80.0 mtp -60.53 -26.33 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.26 -50.28 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.489 ' O ' HD12 ' B' ' 141' ' ' LEU . . . -56.25 -50.02 72.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 130' ' ' LEU . 4.6 mm? -61.94 -41.24 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.167 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -46.27 59.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.8 -35.45 90.92 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.644 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.572 HD13 HD13 ' B' ' 138' ' ' LEU . 0.2 OUTLIER -58.45 -56.14 25.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.87 0.366 . . . . 0.0 110.756 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.585 ' HG ' HG22 ' A' ' 123' ' ' VAL . 3.2 mm? -69.6 -22.82 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -77.53 -27.13 51.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' MET . . . . . . . . . . . . . 57.6 ttp -83.44 -36.26 24.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.578 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . 0.622 ' HB3' HD23 ' A' ' 186' ' ' LEU . 79.5 p -118.85 94.7 4.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.895 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -138.45 -53.27 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.009 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.88 -41.82 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.419 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 63.49 7.57 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.816 0.341 . . . . 0.0 111.034 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -159.48 -93.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.483 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.578 ' H ' ' CD ' ' B' ' 151' ' ' PRO . 5.1 t -116.13 -26.84 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.578 ' CD ' ' H ' ' B' ' 150' ' ' THR . 79.8 Cg_exo -45.31 -60.44 0.84 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.829 1.686 . . . . 0.0 113.131 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -146.32 -4.74 0.6 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.609 0.242 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' CYS . . . . . . . . . . . . . 43.1 t -51.86 -70.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.015 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . . . . . . . . . 31.4 m -139.09 -8.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.179 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 60.36 99.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.263 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.1 m -136.27 172.26 13.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 51.3 m -123.09 -13.65 7.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.73 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.495 ' HB2' ' HD3' ' B' ' 159' ' ' PRO . 76.4 mt -64.05 -48.76 77.01 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.418 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' B' ' 158' ' ' LEU . 80.8 Cg_endo -78.35 21.06 0.71 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.152 1.901 . . . . 0.0 112.502 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 48.4 t 64.21 117.3 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.315 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 73.6 m -76.19 -61.44 1.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.024 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' SER . . . . . . . . . . . . . 79.4 p -148.38 8.75 0.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' CYS . . . . . . . . . . . . . 17.4 p -130.66 77.09 76.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.13 -27.94 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.774 2.316 . . . . 0.0 112.862 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' B' ' 166' ' ' PRO . 16.1 t70 -58.26 -51.44 81.78 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.524 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' B' ' 165' ' ' ASP . 73.4 Cg_endo -75.02 161.36 38.83 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.961 1.774 . . . . 0.0 112.068 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.587 HG23 ' H ' ' B' ' 168' ' ' SER . 1.4 m -139.67 -59.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.307 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.587 ' H ' HG23 ' B' ' 167' ' ' VAL . 47.4 t -173.8 -15.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.821 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.0 t 60.74 104.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.131 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 43.6 t -85.11 -66.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -121.74 18.67 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 14.5 t70 65.79 139.42 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' PRO . . . . . 0.628 ' HB3' ' H ' ' B' ' 182' ' ' SER . 17.2 Cg_endo -57.35 127.81 27.01 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.574 2.183 . . . . 0.0 112.277 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.34 -82.76 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.742 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.38 -62.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.523 2.149 . . . . 0.0 112.494 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 41.4 t -157.87 164.79 36.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' GLY . . . . . . . . . . . . . . . -155.85 121.48 1.1 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.37 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -92.03 -58.26 2.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -126.87 -18.03 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.157 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' SER . . . . . . . . . . . . . 80.3 p -102.73 178.43 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' CYS . . . . . . . . . . . . . 20.6 p 43.26 -157.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.553 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.628 ' H ' ' HB3' ' B' ' 173' ' ' PRO . 50.3 m -110.63 -50.11 2.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.995 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' GLY . . . . . 0.491 ' H ' ' HB3' ' B' ' 173' ' ' PRO . . . 77.85 137.09 1.01 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.466 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 40.0 p -103.89 14.86 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 111.399 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -90.47 -13.03 35.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.384 -179.853 . . . . . . . . 0 0 . 1 stop_ save_